Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.86455220658245,-2.0951650022574024,0.0,0.0,0.0,19/47,4.25%,RSAD2;SAMD9L;IFI44L;DDX60;GBP4;EPSTI1;GBP2;EIF2AK2;CD74;IFIH1;IL15;ISG15;TAP1;IFI27;PARP14;MX1;HERC6;IRF1;PARP9
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.7727599201208024,-1.9973844356375077,0.0,0.01119049013292733,0.02,24/81,3.61%,RSAD2;SAMD9L;IFI44L;VCAM1;DDX60;GBP4;RNF213;EPSTI1;XAF1;EIF2AK2;ARID5B;PLA2G4A;CD74;IFIH1;IL15;ISG15;TAP1;IFI27;PARP14;MX1;STAT1;HERC6;OAS3;IRF1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.8922160630585351,-1.8736629560404496,0.0,0.08455036989322871,0.24,4/20,3.21%,RSAD2;IFI44L;SLC38A3;MX1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8464145258101511,-1.8443067400370325,0.05263157894736842,0.08057152895707677,0.33,9/23,3.61%,RSAD2;XAF1;GBP2;ISG15;IFI27;MX1;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8464145258101511,-1.8443067400370325,0.05263157894736842,0.08057152895707677,0.33,9/23,3.61%,RSAD2;XAF1;GBP2;ISG15;IFI27;MX1;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.8976396311603846,-1.8187091727016451,0.0,0.08330698210068123,0.4,7/20,4.22%,RSAD2;EIF2AK2;IFIH1;ISG15;MX1;OAS3;FAM111A
prerank,MSigDB_Hallmark_2020__Hypoxia,0.7943393249929012,1.758422660599338,0.0,0.0,0.0,30/73,11.90%,MAFF;ANGPTL4;DDIT4;ADM;SERPINE1;AKAP12;DTNA;ATF3;LDHA;PCK1;KLF6;HSPA5;BNIP3L;BHLHE40;GAPDH;PLIN2;PGK1;NDRG1;ERO1A;P4HA1;MT2A;DUSP1;CDKN1B;FOSL2;SLC2A1;JUN;SLC2A3;ANXA2;CDKN1A;FOS
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.8322450560855181,-1.747253283428145,0.0,0.22061251976342447,0.74,7/25,4.22%,RSAD2;EIF2AK2;IFIH1;ISG15;MX1;OAS3;FAM111A
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.8796664915421746,-1.7401649911898818,0.03571428571428571,0.21168677168120864,0.76,5/11,8.53%,PRIMPOL;FAM111A;ATR;THOC1;SAMHD1
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.7886458839748431,1.7216085108743768,0.0,0.0055727227108258726,0.01,24/67,12.14%,PIK3R3;DDIT4;PNP;PSMC6;LDHA;HSPA5;CANX;BHLHE40;PPA1;CALR;STARD4;CD9;GAPDH;PGK1;PLOD2;ERO1A;INSIG1;P4HA1;SLC2A1;HSP90B1;HSPA9;SLC2A3;CDKN1A;MTHFD2L
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8674988642559726,-1.7203350955293855,0.0,0.2428750821442746,0.84,3/10,3.61%,XAF1;STAT1;IRF1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.9339035906951286,1.7062135661818214,0.0,0.02972118779107132,0.07,3/13,1.67%,NRCAM;RTN4;MAP2
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.9328741918203158,-1.7057397922584516,0.0,0.2581273057328571,0.89,1/10,0.05%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.9698665869196597,-1.6971302232830068,0.0,0.24494739513185376,0.93,1/5,0.19%,DDX60
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.9698665869196597,-1.6971302232830068,0.0,0.24494739513185376,0.93,1/5,0.19%,DDX60
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.8740918709981099,-1.6940767539340635,0.0,0.23873045616911637,0.93,2/11,3.98%,DDX60;BMP6
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.8051684167538403,-1.6903631929243215,0.04,0.22807284651870935,0.94,5/13,8.55%,PRIMPOL;FAM111A;ATR;THOC1;MSH3
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.6981631517944434,-1.678749389602047,0.0,0.24569342780738224,0.94,5/32,3.61%,RSAD2;VCAM1;IL15;HERC5;IRF1
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.7946102581363097,-1.6769559239678955,0.04,0.23779791532470573,0.95,7/16,7.28%,GBP1;GBP4;GBP2;CD74;STAT1;SP100;GCH1
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.840968445482801,-1.6628857823238592,0.04,0.26988829144118853,0.97,6/16,5.55%,SAMD9L;GBP2;IFIH1;IRF1;DDX60L;SP100
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.8128932891405869,1.6511383271257654,0.0,0.10309537015027864,0.28,3/22,1.43%,MTHFD1L;LDHA;SCP2
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.8889628830369053,-1.6198562070206903,0.04878048780487805,0.42026507388104856,1.0,3/5,5.23%,SLC22A5;SLC25A26;SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.7811001091846297,-1.6105636112387762,0.037037037037037035,0.4464416589873113,1.0,3/11,2.15%,RSAD2;CD74;IL15
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.9250714733773421,1.6057860973142968,0.0,0.33213427356522196,0.66,5/10,4.75%,PKM;LDHA;PCK1;GAPDH;PGK1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.8876022747800862,-1.6033502383635911,0.030303030303030304,0.46925455290741935,1.0,3/7,8.34%,ARID5B;PKD2;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.7252551783324701,-1.6027180367583775,0.03333333333333333,0.44975112724717453,1.0,3/12,6.11%,ATM;ATR;PARN
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.9268105824782072,-1.6026491147753625,0.029411764705882353,0.42964699995208866,1.0,3/10,2.15%,RSAD2;IFIH1;IL15
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.9566717587621362,-1.6000410837165495,0.0,0.42588734911691545,1.0,1/6,0.24%,CEMIP
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.7592614343498455,1.597899909273649,0.0,0.3195027687540167,0.71,7/49,8.31%,PIK3R3;PKM;PDK4;PCK1;PIK3R1;INSIG1;GRB2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.8753609641598933,-1.5931630945414061,0.05128205128205128,0.44015927856180825,1.0,2/7,5.87%,GBP1;ZDHHC2
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.8649073375623837,1.5773717620222794,0.0,0.43626457793322543,0.85,3/17,6.14%,PIK3R3;TTC7A;PIK3R1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.7520718885372959,1.5743021900485161,0.0,0.41795420331194044,0.86,12/48,8.29%,NRCAM;DDIT4;WNT2B;SPOCK1;BHLHE40;IL1RAPL1;MAP1B;ELP3;PTPRD;FGFR1;NAV1;CDK6
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.8324887351123037,1.5739747703196654,0.0,0.3752299958622754,0.87,7/15,8.61%,SERPINE1;SPOCK1;TIMP3;GAPDH;VSIR;SERPINB6;PICALM
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.9209046047788798,1.5714925988328179,0.0,0.3566542534928558,0.89,1/10,0.03%,PIK3R3
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.8047806308623262,1.5652748068145044,0.014925373134328358,0.37286581046980377,0.91,7/21,7.20%,NRCAM;DDIT4;SPOCK1;MAP1B;ELP3;FGFR1;NAV1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.8350098993838826,1.5622760622193799,0.030303030303030304,0.37151484738839147,0.92,1/15,0.32%,NRCAM
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.9145252122612278,-1.561279016866096,0.08108108108108109,0.602197575686596,1.0,3/6,4.65%,TAP1;DISP1;ABCG2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.9414156120985339,-1.5605449722411573,0.05263157894736842,0.5836271007788254,1.0,3/5,5.55%,ISG15;MX1;SP100
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.8805994390697833,-1.55845538217397,0.0,0.5539292615799027,1.0,1/5,0.13%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.8805994390697833,-1.55845538217397,0.0,0.5539292615799027,1.0,1/5,0.13%,GBP1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.830284286801546,1.5530283179807651,0.0,0.42609895188930125,0.94,1/18,0.08%,CCDC3
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.6699392965240244,-1.5521964585617296,0.038461538461538464,0.5736734022167344,1.0,7/32,3.61%,GBP1;VCAM1;GBP4;GBP2;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.7018752357080636,-1.5516732140226963,0.034482758620689655,0.5402720505036958,1.0,10/37,3.61%,RSAD2;IFI44L;EIF2AK2;IFIH1;ISG15;IFI27;MX1;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.7018752357080636,-1.5516732140226963,0.034482758620689655,0.5402720505036958,1.0,10/37,3.61%,RSAD2;IFI44L;EIF2AK2;IFIH1;ISG15;IFI27;MX1;STAT1;OAS3;IRF1
prerank,MSigDB_Hallmark_2020__Glycolysis,0.8023722364976136,1.54843767317524,0.0,0.4418373006440513,0.95,9/34,7.92%,PKM;ANGPTL4;DDIT4;LDHA;HSPA5;PGK1;PLOD2;ERO1A;P4HA1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.8522867440225586,1.5463940273482186,0.02857142857142857,0.43318631205486446,0.96,6/15,8.63%,PKM;ADAMTS9;KLF2;GLUL;JAK1;KLF4
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.6546766585425841,1.5462077872634112,0.0,0.4061121675514354,0.96,34/142,18.57%,PIK3R3;CEP57;DDIT4;ERBB4;PDK4;NEDD9;FES;GRIN2B;FGFR1;PIK3R1;HSP90AA1;GRB2;COL4A2;ANKS1B;FLT1;BCAR1;SHC2;GIGYF2;ARPC2;KIF16B;PAK2;RASA1;GRB10;RAC1;FOXC1;SHOC2;CRK;PLAT;SPRED1;SDCBP;PXN;NAMPT;KALRN;STAT3
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.9527928923588859,-1.5457901122384463,0.0,0.5555612080576213,1.0,1/6,0.05%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.9074017723057981,1.5452996337699467,0.0,0.3881237464481078,0.96,5/9,5.52%,PNP;BCL6;PCK1;ZBTB1;VSIR
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.8118428031894523,1.5446473880752105,0.0,0.3708956559760775,0.97,6/27,4.38%,DDIT4;PBX3;WNT2B;SPOCK1;IL1RAPL1;PTPRD
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.8382959386649422,-1.5376063876622388,0.0,0.5803229933580698,1.0,9/22,4.22%,RSAD2;EIF2AK2;UBP1;IFIH1;ISG15;MX1;STAT1;OAS3;FAM111A
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.6888124958179334,1.5303553536529848,0.0,0.48570677942777074,0.99,13/54,11.58%,GRIA2;DTNA;SYN3;GRIK1;GRIK2;KCNMB4;GRM7;GRIN2B;MBP;SNAP25;DNAJC5;SLC12A6;NRXN1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.833859945849186,1.5274575315534562,0.0,0.48594142038401605,0.99,2/15,2.82%,PBX3;NES
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.7386330400700098,1.5274115045835606,0.0125,0.4643935592354893,0.99,13/40,13.39%,CCDC3;ADM;MAP2;DOK5;NES;ANK2;MAP1B;PTPRD;NFASC;GJA1;BOC;SHC2;MAPK10
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.8378883618935691,-1.5213981504672718,0.0,0.6595806537172461,1.0,1/10,0.05%,RSAD2
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.7698102183725797,1.5193922816215348,0.012987012987012988,0.5106640447738617,1.0,6/43,6.14%,PIK3R3;TTC7A;INPP5F;ARF1;MTMR12;PIK3R1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.7227080550298501,1.5191088105645902,0.0,0.4903995985526768,1.0,15/65,12.64%,RFTN1;LRRC7;EHD4;ANK2;KCNIP4;TTC7A;CD81;DPP10;PACS1;ANK3;RAP1A;ATP1B3;MAGI2;NRXN1;MAP7
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.8556019336230505,-1.5177439776039456,0.05405405405405406,0.6663137553434444,1.0,6/8,12.35%,ISG15;OAS3;SAMHD1;STAT2;NLRC5;PTPN2
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.899365395259577,-1.5173228437152395,0.046511627906976744,0.6500845842035746,1.0,3/5,9.75%,PKD2;OFD1;RFX3
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.7475563359742519,1.5166683395149743,0.013157894736842105,0.5006162568558575,1.0,4/33,8.31%,PIK3R3;PDK4;PIK3R1;GRB2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.7176254438301541,-1.512775213785918,0.037037037037037035,0.6601381026162897,1.0,3/14,6.11%,ATM;ATR;PARN
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.958336929628513,1.5097312885188587,0.01639344262295082,0.5496933681958641,1.0,1/5,0.08%,CCDC3
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.9176884385908365,1.5048914355785568,0.030303030303030304,0.5898512653920307,1.0,2/7,1.91%,PDK4;PRKAG2
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.9167354154002063,1.504629713596158,0.0,0.5700688936037429,1.0,1/7,0.85%,AKAP12
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.9466935796248326,1.5032654760496873,0.0,0.5660294067710279,1.0,2/7,2.44%,KLF2;KCNMB4
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.9782892173786697,1.5030195952178325,0.0,0.5492014312944946,1.0,2/6,1.67%,RTN4;MAP2
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.9844216223227397,1.5028149969812663,0.0,0.5331238060023418,1.0,1/5,0.11%,CEP57
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.7203082408759665,1.5022215594231227,0.0,0.5191620383504877,1.0,12/47,15.30%,PIK3R3;CALR;ARF1;GRB2;CDKN1B;SLC2A1;HSP90B1;PIKFYVE;CDKN1A;MAPK10;RAC1;ADCY2
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.8329712721336202,1.498835774156972,0.0,0.5422955787972428,1.0,2/17,1.62%,DIXDC1;WNT2B
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.8542536977523835,-1.4972179031417066,0.030303030303030304,0.7403392682678764,1.0,2/8,7.30%,CEMIP;PKD2
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.9453997785760687,1.49585142940869,0.0,0.5538948633790565,1.0,1/7,0.74%,MTFR1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.8194002384058208,-1.4953963797038927,0.027777777777777776,0.7320684741660324,1.0,1/7,0.82%,EIF2AK2
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.6993887140021482,1.491303235874659,0.028169014084507043,0.5959535228400844,1.0,11/43,11.58%,GRIA2;DTNA;GRIK1;GRIK2;KCNMB4;GRM7;GRIN2B;MBP;SNAP25;SLC12A6;NRXN1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.8076765557824186,1.4902267879376254,0.045454545454545456,0.589753283454258,1.0,4/15,4.75%,ERBB4;PCK1;ANXA1;PGK1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.6829337969848164,-1.48959146659259,0.03571428571428571,0.7508818879194239,1.0,8/26,7.22%,GBP1;VCAM1;GBP2;STAT1;OAS3;IRF1;SP100;TRIM25
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.758857066334371,1.488321315342954,0.0,0.5916373944660135,1.0,5/26,9.03%,PKM;PCK1;PIK3R1;INSIG1;OGT
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.8420763775292465,1.486662427446892,0.0,0.5982393137135233,1.0,5/10,7.44%,SERPINE1;SPOCK1;TIMP3;GAPDH;SERPINB6
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.9427028253957861,1.4862960799586975,0.01694915254237288,0.5877755953944763,1.0,3/8,1.91%,PDK4;PCK1;PRKAG2
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.6718512254534968,1.4861508569630173,0.0,0.5744191101928207,1.0,14/71,9.59%,NRCAM;DDIT4;PBX3;GRIK1;TBX3;SPOCK1;NES;ELP3;GRIN2B;ROBO2;MBP;SEMA6B;SLC2A1;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.8835959342737602,1.486025592082676,0.030303030303030304,0.5614518131157066,1.0,1/8,0.88%,PSMC6
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.7453913962283378,-1.4859048957297945,0.0967741935483871,0.758223941201759,1.0,1/9,1.20%,UBP1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.7597912578372226,1.4854946571831948,0.013333333333333334,0.5542820296279977,1.0,12/28,17.29%,GRIA2;PDK4;SLC8A1;GLUL;ENPP2;VWF;GAS7;NRXN1;TMEM132C;TNS1;PLXDC2;SLC1A2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.9222006326096605,-1.485363591103239,0.030303030303030304,0.7426577658058597,1.0,2/6,0.72%,GBP4;GBP2
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.8728114796299176,-1.484591866197285,0.08333333333333333,0.728856574394228,1.0,1/5,1.06%,CTNNA2
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.8326058004324813,1.4819367541114488,0.015384615384615385,0.5742558069631994,1.0,5/11,7.44%,SERPINE1;SPOCK1;TIMP3;GAPDH;SERPINB6
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.8144932567311096,1.4811079572632468,0.0,0.5681585200990843,1.0,3/17,4.01%,ERBB4;NES;MAP1B
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.8227850621822154,-1.4783620562454323,0.09090909090909091,0.7546798724493871,1.0,1/5,2.95%,ATM
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.7570120063039343,1.4780764070318968,0.02531645569620253,0.5853891902144814,1.0,2/26,0.88%,ST18;PSMC6
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.9743807140709184,1.477812242299183,0.0,0.5763433665818579,1.0,1/5,0.03%,PIK3R3
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.7216041851072642,1.4778062968415917,0.0,0.5638141629605132,1.0,13/49,14.08%,NFKBIZ;AFF3;TRIM5;SLC8A1;ARF1;SCARB2;YBX3;AFF4;CDK6;HIF1A;REST;KIF16B;RASA1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.8248351927991915,1.477440950322838,0.0,0.5549008997162783,1.0,8/16,11.37%,MAFF;SERPINE1;NFKBIZ;BHLHE40;TINAGL1;KLF4;FOSL2;ANXA2
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.7089357606739973,1.477409922283094,0.0,0.5435726610851404,1.0,7/42,8.39%,LAMC1;PLS3;TBX3;NES;PLOD2;MYO1B;COL4A2
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.8812402107847188,-1.4764906308791608,0.05263157894736842,0.7520009369327164,1.0,2/5,1.86%,CD74;IFIH1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.7344919575949624,1.4760582659470711,0.0,0.5449895353117873,1.0,9/40,13.52%,ERBB4;NEDD9;FES;PTPRD;FGFR1;FLT1;BCAR1;SHC2;ACVR2A
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.6830859703704982,1.4759270752272855,0.0,0.5352042891477168,1.0,18/81,11.37%,PIK3R3;LAMC1;SERPINE1;BHLHE40;MGLL;MAP1B;PRKCE;SMAD7;INSIG1;DLC1;DUSP1;ATP2B1;CDKN1B;WDR37;YTHDC1;GJA1;MAGI2;ANXA2
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.8380809365622912,-1.4757523090410003,0.06818181818181818,0.738734529789623,1.0,1/6,0.05%,RSAD2
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.7871897509469008,-1.4743727433519038,0.041666666666666664,0.7314294827309097,1.0,2/10,5.55%,EPSTI1;SP100
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.7895000831571714,1.4740174736237868,0.014705882352941176,0.5404448338773483,1.0,7/18,16.49%,IL1RAPL1;PTPRD;CNTNAP2;NRXN1;CLDN5;RAC1;LIMS1
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.8066349962150606,-1.4739334559683182,0.034482758620689655,0.7182118736702388,1.0,6/13,12.35%,ISG15;OAS3;SAMHD1;STAT2;NLRC5;PTPN2
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.7950642415618109,1.4737783879733313,0.0273972602739726,0.5313376769283591,1.0,4/17,7.38%,MAP2;GPC5;HSP90AA1;KDM1A
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.7136576770064812,1.4727544882710204,0.013888888888888888,0.5309858432013331,1.0,12/37,7.17%,SERPINE1;GRIA2;AKAP12;MAP2;CNTN1;ANK2;MAP1B;LSAMP;PTPRD;NFASC;SNAP25;TTLL7
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.8458539954274754,-1.4717700561273483,0.037037037037037035,0.7181706388709961,1.0,2/6,3.61%,STAT1;IRF1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.9327410969565612,1.4710029523931303,0.01639344262295082,0.5391093229880436,1.0,1/6,0.56%,ADM
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.8665930436131972,1.469484712099244,0.027777777777777776,0.5438977365766051,1.0,4/12,7.38%,CALR;UFL1;CBFB;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.8428976388283965,1.4681921475852295,0.014084507042253521,0.5467239030942382,1.0,7/15,11.90%,DDIT4;MAP3K5;GRIN2B;PRNP;PICALM;REST;FOS
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.7461072471926566,1.467693576754774,0.014705882352941176,0.541238472405825,1.0,2/25,0.64%,LAMC1;RTN4
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.931315842743779,1.467029236522028,0.015151515151515152,0.5369030087602582,1.0,1/5,0.77%,ADAMTS9
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.8610310639261103,1.4666106904164293,0.0,0.5325256041294283,1.0,1/10,0.03%,PIK3R3
prerank,MSigDB_Hallmark_2020__Coagulation,0.7024771866694077,1.4653842332858888,0.0136986301369863,0.535167137662978,1.0,12/30,11.71%,MAFF;SERPINE1;CD9;ANXA1;TIMP3;DUSP6;RAPGEF3;CRIP2;LAMP2;VWF;PECAM1;CFH
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.8416062387688359,1.4649268101204747,0.02666666666666667,0.5302308625185796,1.0,6/11,11.58%,GRIA2;ATRNL1;CTNND2;HS6ST3;SNAP25;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.8535643395140691,-1.4629662042254672,0.07142857142857142,0.7545374480295134,1.0,2/7,10.25%,CAPRIN1;CPEB3
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.7058262199841783,1.4604989034702973,0.0273972602739726,0.5671593597630847,1.0,18/50,14.10%,ADM;CANX;CALR;CD9;HSPH1;CD81;INPP5F;SGIP1;SCARB2;LRP1B;HSP90AA1;GRB2;PICALM;HSP90B1;PIKFYVE;ITGB1;HIP1R;AP1G1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.7697436777827675,-1.4591672331631906,0.0,0.7616847336229099,1.0,3/12,7.30%,SLC22A5;SLC25A29;PKD2
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.9712637486987115,1.4588334656817017,0.0,0.569656099328867,1.0,2/5,0.64%,NRCAM;RTN4
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.8291538755035333,-1.4560625890520262,0.05555555555555555,0.7646834924167009,1.0,1/7,2.84%,HERC5
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.8584940863141762,-1.4548400927536784,0.045454545454545456,0.7581381113955546,1.0,1/7,0.16%,VCAM1
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.8591607370011469,-1.453201415878955,0.030303030303030304,0.7537693106821173,1.0,5/6,13.78%,PLA1A;PLA2G4A;PLAAT3;OSBPL8;MBOAT2
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.6503686216620612,1.45270931835308,0.0,0.6215327298417981,1.0,16/65,13.86%,RTN4;ANK2;CALR;GAPDH;PIK3R1;SMAD7;PINK1;HSP90AA1;RAB21;RPL23;LAMP2;CCNH;ATP1B3;CDKN1A;HIP1R;NAA16
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.9055229201377302,-1.4493594507477692,0.0392156862745098,0.7496296187855009,1.0,2/5,1.83%,PLA2G4A;CD74
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.9055229201377302,-1.4493594507477692,0.0392156862745098,0.7496296187855009,1.0,2/5,1.83%,PLA2G4A;CD74
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.7231141869727986,1.4486950193456825,0.038461538461538464,0.6544948488376109,1.0,5/39,6.14%,PIK3R3;INPP5F;ARF1;MTMR12;PIK3R1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.7447387917785969,1.4482327336094507,0.0,0.6486311494630963,1.0,5/34,8.39%,LAMC1;PLS3;NES;GAPDH;COL4A2
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.8124402136370387,1.4470993297730617,0.045454545454545456,0.6485983835674649,1.0,6/18,12.93%,MTHFD1L;SLC52A3;SLC2A1;SLC2A3;MTHFD2L;BTD
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.7557554149260278,-1.4470001314996457,0.12,0.7523150559539916,1.0,4/10,9.30%,IL15;STAT1;PKD2;STAT2
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.7557746121580888,1.4463580180498066,0.012987012987012988,0.6472553525015109,1.0,9/32,11.87%,RTN4;BCL6;MAP2;HYAL2;ESR2;CDKN1B;GJA1;ADAM15;CDKN1A
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.906910441374277,1.4460101231484257,0.034482758620689655,0.6417515168148171,1.0,1/5,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.8900058680774703,1.4448628126593064,0.043478260869565216,0.6456397312113975,1.0,1/7,0.69%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.8480459735870853,1.440338826589729,0.029850746268656716,0.6828547547068322,1.0,3/9,4.91%,GRIA2;LRRC7;GRIN2B
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.6893330360922019,1.4381844783929068,0.04878048780487805,0.6970547324124696,1.0,6/53,6.14%,PIK3R3;CHPT1;INPP5F;ARF1;MTMR12;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.8215517336019362,1.434881664520314,0.057971014492753624,0.725980725752795,1.0,2/12,11.47%,RTN4;REST
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.7217464129254799,1.4336153527500042,0.012987012987012988,0.730478517500148,1.0,4/30,7.25%,PKM;PCK1;PIK3R1;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.7517367478744336,1.433319083169318,0.046875,0.7248997702242295,1.0,7/22,11.90%,DDIT4;MAP3K5;GRIN2B;PRNP;PICALM;CDKN1B;FOS
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.8997071881303675,1.4319545950867107,0.031746031746031744,0.732226434082989,1.0,1/7,7.38%,KDM1A
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.9393453360929365,1.4307689918598518,0.0,0.7355993978290151,1.0,1/5,0.32%,NRCAM
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.7193404799288847,1.430467496690174,0.039473684210526314,0.7295980041404334,1.0,7/27,16.68%,CEP57;HYAL2;FGFR1;GRB2;KIF16B;SHOC2;SPRED1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.7768759601139879,1.4298827855611334,0.03278688524590164,0.7275577473349121,1.0,7/18,11.58%,RFTN1;IL1RAPL1;PTPRD;PICALM;ANK3;ANXA2;NRXN1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.8157959721866948,1.4295977236605688,0.0,0.7215282729841798,1.0,6/16,8.98%,GRIA2;CADM2;ANK2;MAP1B;CTNND2;LRRC4C
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.7910465873346618,-1.4290258408020475,0.16666666666666666,0.8453321971677978,1.0,1/6,0.16%,VCAM1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.761977619456714,1.4260622933505915,0.015873015873015872,0.7494968050831735,1.0,6/15,13.47%,GPM6B;PICALM;CTNNA1;OTUD7B;COMMD1;NEDD4L
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.7723935164718564,1.4252471677255734,0.0,0.7491914044407856,1.0,8/15,8.50%,GRIA2;MAP2;CADM2;ANK2;CTNND2;HS6ST3;SNAP25;PPFIA2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.737654420479411,1.4244775049296798,0.06578947368421052,0.7480876680002635,1.0,9/24,12.96%,CCDC3;CNTN1;ANK2;GPM6B;PTPRD;NFASC;NRXN1;TMEM132C;SHC2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.8869912259480824,-1.4240802543307474,0.0625,0.8588227003711009,1.0,1/5,0.37%,RNF213
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.6964101376044265,1.4239042068423684,0.0641025641025641,0.7466121593765995,1.0,14/39,13.39%,ERBB4;GRIA2;MAP2;CNTN1;ANK2;PTPRD;NFASC;SNAP25;PPFIA2;PPP1R9A;UNC5C;NRXN1;SHC2;MAPK10
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.8607261642786003,-1.4236097690603247,0.02631578947368421,0.8461253928285607,1.0,3/5,13.65%,RFX3;FOXO1;CLOCK
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.8504641508419499,1.4193555387509331,0.05128205128205128,0.7879174298671217,1.0,4/8,11.08%,PKM;YBX3;CPEB4;CNBP
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.8806810210998617,1.418091658439518,0.014492753623188406,0.7917154195450059,1.0,3/6,10.62%,ANXA1;KLF4;OTUD7B
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.896757114378146,1.4177664945594632,0.03571428571428571,0.7863303907827403,1.0,1/6,0.88%,PSMC6
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.6537954808024743,-1.416881081483501,0.06666666666666667,0.8702899211574958,1.0,4/20,5.23%,SLCO1A2;SLC38A3;ABCG2;SLC25A29
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.7161888581190353,1.4163070089991892,0.029411764705882353,0.7918332360928034,1.0,13/37,8.98%,GRIA2;ATRNL1;CADM2;NES;ANK2;GPM6B;LSAMP;NPAS3;ROBO2;CTNND2;SNAP25;PPFIA2;LRRC4C
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.7979720192036444,-1.4152402914976876,0.0975609756097561,0.8679247884817723,1.0,3/7,12.91%,HLA-F;HLA-C;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.8751130244278574,1.4151709889200423,0.07042253521126761,0.7930798410710169,1.0,5/9,9.83%,ATF3;HSPA5;KLF2;NFE2L2;HIF1A
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.7747547307425801,1.4150749130406586,0.028169014084507043,0.7853823873790594,1.0,3/14,4.91%,GRIA2;LRRC7;GRIN2B
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.8037185953978925,1.4150323034114296,0.02857142857142857,0.7768742891157914,1.0,6/22,13.73%,SCP2;ACOX1;ESR2;ACSL5;CNBP;SMARCC1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.7444527205743539,1.413430747766696,0.11842105263157894,0.7861173406641105,1.0,5/17,7.38%,MAP2;FES;PINK1;HSP90AA1;KDM1A
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.6924961428929848,-1.4129889911672224,0.16666666666666666,0.8685951865081689,1.0,5/11,11.61%,PARP14;PARP9;ZC3HAV1;PARP12;PARP11
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.7759989782256226,1.4129173622610465,0.06153846153846154,0.7828177364970882,1.0,7/15,15.30%,DTNA;CADM2;ANO5;LRP1B;CTNNA3;PIAS2;ADCY2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.8169471906922958,-1.4127925191348418,0.10256410256410256,0.8558393599578379,1.0,3/7,12.91%,TAP1;HLA-F;HLA-A
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.7173670000062627,1.411253482525814,0.03076923076923077,0.7909709192323275,1.0,11/24,11.58%,GRIA2;SPOCK1;CADM2;LSAMP;NFASC;SNAP25;PPFIA2;LRRC4C;NEGR1;PDE10A;NRXN1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.7393832636929561,1.4109881277782936,0.041666666666666664,0.7854606010311413,1.0,6/22,16.68%,CEP57;FGFR1;GRB2;KIF16B;SHOC2;SPRED1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.8468011552123229,1.409919802237957,0.047619047619047616,0.7878436732430076,1.0,2/8,4.01%,MAP2;MAP1B
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.8000474246982886,-1.409109422017282,0.10344827586206896,0.8600035134976869,1.0,1/8,0.19%,DDX60
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.8140034992660615,1.4088645284907002,0.029411764705882353,0.7915564279356584,1.0,3/16,1.91%,PSMC6;PDK4;PRKAG2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.7120751493699436,1.4086481817735181,0.0,0.7862088183661072,1.0,12/50,11.21%,ADAMTS9;AKAP12;DIXDC1;NES;ANK2;MAP1B;NFASC;NAV1;COL4A2;GJA1;PDE10A;MYH10
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.8241614412459562,1.4085080951913709,0.013157894736842105,0.7791679572045629,1.0,3/14,5.15%,AFF3;TBX3;CACNA1C
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.6423443250219867,-1.4082788043747656,0.14285714285714285,0.8534161667030438,1.0,4/24,8.50%,RNF213;UBE3D;NFX1;MDM2
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.6955711712718163,1.4081749170994924,0.025974025974025976,0.775834455801178,1.0,11/49,12.64%,EHD4;ANK2;KCNIP4;TTC7A;CD81;DPP10;PACS1;ANK3;RAP1A;ATP1B3;MAP7
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.7498795374080673,-1.4078951514442306,0.09090909090909091,0.8423488343840324,1.0,1/6,1.41%,STARD3
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.8790736402274895,1.4076283672570198,0.07352941176470588,0.7727876662161105,1.0,1/5,2.44%,KCNMB4
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.8212551642067941,-1.4067626850106891,0.15789473684210525,0.8361051500297958,1.0,3/6,13.68%,MSH3;XPC;MCM9
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.6660507379042246,1.4062055643774938,0.04054054054054054,0.7796348341518157,1.0,12/48,8.98%,GRIA2;ATRNL1;MAP2;CNTN1;CADM2;ANK2;MAP1B;LSAMP;NFASC;SNAP25;PPFIA2;LRRC4C
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.7830403275436382,1.4049513732465562,0.1,0.7845095078347102,1.0,5/14,14.08%,NRCAM;CDK6;UNC5C;ADGRG1;RASA1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.936806985007763,1.4049349960217001,0.015384615384615385,0.7770733149268922,1.0,4/5,4.75%,PKM;LDHA;GAPDH;PGK1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.8320754592595159,-1.4048118362139301,0.027777777777777776,0.8333941830396507,1.0,1/6,1.17%,MLLT3
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.9489960371657209,1.4043250375314393,0.016666666666666666,0.7771029136372611,1.0,3/6,3.80%,RIMKLB;GLUD1;GLUL
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.7816970487311214,1.4042392963907533,0.03896103896103896,0.7707180654783706,1.0,4/15,10.39%,PRKAG2;HSPA5;CPEB4;SIK2
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.8589983629555451,1.4039074833897798,0.08333333333333333,0.7660150058955788,1.0,1/8,0.98%,BCL6
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.86581463669736,1.4038827025417155,0.015151515151515152,0.7590254729282275,1.0,3/9,5.13%,RTN4;CD81;SCARB2
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.9158035165782225,1.4022850992445215,0.014285714285714285,0.7661726838939131,1.0,4/6,4.75%,PKM;LDHA;GAPDH;PGK1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.6450532504249852,-1.401996737040775,0.125,0.8375815424254845,1.0,2/19,0.72%,GBP1;GBP2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.7611088118054885,-1.4016713440874333,0.16666666666666666,0.8269404445646769,1.0,2/7,0.77%,GBP1;HOMER2
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.8676235775563982,1.4015838311412068,0.07936507936507936,0.7673132561651698,1.0,2/6,6.91%,ARF1;PRNP
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.7343063140373383,1.3998741811343751,0.0273972602739726,0.7794783135881306,1.0,10/35,11.87%,RTN4;BCL6;HYAL2;ESR2;MT1M;MT2A;CDKN1B;GJA1;ADAM15;CDKN1A
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.7125930444111424,1.3995547124897587,0.05714285714285714,0.7754045600492,1.0,13/27,16.12%,GRIA2;CNTN1;CADM2;LSAMP;ROBO2;CTNND2;NFASC;SNAP25;LRRC4C;NRXN1;MAPK10;ERO1B;ADGRB3
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.6521640199682293,-1.3993839764146685,0.10714285714285714,0.8279926541872434,1.0,2/14,3.69%,FAXDC2;TNRC6C
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.9523100319072725,1.3980743696356084,0.014285714285714285,0.7826469860248371,1.0,1/5,0.03%,PIK3R3
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.6948042626063777,1.39803051602208,0.02564102564102564,0.7759771957162271,1.0,12/52,12.64%,EHD4;ANK2;KCNIP4;TTC7A;CD81;DPP10;PACS1;CCDC88A;ANK3;RAP1A;ATP1B3;MAP7
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.6915519878737562,-1.3979085313975643,0.06060606060606061,0.8251325783858928,1.0,6/13,12.35%,ISG15;OAS3;SAMHD1;STAT2;NLRC5;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.7084999258217675,1.3978706484785548,0.02666666666666667,0.7705864047613307,1.0,10/35,13.68%,PKM;ANGPTL4;SERPINE1;RAPGEF3;JAK1;KLF4;HIF1A;FLT1;AGO2;ITGB1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.8039620352402266,1.3970554796428027,0.04411764705882353,0.771245606893091,1.0,6/14,11.85%,RTN4;SLC2A13;PRNP;TMED10;PICALM;IFNGR1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.8714231473347148,1.3965921946548419,0.058823529411764705,0.769702555614924,1.0,4/8,8.79%,ANK2;KCNIP4;DPP10;ANK3
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.7642861145793101,1.3963886811856503,0.0625,0.7645964465107701,1.0,2/19,6.96%,CCDC3;PLCL1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.6086199030104442,1.3958047253575965,0.04819277108433735,0.7654766842954598,1.0,29/91,23.03%,ERBB4;PSMC6;LRRC7;MAP3K5;GRIN2B;DUSP6;MBP;NRG2;FGFR1;PIK3R1;JAK1;RPS27A;GRB2;PEBP1;SHC2;KRAS;RASA1;SHOC2;PSMA7;SPRED1;PPP1CB;BCL2L1;TAOK1;ZFP36;YWHAB;SETX;YWHAE;UBC;MEF2C
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.6795743010981083,1.3956587378284968,0.06493506493506493,0.7606766500277317,1.0,4/28,6.35%,CCDC3;PCK1;PRKAG2;SIN3B
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.8739043780874542,1.3954120006375406,0.06153846153846154,0.756692844122885,1.0,2/6,1.86%,MTHFD1L;PCK1
prerank,PanglaoDB_Augmented_2021__T Cells,0.7550602976663741,1.3946502574750697,0.05405405405405406,0.7577075764522916,1.0,3/16,3.75%,MAFF;JUNB;CD81
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.6781952643075262,1.3945430422549177,0.05714285714285714,0.7529065529146696,1.0,8/29,14.45%,ERBB4;NRG2;PIK3R1;HSP90AA1;GRB2;BCAR1;KIF16B;ERBIN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.8402959148280617,1.3944399840749604,0.05333333333333334,0.7481829652405574,1.0,2/9,3.90%,PNP;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.7134572327536484,1.3936906661279826,0.04054054054054054,0.7496872408419829,1.0,7/26,12.43%,SLC8A1;IPO7;PKIG;HYAL2;DUSP1;CDKN1B;STK38
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.7052859676609377,1.3933239238098538,0.04,0.7464794755025324,1.0,12/34,13.39%,GRIA2;CADM2;LSAMP;PTPRD;SGIP1;ROBO2;CACNA1C;NFASC;CPEB4;MAGI2;NRXN1;MAPK10
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.8387122457750668,1.3921313060823537,0.04918032786885246,0.751483851540188,1.0,1/8,1.91%,PRKAG2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.8971108137609273,1.3920744828085787,0.037037037037037035,0.7457870315347437,1.0,1/6,0.53%,DDIT4
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.7950382252992272,1.3915132718497898,0.1076923076923077,0.7445848732077112,1.0,5/8,20.03%,TSG101;HYAL2;ZFYVE28;DUSP22;SH3BP5
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.6324219687509027,1.3914236405024265,0.02564102564102564,0.7394574366288177,1.0,16/63,11.85%,MAFF;PNP;KLF6;NFKBIZ;BHLHE40;CD81;PLIN2;NDRG1;PRNP;SERPINB6;P4HA1;EMP1;AHNAK;MYO1E;SLC2A3;IFNGR1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.8740638953515403,1.390162438064226,0.01639344262295082,0.7438521322252,1.0,3/6,8.61%,PRNP;TMED10;PICALM
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.7163549610167395,1.389533150743229,0.029411764705882353,0.74269195400643,1.0,4/18,4.99%,BCAP31;CANX;CALR;SEC24D
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.9017866429095924,1.3887803462221935,0.037037037037037035,0.7436442306145683,1.0,1/5,0.24%,LAMC1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.8346925318996271,-1.3882339444714935,0.125,0.8546550330854366,1.0,2/8,3.27%,IFIH1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.8346925318996271,-1.3882339444714935,0.125,0.8546550330854366,1.0,2/8,3.27%,IFIH1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.8531725024983867,-1.3869607493528509,0.16666666666666666,0.8514588720439618,1.0,2/5,2.15%,RSAD2;IL15
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.8360217791032396,-1.3826354647888945,0.07894736842105263,0.8645259173689226,1.0,3/6,15.96%,ATG10;SENP6;UBA2
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.8938819065441381,1.382162654638961,0.03333333333333333,0.7970656975797662,1.0,3/6,8.45%,ADM;KCNMB4;ATP2B1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.7623197472992896,1.3814549688989026,0.08450704225352113,0.7975185390604138,1.0,1/14,0.03%,PIK3R3
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.798468857166585,1.3814391898966019,0.07042253521126761,0.7918183357646997,1.0,3/10,12.01%,ADAMTS9;SMAD7;FOXF1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.8830833085900878,1.3808561169222462,0.04411764705882353,0.7915706857859232,1.0,1/6,1.62%,WNT2B
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.7440884827336409,-1.380665327971671,0.06060606060606061,0.8647283871093674,1.0,5/9,13.78%,PLA1A;PLA2G4A;PLAAT3;OSBPL8;MBOAT2
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.8033709017049947,1.3803737717355578,0.0625,0.7909228044509822,1.0,4/12,7.62%,PLS3;NEDD9;EPS8;MYO1B
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.9063807959375009,1.380308992299771,0.04838709677419355,0.785473261514392,1.0,1/6,1.91%,PRKAG2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.7929960081394958,1.379755608642035,0.09090909090909091,0.7840024750887598,1.0,5/13,9.56%,PLS3;NEDD9;EPS8;MYO1B;HSP90B1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.7826206906783699,1.3793273975296407,0.058823529411764705,0.7817620937598281,1.0,2/9,6.32%,SERPINE1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.653935219604405,1.3792678709936779,0.05128205128205128,0.7767276612159554,1.0,12/57,12.88%,RTN4;CHPT1;BCL6;SPOCK1;HYAL2;ESR2;CDKN1B;NRG3;GJA1;ADAM15;CDKN1A;BCAR1
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.8817762255984632,1.378414723455149,0.03076923076923077,0.7800252991600745,1.0,2/7,7.07%,MAFF;CBFB
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.743922851115029,1.3771890628746046,0.06060606060606061,0.786063497932605,1.0,5/15,8.31%,ERBB4;NRG2;PIK3R1;HSP90AA1;GRB2
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.6893891453327136,-1.3765022514882785,0.08695652173913043,0.8768244800356984,1.0,3/14,3.37%,PLA1A;PLA2G4A;GPCPD1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.8702026318412744,1.3764498880166602,0.05970149253731343,0.7876370981770029,1.0,3/6,8.63%,PKM;JAK1;KLF4
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.8621522842673617,-1.3718558976822177,0.037037037037037035,0.8866598348656087,1.0,2/5,7.30%,TTN;PKD2
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.6798692612582291,1.3718482483194203,0.1111111111111111,0.8250683158713153,1.0,6/27,8.29%,ERBB4;FES;CD9;INPP5F;NRG2;CDK6
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.9127515483557171,1.3716472670186846,0.015625,0.821806006294444,1.0,2/5,1.91%,PDK4;PRKAG2
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.777327148351005,1.370962840703251,0.045454545454545456,0.821675371592177,1.0,2/12,4.94%,SCP2;ACOX1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.8142034832767212,1.3698219034910843,0.06557377049180328,0.825136969437855,1.0,2/8,12.54%,TSG101;ZFYVE28
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.7944071832364153,1.3693672503224037,0.02857142857142857,0.8234255077516308,1.0,7/13,14.98%,GRIA2;CTNND2;NFASC;SNAP25;ENPP2;NRXN1;ALCAM
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.8762817373105867,-1.3690329062961806,0.10526315789473684,0.8905419678623403,1.0,1/5,0.16%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.7283169528139265,1.3688294718844773,0.05555555555555555,0.8224010125036009,1.0,4/19,6.06%,SERPINE1;NFKBIZ;CD81;HYAL2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.7845623572119697,1.367234395512328,0.031746031746031744,0.8320221657860681,1.0,4/10,16.04%,TIMP3;PRNP;TMEM59;PLAT
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.9034133131837742,1.3668588997024538,0.03278688524590164,0.8310277213738765,1.0,1/5,1.67%,MAP2
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.8936179444236713,1.3667616972067558,0.08450704225352113,0.826427540713255,1.0,1/5,1.25%,ATF3
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.7847690925485296,1.365931716441347,0.07352941176470588,0.8290773271719007,1.0,2/12,4.94%,SCP2;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.7313980838662192,-1.365930060430671,0.15625,0.8973317413094491,1.0,4/12,3.61%,IFIH1;ISG15;OAS3;IRF1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.6646629375740934,1.365902147069068,0.1,0.8239770644096768,1.0,2/33,0.88%,ST18;PSMC6
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.7459009506615921,1.3654501970786324,0.11428571428571428,0.8226332582554166,1.0,3/10,9.91%,UFL1;CBFB;ZNF366
prerank,PanglaoDB_Augmented_2021__Podocytes,0.6078768776257313,1.3649752326704756,0.023255813953488372,0.8213770030994488,1.0,21/88,18.91%,LAMC1;ADM;PLS3;EHD4;PLOD2;PLSCR4;MYO1B;SRGAP1;COL4A2;GJA1;MYO1E;TRIB2;MAGI2;BCAR1;WWTR1;FOXC1;NAV2;CADPS2;FZD4;PODXL;NFIB
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.8141473803176498,1.3631134454629927,0.04285714285714286,0.8322633552910137,1.0,2/14,2.71%,RTN4;SPOCK1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.8510393628871139,1.3624650469185875,0.0625,0.8320075007263027,1.0,2/6,8.26%,SMAD7;RPL23
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.875685404816672,-1.3612631221702152,0.08333333333333333,0.9138450857949572,1.0,3/5,10.36%,PGM5;TTN;CFLAR
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.850616145646122,1.3610968121888434,0.08064516129032258,0.8393004987087314,1.0,2/6,9.30%,PRKAG2;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.7686500873591615,1.360517614404358,0.09375,0.8397611531893902,1.0,3/15,6.91%,DOCK3;NEDD9;PRNP
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.8470575430071571,-1.3601561819738637,0.08571428571428572,0.9086500361109484,1.0,1/6,0.85%,MVB12B
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.8813207802511923,1.359710969757089,0.11864406779661017,0.8422674644411422,1.0,1/5,1.43%,SCP2
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.8767912819840431,1.3595523382504004,0.10344827586206896,0.8384908878801172,1.0,3/6,3.80%,RIMKLB;GLUD1;GLUL
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.7016669079311952,1.3584284507518403,0.039473684210526314,0.843608896187931,1.0,6/27,9.83%,PSMC6;ATF3;KLF2;NFE2L2;RPS27A;HIF1A
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.636664847322192,1.3581949857059503,0.03529411764705882,0.8404068695350294,1.0,18/70,11.90%,MAFF;SERPINE1;BCL6;ATF3;KLF6;KLF2;BHLHE40;JUNB;NFE2L2;REL;DUSP1;ATP2B1;KLF4;FOSL2;JUN;SLC2A3;CDKN1A;FOS
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.6568898499493655,1.3581856039404157,0.02666666666666667,0.8355747106531727,1.0,11/38,17.05%,ERBB4;FES;INPP5F;NRG2;ENPP2;CDK6;PRAG1;RAC1;CRK;PLXNA2;PRKX
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.7834292116691173,-1.3577295521992805,0.1891891891891892,0.9110375496453778,1.0,3/6,14.71%,RC3H1;ZC3HAV1;PNPT1
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.7105479699641687,1.3574740929036606,0.1111111111111111,0.8368371937423518,1.0,8/23,12.30%,DDIT4;MAP3K5;GRIN2B;PRNP;PICALM;REST;FOS;BTBD10
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.670065239352007,-1.3570574519160332,0.19444444444444445,0.9041742531434229,1.0,2/12,5.87%,GBP1;ZDHHC2
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.884178049637754,1.3543368484671658,0.09859154929577464,0.8600458801405941,1.0,3/5,11.08%,PKM;YBX3;CNBP
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.8656798095049154,1.3540547537538201,0.10294117647058823,0.857150314368676,1.0,3/7,9.83%,NFE2L2;PINK1;HIF1A
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.8054646394920144,-1.3532980791601235,0.17073170731707318,0.9045646190782926,1.0,4/5,19.36%,HIBCH;ACAT1;HIBADH;AUH
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.8054646394920144,-1.3532980791601235,0.17073170731707318,0.9045646190782926,1.0,4/5,19.36%,HIBCH;ACAT1;HIBADH;AUH
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.8740261772802509,1.3527074504782952,0.014492753623188406,0.8637394311563095,1.0,2/7,4.01%,MAP2;MAP1B
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.703318445664938,1.3524418464173662,0.0958904109589041,0.8606616633161539,1.0,12/29,11.58%,GRIA2;CNTN1;ANK2;MAP1B;GPM6B;LSAMP;PTPRD;ROBO2;NFASC;SNAP25;MAGI2;NRXN1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.6819589646522115,-1.351456647813207,0.13513513513513514,0.9030348329739785,1.0,5/11,14.42%,GBP2;GIMAP8;TNFRSF1B;HLA-F;GIMAP4
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.8566723329949026,1.3513992361869323,0.09722222222222222,0.863933081528034,1.0,2/8,5.13%,PDK4;SCARB2
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.8589159585763084,-1.3508522883016563,0.11363636363636363,0.8967312759852433,1.0,1/6,0.16%,VCAM1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.8648866473433168,1.350831578021156,0.058823529411764705,0.86428445445027,1.0,2/6,4.36%,SERPINE1;INPP5F
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.809716107237779,1.3500455020757,0.11428571428571428,0.8662877064303259,1.0,2/8,4.33%,B3GNT2;GPC5
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.8610633299901342,1.349825257283854,0.04918032786885246,0.8634553882058043,1.0,2/6,2.52%,TSG101;TRIM5
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.7969831823672391,-1.3495066687936426,0.14705882352941177,0.8940914680564502,1.0,1/8,0.16%,VCAM1
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.7138339640621278,1.3487680347313746,0.12698412698412698,0.8680853705248076,1.0,6/16,6.67%,RTN4;GRIA2;MAP2;CADM2;GRIN2B;SNAP25
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.8049154807545058,1.3485475221946681,0.08955223880597014,0.8650869322783173,1.0,4/10,11.58%,IL1RAPL1;PTPRD;ROBO2;NRXN1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.6665612865850878,1.3480573350299077,0.04878048780487805,0.8650484538715513,1.0,8/42,8.63%,SERPINE1;BCL6;NFKBIZ;MGLL;ANXA1;UFL1;HYAL2;KLF4
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.822928979135371,1.3477527604138777,0.10144927536231885,0.8621002033647623,1.0,4/8,17.21%,GRB2;ERBIN;SHOC2;TGM2
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.6839157580807744,1.3469548152015494,0.12987012987012986,0.8638643857478029,1.0,8/29,15.25%,LAMC1;PLS3;TBX3;TIMP3;COL4A2;BOC;WWTR1;FOXC1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.6670475405969568,1.3461658056308368,0.056338028169014086,0.8664052847556531,1.0,11/31,18.65%,SPNS2;VAPB;ENPP2;KDSR;SAMD8;NSMAF;SERINC1;PLPP1;PSAP;ESYT2;ST6GALNAC3
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.7459905768736506,1.3460656624836886,0.1,0.8624625826011495,1.0,6/15,10.07%,ITPR1;CACNA1C;RAPGEF3;SNAP25;SLC2A1;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.8912666106146867,1.3460535841486412,0.09836065573770492,0.8578964321024656,1.0,1/5,0.69%,SERPINE1
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.8103812662125105,-1.3441099253950828,0.1282051282051282,0.9127547604074638,1.0,2/5,9.00%,ATG10;UGCG
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.6621181625889658,1.3440416054201465,0.07352941176470588,0.8728389906426511,1.0,8/38,8.31%,RTN4;ERBB4;NRG2;FGFR1;PIK3R1;PINK1;HSP90AA1;GRB2
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.7367860865885988,1.343920464676026,0.1111111111111111,0.8695844298871512,1.0,6/19,18.65%,ADAMTS9;MGAT4A;HIF1A;GOLPH3;FUT8;ST6GALNAC3
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8340610116599594,-1.3438814190360164,0.06976744186046512,0.8943661936734615,1.0,3/5,12.91%,HLA-F;HLA-C;HLA-A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8340610116599594,-1.3438814190360164,0.06976744186046512,0.8943661936734615,1.0,3/5,12.91%,HLA-F;HLA-C;HLA-A
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.804302973539141,1.3438138176666918,0.07246376811594203,0.8612820802433858,1.0,3/13,8.23%,ATG12;PINK1;RB1CC1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.804302973539141,1.3438138176666918,0.07246376811594203,0.8612820802433858,1.0,3/13,8.23%,ATG12;PINK1;RB1CC1
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.5699091480568109,1.3435167385085718,0.03488372093023256,0.8590838566276329,1.0,31/120,21.70%,PKM;PNP;LRRC7;NFASC;SNAP25;TUBB4B;DNAJC5;HSP90AA1;SERPINB6;BRI3;LAMP2;RAP1A;PECAM1;SLC2A3;ANXA2;ANO6;EEF1A1;CD55;RAC1;PSAP;SDCBP;LGALS3;DYNC1H1;KMT2E;CAB39;GSN;HSPA8;CEP290;DNAJC13;ANXA3;B4GALT1
prerank,MSigDB_Hallmark_2020__DNA Repair,0.6929482285520975,1.3432027652906673,0.1,0.8578473360328164,1.0,6/23,10.23%,PNP;TSG101;BCAP31;POLA1;SMAD5;RFC3
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.7308441379644359,1.342639093707779,0.10606060606060606,0.8578491787628392,1.0,9/20,17.29%,SYN3;GLUL;SNAP25;DNAJC5;PPFIA2;SLC38A2;NRXN1;SYT1;SLC1A2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.682166026693755,1.3426015783802658,0.0945945945945946,0.8537295094595427,1.0,3/27,3.43%,PSMC6;SEC22B;CALR
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.6980447143067479,1.3425633257688065,0.11392405063291139,0.8494215373423601,1.0,5/23,9.16%,LAMC1;ATRNL1;LAMA5;PIK3R1;MICALL2
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.6942772220436285,1.3421363051825201,0.05970149253731343,0.84843267003584,1.0,5/18,13.47%,SPOPL;KLF2;SSH1;KLF4;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.742361315925099,1.342024564868425,0.16417910447761194,0.8451676997434069,1.0,4/15,14.08%,SERPINE1;DLC1;ADAM15;RASA1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.6536055900605915,1.3419923036317956,0.043478260869565216,0.8410830777125048,1.0,15/47,17.10%,RTN4;ERBB4;HYAL2;NRG2;FGFR1;PIK3R1;PINK1;HSP90AA1;GRB2;PHLPP1;MAGI2;ITGB1;RAC1;MTDH;DAG1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.7192207643210584,1.3418080867685147,0.07792207792207792,0.8383411688225154,1.0,7/25,11.24%,ITPR1;SLC8A1;ANK2;SMAD7;ATP2B1;ATP1A1;ATP1B3
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.7425098473787594,1.3417957983026725,0.08,0.8341634126437233,1.0,4/17,17.21%,BHLHE40;SPEN;REST;TGM2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.6838766966260315,1.3414594788805698,0.0945945945945946,0.8326599853452085,1.0,3/26,3.43%,PSMC6;SEC22B;CALR
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.7170683559898411,1.3411482927144587,0.07792207792207792,0.8306700472757046,1.0,6/18,16.12%,ADM;S1PR1;GNA13;ADGRG1;ADCY2;ADGRB3
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.6589282817221102,1.3411163838726867,0.06944444444444445,0.8268146103594485,1.0,5/35,7.36%,DDIT4;RAPGEF3;SMAD7;PINK1;HSP90AA1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.8172697861796187,1.340677640812212,0.11267605633802817,0.8266389272632991,1.0,3/10,10.17%,SUN2;MYO1B;MYO1E
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.8902935626420826,1.339888774735941,0.05970149253731343,0.8214465115889571,1.0,2/6,7.84%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.8902935626420826,1.339888774735941,0.05970149253731343,0.8214465115889571,1.0,2/6,7.84%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.8902935626420826,1.339888774735941,0.05970149253731343,0.8214465115889571,1.0,2/6,7.84%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.836340933429114,1.3398768742582758,0.078125,0.8174589071637681,1.0,1/8,0.72%,ERBB4
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.6888356164137133,1.3392031189045723,0.12857142857142856,0.8185172043475837,1.0,5/18,11.37%,SERPINE1;SGIP1;RAB21;MAGI2;ANXA2
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.8180505545781431,1.3391275367258664,0.07017543859649122,0.8151714480749421,1.0,1/6,0.66%,PNP
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.6738153425439467,1.3387264293059835,0.14285714285714285,0.8144707556214694,1.0,5/36,8.23%,PRKAG2;BNIP3L;GAPDH;PINK1;RB1CC1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.853169616473695,1.3385305156406737,0.03076923076923077,0.8120253092917699,1.0,3/5,12.40%,SERPINE1;DUSP1;ANO6
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.7780953752665576,1.3383356679215186,0.09333333333333334,0.8098671526292158,1.0,2/13,3.64%,ERBB4;CCDC60
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.8477922039596859,1.3382657692314646,0.08333333333333333,0.8064150345411137,1.0,3/7,11.87%,IPO7;CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.8549061464562107,1.3372557074376352,0.16393442622950818,0.8112628442126228,1.0,3/5,8.63%,KLF2;NFE2L2;KLF4
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.7772217557210064,1.3371676769269212,0.09859154929577464,0.8080447930697514,1.0,6/12,14.71%,FES;JUNB;MBP;PRNP;MSRA;TXNRD1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.7379822787639723,-1.3370350859776208,0.06896551724137931,0.9187196074745041,1.0,4/10,14.82%,TENT2;PARN;LARP1;CIRBP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.7564526788004143,1.3367344880454557,0.03389830508474576,0.8067228914034625,1.0,2/11,3.43%,SERPINE1;CALR
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.6138787230641332,1.3364776101312028,0.08433734939759036,0.8055680274204956,1.0,10/57,16.02%,PSMC6;LDHA;CANX;PGK1;CNBP;DDX18;RPL34;SMARCC1;SRSF7;PSMA7
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.5703498561878511,1.3362822248442676,0.03488372093023256,0.7996090201588684,1.0,30/118,21.70%,PKM;PNP;LRRC7;NFASC;SNAP25;TUBB4B;DNAJC5;HSP90AA1;SERPINB6;BRI3;LAMP2;RAP1A;PECAM1;SLC2A3;ANXA2;ANO6;EEF1A1;CD55;RAC1;PSAP;SDCBP;LGALS3;DYNC1H1;CAB39;GSN;HSPA8;CEP290;DNAJC13;ANXA3;B4GALT1
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.5703498561878511,1.3362822248442676,0.03488372093023256,0.7996090201588684,1.0,30/118,21.70%,PKM;PNP;LRRC7;NFASC;SNAP25;TUBB4B;DNAJC5;HSP90AA1;SERPINB6;BRI3;LAMP2;RAP1A;PECAM1;SLC2A3;ANXA2;ANO6;EEF1A1;CD55;RAC1;PSAP;SDCBP;LGALS3;DYNC1H1;CAB39;GSN;HSPA8;CEP290;DNAJC13;ANXA3;B4GALT1
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.784758456090524,1.335920428636792,0.14492753623188406,0.7990113841092803,1.0,4/9,14.74%,PDK4;PRKAG2;NOS1AP;RAC1
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.7627911137601137,-1.3353939911959973,0.1935483870967742,0.9171539204778357,1.0,4/10,9.93%,COL8A1;RTF1;LAMA3;FN1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.7335017999365276,-1.335369345025901,0.16666666666666666,0.9079294571766812,1.0,1/8,1.01%,CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.6925823458591746,1.33530346665408,0.1044776119402985,0.7995843867724067,1.0,5/21,11.87%,MAP2;NES;KDM1A;ADAM15;CDKN1A
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.7814032918730242,1.335068096163462,0.13432835820895522,0.7978323374232154,1.0,4/11,11.87%,TBX3;CALR;SMC6;CDKN1A
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.7033605347438093,1.3347069402742886,0.017241379310344827,0.7965479146843539,1.0,6/18,16.12%,GRIA2;DPP10;SNAP25;MTUS2;BTBD10;ADGRB3
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.8495721150856479,1.334692674599689,0.08064516129032258,0.7930759100931386,1.0,1/6,7.30%,ACSL5
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.6884027343787833,1.3328868381203471,0.08196721311475409,0.8013276719450952,1.0,7/21,14.74%,SERPINE1;ARF1;SGIP1;RAB21;PICALM;HIP1R;RAC1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.8197312616927599,1.3318872235805874,0.10909090909090909,0.8055927950769881,1.0,2/8,4.20%,HSPA5;VAPB
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.8275750347806657,-1.3315997609220203,0.17777777777777778,0.9183053229489956,1.0,3/5,13.65%,ATM;ATR;CLOCK
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.7864551118008171,1.3310684121819039,0.0967741935483871,0.8086365866319631,1.0,3/13,16.04%,SPOPL;OGT;PLAT
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.6683985895130278,1.3310160269844906,0.057971014492753624,0.8053198053124754,1.0,9/26,20.61%,CEP57;TUBB4B;HSP90AA1;CEP70;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.5866947759131014,1.3306964982366056,0.033707865168539325,0.8046229457911741,1.0,26/106,15.75%,NRCAM;ZEB2;ERBB4;GRIK1;RAPGEF5;TBX3;SPOCK1;NES;GPM6B;ELP3;LSAMP;ROBO2;MBP;NFASC;NAV1;NAV3;SEMA6B;SLC2A1;NRXN1;BTD;TRAK1;PRX;ECT2;WWTR1;FEZ2;NAV2
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.8137365287452755,-1.3305028906537035,0.16666666666666666,0.9149073448072101,1.0,4/6,11.61%,PARP14;PARP9;PARP12;PARP11
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.6998750002236565,1.330465658440285,0.07894736842105263,0.8025207404262691,1.0,6/22,9.54%,GRIA2;LRRC7;ANK2;GRIN2B;ANK3;AHNAK
prerank,MSigDB_Hallmark_2020__E2F Targets,0.660625742789043,1.3301690166054858,0.09090909090909091,0.8008244827748553,1.0,8/36,11.87%,PPM1D;LBR;IPO7;CDKN1B;SMC6;RAD21;RFC3;CDKN1A
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.8098465327831482,1.328789148524196,0.18032786885245902,0.8069591977364736,1.0,2/7,3.96%,GRIK2;SLC4A10
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.5741825598584787,1.3286854899813656,0.1038961038961039,0.804249576740827,1.0,25/72,23.56%,CEP57;NES;EPS8;TUBB4B;HSP90AA1;CDK6;CDKN1B;CCNH;CDKN1A;CEP70;CRLF3;ENSA;PPP1CB;ALMS1;CSNK1D;DYNC1H1;CHMP4B;PAFAH1B1;CEP290;DNM2;ARPP19;YWHAE;PLCB1;MAX;CCNY
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.6049021429431393,1.3280786912777152,0.04878048780487805,0.8050551349630851,1.0,13/72,13.68%,LAMC1;PLS3;NES;CD9;SMAD5;MYO1B;COL4A2;KLF4;CTNNA1;GJA1;PECAM1;ANO6;ITGB1
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.6171162826868895,1.3276639377583221,0.08571428571428572,0.8051869865513793,1.0,18/47,22.39%,CEP57;NES;TUBB4B;HSP90AA1;CCNH;CDKN1A;CEP70;ENSA;PPP1CB;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290;DNM2;ARPP19;YWHAE;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.8996860384500526,1.327632599825755,0.07936507936507936,0.8020926509403162,1.0,2/5,2.42%,ADAMTS9;KLF2
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.8964668782558303,1.3260786709341261,0.017241379310344827,0.8107367014978623,1.0,1/5,4.94%,ACOX1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.6968225324901522,1.325912878740785,0.056338028169014086,0.808538578626407,1.0,5/22,15.19%,SPNS2;VAPB;KDSR;SAMD8;PLPP1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6974572387506348,1.3244947115689802,0.056338028169014086,0.8159121663085646,1.0,5/22,15.19%,SPNS2;VAPB;KDSR;SAMD8;PLPP1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.7813932638243073,1.3231042685918255,0.0967741935483871,0.8229442483509971,1.0,6/14,15.64%,PDK4;ARF1;PINK1;SSH1;KIF16B;NCOR2
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.7154596558019688,1.3229844925359975,0.10810810810810811,0.8202583436776448,1.0,9/25,16.97%,ADM;AKAP12;S1PR1;GNA13;ADGRG1;ADCY2;ADGRB3;PSAP;GRK5
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.6162459505582578,1.3226583817746096,0.08823529411764706,0.8196295817756593,1.0,18/48,22.39%,CEP57;NES;TUBB4B;HSP90AA1;CCNH;CDKN1A;CEP70;ENSA;PPP1CB;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290;DNM2;ARPP19;YWHAE;PLCB1
prerank,PanglaoDB_Augmented_2021__Pericytes,0.6352829498846319,1.3223827462052433,0.07692307692307693,0.8180388495015631,1.0,10/35,15.25%,ADM;TIMP3;PDE5A;PLSCR4;ALPL;MYO1B;COL4A2;PECAM1;TNS1;FOXC1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.7721814185884083,1.3220731059639177,0.171875,0.8171492001322942,1.0,1/8,0.69%,SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.8689655967435244,1.3218016246502717,0.06896551724137931,0.8162211649159632,1.0,2/6,8.82%,IPO7;CDKN1B
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.7816309846462834,1.3209481166445207,0.11428571428571428,0.81939495075425,1.0,2/8,8.23%,UFL1;RB1CC1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.9154341278354529,1.3206257259789702,0.04838709677419355,0.8115951567322938,1.0,3/6,4.75%,PKM;GAPDH;PGK1
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.9154341278354529,1.3206257259789702,0.04838709677419355,0.8115951567322938,1.0,3/6,4.75%,PKM;GAPDH;PGK1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.9154341278354529,1.3206257259789702,0.04838709677419355,0.8115951567322938,1.0,3/6,4.75%,PKM;GAPDH;PGK1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.7657725129567544,1.320494571184172,0.041666666666666664,0.8093652374068547,1.0,4/17,8.61%,CANX;INPP5F;SGIP1;PICALM
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.845005762589974,1.3204198735493553,0.1,0.8067073396191532,1.0,3/7,5.15%,SLC8A1;GRIN2B;CACNA1C
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.8890426399666743,1.3201907833768387,0.03333333333333333,0.8057135744058602,1.0,3/7,4.75%,PCK1;GAPDH;PGK1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.7825302022688818,1.3200997272723547,0.15384615384615385,0.8030470338132172,1.0,2/8,3.43%,SERPINE1;CALR
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.834037804898904,1.320079834604373,0.1,0.799961041153257,1.0,1/6,2.39%,FES
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.8924215529026394,1.3194359172280858,0.08823529411764706,0.8016822356440054,1.0,2/5,2.55%,ERBB4;TBX3
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.8181202134183593,1.3186213177611452,0.12,0.8040892526357927,1.0,5/9,13.63%,PPM1D;DUSP6;DUSP1;PPM1A;DUSP16
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.7046327928236289,1.318394641250338,0.13432835820895522,0.8024285334627472,1.0,4/16,11.63%,EHD4;RAB11FIP3;MICALL2;ACAP2
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.8517300076282461,1.3177803355531104,0.12857142857142856,0.802905745278056,1.0,2/6,8.23%,ATG12;RB1CC1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.839388973777192,1.317029927497174,0.11290322580645161,0.8045024421993041,1.0,2/5,14.32%,HIF1A;GRB10
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.6825374240088597,1.3170022259769103,0.12162162162162163,0.801439287771591,1.0,14/29,22.66%,ANGPTL4;SERPINE1;RAPGEF3;HIF1A;FLT1;AGO2;ITGB1;MTDH;GATA2;BTG1;VEGFC;ANXA3;CDH5;ETS1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.8330829462699539,-1.3165641648005175,0.16666666666666666,0.9770043918721087,1.0,3/5,12.91%,HLA-F;SERPINB9;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.8098111018761516,1.3160836335141133,0.1206896551724138,0.804401089758827,1.0,2/8,5.29%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.8539651502684957,-1.3156309771664108,0.07692307692307693,0.9731663861473105,1.0,1/5,0.37%,RNF213
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.8522431085559112,1.3150438592451927,0.1267605633802817,0.8084077673459354,1.0,4/8,5.15%,CLIC2;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.6553421433144458,1.3141736411380516,0.10294117647058823,0.8115330622475203,1.0,12/34,16.63%,SYN3;GRIK1;GRIK2;KCNMB4;GRM7;BCR;NRG3;LRRC4C;ITGB1;DLGAP2;DGKI;SYT1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.8659419940132211,1.3132238593464798,0.01639344262295082,0.8154821530374317,1.0,3/8,4.75%,PCK1;GAPDH;PGK1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.6424170305265482,1.3124893923038023,0.04,0.8176281874285203,1.0,12/40,11.13%,GRIA2;ATRNL1;MAP2;CADM2;ANK2;MAP1B;GPM6B;INSYN2A;SNAP25;PPFIA2;CNTNAP2;PREPL
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.8166902571592354,1.3119999999025609,0.08064516129032258,0.8184962767953381,1.0,4/8,8.63%,KLF2;SMAD7;NFE2L2;KLF4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.7368208739151384,-1.311619039582719,0.08,0.9641754992094631,1.0,1/8,0.13%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.7368208739151384,-1.311619039582719,0.08,0.9641754992094631,1.0,1/8,0.13%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.7368208739151384,-1.311619039582719,0.08,0.9641754992094631,1.0,1/8,0.13%,GBP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.7479384819715884,1.311414774865788,0.11594202898550725,0.8192740388329194,1.0,1/13,0.53%,DDIT4
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.8319445097793845,-1.311309914884062,0.125,0.9560586363725088,1.0,4/6,13.65%,ATM;ATR;STK33;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.8445551766742588,1.311251916394232,0.10344827586206896,0.8174161507370203,1.0,3/7,8.61%,RTN4;PRNP;PICALM
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.5578282603474582,1.3111375875914069,0.10714285714285714,0.8154473650289082,1.0,22/101,14.40%,LAMC1;ERBB4;TBX3;NES;CALR;CD81;ZFPM2;UFL1;FGFR1;RPS9;KDM1A;RPL23;CDK6;GJA1;CNBP;CDKN1A;FLT1;CNOT6L;CLDN5;KRAS;S100A6;WWTR1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.8075482416965268,1.3109555924086576,0.13333333333333333,0.8134932171327521,1.0,4/8,11.55%,ARF1;PRNP;MT2A;COMMD1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.8330379540313149,1.3092434282358718,0.15789473684210525,0.8222861955529732,1.0,2/7,5.29%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.6567786985181358,1.3090687511113859,0.1323529411764706,0.8206913778194117,1.0,7/25,11.87%,STARD4;INPP5F;GRB2;KLF4;MAGI2;ANXA2;CDKN1A
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.7894322575965729,1.308085318617029,0.171875,0.8180919646724812,1.0,3/6,13.78%,CD81;CFH;CD55
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.7894322575965729,1.308085318617029,0.171875,0.8180919646724812,1.0,3/6,13.78%,CD81;CFH;CD55
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.7894322575965729,1.308085318617029,0.171875,0.8180919646724812,1.0,3/6,13.78%,CD81;CFH;CD55
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.7313852186705279,-1.3076547354056731,0.21212121212121213,0.9656196517217795,1.0,3/5,20.35%,BICD1;CCDC68;NIN
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.7032789069129122,1.3067559390522665,0.109375,0.8253708945888645,1.0,6/13,6.37%,GRIA2;GRIK1;GRIK2;GRM7;GRIN2B;CPEB4
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.8321245372072008,1.306354872506011,0.06153846153846154,0.8252071637371501,1.0,1/5,1.91%,PRKAG2
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.6291497329617819,-1.305185833479612,0.16,0.970051646226903,1.0,7/14,13.73%,CTNNA2;SRGAP2;SRGAP2C;SEMA6A;NTNG1;RAPGEF2;ULK4
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.8718346756873456,1.304721482448794,0.125,0.8335344669853341,1.0,2/5,4.78%,ADM;PRKCE
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.6913498184413001,1.3042632009430726,0.08620689655172414,0.8337434639880205,1.0,5/18,13.28%,PSMC6;UFL1;PINK1;COMMD1;TMF1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.6375885045864907,1.3041853593427983,0.10810810810810811,0.8312345101567366,1.0,13/41,23.48%,RTN4;CALR;PRKCE;ENPP2;HIF1A;BCAR1;RAC1;ATOH8;ANXA3;SPARC;ETS1;SCARB1;ADAM9
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.6429045329333553,1.3039794559142226,0.17142857142857143,0.8299774374530733,1.0,8/38,10.78%,ADAMTS9;NES;ANK2;MAP1B;TIMP3;COL4A2;GJA1;BOC
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.8318279500405636,1.303514253617889,0.06382978723404255,0.8310297952827309,1.0,1/5,6.11%,FGFR1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.8751569785221466,1.3033410805323038,0.04838709677419355,0.8289523839493749,1.0,2/5,3.43%,KLF2;CALR
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.7301761382460219,1.3032982732995249,0.12987012987012986,0.8262595227782813,1.0,6/19,14.16%,ANK2;SYTL4;PLSCR4;ANK3;ANO6;DYSF
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.7836111657386591,1.3030549429654363,0.13636363636363635,0.8249199393067594,1.0,3/9,13.71%,SGIP1;PICALM;HIP1R
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.850657394178436,1.3029366944264145,0.11666666666666667,0.8228467267262257,1.0,2/6,6.91%,RTN4;PRNP
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.8092124927496548,-1.301634423467369,0.21428571428571427,0.9792369637307272,1.0,2/5,12.91%,TAP1;HLA-A
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.7540506800772259,1.3016176538065494,0.14666666666666667,0.8302967138241679,1.0,1/9,1.06%,PDK4
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.6785102415058064,-1.3016036923132206,0.21212121212121213,0.9703900251048543,1.0,2/8,9.54%,CLCN3;ATP6V1H
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.6636595100149569,1.301490877929871,0.11538461538461539,0.828025042789054,1.0,10/30,16.68%,SERPINE1;ADAMTS9;KLF2;PGK1;COL4A2;KLF4;CLDN5;FOXC1;ATF2;SPRED1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.7849176491403883,1.3013461146377907,0.15873015873015872,0.8260400434901267,1.0,5/11,12.88%,DDIT4;GRB2;RAP1A;MAGI2;BCAR1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.6326951192620992,1.3013312268176351,0.1111111111111111,0.8232589045536325,1.0,16/38,25.95%,FES;INPP5F;RAB21;PICALM;STXBP5L;HIP1R;SYT1;ABL2;RIMS2;PTPN1;DNAJC13;RUFY2;RAB8B;SCARB1;FGR;MAP2K1
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.7889518862439884,1.300818295341073,0.16417910447761194,0.8236484166600639,1.0,5/9,17.21%,IL1RAPL1;PTPRD;SPEN;NRXN1;TGM2
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.7075577688535493,1.3006068939884765,0.1,0.8222734287197295,1.0,7/16,13.78%,PCK1;TMEM45B;TTC7A;PLIN2;ACSL5;SLC26A2;CD55
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.8345300254967352,1.300584958355742,0.09859154929577464,0.816736718936125,1.0,2/6,6.19%,GRIN2B;INSYN2A
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.8345300254967352,1.300584958355742,0.09859154929577464,0.816736718936125,1.0,2/6,6.19%,GRIN2B;INSYN2A
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.8366808241161701,1.3004268102332839,0.11267605633802817,0.8154750900175194,1.0,3/7,8.63%,ANGPTL4;TMEM45B;KLF4
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.6900392627214533,1.3003346019550808,0.09876543209876543,0.8133908287550523,1.0,6/21,9.83%,BNIP3L;PGK1;NDRG1;CPEB4;PINK1;HIF1A
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.8005950962551523,-1.2993791963603536,0.23809523809523808,0.9724875031275454,1.0,1/5,1.83%,CD74
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.6223954060033949,1.2992389482496427,0.05194805194805195,0.8189266637685939,1.0,14/39,22.28%,CEP57;PSMC6;TUBB4B;HSP90AA1;CEP70;BRD4;PSMA7;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290;AVEN;YWHAE
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.6943744723428518,1.298731342919574,0.10294117647058823,0.819471689133364,1.0,6/25,8.61%,MAP2;TRIM5;UFL1;HSP90AA1;KDM1A;PICALM
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.821172916698039,1.2983860398362177,0.12857142857142856,0.8186292261379644,1.0,4/10,5.15%,CLIC2;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.7431357131027568,-1.2983717697848547,0.18421052631578946,0.9685654853190134,1.0,1/6,0.35%,SLCO1A2
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.7210719568541187,-1.2980163563739997,0.2,0.9613163904667096,1.0,2/10,3.61%,HABP4;IRF1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.8664243674767278,1.2978564561755923,0.12903225806451613,0.8199543911039245,1.0,2/5,12.54%,TSG101;ZFYVE28
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.8627804098879829,1.2978280917408909,0.07692307692307693,0.8174441187086777,1.0,1/5,4.70%,GAPDH
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.8355826982092904,1.2976191514226354,0.058823529411764705,0.8160613676006073,1.0,4/10,5.15%,CLIC2;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.8399789064658683,1.2971384946953322,0.13333333333333333,0.816274708066534,1.0,1/7,1.43%,SCP2
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.7364051010050829,1.296718034809959,0.09859154929577464,0.8162659384550291,1.0,11/18,22.92%,ITPR1;SLC8A1;ANK2;ATP2B1;ATP1A1;ATP1B3;RYR3;ATP2B4;AHCYL1;ATP1B1;TMEM65
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.887381753414689,1.296200241868735,0.11764705882352941,0.8167338409807103,1.0,1/5,0.40%,ANGPTL4
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.7265961422040496,1.2961556013517619,0.1076923076923077,0.8142752797726749,1.0,8/21,8.71%,ADM;PCK1;LSAMP;PTPRD;SGIP1;NFASC;ENPP2;ITGA1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.8077435453886055,1.29590046670008,0.18181818181818182,0.8134718236835623,1.0,3/7,13.57%,KCNMB4;ANK2;NOS1AP
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.7737386768716046,1.2953912070748095,0.11594202898550725,0.8141257771353106,1.0,3/8,18.88%,NUDCD3;CCDC14;CSNK1D
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.8717286460465441,1.2952605363583323,0.11666666666666667,0.8124233609139717,1.0,1/5,1.01%,RFTN1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.8396956811438553,1.292049580189444,0.23880597014925373,0.830678343238316,1.0,3/6,7.54%,RTN4;MAP2;SEMA6B
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.7506840202707233,1.2918971214363357,0.1746031746031746,0.8290773271719007,1.0,4/11,11.10%,SLC8A1;CACNA1C;ATP2B1;MICU2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.8487556963272438,1.2918875794034272,0.125,0.8264831585663425,1.0,1/6,1.43%,SCP2
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.7112514345197555,1.2916946401151002,0.18840579710144928,0.8254059676688629,1.0,4/12,7.30%,SCP2;MGLL;ACOX1;ACSL5
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.8485069812424394,1.2912156676710815,0.18333333333333332,0.8257599978533673,1.0,1/5,2.92%,ANK2
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.8661700835069075,1.291147388039895,0.09523809523809523,0.8240175651708447,1.0,3/5,9.56%,HSPA5;CALR;HSP90B1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.6825815790221742,1.2909245985548463,0.07462686567164178,0.8233830489119294,1.0,10/22,20.61%,CEP57;TUBB4B;HSP90AA1;CEP70;ALMS1;CSNK1D;DYNC1H1;NPM1;PAFAH1B1;CEP290
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.8424014892577151,1.2903932041806119,0.10344827586206896,0.8241280940579578,1.0,1/6,1.94%,DOK5
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.8689842967351752,1.2901613828985992,0.09090909090909091,0.8227940497081834,1.0,3/6,8.02%,ARF1;PRNP;MT2A
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.6441105783930938,1.289873295664761,0.15789473684210525,0.8221693669846121,1.0,10/31,17.98%,MYO9B;EPS8;BCR;DLC1;GRB2;OGT;DENND3;ERBIN;SHOC2;ARHGEF2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.7659222278896377,1.2897787645903234,0.16071428571428573,0.8175880807120407,1.0,1/8,0.61%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.7659222278896377,1.2897787645903234,0.16071428571428573,0.8175880807120407,1.0,1/8,0.61%,ZEB2
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.7890535802607515,1.289658507493035,0.125,0.8158743816759275,1.0,5/10,8.98%,GRIK1;GRIK2;BCR;NRG3;LRRC4C
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.6625722488932843,1.2895056478810198,0.09722222222222222,0.8144482322095203,1.0,5/32,6.75%,ST18;GRIA2;GPM6B;MBP;ENPP2
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.6212834837767568,1.289021900258287,0.09210526315789473,0.8149632506766902,1.0,6/40,9.59%,PBX3;MAP2;GPM6B;PPP1R9A;MICALL2;CNTNAP2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.8412400843207969,1.2889696460699844,0.11290322580645161,0.8103253226714124,1.0,2/5,13.25%,CCNH;TAF1D
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.8412400843207969,1.2889696460699844,0.11290322580645161,0.8103253226714124,1.0,2/5,13.25%,CCNH;TAF1D
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.6294455700179744,1.288915511659557,0.1038961038961039,0.8081815470013054,1.0,13/48,12.64%,ANGPTL4;AKAP12;DUSP6;SNAP25;ERO1A;KLF4;TOR1AIP2;PTBP2;EMP1;PECAM1;TRIB2;CFH;MAP7
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.7912942559201368,1.2882866066822785,0.171875,0.8101750387543178,1.0,2/7,7.36%,MAP2;HSP90AA1
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.6947129851958262,-1.2867182169691807,0.1794871794871795,1.0,1.0,1/14,0.16%,VCAM1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.6502953583764571,1.2866801148645715,0.1111111111111111,0.818374718094697,1.0,9/32,17.50%,LAMC1;ATRNL1;LAMA5;PIK3R1;MICALL2;RAC1;PARVB;ACTN1;PXN
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.746229963047917,-1.2866459502729644,0.17647058823529413,0.995037441351813,1.0,5/6,22.52%,GIMAP8;GIMAP4;RORA;CYLD;GIMAP7
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.7958327486339984,1.285236575700448,0.125,0.825982523619188,1.0,4/9,8.61%,GRIN2B;MBP;VSIR;PICALM
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.6862560033416155,1.2846400086501824,0.140625,0.8272622429028419,1.0,5/18,13.47%,SERPINE1;SGIP1;RAB21;ANO6;NEDD4L
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.6046691561266646,1.2844757159895792,0.1038961038961039,0.8258404664997905,1.0,12/51,11.90%,DDIT4;ATF3;PPM1D;CD81;UPP1;NDRG1;KLF4;JAG2;JUN;PITPNC1;CDKN1A;FOS
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.6608970301688976,1.2840341508529876,0.09876543209876543,0.8261057859518257,1.0,6/27,11.55%,POLA1;RPS27A;RFC3;USP45;CCNH;COMMD1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.9046728146790624,-1.2832011291105858,0.08333333333333333,1.0,1.0,2/5,2.97%,RNF213;ZNRF3
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.8122442531496029,1.2818505583889126,0.11594202898550725,0.8381508836306397,1.0,3/8,14.16%,CRTC3;IFNGR1;DYSF
prerank,PanglaoDB_Augmented_2021__Keratinocytes,0.8505603121788425,1.2818118757836838,0.09375,0.8360418850121641,1.0,2/5,6.72%,LAMA5;REL
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.8329165924759862,1.281025468059478,0.21621621621621623,0.8387363554622104,1.0,3/5,10.57%,SLC8A1;ANK3;SLC12A6
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.889640584118742,1.280954852613304,0.03571428571428571,0.8366713388997676,1.0,3/6,4.75%,PCK1;GAPDH;PGK1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.6954102783009236,-1.2806385101320477,0.18421052631578946,1.0,1.0,1/13,0.16%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.8393633570286669,1.2801201185366415,0.061224489795918366,0.8393810231499146,1.0,2/6,3.67%,PNP;HSPH1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.6763435717288827,1.2790879783906457,0.19696969696969696,0.8427671422679742,1.0,10/17,21.91%,MGAT4A;MCFD2;UBE2J1;TMEM165;MGAT5;FUT8;MGAT1;PMM2;B4GALT1;UGGT2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.8237246654141512,1.2789145527392791,0.17543859649122806,0.8412345486837852,1.0,1/5,0.69%,SERPINE1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.6234943776317811,1.2787909501474883,0.136986301369863,0.8371831056603747,1.0,13/45,21.22%,PSMC6;PIK3R1;GRB2;JUN;FOS;TAB2;MAPK10;PAK2;RAC1;PSMA7;MALT1;TEC;PPP3CB
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.6234943776317811,1.2787909501474883,0.136986301369863,0.8371831056603747,1.0,13/45,21.22%,PSMC6;PIK3R1;GRB2;JUN;FOS;TAB2;MAPK10;PAK2;RAC1;PSMA7;MALT1;TEC;PPP3CB
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7729401145084402,-1.278463883360089,0.18181818181818182,1.0,1.0,3/5,6.51%,PARP14;PARP9;ZC3HAV1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.8260880573242719,1.2782790390873107,0.1,0.8385481173816404,1.0,1/5,6.11%,FGFR1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.6596344649517202,-1.278241032989056,0.25806451612903225,0.9984193230462621,1.0,1/8,5.87%,ZDHHC2
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.630640744598155,1.2781521833962861,0.16666666666666666,0.8372406610328829,1.0,9/32,20.29%,NEDD9;S1PR1;ANXA1;GRB2;MICALL2;BCAR1;PARVB;PTPN1;GSN
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.8354902279784333,1.2777055823190626,0.13636363636363635,0.8376903819093193,1.0,4/6,13.57%,KCNMB4;ANK2;ANK3;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.7840732588196953,1.2775070463049627,0.16417910447761194,0.8369421870687878,1.0,3/7,14.24%,CD81;HSP90AA1;PTTG1IP
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.8124481742838108,1.27721703360583,0.14285714285714285,0.8361983170539238,1.0,3/8,9.24%,PURA;POLA1;NOC3L
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.8260331887777016,1.2770924008462594,0.1694915254237288,0.8344630318573842,1.0,1/5,0.66%,PNP
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.8289580993300508,1.2768054154991781,0.16129032258064516,0.8315651958005438,1.0,1/6,5.79%,NDUFA12
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.8289580993300508,1.2768054154991781,0.16129032258064516,0.8315651958005438,1.0,1/6,5.79%,NDUFA12
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.7612335198673276,1.276568321548237,0.09230769230769231,0.830558592821488,1.0,4/11,19.50%,PLS3;GJA1;TGM2;SULF2
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.8819134472122199,1.2765607622329647,0.04918032786885246,0.8282240824300354,1.0,2/5,11.47%,CALR;REST
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.7627131970543949,1.276260168913714,0.18840579710144928,0.8279609441215098,1.0,4/11,14.74%,PRKCE;HYAL2;ITGB1;RAC1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.763609250085904,1.2761632042075566,0.136986301369863,0.8262784891915754,1.0,1/8,1.06%,PDK4
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.7202073422462694,1.2755200561633373,0.22077922077922077,0.8279743607305016,1.0,3/17,5.15%,BCAP31;SLC8A1;CACNA1C
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.9175860051046747,1.2743518297668106,0.04477611940298507,0.8326432620496504,1.0,2/5,6.14%,PIK3R3;PIK3R1
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.6659583215776804,1.2743129529152672,0.13157894736842105,0.830554835929773,1.0,10/31,18.17%,SERPINE1;PDK4;UPP1;ACOX1;PINK1;MT2A;BCAR1;LPIN2;ATOH8;TMBIM6
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.7920527165268915,1.2738558405605989,0.08771929824561403,0.8313503253029813,1.0,2/8,7.38%,NES;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.6886862485267112,-1.2736178208547797,0.1891891891891892,1.0,1.0,1/10,0.05%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.8592131878391986,1.2733618735308088,0.10526315789473684,0.8322659007179221,1.0,1/7,0.72%,ERBB4
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.7794466349739239,1.273046699664774,0.1506849315068493,0.8324002302098233,1.0,3/10,2.92%,HSPA5;BCAP31;ANK2
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.8631965408654598,1.273038944246363,0.11864406779661017,0.8301189669187451,1.0,3/5,12.91%,CALR;GJA1;AGO2
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.6371569845754053,1.273013671835907,0.15294117647058825,0.828097332685715,1.0,3/32,8.07%,DIXDC1;WNT2B;RPS27A
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.6973326103751325,1.2729780333866132,0.16216216216216217,0.8259945021327983,1.0,9/20,22.28%,BCAP31;SLC8A1;CACNA1C;ATP2B1;CD55;ABL2;ATP2B4;CAV2;YWHAE
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.6983840626190047,1.2724987679785897,0.1095890410958904,0.8269429243563262,1.0,1/15,0.32%,NRCAM
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.8780876803596682,1.2724786712426464,0.05555555555555555,0.8247935805577831,1.0,3/5,11.58%,IL1RAPL1;PTPRD;NRXN1
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.7749079419341063,1.2722168668693072,0.14492753623188406,0.8238468971949701,1.0,1/8,1.54%,SUN2
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.6073792613912137,1.2721671160704526,0.09876543209876543,0.8219309217918095,1.0,8/58,6.75%,ANGPTL4;BCL6;SCP2;MGLL;PLIN2;ACOX1;DHRS7B;ENPP2
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.6450768125944998,1.2720698103790595,0.125,0.8203898164046327,1.0,11/40,15.27%,RAPGEF5;BCR;CCDC88A;RASSF1;GRB2;JUN;CDKN1A;SHC2;KRAS;RAC1;SHOC2
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.7826991773846576,1.2716903349540343,0.1724137931034483,0.8203108403408628,1.0,1/6,5.15%,CACNA1C
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.6963288488816677,1.2716071110828242,0.14705882352941177,0.8184200247834029,1.0,3/15,9.19%,TSG101;RPL23;LAMP2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.8223936036030921,1.2710595352438985,0.11864406779661017,0.8193408526187227,1.0,2/6,11.37%,RFTN1;ANXA2
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),0.8641754979928291,1.27100867165407,0.11475409836065574,0.8175229279229351,1.0,1/5,2.92%,ANK2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.7351742857764515,1.2703293181249353,0.11290322580645161,0.8175916290274399,1.0,1/14,1.57%,ELL2
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.7351742857764515,1.2703293181249353,0.11290322580645161,0.8175916290274399,1.0,1/14,1.57%,ELL2
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.7065191427243288,1.270166000069992,0.2054794520547945,0.8165379800889246,1.0,4/10,16.52%,PCK1;ADAM15;ADCY2;GOLPH3
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.6667160644348249,1.2700069260221154,0.17105263157894737,0.8153710658602504,1.0,6/20,20.56%,ADM;SMAD7;FLT1;RASA1;EGFL7;RASIP1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.6862461426546527,1.2691333436245429,0.15714285714285714,0.8182416899448797,1.0,5/19,15.19%,MTHFD1L;NSMAF;MTHFD2L;BTD;PLPP1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.7611808373211741,1.2689696321052026,0.16666666666666666,0.8171355741497459,1.0,2/7,5.15%,NES;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.7901230545710839,1.26861969172391,0.14516129032258066,0.8171557524223716,1.0,4/6,19.10%,FGFR1;GNA13;FLT1;ABL2
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.6534509110420537,1.2685455444869607,0.13580246913580246,0.8157348563356142,1.0,11/30,20.29%,SLC2A1;VWF;HIF1A;LRRC32;ITGB1;DYSF;TNS1;KCTD12;PSAP;EGFL7;GSN
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.8193024993102926,1.2685299594066946,0.1076923076923077,0.8136468459001079,1.0,3/8,7.68%,ANK2;CACNA1C;CTNNA3
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.8567920341533651,1.2684438258620128,0.09836065573770492,0.812037846350737,1.0,1/6,6.32%,NFE2L2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.7781931610476394,1.2683781337827258,0.1111111111111111,0.8102038584132129,1.0,2/9,6.27%,DDIT4;SMAD7
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.6598982698964379,1.2680248083787096,0.17142857142857143,0.8101836709770397,1.0,14/26,22.87%,SLC8A1;ANK2;CALR;VAPB;ATP2B1;ATP1A1;ATP1B3;TMEM165;NEDD4L;SLC30A1;ATP2B4;ATP13A3;CDH5;ATP1B1
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.7512406746453206,1.2673603556152975,0.15492957746478872,0.8123984826875842,1.0,4/14,14.08%,CPEB4;PRNP;PINK1;RASA1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.6390976719773378,1.26645876639434,0.1891891891891892,0.8152097222693847,1.0,8/22,18.03%,SMAD7;PINK1;KDM1A;COMMD1;PTTG1IP;NDFIP1;MALT1;CRY1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.6336917060358066,-1.2664446122392847,0.18181818181818182,1.0,1.0,2/13,7.22%,UBE3D;TRIM25
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.7395753484587173,1.2657497697940365,0.15492957746478872,0.8171690437258187,1.0,2/10,6.27%,ROBO2;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.8791716998826735,1.2649302166743328,0.11666666666666667,0.8205870191191813,1.0,1/5,8.29%,CDK6
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.6070321021832977,1.2646672544421822,0.08108108108108109,0.819965823610951,1.0,10/51,17.18%,LAMC1;TIMP3;EPS8;COL4A2;EMP1;WWTR1;ZC3H7A;NAV2;PLAT;AFAP1L1
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.8104494090207588,-1.2646081782429839,0.2564102564102564,1.0,1.0,1/6,4.36%,EZH1
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.6205754961011131,1.2641688760915661,0.13414634146341464,0.8209809591568358,1.0,13/50,20.19%,TBX3;CALR;ZFPM2;SMAD7;CDK6;TRIB2;REST;WWTR1;SPRED1;HDAC7;GATA2;NOTCH4;SMAD6
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.7646024062473952,1.264048192435473,0.171875,0.8195045972084243,1.0,1/12,0.69%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.7624154519508654,-1.2636057431746979,0.1276595744680851,1.0,1.0,1/7,0.05%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.5917356913173428,1.2633678628000968,0.21052631578947367,0.821142829313355,1.0,11/36,22.90%,CALR;FGFR1;HIF1A;BCAR1;RAC1;ATOH8;GATA2;ANXA3;SPARC;ETS1;SCARB1
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.7656358906842498,1.263355893269161,0.15492957746478872,0.8191333739739457,1.0,2/10,5.60%,ANXA1;BCR
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.8228431597733579,1.262793569894655,0.17391304347826086,0.819998495983813,1.0,3/6,17.16%,RTN4;REEP3;RTN3
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.656659907252439,1.262704114480471,0.11688311688311688,0.818426464312762,1.0,10/35,9.77%,ATF3;ITPR1;HSPA5;BCAP31;MAP3K5;UFL1;PIK3R1;ERO1A;HSP90B1;JUN
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.726236627630762,1.2624262737855854,0.15584415584415584,0.8177935307740063,1.0,4/14,3.90%,SLC8A1;ANK2;MGLL;ANXA1
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.8215832817893203,1.2619347902438631,0.14285714285714285,0.8189369329136384,1.0,3/6,16.04%,PGK1;VSIR;PLAT
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.7631096647341574,1.261319485698284,0.17567567567567569,0.8207202807470204,1.0,2/12,7.09%,ST18;JAK1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.7720367302216038,1.260387582632088,0.22033898305084745,0.8220813502737113,1.0,1/6,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.7720367302216038,1.260387582632088,0.22033898305084745,0.8220813502737113,1.0,1/6,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.5611904691108882,1.2599089443589297,0.08045977011494253,0.8232861896838604,1.0,29/73,27.33%,SERPINE1;PDK4;FES;RAPGEF3;CPEB4;INSIG1;SSH1;HSP90B1;JUN;RAP1A;FOS;TGM2;PXN;FZD4;PDE4B;RYR3;ABL2;ATP2B4;ACTB;ZFP36;SETX;MEF2C;ADAM9;MTOR;SLC38A9;EGFR;CAPN2;VCP;AKAP6
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.7311281259005317,1.2597422755558358,0.12121212121212122,0.8220947248918088,1.0,7/11,20.58%,SYN3;SNAP25;DNAJC5;NRXN1;SYT1;RIMS2;HSPA8
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.6511065556477191,1.2597411429095637,0.1794871794871795,0.8200497131383465,1.0,2/22,9.14%,KHDRBS3;YTHDC1
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.6204096585850907,1.2591835018471125,0.13333333333333333,0.8215271867249753,1.0,15/38,22.44%,ANGPTL4;TBX3;TIMP3;LAMA5;EPS8;PLSCR4;SHC2;CD55;TNS1;FZD4;TF;DIAPH2;GSN;EPAS1;COL18A1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.8524669388734325,1.2589132583657243,0.1746031746031746,0.8212317309696265,1.0,3/5,8.02%,MT1M;PRNP;MT2A
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.6634443867017128,1.2587786631617002,0.17391304347826086,0.8202497437969183,1.0,4/22,13.31%,RFTN1;RPS27A;HSP90B1;TAB2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.5694275609470634,1.2585290228278723,0.15294117647058825,0.8194098531795146,1.0,8/53,8.79%,SEC22B;BCAP31;ANK2;VAPB;SEC24D;MCFD2;TMED10;ANK3
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.8348472014860309,1.258380827408395,0.171875,0.8181085552133806,1.0,2/5,10.23%,POLA1;RFC3
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.7876246971835421,1.25823301119176,0.13333333333333333,0.8168955879634161,1.0,2/6,15.99%,POLA1;BRD4
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.5623067177864033,1.2578150757918247,0.1111111111111111,0.8172145788506459,1.0,16/60,16.18%,RRBP1;RPS11;RPS18;RPS9;RPS27A;RPL23;GGT5;RPL8;RPL34;RPL37;RPLP2;AGO2;EEF1A1;RPL13A;RPS12;DMD
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.7691686824683955,-1.2578148371754898,0.20588235294117646,1.0,1.0,2/7,9.35%,IRF1;OTUD4
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.6104879911577155,1.2576630433931986,0.07692307692307693,0.8163087330897079,1.0,13/36,13.39%,GRIA2;MAP2;CADM2;ANK2;MAP1B;LSAMP;PTPRD;NFASC;SNAP25;PPFIA2;MAGI2;NRXN1;MAPK10
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.7245884428368726,1.2576094491333616,0.15151515151515152,0.8145124055589581,1.0,4/9,23.61%,CBFB;FOXC1;ZFP36;PRKCH
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.5777799386876545,-1.2572624905913667,0.23333333333333334,1.0,1.0,2/16,5.42%,EIF2AK2;NOD1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.7486496592577994,1.2569671514417282,0.19444444444444445,0.8164850332919733,1.0,3/11,7.68%,ANK2;CACNA1C;CTNNA3
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.8218936691799723,1.256512478886777,0.23880597014925373,0.817368646322005,1.0,2/5,6.32%,BCAP31;NFE2L2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.7752884528550179,1.2556660331945626,0.19480519480519481,0.8210208913625924,1.0,3/10,6.27%,SLC8A1;ANK2;SMAD7
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.6670033384417444,-1.2547300203360705,0.23684210526315788,1.0,1.0,1/6,4.59%,MTERF1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.748409551197431,-1.2546374640445492,0.3055555555555556,1.0,1.0,1/5,3.05%,IFI27
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.7278530730721632,-1.254118804480918,0.21052631578947367,1.0,1.0,1/7,0.35%,SLCO1A2
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.8056630887622405,1.2540530785536501,0.2028985507246377,0.8282543055511802,1.0,3/6,17.00%,RTN4;AHCTF1;TPR
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.7744777131654902,1.2537576491325606,0.1896551724137931,0.8277368661104101,1.0,3/8,11.85%,SLC2A13;PICALM;IFNGR1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.8573942122271823,1.2535485620245752,0.17142857142857143,0.8250295986525079,1.0,3/5,14.21%,LBR;INSIG1;LSS
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.8573942122271823,1.2535485620245752,0.17142857142857143,0.8250295986525079,1.0,3/5,14.21%,LBR;INSIG1;LSS
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.5435225575658756,1.2529886461696105,0.08421052631578947,0.8256673648879956,1.0,40/147,20.19%,ST18;RTN4;ERBB4;BCL6;BNIP3L;PPM1D;PBRM1;CD9;HYAL2;ESR2;DLC1;CDK6;DUSP1;KLF4;ITGA1;CDKN1B;GJA1;ADAM15;MAGI2;REST;CDKN1A;ADGRG1;RASA1;DYSF;CTTNBP2NL;PLPP1;CRLF3;PLXNA2;ACTN1;BTG2;NPAS2;TMBIM6;PODXL;NACC2;ABI1;RERG;NOTCH4;CHMP4B;NPM1;SMAD6
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.7758061379771105,1.2529050836626845,0.13432835820895522,0.8241526153815196,1.0,5/9,20.66%,RTN4;ANO6;AHCTF1;TPR;AFDN
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.6010700891355947,-1.25206677642868,0.14814814814814814,1.0,1.0,3/16,4.62%,MGMT;BABAM2;SLF2
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.832214467438902,1.250785644340996,0.13793103448275862,0.8342935083561356,1.0,3/8,13.71%,RTN4;CCDC88A;HIP1R
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.7482207728300748,-1.2506184281850792,0.17073170731707318,1.0,1.0,3/5,12.83%,MRPS31;GSPT1;PTCD3
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.7441942921783531,1.2504370235922944,0.1791044776119403,0.8341652800887409,1.0,4/10,19.28%,MAP2;HSP90AA1;RASA1;ESAM
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.7578687865576229,1.2490577351514178,0.2028985507246377,0.8399660865173428,1.0,4/11,14.08%,CPEB4;PINK1;HIF1A;RASA1
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.6867044072108328,-1.2489080855913322,0.2777777777777778,1.0,1.0,3/11,5.55%,ATM;ATR;SP100
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.8153783528778296,1.248899258844637,0.14925373134328357,0.8392204965369189,1.0,3/6,18.03%,BHLHE40;PPP1CB;CRY1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.5327245255173875,1.2486056667770005,0.03260869565217391,0.83860953810254,1.0,47/180,20.19%,ST18;ERBB4;BCL6;FES;TBX3;PPM1D;PBRM1;CALR;JUNB;CD81;UFL1;FGFR1;CCDC88A;RPS9;JUND;DLC1;RPL23;CDK6;KLF4;ITGA1;CDKN1B;JAG2;JUN;CNBP;MAGI2;REST;CDKN1A;FLT1;CNOT6L;CLDN5;ADGRG1;KRAS;WWTR1;PLPP1;LIMS1;SDCBP;GRK5;BTG2;ARHGEF2;NAMPT;STAT3;DUSP22;NACC2;ABI1;RERG;NPM1;SMAD6
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.6722627819370962,1.2482199131920617,0.2289156626506024,0.8386555234531612,1.0,7/15,23.82%,MAP3K5;ANXA1;NFE2L2;ECT2;SETX;ADAM9;FYN
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.7551201974357474,1.2474891721164614,0.18333333333333332,0.8409199418017664,1.0,3/9,11.85%,SLC2A13;PICALM;IFNGR1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.7958221024147007,1.246991985696969,0.24285714285714285,0.8417415369380163,1.0,2/6,14.16%,SYTL4;DYSF
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.8238195700728842,1.2466302527209068,0.12962962962962962,0.8418578401939467,1.0,2/5,11.37%,RFTN1;ANXA2
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.6161606040406971,1.2463535917233086,0.14864864864864866,0.8414033704131603,1.0,3/30,7.04%,ZEB2;SCARB2;PINK1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.8010205180486987,1.24555122609439,0.203125,0.8443127448188619,1.0,3/5,15.06%,ACOX1;ENPP2;LPIN2
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.7517711307076613,1.2453199537158255,0.125,0.8435451007090866,1.0,4/12,13.04%,SPOCK1;ANXA1;CDK6;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.7388934139099099,1.245236082666932,0.18181818181818182,0.8420860207144036,1.0,2/8,8.63%,KLF2;KLF4
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.6953118493747767,1.2448043511428462,0.18309859154929578,0.8420204250809157,1.0,5/19,16.36%,RTN4;ROBO2;LRRC4C;PAK2;PLXNA2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.6520482585428853,1.2446980646150365,0.17142857142857143,0.8408277756375755,1.0,7/28,8.45%,SLC8A1;ANK2;CALR;VAPB;MT1M;MT2A;ATP2B1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.7807540393666886,1.2445825963030464,0.234375,0.8395894711668117,1.0,4/7,19.76%,SEC22B;PINK1;FEZ2;CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.8087517415138283,1.2445428482163217,0.14705882352941177,0.8378977538616128,1.0,2/6,6.27%,DDIT4;SMAD7
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.6956881867813276,1.2444773986285107,0.19736842105263158,0.836442777294782,1.0,8/15,22.28%,KCNMB4;KCNIP4;DPP10;NEDD4L;NOS1AP;CAB39;NEDD4;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.808347433481667,1.2444301591211684,0.23636363636363636,0.8349690410644249,1.0,3/6,15.96%,ERBB4;CRLF3;MGAT5
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5795581474473303,-1.2443169744819134,0.23684210526315788,1.0,1.0,6/20,6.16%,GBP4;GBP2;ISG15;OAS3;NOD1;OPTN
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.8579696913934953,1.2440263792190214,0.13846153846153847,0.8356804316038926,1.0,2/5,7.36%,MTHFD1L;HSP90AA1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.7003194333076026,1.2438786405969002,0.17567567567567569,0.8346700237992529,1.0,3/14,3.96%,ST18;GRIA2;SLC4A10
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.6660452828259302,1.2436761262656675,0.16666666666666666,0.8343702342919335,1.0,1/20,0.53%,DDIT4
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.7535011360988153,1.2434981440531827,0.19718309859154928,0.8337950490269987,1.0,3/11,11.47%,NFE2L2;PINK1;REST
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.5516812794713964,1.2432233323749664,0.08045977011494253,0.8337245017777464,1.0,8/85,11.55%,LAMC1;PSMC6;FEM1C;MGAT4A;DCAF10;HSP90B1;HIF1A;COMMD1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.7278754199532521,1.2431020142854021,0.12121212121212122,0.8326774797488401,1.0,6/10,20.58%,SYN3;SNAP25;DNAJC5;NRXN1;SYT1;HSPA8
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.8471178517524195,1.2427631826174395,0.13559322033898305,0.832609754615679,1.0,3/5,8.29%,CD9;ANXA1;CDK6
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.6247033871461303,1.2421088728816398,0.10126582278481013,0.8340134315633763,1.0,7/39,9.83%,PSMC6;BNIP3L;PGK1;NDRG1;PINK1;RPS27A;HIF1A
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.7743249257046938,1.241291210770604,0.140625,0.8362815800196951,1.0,3/9,11.47%,PCK1;ANXA1;REST
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.6425582576080345,1.2409253882002915,0.2028985507246377,0.8370502562661881,1.0,5/23,7.99%,SEC22B;VAPB;SEC24D;MCFD2;TMED10
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.7626208489816043,1.2406049790364349,0.15942028985507245,0.8369981835095534,1.0,4/14,6.80%,ITPR1;SLC8A1;GRIN2B;ERO1A
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.6113083937214734,1.2405504864161432,0.15492957746478872,0.8354388645772924,1.0,6/28,8.71%,TIMP3;SEC24D;PLSCR4;MSRB3;COL4A2;ITGA1
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.6133618074874436,1.2399513481285738,0.15384615384615385,0.8368207550322904,1.0,11/44,19.68%,PSMC6;RFTN1;NFKBIZ;PIK3R1;BCAR1;TAB2;PAK2;PSMA7;MALT1;PDE4B;TEC
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.7357997426018084,1.2390132042840183,0.19117647058823528,0.8395497442009325,1.0,2/9,9.38%,FGFR1;JAG2
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.7742119560501135,1.2388093656871169,0.14035087719298245,0.8388543393344495,1.0,2/8,12.54%,TSG101;ZFYVE28
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.6247575916760121,1.2385628269356004,0.15,0.8383089640993135,1.0,9/32,20.19%,SERPINE1;JUNB;SMAD7;PPM1A;SLC20A1;WWTR1;NCOR2;IFNGR2;SMAD6
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.6015227535843706,1.2382311065147107,0.14285714285714285,0.8383770250177115,1.0,3/29,10.76%,PSMC6;SMAD7;TRIB2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.7812709008444066,1.2365176849344859,0.2631578947368421,0.8471270168951277,1.0,2/6,7.04%,SMAD7;PINK1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.7394947379697003,1.2363772629229584,0.16417910447761194,0.8461047857323352,1.0,3/10,10.70%,HSPA5;ERO1A;HSPA9
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.6514991207302341,1.2363293103366424,0.28,0.8445042403477692,1.0,8/27,13.55%,LAMC1;GRIA2;ANK2;NFASC;NDRG1;TMEM132C;SHC2;PRX
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.6411989297791175,1.2360334004526108,0.24,0.8442674906901195,1.0,3/21,9.43%,ADM;CD81;GGT5
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.6944538035168343,-1.2353048153876154,0.3170731707317073,1.0,1.0,2/7,10.07%,HABP4;LARP1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.7454055033230649,1.2352106024642229,0.20967741935483872,0.8450997804456326,1.0,4/8,11.90%,MT1M;MT2A;JUN;FOS
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.7454055033230649,1.2352106024642229,0.20967741935483872,0.8450997804456326,1.0,4/8,11.90%,MT1M;MT2A;JUN;FOS
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.7632494309811999,1.2352066345397186,0.18181818181818182,0.8432745109414305,1.0,5/10,13.57%,KCNMB4;ANK2;ATP1B3;ANO6;NOS1AP
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.8316612453331653,1.2350305250425437,0.17307692307692307,0.8425380250212426,1.0,1/5,2.44%,KCNMB4
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.7981241264660972,1.2340961155850554,0.16071428571428573,0.8464306658499133,1.0,1/5,2.52%,TRIM5
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.5373046116562846,1.2340223256371328,0.14130434782608695,0.8450208845329995,1.0,20/112,13.89%,PIK3R3;KLF2;ANK2;INPP5F;PPHLN1;VSIR;NFE2L2;RPL23;KLF4;ANK3;SLC38A2;HIF1A;GJA1;MAGI2;ANXA2;IFNGR1;AGO2;CLDN5;NOS1AP;KRAS
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.8261611087128843,1.2337548811300865,0.2,0.844691113080343,1.0,3/6,12.88%,DDIT4;GRB2;BCAR1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.7279629883614717,1.233250556971774,0.17105263157894737,0.8460774348184221,1.0,7/13,13.84%,ANO5;SLC20A2;ANO2;SLC12A6;ANO6;SLC26A2;SLC20A1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5888314333934069,1.2328169715934805,0.1111111111111111,0.8465310379745808,1.0,19/45,16.12%,ZEB2;GRIA2;CADM2;GPM6B;LSAMP;NPAS3;GRIN2B;UFL1;NFASC;PPFIA2;NRXN3;LRRC4C;GJA1;MAGI2;NRXN1;MAPK10;ITGB1;ADCY2;ADGRB3
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.602318789591037,1.2326082930924935,0.16901408450704225,0.8456073155120841,1.0,12/30,17.29%,GRIA2;CADM2;LSAMP;SGIP1;SNAP25;PPFIA2;CNTNAP2;MAGI2;NRXN1;ADGRB3;FRMD3;SLC1A2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.6989939027572919,1.2322271091227657,0.16176470588235295,0.8457523669113695,1.0,5/11,20.56%,ADM;RASA1;SPRED1;EGFL7;RASIP1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.7274401300123381,1.232179941195141,0.21621621621621623,0.8442438774582941,1.0,4/11,14.18%,MAP3K5;ANXA1;NFE2L2;ECT2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.6983383117961028,1.2315068622850671,0.2054794520547945,0.8454751103050449,1.0,4/11,17.45%,SERPINE1;NFE2L2;ANO6;GATA2
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.841950263900415,-1.2309678774396393,0.23684210526315788,1.0,1.0,2/5,14.58%,PDGFB;STX3
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.7791286876851848,1.2307885973291626,0.20588235294117646,0.8472654744269564,1.0,2/7,2.63%,AKAP12;GRM7
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.6199317706980206,-1.2305448908445382,0.37037037037037035,1.0,1.0,6/14,14.16%,CD74;PARP14;PARP9;NLRC5;GAS6;HSPA1A
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.8056368169474544,1.2303632826767046,0.203125,0.8473119570974025,1.0,2/6,7.22%,SNAP25;DNAJC5
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.6800942663272536,1.230184720901156,0.19718309859154928,0.8463045784037408,1.0,4/20,13.09%,ADAMTS9;HSP90AA1;LAMP2;DENND3
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.7737596474030821,1.2300350169482368,0.1917808219178082,0.8452780578064434,1.0,2/9,5.60%,ANXA1;BCR
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.7185230873169572,1.2299469984622224,0.1917808219178082,0.8440459807915721,1.0,2/14,7.09%,ST18;JAK1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.6240917729328849,1.2293960092542089,0.15584415584415584,0.8451691316297626,1.0,16/38,23.93%,SERPINE1;PDK4;FES;INSIG1;ADAM15;ATP1A1;ADCY2;FZD4;PDE4B;ABL2;ZFP36;SETX;TFPI;MEF2C;ADAM9;MSN
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.639387892066429,1.22921849181232,0.2191780821917808,0.8442442710121579,1.0,4/22,14.45%,UFL1;KLF4;COMMD1;ERBIN
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.683396496442171,-1.2291579961864012,0.22727272727272727,1.0,1.0,2/6,4.38%,ATM;ATR
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.6935200082825463,1.2289897876447973,0.15492957746478872,0.8439952266907341,1.0,5/17,19.76%,SEC22B;PINK1;PIKFYVE;FEZ2;CHMP4B
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.699924325968344,1.2288511643879447,0.18571428571428572,0.8430997624872287,1.0,1/12,0.58%,PBX3
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.5546903125420544,1.228637450453723,0.1891891891891892,0.8427387417063009,1.0,13/69,14.74%,PIK3R3;ERBB4;FGFR1;PINK1;HSP90AA1;RB1CC1;HIF1A;PECAM1;BTBD10;FLT1;ACVR2A;KRAS;RAC1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.8334122513918744,1.2279754364180566,0.19672131147540983,0.8449122685244301,1.0,2/5,12.11%,LAMA5;RPL8
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.7371419095121607,1.2276680919066114,0.2328767123287671,0.8451464871589407,1.0,6/9,24.14%,ANK2;ANK3;ATP1B3;DMD;ATP1B1;WNK1
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.7807403083222522,1.2271256492570868,0.2222222222222222,0.8464117276179478,1.0,1/7,3.40%,MAP3K5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.7362670867175588,1.2270236906593122,0.22388059701492538,0.8451314343547344,1.0,4/11,13.57%,ANK2;CACNA1C;CTNNA3;NOS1AP
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.6795022101954322,1.226868469799385,0.24050632911392406,0.8442218126351129,1.0,4/11,16.52%,CTNNA1;ADAM15;ADCY2;GOLPH3
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.6712277072584799,-1.2268035687253118,0.2608695652173913,1.0,1.0,3/8,9.30%,STAT1;PKD2;STAT2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.8356774686662942,1.2263987896623971,0.19230769230769232,0.8448657891406685,1.0,2/6,5.29%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.7680645436662357,1.226270018260368,0.21739130434782608,0.8435737435771392,1.0,3/8,6.80%,ITPR1;MAP3K5;ERO1A
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.668794330128165,1.226075412966888,0.20270270270270271,0.8430814427811965,1.0,7/14,21.67%,YBX3;HSP90AA1;OGT;PELI1;SDCBP;ARHGEF2;CDC37
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.737948900784331,1.2258932490784888,0.20833333333333334,0.8420701162878835,1.0,3/9,6.27%,ROBO2;ZFPM2;SMAD7
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.7744604414179295,1.225760494451535,0.31746031746031744,0.8408142112009568,1.0,2/6,15.11%,FGFR1;ANKRD11
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.6972430251728909,1.2255556651009727,0.2463768115942029,0.8386103327867054,1.0,6/9,21.91%,MCFD2;UBE2J1;MGAT5;FUT8;MGAT1;UGGT2
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.6972430251728909,1.2255556651009727,0.2463768115942029,0.8386103327867054,1.0,6/9,21.91%,MCFD2;UBE2J1;MGAT5;FUT8;MGAT1;UGGT2
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.6467595545637885,1.2255055639560875,0.22972972972972974,0.8370544100845748,1.0,2/22,8.29%,LAMC1;CDK6
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.6117805802579376,1.2254269918834568,0.1917808219178082,0.8357738539628549,1.0,5/29,8.39%,WNT2B;TIMP3;PLSCR4;TPM4;COL4A2
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.6221517417689232,1.2250637952005803,0.25,0.8365798189986791,1.0,8/25,18.03%,WDR48;SMAD7;PINK1;COMMD1;PTTG1IP;NDFIP1;MALT1;CRY1
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.7891061781467321,1.224771482104192,0.208955223880597,0.836489131235029,1.0,1/6,1.91%,PRKAG2
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.6101857003347455,1.2246822910181112,0.2,0.8352842616802683,1.0,7/28,14.74%,ADM;MGLL;ANXA1;REL;GGT5;FOS;RAC1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.8174734834824968,1.2245979806922982,0.20588235294117646,0.8340842019840097,1.0,4/6,11.00%,SLC8A1;CACNA1C;GJA1;ATP1A1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.6317713482378884,1.2240250599679414,0.2,0.8355975774686955,1.0,8/32,12.72%,DDIT4;ATF3;HSPA5;CALR;ERO1A;HSP90B1;HSPA9;DCP2
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.5636135790313619,1.223779773451161,0.1125,0.8350664047828813,1.0,6/78,7.36%,CEP57;EHD4;RAB11FIP3;NUDCD3;TUBB4B;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.8249577771685934,1.223628491141554,0.13846153846153847,0.8340729463659501,1.0,2/6,7.07%,CD81;CBFB
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.7000960083674574,1.2235028075453105,0.18840579710144928,0.83297307149303,1.0,4/14,15.80%,SCP2;ACSL5;LSS;AGPAT4
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.8172254136320335,1.2221038697727145,0.13114754098360656,0.8381110638218358,1.0,1/6,2.55%,TBX3
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.772651914964984,1.2220280170808315,0.25675675675675674,0.8367437654523281,1.0,1/9,1.06%,PDK4
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.715566999344555,-1.2220126703999112,0.2564102564102564,1.0,1.0,2/5,8.79%,HABP4;HIPK2
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.5119649477647684,1.2213950389163915,0.044444444444444446,0.8383876100346026,1.0,49/279,16.49%,PIK3R3;CCDC3;BCL6;NFKBIZ;AFF3;TRIM5;BHLHE40;SLC8A1;ANK2;CALR;ZNF280D;VSIR;YBX3;AFF4;NFE2L2;ESR2;REL;PINK1;RPL23;CDK6;PICALM;KLF4;ANK3;YTHDC1;PTBP2;SLC38A2;AHNAK;HIF1A;GJA1;CREM;LARP4;CNBP;REST;IFNGR1;AGO2;CLDN5;SBNO1;PRX;NOS1AP;ZBTB38;KRAS;WWTR1;ZC3H7A;NDFIP1;FOXC1;ATF2;HNRNPH3;ATOH8;LIMS1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.7184255564730331,1.2212193032778835,0.14925373134328357,0.8375287660761446,1.0,1/12,2.74%,BHLHE40
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.6666441066256543,1.2210592296407186,0.25675675675675674,0.8364766058022396,1.0,1/16,0.69%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.7307709472543371,1.2209710962337827,0.1935483870967742,0.8336662564706969,1.0,4/10,13.57%,KLF2;HSP90AA1;KLF4;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.7307709472543371,1.2209710962337827,0.1935483870967742,0.8336662564706969,1.0,4/10,13.57%,KLF2;HSP90AA1;KLF4;NOS1AP
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.804600592619823,1.2209112259587755,0.14925373134328357,0.8323453402512669,1.0,3/6,11.58%,LRRC7;MAGI2;NRXN1
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.5329154583583461,1.2208599685314014,0.10975609756097561,0.8310295637836637,1.0,35/102,26.29%,CEP57;NEDD9;SUN2;RAPGEF5;MYO9B;BCR;CCDC88A;MYO1E;MYH10;STK38L;BCAR1;DOCK4;RASA1;ECT2;PXN;ARHGEF2;ALMS1;CSNK1D;ABI1;DYNC1H1;GSN;PAFAH1B1;ARFGEF1;TBCD;YWHAE;PREX1;NCK1;FGD4;PPP4R2;SMC3;FSCN1;CDK5RAP2;KIF1B;WASL;CDC42
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.7084568747999065,1.2207567127945111,0.23529411764705882,0.830065163393112,1.0,2/11,22.18%,YTHDC1;SETX
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.7885174381208712,1.2207477608913844,0.2602739726027397,0.8285429087774017,1.0,2/8,13.94%,JAK1;PAK2
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.7584819822428037,-1.2206950365978173,0.2631578947368421,1.0,1.0,2/5,3.90%,CLYBL;DISP1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.7584819822428037,-1.2206950365978173,0.2631578947368421,1.0,1.0,2/5,3.90%,CLYBL;DISP1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.5626227198611558,-1.2206916991233216,0.15384615384615385,1.0,1.0,3/17,7.09%,GBP1;GCNT2;EFNA5
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.5913081865393093,1.2204094164956374,0.1780821917808219,0.8286433870743709,1.0,9/37,16.60%,ERBB4;FGFR1;PINK1;HSP90AA1;KLF4;RFC3;FLT1;SERINC1;TNKS
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.7662598561017684,1.2203448256191596,0.22727272727272727,0.8274094665822739,1.0,5/9,13.47%,ANK2;CACNA1C;GJA1;ATP1A1;NEDD4L
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.773788335437283,-1.2199192991631325,0.3170731707317073,1.0,1.0,2/6,1.83%,EIF2AK2;CD74
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.6240294936366242,1.219912480211046,0.2222222222222222,0.828048612742716,1.0,8/20,19.39%,IL1RAPL1;ANXA1;SYTL4;RAB21;STXBP5L;CADPS2;SYT1;RIMS2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.7953901435163834,1.2198912522502845,0.22058823529411764,0.8265205122110281,1.0,3/5,18.27%,ZBTB1;CBFB;ZMIZ1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.574261721661552,1.2191733230351647,0.1728395061728395,0.8284424556600488,1.0,27/61,24.38%,ANGPTL4;SERPINE1;GLUL;PGK1;RAPGEF3;COL4A2;KLF4;HIF1A;FLT1;AGO2;CLDN5;ITGB1;FOXC1;MTDH;ATF2;SPRED1;GATA2;ATP2B4;BTG1;VEGFC;ANXA3;CDH5;SPARC;ETS1;ADAMTS1;EMP2;PPARG
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.6076713778973621,1.218999857252485,0.16176470588235295,0.8276667554117016,1.0,16/34,22.87%,SLC8A1;ANK2;CALR;VAPB;ATP2B1;MICU2;TMEM165;PDZD8;HERPUD1;SLC30A1;ATP2B4;ATP13A3;CDH5;CAV2;YWHAE;ATP1B1
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.5784564375627878,-1.2184526868840408,0.2903225806451613,1.0,1.0,7/28,5.82%,SLC22A5;SLCO1A2;TAP1;DISP1;ABCG2;CHKA;MIA3
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.8141969256905919,1.2182763154077785,0.203125,0.8295365362967797,1.0,1/5,1.67%,MAP2
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.8423352936267235,1.217985453102772,0.2,0.829335997014548,1.0,1/5,3.45%,STARD4
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.5553775567657352,1.2178268501348373,0.14102564102564102,0.8286267156150684,1.0,19/54,27.57%,RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;TRAM1;RPS27;RPL10;RPL37A;RPL21;RPLP1;SEC62;RPS15
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.649784895119042,1.216730645881589,0.203125,0.8290269384279368,1.0,4/20,7.99%,SEC22B;SEC24D;MCFD2;TMED10
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.649784895119042,1.216730645881589,0.203125,0.8290269384279368,1.0,4/20,7.99%,SEC22B;SEC24D;MCFD2;TMED10
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.649784895119042,1.216730645881589,0.203125,0.8290269384279368,1.0,4/20,7.99%,SEC22B;SEC24D;MCFD2;TMED10
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.795002338384383,-1.2165320332050016,0.1794871794871795,1.0,1.0,2/7,11.69%,PLAAT3;MFF
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.7149794686687176,1.2164165555618904,0.16,0.8289767401896211,1.0,3/11,6.27%,ROBO2;ZFPM2;SMAD7
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.6631313457223141,1.2161454911374276,0.2191780821917808,0.8287164399555698,1.0,7/25,17.16%,RTN4;VAPB;PRNP;TOR1AIP2;REEP3;TRAM1;RTN3
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.7453763319703122,1.2161134727502299,0.2153846153846154,0.8273656640878879,1.0,1/8,7.30%,ACSL5
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.5976221571626131,1.214853861624147,0.19736842105263158,0.8320535909141367,1.0,15/48,24.14%,PSMC6;RFTN1;NFKBIZ;PIK3R1;BCAR1;TAB2;PAK2;PSMA7;MALT1;PDE4B;TEC;MEF2C;NCK1;FYN;WNK1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.5937150082202735,1.2142498195797053,0.22535211267605634,0.8335873101101785,1.0,11/34,23.98%,ADAMTS9;CALR;GLUL;BCAR1;RAC1;ATOH8;ANXA3;SPARC;ETS1;SCARB1;EMP2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.7612377365041755,1.2142212393782457,0.18055555555555555,0.8322350013912766,1.0,1/7,0.58%,PBX3
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6616325364978846,1.2140942581054488,0.2835820895522388,0.8313044001973666,1.0,4/17,17.45%,ANXA1;KLF4;HDAC7;GATA2
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5617740396648924,1.21393090925755,0.15789473684210525,0.8306060025520129,1.0,11/51,15.51%,RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.6469105272426906,-1.2135933922904316,0.2222222222222222,1.0,1.0,1/8,2.18%,ISG15
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.7416955574108448,1.2133322761386056,0.23333333333333334,0.8324423183828829,1.0,2/8,16.79%,RAD21;NAA50
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.7039334096736901,1.2132922374812298,0.24615384615384617,0.8311021922413098,1.0,4/15,9.83%,PRKAG2;SCARB2;OGT;HIF1A
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6184255565428226,1.2130176400407946,0.18055555555555555,0.8311111091511105,1.0,18/35,31.45%,PIK3R1;HSP90AA1;FLT1;BCAR1;SHC2;PAK2;RAC1;CRK;PXN;ABI1;VEGFC;NCK1;FYN;CDC42;PIK3CB;DAB2IP;DOCK1;PTK2
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.6410544683247796,1.2130017173244618,0.16883116883116883,0.8296545733595097,1.0,6/28,12.91%,PKM;YBX3;RPS9;LARP4;CNBP;AGO2
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.6519577669102007,1.2129615810556214,0.18055555555555555,0.8283270315496335,1.0,7/21,17.50%,TINAGL1;SMIM3;COL4A2;EMP1;WWTR1;SEMA3F;PXN
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.7298008868573452,1.2125132605277473,0.22857142857142856,0.8290196165569929,1.0,2/10,13.68%,HIF1A;ITGB1
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.6804809048561301,1.2124425052732508,0.15625,0.8278418135286523,1.0,5/18,8.61%,ADM;CD9;CD81;GRB2;PICALM
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.6816368159856172,1.2122304394989216,0.26229508196721313,0.8271600514859299,1.0,7/14,21.83%,NEDD9;HYAL2;PRNP;PTPN1;SH3BP5;GRM5;GPRC5B
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.592358463928155,1.2119458614793304,0.21794871794871795,0.826930699210844,1.0,8/39,14.45%,BHLHE40;UFL1;SMAD7;PRNP;KDM1A;KLF4;COMMD1;ERBIN
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.65454934396153,1.2118297338478767,0.21333333333333335,0.8259877354243886,1.0,10/20,24.38%,ATF3;STARD4;CD9;LSS;ALCAM;LGALS3;PNRC1;SREBF2;LDLR;PPARG
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.7372475806468972,1.2117170419016035,0.15789473684210525,0.823440964938712,1.0,6/9,25.26%,EPS8;TRIOBP;ADD3;GSN;CAPZA2;ADD1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.7372475806468972,1.2117170419016035,0.15789473684210525,0.823440964938712,1.0,6/9,25.26%,EPS8;TRIOBP;ADD3;GSN;CAPZA2;ADD1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.6779299726061119,1.2115121930325148,0.15625,0.8229358390019582,1.0,2/15,4.94%,SCP2;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.7893758777476553,1.2112712532549053,0.2033898305084746,0.8224325498867927,1.0,1/6,5.66%,CRTC3
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.6178323423423654,1.211111929157093,0.1643835616438356,0.8217692662432373,1.0,8/38,11.58%,NRCAM;PTPRD;CTNND2;PPFIA2;ANK3;LRRC4C;REST;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.5551910155946014,1.2104641695316356,0.16470588235294117,0.823450544621781,1.0,16/90,13.68%,PIK3R3;RTN4;NEDD9;SUN2;HSPA5;ELP3;PRKCE;VSIR;ENPP2;SEMA6B;HIF1A;PECAM1;FLT1;BCAR1;AGO2;ITGB1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.8196412444140873,1.2104413305896653,0.208955223880597,0.8221227200625612,1.0,3/5,17.00%,RTN4;AHCTF1;TPR
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.7504721027315164,1.2104402576075586,0.22388059701492538,0.8206387440335674,1.0,3/5,24.75%,HIF1A;EPAS1;DCUN1D4
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.780812851251656,1.2104139275205035,0.24324324324324326,0.819280606967795,1.0,3/6,7.07%,BCL6;VSIR;CBFB
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7262883531896519,1.2102024329234933,0.2459016393442623,0.8187091401278787,1.0,6/8,24.38%,CD9;CD81;ITGB1;SREBF2;LDLR;PPARG
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.7511430308855735,-1.2098741235967139,0.2926829268292683,1.0,1.0,1/5,1.01%,CARMIL1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.8285181588650885,1.2095628693113618,0.15151515151515152,0.8202607615256193,1.0,1/6,0.77%,ADAMTS9
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.746455726718374,1.2094674085730726,0.2112676056338028,0.819330055907087,1.0,1/8,11.47%,REST
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.8263284929505383,1.2093545275008686,0.16129032258064516,0.8185621856635283,1.0,2/5,7.68%,CACNA1C;CTNNA3
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.5607845645220275,1.2088670881601795,0.21333333333333335,0.8192300436536233,1.0,11/46,10.78%,DOK5;NES;ANK2;GLUL;TIMP3;PTPRD;NFASC;PLSCR4;COL4A2;GJA1;BOC
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.6873498635635809,1.2088497159333806,0.22535211267605634,0.81784920896206,1.0,11/15,29.19%,HSPA5;GLUD1;MBP;CCDC14;ACTB;PLP1;YWHAE;CDC42;ZNF148;CALM1;YWHAQ
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.6739091388838655,1.2086811097912482,0.21428571428571427,0.8171475678892144,1.0,2/13,5.15%,PBX3;CACNA1C
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.6358157430732985,1.208182607381089,0.2638888888888889,0.8178143797759417,1.0,3/29,3.27%,PDK4;LDHA;GLUD1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.6080077715934669,-1.2078838411233255,0.20588235294117646,1.0,1.0,1/12,0.56%,PRIMPOL
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.7755381384119664,1.207342444559854,0.21428571428571427,0.8202771170342948,1.0,1/5,4.91%,GRIN2B
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.7461069714130567,1.2071053183362441,0.28125,0.8198313481837992,1.0,1/9,0.72%,ERBB4
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.595827627250273,1.2068160179803966,0.24324324324324326,0.8197416032825804,1.0,12/32,21.70%,B3GNT2;MGAT4A;PLOD2;OGT;TMEM165;TRAK1;MGAT5;FUT8;EOGT;MGAT1;PMM2;B4GALT1
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.5454230000226624,1.2064543634987204,0.15384615384615385,0.8200649692167358,1.0,15/67,15.51%,PPA1;RRBP1;RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;AGO2;EEF1A1;RPL13A;RPS12
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.752370712549319,1.2061138180368778,0.21875,0.8200339958032535,1.0,1/8,7.30%,ACSL5
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.7244397517228417,1.2061055122861075,0.265625,0.818612399053901,1.0,1/8,1.97%,KLF6
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.645344309818969,-1.206030890315179,0.3235294117647059,1.0,1.0,1/10,3.27%,STAT1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.6475768112593692,1.2060033659691598,0.28378378378378377,0.8176650722758086,1.0,2/13,6.00%,MBP;NFASC
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.5390105164984059,1.2058484957132352,0.2261904761904762,0.8171114470073297,1.0,25/90,22.42%,SUN2;ANK2;VAPB;SGIP1;SCARB2;CCDC88A;RPS27A;GRB2;PICALM;ANK3;TOR1AIP2;ARPC2;HIP1R;DYSF;REEP3;SYT1;FZD4;TF;CHMP4B;SH3KBP1;HSPA8;ACTB;DNM2;SYNJ2;UBC
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.6608738389428745,1.205344105063099,0.19117647058823528,0.8183134114914481,1.0,5/16,14.74%,KLF2;HSP90AA1;KLF4;NOS1AP;RAC1
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.7584165214023509,1.2053270897676114,0.26865671641791045,0.8169241924327254,1.0,4/9,11.87%,RTN4;MAP2;CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.6435319204480138,1.205141730106557,0.17105263157894737,0.8164524200167467,1.0,12/30,20.16%,PRKAG2;SLC8A1;HYAL2;CDKN1B;TRIB2;CDKN1A;PAK2;WWTR1;SPRED1;PTPN1;SH3BP5;NPM1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6602920143408394,1.2048101311872632,0.208955223880597,0.816699473731956,1.0,5/27,9.83%,RTN4;GLUL;PRKCE;ENPP2;HIF1A
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7540104934084453,1.2038036331920654,0.2564102564102564,0.820138375341509,1.0,4/7,19.42%,PIK3R1;PXN;STAT3;PTPN1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6639740352088652,1.2037936179511317,0.24050632911392406,0.8187942564616911,1.0,8/20,22.15%,CADM2;SMAD7;CTNNA1;PAK2;AFDN;ACTB;TBCD;CDH5
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.6343774834019343,1.203738031821207,0.1917808219178082,0.8175512023999839,1.0,7/23,17.50%,MAP3K5;ANXA1;NFE2L2;JUN;FOS;ECT2;PXN
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.6965418496033398,-1.2036001472466635,0.2571428571428571,1.0,1.0,1/5,8.55%,MSH3
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.6949728444025799,1.2032014917514542,0.23880597014925373,0.8185838800617279,1.0,4/15,9.83%,PRKAG2;PINK1;OGT;HIF1A
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.7823779643453812,1.203138041759081,0.24,0.8175184216781555,1.0,2/8,8.37%,PPP2R2B;DUSP1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.6595501298858817,1.2029907433652012,0.1917808219178082,0.8168019287581921,1.0,10/20,22.15%,LAMC1;MBP;GJA1;PECAM1;CLDN5;ITGB1;DMD;ESAM;ACTB;CDH5
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.6221092344578448,1.2027858292619522,0.21875,0.816164499012673,1.0,7/21,12.43%,TSG101;HYAL2;FGFR1;DUSP1;TRIB2;FLT1;STK38
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.7005089237436253,1.2020378578698547,0.25,0.8184733359128236,1.0,5/12,14.74%,PINK1;GRB2;PIKFYVE;CDKN1A;RAC1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6568354786495183,1.201642708212669,0.16901408450704225,0.8187894604882272,1.0,8/23,19.68%,ERBB4;FES;FGFR1;FLT1;TPST2;ABL2;ABI1;TEC
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.6965676556932985,1.2012741903762172,0.288135593220339,0.8189901920351172,1.0,1/9,1.86%,PCK1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.7109041262535035,1.200873696283468,0.21666666666666667,0.8195135705258197,1.0,4/12,16.87%,TSG101;SYTL4;CADPS2;SDCBP
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.5080798777849282,-1.2002549947347751,0.21428571428571427,1.0,1.0,7/30,10.33%,RNF213;ALS2;CLYBL;DISP1;PKD2;SAMHD1;RBMX
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.7194684126731978,1.2002072505427561,0.19298245614035087,0.8210224965547582,1.0,4/9,13.47%,GPM6B;PICALM;COMMD1;NEDD4L
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.772487245894013,1.2001341992605676,0.3103448275862069,0.8200052965749594,1.0,2/5,8.07%,PGK1;RPS27A
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.8032408475377788,1.199978032949125,0.22580645161290322,0.8180001316073964,1.0,1/6,5.79%,NDUFA12
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.8032408475377788,1.199978032949125,0.22580645161290322,0.8180001316073964,1.0,1/6,5.79%,NDUFA12
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.7194675307560171,-1.1996000061864331,0.3,1.0,1.0,1/6,1.86%,IFIH1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.7460924680901456,1.1985041198109199,0.25806451612903225,0.823461716305285,1.0,2/7,17.85%,MGAT5;LGALS3
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.6227287596271853,1.198425903659484,0.2714285714285714,0.822428442228775,1.0,4/25,4.01%,NRCAM;RTN4;GRM7;MAP1B
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.714198751413877,1.1982285973942648,0.23880597014925373,0.8219061185309119,1.0,3/14,7.54%,ERBB4;PKN3;SEMA6B
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.7425267629601068,1.198059482222286,0.3333333333333333,0.8212729732419138,1.0,3/7,13.57%,ANK2;PRNP;NOS1AP
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.7098485145494227,1.197568451291779,0.26153846153846155,0.8224402129126747,1.0,4/8,22.18%,JUN;BCLAF1;MED4;SETX
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.6772648793991793,-1.1975230543618545,0.3235294117647059,1.0,1.0,1/6,0.13%,GBP1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.6279201245388766,1.1973124837874567,0.2535211267605634,0.8221823043764105,1.0,8/24,11.47%,ITPR1;GLUD1;CACNA1C;RAPGEF3;SNAP25;SLC2A1;RAP1A;REST
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.6126551656933082,1.1971459536178566,0.26582278481012656,0.821645223538216,1.0,7/24,22.23%,PICALM;NEDD4L;HIP1R;LGALS3;ABL2;PTPN1;RUFY2
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.739202560517859,-1.1970159798359996,0.2,1.0,1.0,1/7,2.97%,ZNRF3
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.763282536375106,1.196488026472234,0.22857142857142856,0.8236074133491482,1.0,2/10,9.03%,PDK4;OGT
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.6534347564601496,1.1963462290577915,0.25675675675675674,0.8229767128541848,1.0,5/22,9.93%,PSMC6;HSPA5;UBE2J1;HSP90B1;NPLOC4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.6970546429329608,1.196346177455599,0.2807017543859649,0.8216050849994279,1.0,4/8,24.38%,FGFR1;FLT1;MEF2C;PPARG
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.7616371749640466,1.1962715340962193,0.28125,0.8206830976535379,1.0,3/8,11.37%,SCARB2;PIKFYVE;ANXA2
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.6429137827689972,1.196233749576397,0.25,0.8194309208676183,1.0,2/17,2.87%,ZEB2;PKN3
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.678232586461763,1.1958208996313218,0.2318840579710145,0.8197354966007543,1.0,5/12,25.44%,EPS8;PICALM;RAC1;MSN;MTOR
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.6713740749520762,1.195732918373172,0.2638888888888889,0.8187473731104103,1.0,2/13,7.84%,ROBO2;DLC1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.6885947064403142,1.1953408057479935,0.2459016393442623,0.8190520718126224,1.0,1/12,1.67%,MAP2
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.5105836199751792,1.195249820962184,0.12087912087912088,0.8182154718126118,1.0,28/125,19.10%,LAMC1;RRBP1;RPS11;MGAT4A;PLOD2;RPS18;RPS9;ERO1A;MSRB3;RPS27A;RPL23;HSP90B1;MSRA;RPL8;RPL34;STK38;RPL37;RPLP2;AGO2;DENND3;EEF1A1;RPL13A;RPS12;PLAT;TF;CSNK1G3;RPS27;ABL2
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.7801401159728292,1.195169515687511,0.29310344827586204,0.8172347361233541,1.0,3/5,18.57%,BACH2;CD55;STAT3
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.7905288304841609,1.195108244359869,0.24615384615384617,0.8161105759406838,1.0,2/6,6.32%,SERPINE1;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.7167770328287826,1.1943473441906334,0.2638888888888889,0.8181379181108697,1.0,3/10,18.57%,TMED10;MALT1;STAT3
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.7382960062354964,1.19392489183842,0.3389830508474576,0.8184228471672895,1.0,1/6,5.42%,DUSP6
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.788407085404041,-1.1924248703494233,0.3235294117647059,1.0,1.0,1/5,7.30%,PKD2
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.7041346348685774,1.1921369895222589,0.3150684931506849,0.824471100110991,1.0,2/10,14.74%,EPS8;RAC1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.7045913048531598,1.1921127227208614,0.28169014084507044,0.8217993272646611,1.0,1/11,0.88%,PSMC6
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.7045913048531598,1.1921127227208614,0.28169014084507044,0.8217993272646611,1.0,1/11,0.88%,PSMC6
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.6534186659649455,-1.1914837324219232,0.21875,1.0,1.0,4/8,15.17%,EVL;SRGAP2C;KANK1;ODF2L
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.5752996766911156,1.1914441208100701,0.22535211267605634,0.8231474161818269,1.0,11/32,18.03%,SPOPL;UFL1;SMAD7;PINK1;HSP90AA1;OGT;COMMD1;PTTG1IP;NDFIP1;MALT1;CRY1
prerank,MSigDB_Hallmark_2020__Myogenesis,0.5896355693143726,1.190626129731857,0.2125,0.8252522734402528,1.0,13/38,23.03%,DTNA;BHLHE40;PRNP;COL4A2;CDKN1A;ITGB1;WWTR1;NAV2;DMD;GSN;ADCY9;SPARC;MEF2C
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.7147564978722952,1.1903397392013182,0.3142857142857143,0.8251429195688762,1.0,1/7,2.55%,TBX3
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.6706666004645935,1.1889955502281986,0.3,0.8302905240855766,1.0,1/14,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.5450379606839918,1.1888600165135776,0.18421052631578946,0.8296503652625327,1.0,19/55,27.57%,RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;RPS27;CHMP4B;RPL10;RPL37A;RPL21;RPLP1;SEC62;RPS15
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.6108154110554054,-1.1884769396010735,0.19444444444444445,1.0,1.0,3/11,6.11%,UBE3D;CREB5;PARN
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.4729950117043784,-1.1883534088587988,0.11538461538461539,1.0,1.0,5/50,3.56%,RNF213;MLLT3;ANKRD6;ZNRF3;NKD1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.7917131125968941,1.1883072842590316,0.2631578947368421,0.8308128314149512,1.0,2/5,6.32%,BCAP31;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.49537326063667647,1.188298940747666,0.06382978723404255,0.8294907872439944,1.0,59/264,20.16%,MAFF;ST18;ZEB2;SERPINE1;ATF3;KLF6;KLF2;TBX3;PHF10;JUNB;CD81;ZFPM2;CRTC3;HYAL2;PIK3R1;SMAD7;NFE2L2;REL;SMAD5;KDM1A;JUND;RPS27A;KLF4;OGT;FOSL2;JUN;HIF1A;CNBP;SETD3;CCNC;REST;FOS;FOXF1;AGO2;TMF1;ACVR2A;ZBTB38;WWTR1;LPIN2;FOXC1;CRLF3;ATF2;BRD4;ATOH8;TNKS;GATA2;NPAS2;ARHGEF2;NAMPT;ZMIZ1;STAT3;NFIB;NR1D2;NFIC;RLF;NOTCH4;BCLAF1;CDK8;NPM1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.6218865395020963,1.188273277013102,0.19444444444444445,0.8283165814815964,1.0,4/24,9.83%,PSMC6;NFE2L2;RPS27A;HIF1A
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.7726947571859522,1.187707227971096,0.24561403508771928,0.8293501541731982,1.0,3/7,11.10%,SLC8A1;CACNA1C;MICU2
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5670506081375026,-1.1876872955367053,0.2,1.0,1.0,5/29,4.65%,SLC22A5;SLC4A4;SLC38A3;LEPR;ABCG2
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5670506081375026,-1.1876872955367053,0.2,1.0,1.0,5/29,4.65%,SLC22A5;SLC4A4;SLC38A3;LEPR;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.5609103510255813,1.187651118763188,0.20253164556962025,0.8281441637458763,1.0,7/65,7.54%,PIK3R3;NEDD9;SUN2;HSPA5;ELP3;VSIR;SEMA6B
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.745269428324585,1.187646712890513,0.2727272727272727,0.8268527322187889,1.0,2/8,14.50%,AGO2;ZC3H7A
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.7747468308552978,1.1876110924035128,0.3,0.8257259276866599,1.0,2/5,5.58%,HSPA5;UFL1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.7227924134240903,1.1874626644104473,0.24615384615384617,0.8238919455313185,1.0,1/9,0.24%,LAMC1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.7227924134240903,1.1874626644104473,0.24615384615384617,0.8238919455313185,1.0,1/9,0.24%,LAMC1
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.6765177655389364,1.1871022674655072,0.20833333333333334,0.8241063027936285,1.0,6/11,22.15%,MAP2;SSH1;HIP1R;ARFGEF1;TBCD;CDH5
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.7191653676606298,1.1869009558975738,0.25757575757575757,0.8236112061109613,1.0,3/9,9.83%,NFE2L2;SMAD5;HIF1A
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.6028610177887466,-1.1865018675061045,0.23333333333333334,1.0,1.0,1/14,1.51%,RHOBTB1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.6373178046620045,1.1857287698492722,0.2535211267605634,0.8273989475003658,1.0,5/18,10.62%,SERPINE1;ANXA1;HYAL2;KLF4;OTUD7B
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.8123197545075314,1.1852836213292537,0.23376623376623376,0.8280483064453785,1.0,2/5,8.79%,SLC8A1;ANK3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.6373807624847063,-1.18521364735729,0.29411764705882354,1.0,1.0,1/7,2.95%,ATM
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.7573012719569696,1.1850561358370588,0.29577464788732394,0.827690404145258,1.0,3/6,21.59%,CDK6;HSPA9;ZFP36
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.7285878036916078,1.1846907807759033,0.3076923076923077,0.8278090308040391,1.0,3/8,23.98%,MYO1B;SEMA3F;EMP2
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.664604018064731,-1.1844663698695999,0.36363636363636365,1.0,1.0,3/9,17.13%,ST3GAL6;MAML2;PPARD
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.6943964200653832,1.1839797867162811,0.25675675675675674,0.8295094442682323,1.0,3/13,11.29%,ITGA1;HSP90B1;MAGI2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.7543297635976287,1.1834073152713478,0.2608695652173913,0.8309412238611603,1.0,3/6,17.45%,FES;RASSF1;GATA2
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.7535763448637224,1.1833926043505254,0.31666666666666665,0.8297573824996675,1.0,4/7,24.38%,CDK6;HDAC7;SMAD6;PPARG
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6926956979857459,1.1831442563233123,0.17647058823529413,0.8296270645416626,1.0,5/10,21.30%,PINK1;HSP90AA1;HIF1A;ZMIZ1;EPAS1
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.6519111800569833,1.1827838726041877,0.22388059701492538,0.8297242566563813,1.0,7/18,8.98%,GRIA2;MAP2;ANK2;CTNND2;NFASC;SNAP25;LRRC4C
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5769755576843837,1.1826226981480354,0.1518987341772152,0.8290711380710052,1.0,7/50,10.28%,ZEB2;KLF2;STARD4;HSP90AA1;KLF4;HIF1A;LARP4
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5928959695865184,-1.182256756642633,0.2222222222222222,1.0,1.0,4/16,3.61%,IFIH1;ISG15;OAS3;IRF1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.747017113412108,1.1818432075876661,0.2542372881355932,0.8314328136967487,1.0,2/6,18.88%,CCDC14;CSNK1D
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.6140000062305636,1.1815596222268456,0.24285714285714285,0.831422408310642,1.0,7/20,11.58%,GRIA2;LSAMP;GRIN2B;SNAP25;PPFIA2;MAGI2;NRXN1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.6337166514656903,1.1815057214413658,0.2676056338028169,0.8303530444199423,1.0,5/22,14.18%,NRCAM;CALR;FGFR1;REST;ECT2
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6753113225989407,1.181446914533966,0.26153846153846155,0.8293736742382467,1.0,7/13,23.03%,GRIK1;GRM7;NRXN1;DGKI;SYT1;GRM5;MEF2C
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.5686213413757173,-1.1813544463597676,0.25,1.0,1.0,3/10,5.34%,PLA2G4A;PLPPR4;PLAAT3
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.7985725454839776,1.1808441746928493,0.23809523809523808,0.83057797620483,1.0,2/5,6.06%,GPC5;HYAL2
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.5906678538637415,-1.1808180761323148,0.1875,1.0,1.0,3/14,9.08%,SLCO1A2;ABCG2;SLC16A2
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.706668551083235,-1.1793834265804837,0.3783783783783784,1.0,1.0,3/7,8.07%,PLXND1;SP100;WARS1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.6599976505873499,1.1790487227888382,0.22388059701492538,0.8370661505669053,1.0,5/16,15.06%,ACOX1;ACSL5;GGT5;PON2;LPIN2
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.6091482727829113,1.1780197374662664,0.18840579710144928,0.8404632016568779,1.0,12/28,25.66%,MAP2;NAV3;SSH1;HIP1R;ARHGEF2;HSPA8;ARFGEF1;TBCD;TAOK1;CDH5;LDLR;HDGFL3
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.5295428145819391,1.1773338443612344,0.16455696202531644,0.8422132490107811,1.0,16/59,18.30%,RTN4;RAPGEF3;FGFR1;ENPP2;PINK1;ZDHHC6;GJA1;REST;NRXN1;SPIRE1;AGO2;DAG1;RIF1;DDHD1;FZD4;CFL1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.725231123225417,1.1773189526336136,0.2835820895522388,0.8410339355369244,1.0,4/10,19.28%,FES;RAPGEF3;ABL2;ESAM
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.6809345570666115,1.1768219768357022,0.3103448275862069,0.8418160078951415,1.0,1/9,1.86%,PCK1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.7231364690365929,1.176816689969513,0.2535211267605634,0.8405723468618643,1.0,2/9,5.60%,ANXA1;BCR
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.7459194959861393,1.1766020901497343,0.2608695652173913,0.8401542905940338,1.0,7/9,22.87%,SLC8A1;ANK2;CACNA1C;ATP1A1;DMD;YWHAE;ATP1B1
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.6396423756209708,1.1765450237798418,0.24050632911392406,0.839190500981177,1.0,8/20,13.39%,GRIA2;CNTN1;PTPRD;NFASC;SNAP25;NRXN1;SHC2;MAPK10
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.7499270681434901,1.1762718046681246,0.3389830508474576,0.8390830664223912,1.0,1/7,5.15%,CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.6537441159321989,1.1762571017162138,0.18840579710144928,0.837868232653682,1.0,9/15,24.38%,KLF4;JUN;HIF1A;FOS;ATOH8;GATA2;STAT3;ETS1;PPARG
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.7920522856009786,1.1756571947774053,0.20588235294117646,0.8363494744792278,1.0,4/6,13.47%,SLC8A1;ATP1A1;ATP1B3;NEDD4L
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.7920522856009786,1.1756571947774053,0.20588235294117646,0.8363494744792278,1.0,4/6,13.47%,SLC8A1;ATP1A1;ATP1B3;NEDD4L
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.7920522856009786,1.1756571947774053,0.20588235294117646,0.8363494744792278,1.0,4/6,13.47%,SLC8A1;ATP1A1;ATP1B3;NEDD4L
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.7389949959442235,1.1756067103625443,0.25,0.8353663788830104,1.0,1/8,2.74%,BHLHE40
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.6346351774016971,1.1751631391691806,0.21212121212121213,0.8356378040036282,1.0,11/23,22.87%,SLC8A1;ANK2;CALR;VAPB;ATP2B1;TMEM165;SLC30A1;ATP2B4;ATP13A3;CDH5;ATP1B1
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.5423847341244445,1.175016410678941,0.22077922077922077,0.8348951843128215,1.0,10/51,15.51%,RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPL13A;RPS12
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.7023677144682496,1.1747113304264405,0.21428571428571427,0.8348629941940133,1.0,3/12,10.70%,HSPA5;ERO1A;HSPA9
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.6653938805738701,-1.1744216720749936,0.3783783783783784,1.0,1.0,1/8,1.12%,SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.6653938805738701,-1.1744216720749936,0.3783783783783784,1.0,1.0,1/8,1.12%,SLC4A4
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.6559429482314971,1.17381769581098,0.22388059701492538,0.8377435328337902,1.0,7/22,13.68%,ADM;CD9;CD81;GRB2;PICALM;KIF16B;ITGB1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.5064307611625026,-1.1733344892713327,0.20689655172413793,1.0,1.0,8/25,11.45%,RNF213;ALS2;ZNHIT6;HOMER1;PKD2;HGSNAT;RBMX;MCU
prerank,PanglaoDB_Augmented_2021__Interneurons,0.550720867301616,1.172824954465484,0.175,0.8406658139456415,1.0,17/62,17.80%,GRIA2;MAP2;OXR1;CADM2;CTNND2;TRIM9;ATG12;SNAP25;ARHGAP21;SRGAP1;PPFIA2;NRXN1;NCALD;ADGRB3;SYT1;GATA2;LPGAT1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),-0.6760808694033471,-1.1727340450841688,0.3,1.0,1.0,2/6,13.78%,TAPT1;MBOAT2
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7680428052160206,1.1726755551867356,0.3225806451612903,0.8401047339663703,1.0,1/5,3.75%,CD81
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.7730470859119416,1.1725651953683132,0.29850746268656714,0.8392939404211346,1.0,1/6,5.26%,WDR48
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.7317027312661457,1.1725612687128695,0.2753623188405797,0.8380504742124265,1.0,4/8,12.40%,ANO5;ANO2;SLC12A6;ANO6
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.6949497961310857,-1.1721066613217543,0.3235294117647059,1.0,1.0,1/5,6.83%,ACVR1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.7395500799393072,1.1717121563518884,0.3225806451612903,0.8403532169419609,1.0,3/8,17.85%,PICALM;RAC1;LGALS3
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.7809437580835399,1.1715099374967506,0.24615384615384617,0.8399961822650555,1.0,2/5,11.87%,LBR;CDKN1A
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.8234245730595522,1.1713998720987864,0.3064516129032258,0.8379711457765447,1.0,2/5,7.01%,CHSY1;CHST11
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.8234245730595522,1.1713998720987864,0.3064516129032258,0.8379711457765447,1.0,2/5,7.01%,CHSY1;CHST11
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.5557134342061718,1.1712246809090556,0.20253164556962025,0.8374697655950213,1.0,16/57,19.36%,MYO9B;EPS8;RAPGEF3;RASSF1;GRB2;JUN;RAP1A;GNA13;CDKN1A;SHC2;ADGRG1;KRAS;RAC1;SHOC2;CFL1;RERG
prerank,MSigDB_Hallmark_2020__Apical Junction,0.5446823514816151,1.170961110380065,0.24691358024691357,0.8371025614904863,1.0,15/64,14.08%,PIK3R3;CNTN1;CADM2;NFASC;INSIG1;NEGR1;CTNNA1;VWF;PECAM1;ADAM15;MYH10;CLDN5;ARPC2;ITGB1;RASA1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.7487447565844135,1.1709399441432307,0.25675675675675674,0.8359249674640318,1.0,1/7,5.50%,RAPGEF3
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.7712743738282412,1.1709329242430997,0.23076923076923078,0.8347508677818695,1.0,1/7,1.86%,PCK1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.5438448565769749,1.170422060711114,0.24691358024691357,0.8356442182879603,1.0,11/86,9.99%,LAMC1;RTN4;PLS3;NEDD9;GPM6B;EPS8;MYO1B;PICALM;ANK3;SLC2A1;RAD21
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.7038027871117387,1.1702742020375518,0.273972602739726,0.834935653251281,1.0,1/9,3.82%,TRMT9B
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.6843449736713771,1.169906363261958,0.2857142857142857,0.8352828129369935,1.0,3/12,6.91%,ARF1;CTNND2;PRNP
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.7512037949388981,-1.1698300915841664,0.38235294117647056,1.0,1.0,2/5,9.19%,PLA2G4A;PDGFB
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.3991245548238066,-1.1694084024979958,0.09090909090909091,1.0,1.0,14/165,3.61%,RSAD2;GBP1;VCAM1;XAF1;GBP2;IL32;IL15;ISG15;LEPR;IFI27;MX1;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.5211928852961707,-1.1692783449133908,0.21428571428571427,1.0,1.0,2/17,3.40%,IFIH1;OAS3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.5211928852961707,-1.1692783449133908,0.21428571428571427,1.0,1.0,2/17,3.40%,IFIH1;OAS3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.7001283324098986,1.1690159939431788,0.31666666666666665,0.8374043292394714,1.0,2/8,10.62%,CTNNA1;OTUD7B
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.5947984099105321,1.1684740295214093,0.2571428571428571,0.8384526541059957,1.0,5/30,11.29%,LRRC7;FES;SCARB2;RAP1A;MAGI2
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.7192108247376447,1.1684572814010423,0.34545454545454546,0.8372524162188448,1.0,3/8,12.19%,PPHLN1;RAD21;WAPL
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.6844705728136232,1.1684275704612592,0.30985915492957744,0.8361375347235918,1.0,4/14,12.59%,SPOCK1;GRIN2B;PRNP;PRAG1
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.7129464851387124,1.1681708641490822,0.2835820895522388,0.8362025679399947,1.0,3/10,2.71%,MAP2;MDGA2;SPOCK1
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.5310227943652905,1.1680805296363501,0.15384615384615385,0.8353046270036741,1.0,20/61,28.55%,LBR;PURA;MT2A;CDKN1B;YTHDC1;HIF1A;RAD21;SMARCC1;TENT4A;DMD;TRA2B;PAFAH1B1;HSPA8;TMPO;XPO1;NSD2;RASAL2;HNRNPU;SLC7A5;MTF2
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.7242561973438323,1.1680695119257576,0.265625,0.8341160104303402,1.0,4/9,20.58%,SCARB2;LAMP2;NEDD4;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.6663225241383904,1.1677138669146794,0.2463768115942029,0.8343138757460387,1.0,4/13,20.19%,HSPA5;PPM1A;RPL13A;SMAD6
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.7044575406863476,1.167556595002287,0.32727272727272727,0.8336663199355602,1.0,1/8,1.86%,PCK1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.7249648115715124,1.167473609500257,0.3333333333333333,0.832728628890775,1.0,3/6,16.10%,SEMA6B;UNC5C;SEMA3F
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.5895424809035495,1.1673738557264732,0.31343283582089554,0.8319394616699496,1.0,6/23,11.37%,MT1L;CD9;TINAGL1;BACE2;EMP1;ANXA2
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.7454373547074397,1.166823940611988,0.3125,0.8331099130709844,1.0,3/8,14.58%,TMEM45B;MAP7;VWA2
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.6580509014873077,1.16524911355672,0.3194444444444444,0.8382505654443729,1.0,7/17,23.48%,SERPINE1;PRKCE;MTDH;PDE4B;ZFP36;MEF2C;ADAM9
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.7189661519079535,1.1652343282775346,0.24615384615384617,0.8370697265520414,1.0,3/9,16.87%,PICALM;RAC1;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.6048623330035736,1.1641712498301047,0.28205128205128205,0.840369806019542,1.0,6/36,13.71%,ST18;BCAP31;MAP3K5;DLC1;REST;HIP1R
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.7406393451103213,1.1640279082892089,0.2698412698412698,0.8399612958681179,1.0,1/6,1.49%,TSG101
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.8015696011299094,1.1638193061865636,0.29310344827586204,0.8396985004560275,1.0,2/5,9.85%,KDM1A;GJA1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.5823966587854242,-1.1636996240770112,0.25925925925925924,1.0,1.0,4/17,5.52%,GBP1;MGMT;MX1;TNFSF10
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.726234466769257,1.1636163533265047,0.2903225806451613,0.8394524979018448,1.0,3/8,10.57%,GLUL;SNAP25;SLC12A6
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.6386744524160723,-1.163440741982186,0.34375,1.0,1.0,3/7,17.10%,ARHGAP12;SPRY3;CD2AP
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.805574726508655,1.1634268644000847,0.27419354838709675,0.8390951072544968,1.0,2/5,8.79%,SLC8A1;ANK3
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.5418747131450748,1.1632544657839665,0.21794871794871795,0.8386268079462348,1.0,12/63,13.94%,LRRC7;FES;SPOCK1;IL1RAPL1;SCARB2;CCDC88A;PPFIA2;LRRC4C;RAP1A;MAGI2;PRAG1;PAK2
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.6003927846003578,1.1631809579787562,0.23684210526315788,0.8376169491168848,1.0,7/27,12.78%,SLC8A1;GRIN2B;CACNA1C;ATP2B1;MICU2;ANO6;TMEM165
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.6817459300209976,-1.1629636518470228,0.34285714285714286,1.0,1.0,2/5,7.30%,STAT1;PKD2
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6451708360847963,1.162779068001457,0.34375,0.8378217878121473,1.0,5/12,18.03%,CALR;ZNF366;PIAS2;NCOR2;CRY1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.6736774119898755,1.1627404866049127,0.28125,0.8367363539980608,1.0,5/12,24.38%,ACOX1;NR1D2;PNPLA8;ABCG1;PPARG
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.7311820606990611,1.1626760501138802,0.23728813559322035,0.8357176144055359,1.0,4/6,26.40%,FGFR1;FLT1;ABL2;EGFR
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.6083343543052443,1.1625322121284762,0.2898550724637681,0.8350351879654894,1.0,3/20,6.06%,SERPINE1;NFKBIZ;HYAL2
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.5035402576891191,1.1623970353439543,0.2087912087912088,0.834354702994689,1.0,29/140,17.10%,PIK3R3;SERPINE1;ERBB4;NEDD9;SUN2;HSPA5;ANXA1;ELP3;VSIR;SMAD7;ENPP2;NAV3;SEMA6B;SRGAP1;DLC1;PECAM1;ADAM15;MAGI2;FLT1;BCAR1;CLDN5;ITGB1;RAC1;MGAT5;SEMA3F;PLXNA2;SDCBP;PRKX;DAG1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.5486802343355509,1.1621672204644047,0.23529411764705882,0.8340244463892551,1.0,9/37,17.50%,NFE2L2;ERO1A;PINK1;MSRA;JUN;HIF1A;FOS;TXNRD1;PXN
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.5450826172165687,1.1618825190269078,0.25925925925925924,0.834106164385486,1.0,10/62,11.85%,ADM;CALR;RAB11FIP3;CHSY1;SMAD7;PLCL1;SRGN;ATP2B1;GJA1;IFNGR1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7544112511218886,1.16152473953766,0.25,0.8346138931329807,1.0,3/5,21.38%,HS6ST3;SULF2;EXT1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.590375076926237,1.1610328765341225,0.25675675675675674,0.8353251230586741,1.0,6/29,18.88%,BCAP31;SMAD7;NFE2L2;TRIB2;HERPUD1;CSNK1D
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.6438586398209767,-1.1607752000688798,0.2903225806451613,1.0,1.0,3/9,9.19%,PPP2R5A;PDGFC;PDGFB
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.6854632796162707,1.1606849977900318,0.20833333333333334,0.8357824693874779,1.0,6/10,27.22%,ITGB1;RAC1;PARVB;GSN;CDC42;RHOJ
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.7304397784946897,1.160587983542996,0.3142857142857143,0.8349180496964279,1.0,2/5,22.15%,AFDN;CDH5
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.742919264293016,1.1605320637543655,0.2753623188405797,0.8338676912649869,1.0,2/7,21.14%,PRNP;MCL1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.6758233751382604,1.1597994496976578,0.25396825396825395,0.8353284045414602,1.0,6/11,20.61%,ROBO2;HYAL2;FOXC1;PRKX;SULF2;CEP290
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.74576990093399,1.1597552982952675,0.3142857142857143,0.8343743425068557,1.0,1/7,3.45%,STARD4
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.5308001774089186,-1.1595691941458586,0.3181818181818182,1.0,1.0,3/13,11.21%,SLC38A3;SLC25A29;SLC38A6
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.7071405590388014,1.1595285479446467,0.3382352941176471,0.8341732811795564,1.0,4/11,11.24%,SLC8A1;SLC12A6;ATP1A1;ATP1B3
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.5033126605366228,-1.1592747584711345,0.2222222222222222,1.0,1.0,3/24,3.82%,GBP1;CARMIL1;LIMS2
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.744542708347252,1.1589871940414664,0.29577464788732394,0.8349405948365666,1.0,3/8,10.07%,TMEM45B;ACSL5;RAP1A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.6488144658406368,1.1580226654710852,0.31343283582089554,0.8379972033882184,1.0,8/19,26.40%,DPP10;PRKCE;PIK3R1;ITGB1;LGALS3;ATP2B4;PRKCH;EGFR
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6334862965944439,1.1580223115854855,0.22972972972972974,0.8368268162326482,1.0,11/20,24.38%,KLF4;JUN;HIF1A;REST;FOS;ATOH8;GATA2;STAT3;NFIB;ETS1;PPARG
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.5419598984877779,1.1579365810283146,0.189873417721519,0.8359861293953009,1.0,9/42,16.52%,CHPT1;SPNS2;VAPB;KDSR;SAMD8;LPIN2;PLPP1;DMD;GOLPH3
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.6469854214794358,1.1578728675769079,0.25757575757575757,0.8350701697815838,1.0,2/13,5.23%,PPM1D;PPHLN1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6936045322463006,1.1570650939831977,0.23943661971830985,0.8374120341703345,1.0,8/12,22.87%,ANK2;ATP1B3;NEDD4L;ITGB1;CAB39;NEDD4;YWHAE;ATP1B1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.5617495901818615,1.1569779265046392,0.20987654320987653,0.8365585576068104,1.0,16/46,23.93%,FES;RAPGEF3;INSIG1;SSH1;CTNNA1;HSP90B1;RAP1A;ATP1A1;ADCY2;GOLPH3;TGM2;RYR3;ACTB;TFPI;MEF2C;MSN
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.5811201981090912,1.156821344781043,0.28125,0.8360166148318582,1.0,7/25,11.58%,GRIA2;CADM2;PDE5A;CTNND2;SNAP25;CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.5332045754091966,1.1561890282301566,0.25316455696202533,0.8377299614157853,1.0,7/65,8.23%,PIK3R3;ERBB4;RAPGEF3;PINK1;HSP90AA1;DLC1;RB1CC1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.593321105093191,1.1561714460318846,0.31343283582089554,0.8366945998693915,1.0,12/27,24.99%,PCK1;ANXA1;ALPL;GGT5;PELI1;TAB2;ERBIN;STAT3;SMAD6;ABCG1;PPARG;RPS6KA3
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.6641297944299918,1.1557835533782088,0.3142857142857143,0.8369706106764968,1.0,2/10,3.93%,KCNIP4;DPP10
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.7093257757758842,1.155657655926499,0.3582089552238806,0.8363234783844113,1.0,2/8,7.54%,ERBB4;SEMA6B
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.6232842241300517,1.1551705879111898,0.2647058823529412,0.837167258586106,1.0,3/17,10.07%,PINK1;HSP90AA1;RAP1A
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6721585191601982,1.1551378469187674,0.2537313432835821,0.8361383676710952,1.0,5/13,12.40%,SLC4A10;ANO5;ANO2;SLC12A6;ANO6
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.5606616698297149,1.1550621010076065,0.2891566265060241,0.835341948546132,1.0,14/60,19.42%,PPP2R3A;PPM1D;PPP2R2B;PTPRD;DUSP6;DUSP1;SSH1;PPM1A;DUSP16;CTTNBP2NL;PPP1CB;DUSP22;MTMR6;PTPN1
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.7839225110394359,1.154840957290642,0.265625,0.8349757973361981,1.0,1/5,12.91%,AGO2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.5505756969968357,1.1547006497189924,0.2564102564102564,0.834381633278449,1.0,9/48,11.47%,BCL6;FES;PLEKHB2;FGFR1;SMAD7;CBFB;CDK6;KLF4;REST
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.6035116222736121,1.1545551355184864,0.32894736842105265,0.8337890948405572,1.0,6/30,12.78%,ITPR1;SLC8A1;ANK2;CACNA1C;ANO6;TMEM165
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.750554216330044,1.1542866694959242,0.35294117647058826,0.8336092778552068,1.0,2/5,21.14%,BCL2L1;MCL1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.6148631374920355,1.1535246395281438,0.25333333333333335,0.8357867646547497,1.0,3/16,13.31%,REL;RPS27A;TAB2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.6944124402403397,1.152991718931394,0.23333333333333334,0.8371839071898465,1.0,5/12,23.03%,KCNMB4;PREPL;SLC30A1;RIMS2;MEF2C
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.6222980078558393,1.1527393566060955,0.28378378378378377,0.8371821718149267,1.0,3/24,7.68%,ADM;ZFPM2;CTNNA3
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.4821237464305977,1.152605331197408,0.16304347826086957,0.8365747104262622,1.0,53/209,22.42%,ANGPTL4;RTN4;BCL6;HSPA5;BNIP3L;TBX3;MAP3K5;CALR;ANXA1;DUSP6;PIK3R1;NDRG1;PINK1;HSP90AA1;RPS27A;ARHGEF4;HSP90B1;JUN;HSPA9;GNA13;PHLPP1;REST;ANO6;BCAR1;ITGB1;HIP1R;NAA16;PAK2;RASA1;ECT2;MTDH;GOLPH3;ACTN1;GRK5;MALT1;TGM2;ARHGEF2;TMBIM6;CFL1;KALRN;BCLAF1;NPM1;SMAD6;BCL2L1;TNFRSF10B;DNM2;MCL1;TNFAIP8;AVEN;RPL10;BCL2L14;SETX;UBC
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.7375318077530315,1.1525567085658048,0.2037037037037037,0.8356059522026691,1.0,2/8,13.71%,CCDC88A;HIP1R
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.6882076619020047,1.1517951773909134,0.34782608695652173,0.8373582206624697,1.0,5/7,29.14%,CACNA1C;ATP1A1;GSN;CAMK2D;FGF12
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.699034999269157,1.151703632126346,0.3888888888888889,0.8355168098928497,1.0,1/8,5.52%,VSIR
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.699034999269157,1.151703632126346,0.3888888888888889,0.8355168098928497,1.0,1/8,5.52%,VSIR
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.5187379674903195,-1.1513925597342467,0.23809523809523808,1.0,1.0,4/19,8.92%,PLA2G4A;OCLN;NKD1;PROM1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.561576584144308,1.1511923372268313,0.2716049382716049,0.8363897214059225,1.0,12/50,17.21%,RTN4;BCL6;BNIP3L;CALR;NDRG1;PINK1;HSP90AA1;PHLPP1;BCAR1;ACTN1;MALT1;TGM2
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.6694286103274532,1.151003344111966,0.28169014084507044,0.8360586147832023,1.0,3/12,9.43%,ANXA1;ALPL;GGT5
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.669804711940216,1.1509004104313791,0.3142857142857143,0.8353983862411942,1.0,6/12,24.38%,CD9;VWF;PECAM1;GATA2;FGR;PPARG
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.7844275080252235,1.1507642416197996,0.3125,0.8347249520697001,1.0,3/6,11.47%,PINK1;HIF1A;REST
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.4850283340846567,-1.1505949116385727,0.21739130434782608,1.0,1.0,5/39,3.27%,GBP2;CD74;IL15;TAP1;STAT1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.6030007008266982,1.1503577556484208,0.26506024096385544,0.8353548744351545,1.0,3/25,11.47%,KHDRBS3;YTHDC1;REST
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.4963368222377554,-1.1500456342272092,0.25,1.0,1.0,4/36,3.98%,RSAD2;TTN;DISP1;BMP6
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.7432198854532925,1.1498687633736435,0.2857142857142857,0.8358337052470601,1.0,1/6,2.52%,TRIM5
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.6746435029818536,-1.1492306010923365,0.3611111111111111,1.0,1.0,1/7,0.24%,CEMIP
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.7043691956662772,-1.1481716957738937,0.2857142857142857,1.0,1.0,2/5,18.11%,ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.7371907662448223,-1.1481586760889706,0.4,1.0,1.0,2/5,16.79%,ACVR1;MDM4
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.6096284528684321,1.1476951397360977,0.22535211267605634,0.8434133049466263,1.0,5/23,13.41%,B3GNT2;CHSY1;CHST11;GGT5;SLC26A2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.7076259095306501,1.1472487863710024,0.38028169014084506,0.8439396834718357,1.0,2/10,6.37%,KLF2;CPEB4
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.6954281478379839,1.1471960282887634,0.2727272727272727,0.8431402977786508,1.0,4/11,19.76%,SEC22B;PINK1;FEZ2;CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.5173578492605209,1.1471819939363537,0.30434782608695654,0.842045831902737,1.0,28/89,23.08%,ST18;ERBB4;TBX3;PPM1D;PBRM1;DLC1;CDK6;KLF4;ITGA1;CDKN1B;MAGI2;REST;CDKN1A;ADGRG1;PLPP1;GATA2;BTG2;NACC2;ABI1;RERG;NPM1;SMAD6;BTG1;MORC3;COL18A1;MTSS1;ETS1;ADAMTS1
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.5801740291834965,1.1470488654714575,0.2857142857142857,0.8414143457070136,1.0,6/34,12.88%,PLS3;GAPDH;MYO1B;PEBP1;FKBP5;BCAR1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.5791545651075218,1.1469901438454384,0.3108108108108108,0.8406066861433803,1.0,6/33,10.78%,PBX3;TIMP3;COL4A2;EMP1;GJA1;BOC
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.6964670805293529,1.146897734495299,0.3384615384615385,0.8399343842529502,1.0,2/6,3.90%,IL1RAPL1;ANXA1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.7203088414234095,1.146758198263122,0.31343283582089554,0.8393673379616349,1.0,4/9,18.43%,ANXA1;PIKFYVE;LGALS3;PDE4B
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.6669685939568457,-1.146586905340085,0.41025641025641024,1.0,1.0,2/5,8.58%,PARN;ST3GAL1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.7801046983288452,1.1463872161791127,0.2903225806451613,0.8388569371587093,1.0,3/5,17.98%,YBX3;PELI1;ARHGEF2
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.7801046983288452,1.1463872161791127,0.2903225806451613,0.8388569371587093,1.0,3/5,17.98%,YBX3;PELI1;ARHGEF2
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.6383603654043247,1.1462468303177396,0.2898550724637681,0.8383966236334703,1.0,1/15,0.08%,CCDC3
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.6824462316575122,1.1462397424579671,0.40298507462686567,0.8373640782554685,1.0,2/10,9.16%,PINK1;MICALL2
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5891544596171255,1.1460189739176228,0.23809523809523808,0.8369069445536204,1.0,5/24,17.45%,ANXA1;FGFR1;HIF1A;HDAC7;GATA2
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.6530015578770263,-1.145288088009241,0.41935483870967744,1.0,1.0,2/8,14.21%,YEATS2;KAT6B
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.6620061839927109,-1.145180153077063,0.38095238095238093,1.0,1.0,2/6,12.91%,HLA-F;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.7166162704397627,1.1450367306500897,0.34545454545454546,0.8400146233581736,1.0,2/7,4.38%,IL1RAPL1;PTPRD
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.6665803334433138,-1.1450298272305595,0.3235294117647059,1.0,1.0,7/10,19.18%,PDGFB;ZSWIM5;PTPN2;USP14;STX3;MYCBP2;ZSWIM6
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.7341547382156951,1.1449237737747164,0.3188405797101449,0.8393355212476213,1.0,2/5,17.53%,KDM1A;RIF1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.6795148174271102,1.1449209738386514,0.2753623188405797,0.838234031062257,1.0,7/10,28.58%,HYAL2;PHLPP1;MAGI2;DAG1;RACK1;PIK3CB;PLEKHA1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.537752462324389,1.144731589697377,0.2727272727272727,0.8378365832892256,1.0,6/37,15.70%,BNIP3L;TRIM5;UFL1;PINK1;TMEM59;MTDH
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6663404084885214,-1.1443109095454336,0.2857142857142857,1.0,1.0,1/9,0.82%,EIF2AK2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.7539662397264191,1.1442074291054987,0.2876712328767123,0.838884415610814,1.0,1/6,1.30%,CLIC2
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.7361793628582691,1.1438585556295584,0.3787878787878788,0.8391282019679135,1.0,2/8,10.17%,MYO1B;MYO1E
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.7233069744395088,1.143750817558516,0.3114754098360656,0.8383819388976156,1.0,2/8,15.67%,AGO2;TUT7
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.6090064165873853,1.1431203087304103,0.3717948717948718,0.8396429300572114,1.0,5/26,18.25%,PSMC6;MAGI2;RAC1;PSMA7;FZD4
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.5510401791342592,1.142926956937341,0.2894736842105263,0.8392317230321599,1.0,5/51,8.07%,CEP57;PSMC6;TUBB4B;HSP90AA1;RPS27A
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.6779826087697516,1.1427032153925125,0.36363636363636365,0.8390100000182027,1.0,2/10,5.29%,ROBO2;ZFPM2
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.5353418724770005,1.1426665638950062,0.25925925925925924,0.8380361734771052,1.0,19/63,21.14%,DDIT4;ITPR1;HYAL2;PINK1;DUSP1;PDE10A;PEBP1;OTUD7B;PHLPP1;MAGI2;PPM1A;UBE2B;SPRED1;DAG1;HDAC7;HERPUD1;BCL2L1;ATP2B4;MCL1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.6377215733146979,1.1425239092647812,0.25,0.8376286504697649,1.0,2/16,8.07%,MAP3K5;RPS27A
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.7476165898500038,1.1425104985313397,0.23809523809523808,0.8366591361082407,1.0,3/7,18.03%,BHLHE40;PPP1CB;CRY1
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.7151835899543809,1.141780244926003,0.3442622950819672,0.8380855893647209,1.0,2/8,7.54%,ERBB4;SEMA6B
prerank,MSigDB_Hallmark_2020__Complement,0.5228443294470302,1.1405006581766708,0.28205128205128205,0.8418123247412932,1.0,11/60,13.78%,MAFF;SERPINE1;HSPA5;ZFPM2;DUSP6;GRB2;COL4A2;LAMP2;CFH;DOCK4;CD55
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.7104661114144468,1.1404092183826813,0.34375,0.8409993584680933,1.0,4/6,24.81%,ADGRB3;MYEF2;MEF2C;SORT1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.6697294942259021,-1.1403187337169913,0.375,1.0,1.0,1/8,2.95%,ATM
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.6570668749546544,1.1399073765772838,0.29850746268656714,0.8418401965196824,1.0,1/14,0.77%,ADAMTS9
prerank,PanglaoDB_Augmented_2021__Platelets,0.567776928519359,1.1398582311423682,0.2987012987012987,0.8409288775345347,1.0,8/35,11.31%,SERPINE1;CD9;ERO1A;SRGN;VWF;PECAM1;LRRC32;SLC2A3
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.7077339326781018,1.139777495213443,0.31343283582089554,0.8401631589249484,1.0,3/8,10.23%,RPS27A;NPLOC4;RFC3
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.5752653480740172,1.1392513742308972,0.27848101265822783,0.8411162912624961,1.0,5/38,5.58%,BCL6;TRIM5;MGLL;ANXA1;UFL1
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.5596854481385881,-1.1392170337997436,0.37142857142857144,1.0,1.0,3/19,8.50%,VCAM1;NOD1;MDM2
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.6684430872578673,1.1386798072797275,0.3181818181818182,0.8419240893450544,1.0,5/9,24.14%,DUSP1;FOXC1;LRCH1;OXSR1;WNK1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.4971700579910481,-1.1384344961081736,0.3181818181818182,1.0,1.0,10/42,10.52%,GBP1;GBP2;ISG15;DCP1A;OPTN;BICD1;MDM2;COG3;CNTLN;CEP68
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.6931048586965075,1.1384063731039589,0.328125,0.8418022209121551,1.0,2/8,17.90%,MGAT4A;FUT8
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.6967383866960567,1.1381099772873593,0.3698630136986301,0.8418089365529905,1.0,2/8,6.48%,TINAGL1;ATP8B1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.6725836492810845,1.1379332544108598,0.32432432432432434,0.841488246477377,1.0,3/12,15.64%,KDM1A;PIAS2;NCOR2
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.7455436293765383,1.1378138998002474,0.3728813559322034,0.8409977809363187,1.0,2/5,15.64%,PIAS2;NCOR2
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.6609977011662216,1.1377547373604027,0.4050632911392405,0.840210406576442,1.0,3/12,4.78%,SERPINE1;ANXA1;PRKCE
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.760147712654663,1.1375883821463788,0.3770491803278688,0.8396377350537719,1.0,2/5,13.20%,SPIRE1;ARPC2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.5464296462683229,-1.1372155085311457,0.25,1.0,1.0,3/17,6.11%,ATM;ATR;PARN
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.758620466265852,1.1372044995228505,0.3181818181818182,0.8400012067850718,1.0,3/6,16.18%,ANK2;SMAD7;DMD
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.6676375227696422,1.136928776408264,0.3333333333333333,0.8400808766738647,1.0,5/10,24.14%,DUSP1;FOXC1;LRCH1;OXSR1;WNK1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.6623823375358711,-1.1366880339375043,0.2571428571428571,1.0,1.0,2/5,10.25%,RC3H1;CPEB3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.7114678904846975,1.1360553833304856,0.3333333333333333,0.8412271824769981,1.0,1/8,2.55%,TBX3
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.7114678904846975,1.1360553833304856,0.3333333333333333,0.8412271824769981,1.0,1/8,2.55%,TBX3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.7595744680851063,1.1358195976625465,0.3230769230769231,0.8412345486837853,1.0,5/5,24.14%,ANK3;ATP1B3;DMD;ATP1B1;WNK1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.7095225019754513,1.1353006821511231,0.3333333333333333,0.8420862482149227,1.0,2/10,6.27%,ZFPM2;SMAD7
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.5412112020079077,1.1351722322651345,0.2625,0.841614649803188,1.0,8/55,11.87%,PDK4;PRKAG2;HSPA5;MAP3K5;CPEB4;LAMP2;SIK2;CDKN1A
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.6767533539683678,1.1351501285620824,0.3333333333333333,0.8405827559002158,1.0,2/11,4.36%,MAP2;INPP5F
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.45819189417987766,1.1346513121317583,0.1111111111111111,0.8414040224795883,1.0,109/490,21.30%,MAFF;ST18;PBX3;ZEB2;ERBB4;BCL6;ATF3;KLF6;MAFK;KLF2;TBX3;BHLHE40;ZNF160;PHF10;MAP3K5;CALR;JUNB;ELP3;NPAS3;BAZ1A;ZBTB1;ZFPM2;ZNF280D;PURA;POLA1;SMAD7;NFE2L2;ESR2;ATP8B1;ZNF586;REL;BACH2;CBFB;SMAD5;KDM1A;JUND;ARID5A;ELP4;PICALM;KLF4;CDKN1B;OGT;FOSL2;JUN;HIF1A;ZNF366;RAD21;CREM;SPEN;CCNH;CNBP;SETD3;CCNC;REST;CDKN1A;FOS;PPM1A;FOXF1;TRAK1;SBNO1;ZBTB10;SMARCC1;ZBTB38;NAA16;LRRFIP1;PIAS2;WWTR1;BRWD3;FOXC1;CRLF3;CCNL1;NCOR2;MTDH;CRK;ATF2;BRD4;NR2C1;ATOH8;LIMS1;GATA2;NPAS2;CRY1;FZD4;ZMIZ1;STAT3;ZNF43;NFIB;MBD2;NACC2;NR1D2;HBP1;NFIC;RLF;NOTCH4;BCLAF1;KMT2E;CREBZF;NPM1;SMAD6;RCOR3;ELK3;HSPA8;CEP290;ATP2B4;BTG1;DENND4A;DNM2;PPP3CB;EPAS1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.6430274042434633,1.1343372070748605,0.36764705882352944,0.8415931438615575,1.0,1/13,0.53%,DDIT4
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.6124216428098532,1.1340846339172979,0.3333333333333333,0.8414461687154419,1.0,7/21,17.21%,IL1RAPL1;PTPRD;ROBO2;KDM1A;SPEN;PLXNA2;TGM2
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.5182502785418628,-1.1334584970982122,0.2413793103448276,1.0,1.0,7/17,22.50%,BICD1;EFNA5;CLASP1;CYLD;PHLDB1;PHLDB2;MARK2
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.7450657078420504,1.1333367144350397,0.3,0.8421576676362712,1.0,2/5,18.57%,JAK1;STAT3
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.7450657078420504,1.1333367144350397,0.3,0.8421576676362712,1.0,2/5,18.57%,JAK1;STAT3
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.5834608797995052,1.1333320704632417,0.30985915492957744,0.8411049705517261,1.0,4/23,16.79%,SRGN;OGT;NAA16;NAA50
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.6384260775296164,1.13332463357672,0.35135135135135137,0.84011055957936,1.0,4/9,12.40%,ANK2;ATP2B1;ANK3;ANO6
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.6551024743204104,1.1331309273419479,0.31343283582089554,0.8398551728330442,1.0,4/14,17.00%,PRKAG2;OGT;HIF1A;TPR
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.6875299461407538,1.1327398375877087,0.34285714285714286,0.8402388910218327,1.0,2/8,8.79%,ANK2;ANK3
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.6603430014944978,1.1327155280497447,0.359375,0.8393324427173485,1.0,2/12,9.16%,PINK1;MICALL2
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.7524186373702284,1.132548634620699,0.30303030303030304,0.8388989857680756,1.0,1/5,11.16%,SETD3
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.6549117068972066,1.1324062049259698,0.23880597014925373,0.8383421515298495,1.0,3/17,16.55%,ADAMTS9;DENND3;SND1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.5578901586557403,1.132295819150305,0.35526315789473684,0.8376762096151713,1.0,5/24,9.03%,INPP5F;FGFR1;PIK3R1;PLCL1;OGT
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.5076252376434798,1.132229832010904,0.24705882352941178,0.8369153589948963,1.0,28/95,24.78%,BCL6;BNIP3L;MAP3K5;DUSP6;PRNP;DLC1;RPS27A;ARHGEF4;JUN;GNA13;REST;ANO6;ITGB1;HIP1R;ECT2;TGM2;ARHGEF2;KALRN;BCLAF1;BTG1;TNFRSF10B;DNM2;TNFAIP8;UBC;PREX1;ATF6;RACK1;FGD4
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.614107883426365,-1.1319769294082758,0.3333333333333333,1.0,1.0,2/10,9.19%,SLC4A4;PDGFB
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.5908116709533133,1.1317889052614816,0.2916666666666667,0.8374100797400242,1.0,8/20,26.40%,HYAL2;JUN;HIF1A;FOS;PXN;ADAM9;FYN;EGFR
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.7074057791678064,1.1311540823140307,0.34328358208955223,0.8386878880747124,1.0,1/8,0.98%,BCL6
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.5844229417014232,1.1296060661490732,0.2911392405063291,0.8438105411706746,1.0,6/30,11.87%,TSG101;SLC8A1;CDKN1B;TRIB2;CCNH;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.6192737820434115,1.1290532575064065,0.3333333333333333,0.8445557349682659,1.0,8/19,23.03%,CPEB4;PINK1;REST;BTBD10;RASA1;INPP5A;CHMP4B;MEF2C
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.5097152797860502,1.1289518082806436,0.23863636363636365,0.8439967372496798,1.0,8/86,8.23%,PIK3R3;ERBB4;ATF3;CCDC88A;PRNP;PINK1;HSP90AA1;RB1CC1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.4623397050773214,-1.1283779813604222,0.23809523809523808,1.0,1.0,5/46,2.84%,GBP1;HOMER2;IFIH1;ISG15;HERC5
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.736888315448737,1.1283283320009672,0.3442622950819672,0.8453423278714461,1.0,4/6,26.29%,CTNND2;DIP2A;WASL;CDC42
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.7236870634822524,1.1282977370355216,0.2641509433962264,0.8443871503802294,1.0,1/6,9.56%,HSP90B1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6992021563203616,1.127202979149751,0.4126984126984127,0.8469719002409616,1.0,3/9,17.45%,ANXA1;HDAC7;GATA2
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.6854928716789734,1.127011879741708,0.3484848484848485,0.8465900268994663,1.0,1/11,0.53%,DDIT4
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.6089449120306687,1.1262998175075745,0.30864197530864196,0.8483755002190047,1.0,4/25,5.58%,BCL6;MGLL;ANXA1;UFL1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.6952218697571089,1.1262662091213214,0.3333333333333333,0.847502935926991,1.0,3/8,8.63%,KLF2;NFE2L2;KLF4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.6387903033108908,1.1258911728368566,0.2777777777777778,0.8479101484620741,1.0,1/16,0.88%,PSMC6
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.584897456239396,1.1258430170736702,0.3142857142857143,0.8470131256919821,1.0,5/28,15.25%,NES;MAP1B;BOC;BCAR1;FOXC1
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.6016504604400417,1.125827008134225,0.2753623188405797,0.8460098139707549,1.0,8/19,23.03%,KCNMB4;ANXA1;RAB21;STXBP5L;SYT1;RIMS2;RAB8B;MEF2C
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.6142336736043837,1.125719813995938,0.373134328358209,0.845388129339745,1.0,5/13,21.22%,MAP1B;HSP90AA1;ALCAM;SEMA3F;PPP3CB
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.7191489361702127,1.1255827793310553,0.27941176470588236,0.8449032139119856,1.0,5/5,28.18%,COMMD1;NEDD4L;NEDD4;WNK1;CAMK2D
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.7173677994669619,1.1255330450224776,0.375,0.8439871658507266,1.0,4/7,24.65%,MT1M;MT2A;SLC30A1;MT1E
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5682584158207308,1.1252757206053,0.3026315789473684,0.8439503987198912,1.0,7/38,16.87%,ZEB2;SMAD7;RPS27A;PPM1A;STRAP;SPRED1;SDCBP
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.6487830187403808,-1.124865700575396,0.37142857142857144,1.0,1.0,1/10,0.16%,VCAM1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.6945661766097043,-1.1248506523897406,0.40625,1.0,1.0,1/6,4.94%,BCOR
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.6649787565946341,1.1248134555309515,0.4411764705882353,0.8446414763133975,1.0,3/7,29.38%,REST;WDR43;CNOT2
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.4589968535475074,1.124665771965792,0.1958762886597938,0.8440521197640974,1.0,81/334,22.66%,MAFF;ST18;ZEB2;SERPINE1;ERBB4;ATF3;KLF6;KLF2;TBX3;PHF10;MAP3K5;JUNB;CD81;NPAS3;ZFPM2;CRTC3;HYAL2;PIK3R1;SMAD7;NFE2L2;ESR2;REL;SMAD5;KDM1A;JUND;RPS27A;PICALM;KLF4;OGT;FOSL2;JUN;HIF1A;CNBP;SETD3;CCNC;REST;FOS;PPM1A;FOXF1;AGO2;TMF1;ACVR2A;SMARCC1;ZBTB38;NAA16;WWTR1;LPIN2;FOXC1;CRLF3;ATF2;BRD4;ATOH8;TNKS;GATA2;NPAS2;ARHGEF2;NAMPT;FZD4;ZMIZ1;STAT3;NFIB;NR1D2;NFIC;RLF;NOTCH4;BCLAF1;KMT2E;CDK8;NPM1;ELK3;CEP290;DNM2;PPP3CB;EPAS1;TFCP2;MED4;SETX;PLCB1;UBC;SREBF2;ETS1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5418750381604828,1.1245993655090518,0.3333333333333333,0.8433028517166534,1.0,13/34,10.78%,GRIA2;MAP2;DOK5;ANK2;MAP1B;GPM6B;NPAS3;PTPRD;NFASC;PPFIA2;LRRC4C;GJA1;BOC
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.7046237831189351,1.1245897406712113,0.3333333333333333,0.8423002524319606,1.0,3/6,26.64%,UFL1;MBD2;CHD1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6301073231982769,1.124490965689685,0.4027777777777778,0.8416487804391238,1.0,4/10,19.39%,PDE7A;RAPGEF3;ADCY2;RIMS2
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.7052033635255601,1.1243152605580151,0.4032258064516129,0.8411864180374996,1.0,3/7,10.49%,GLUL;ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.5838098411980888,1.1240691559978648,0.323943661971831,0.8409392439330537,1.0,12/29,24.99%,SERPINE1;GGT5;PELI1;TAB2;ERBIN;PDE4B;SMAD6;ZFP36;SCARB1;MEF2C;ADAM9;RPS6KA3
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.738965057302993,1.123891874447448,0.3880597014925373,0.8404120218602078,1.0,2/5,14.21%,SCP2;LSS
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.6973179620917681,1.1238090769633822,0.3380281690140845,0.8397659320452668,1.0,1/7,1.99%,HSPA5
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.3939257368140624,-1.1231093123562563,0.125,1.0,1.0,14/132,8.50%,RNF213;ATG10;MSL2;IFIH1;ANAPC16;ISG15;HERC5;ZNRF3;NFX1;NUP214;RTF1;HECW2;HERC2;MDM2
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.7170686556717726,1.1230319686822474,0.391304347826087,0.8414411337171649,1.0,1/5,3.90%,ANXA1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.7333527154407607,1.1228882333113424,0.3424657534246575,0.841008413310252,1.0,1/9,2.55%,TBX3
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.7856635094529495,1.1227411731065933,0.30434782608695654,0.8405900257031427,1.0,1/5,3.82%,TRMT9B
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.6980709987898923,-1.1226921607531701,0.325,1.0,1.0,2/5,9.59%,MX1;DNM3
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.6980709987898923,-1.1226921607531701,0.325,1.0,1.0,2/5,9.59%,MX1;DNM3
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.6062294289160681,-1.1222743628767702,0.375,1.0,1.0,2/11,1.81%,CPQ;PLA2G4A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.7316971435363689,1.1214113515016444,0.3484848484848485,0.843272361634615,1.0,2/9,6.80%,ITPR1;ERO1A
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.7316971435363689,1.1214113515016444,0.3484848484848485,0.843272361634615,1.0,2/9,6.80%,ITPR1;ERO1A
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5645829690812028,1.1213879302768999,0.3037974683544304,0.8404168252345371,1.0,19/35,31.45%,PRKCE;PIK3R1;HSP90AA1;GRB2;ARPC2;RAC1;CRK;ABI1;WIPF1;ACTB;NCK1;FYN;FGR;WASL;CDC42;PIK3CB;ACTR2;DOCK1;PTK2
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5645829690812028,1.1213879302768999,0.3037974683544304,0.8404168252345371,1.0,19/35,31.45%,PRKCE;PIK3R1;HSP90AA1;GRB2;ARPC2;RAC1;CRK;ABI1;WIPF1;ACTB;NCK1;FYN;FGR;WASL;CDC42;PIK3CB;ACTR2;DOCK1;PTK2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.5645829690812028,1.1213879302768999,0.3037974683544304,0.8404168252345371,1.0,19/35,31.45%,PRKCE;PIK3R1;HSP90AA1;GRB2;ARPC2;RAC1;CRK;ABI1;WIPF1;ACTB;NCK1;FYN;FGR;WASL;CDC42;PIK3CB;ACTR2;DOCK1;PTK2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.7145575266775952,1.1211896116805296,0.3466666666666667,0.8399492908644322,1.0,6/7,28.47%,ANK2;AHNAK;DMD;YWHAE;CAMK2D;CALM1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.6542297408084427,1.1211387765464063,0.3333333333333333,0.8391135465498705,1.0,3/13,16.49%,PIK3R1;RAC1;LIMS1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.6545347611076173,1.1209665357504859,0.3424657534246575,0.8388199236902935,1.0,4/8,29.93%,HSP90AA1;PTTG1IP;MSN;DAB2IP
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5843008631082254,1.1209562444148926,0.35135135135135137,0.8378822163207496,1.0,5/27,13.04%,B3GNT2;PLOD2;OGT;TMTC1;TRAK1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.6802976401259213,1.1205580210616857,0.3384615384615385,0.838155896207728,1.0,4/8,23.69%,PTBP2;NCOR2;TMBIM6;PTBP3
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.6050179666448653,1.1201196451507671,0.35714285714285715,0.8386783583128897,1.0,5/15,14.66%,MAP3K5;RPS27A;TAB2;MAPK10;SH2D3C
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.7618631769675082,1.12007807165646,0.3384615384615385,0.8368120913877986,1.0,3/5,11.24%,SLC12A6;ATP1A1;ATP1B3
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.7618631769675082,1.12007807165646,0.3384615384615385,0.8368120913877986,1.0,3/5,11.24%,SLC12A6;ATP1A1;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.7144088529670662,1.1199388049076087,0.38333333333333336,0.8363139333939175,1.0,2/7,11.87%,CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6088252776663614,-1.1197621224878676,0.38461538461538464,1.0,1.0,5/13,20.82%,STAT1;PDGFB;IGFBP3;CDH13;IL6R
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.6700390934356862,1.1196351327453882,0.36507936507936506,0.8364179873641439,1.0,1/11,0.69%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.45871686141983015,1.1191820103750194,0.10101010101010101,0.8370177308169023,1.0,114/514,20.64%,MAFF;ST18;PBX3;ZEB2;SERPINE1;BCL6;ATF3;KLF6;MAFK;KLF2;TBX3;BHLHE40;ZNF160;PHF10;PPM1D;CALR;JUNB;CD81;ELP3;NPAS3;BAZ1A;ZBTB1;ZFPM2;CRTC3;PURA;HYAL2;PIK3R1;SMAD7;NFE2L2;SIN3B;ESR2;ZNF586;REL;BACH2;CBFB;SMAD5;KDM1A;JUND;ARID5A;RPS27A;RPL23;ELP4;KLF4;OGT;FOSL2;JUN;HIF1A;ZNF366;RAD21;CREM;SPEN;OTUD7B;CCNH;CNBP;SETD3;CCNC;REST;CDKN1A;FOS;PPM1A;FOXF1;AGO2;TRAK1;TMF1;NEDD4L;ACVR2A;ZBTB10;SMARCC1;ZBTB38;LRRFIP1;PIAS2;WWTR1;LPIN2;BRWD3;FOXC1;CRLF3;CCNL1;NCOR2;MTDH;CRK;ATF2;BRD4;NR2C1;ATOH8;TNKS;MCPH1;SDCBP;TPR;GATA2;RIF1;NPAS2;ARHGEF2;NAMPT;CRY1;ZMIZ1;STAT3;DUSP22;ZNF43;NFIB;MBD2;NACC2;NR1D2;HBP1;NFIC;RLF;NOTCH4;BCLAF1;CREBZF;CDK8;NPM1;SMAD6;RCOR3;ELK3;ATP2B4
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.6823563114633584,1.1188571238655522,0.359375,0.8370946470137876,1.0,4/13,19.76%,SUN2;REEP3;TPR;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.6591516306783533,1.1187803298406291,0.32432432432432434,0.8364292218305001,1.0,7/12,30.46%,ANXA1;ANXA2;KATNBL1;UVRAG;RAB3GAP2;ATL3;CALCOCO2
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.7364210416744321,1.118413369630011,0.328125,0.8365196504218011,1.0,2/5,12.88%,NEDD9;BCAR1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.5855429444272465,1.1183014360841486,0.358974358974359,0.8359603667423967,1.0,4/24,18.25%,PSMC6;RAC1;PSMA7;FZD4
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5481487622171568,-1.117938829303451,0.25,1.0,1.0,5/27,3.61%,IFIH1;ISG15;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6080076339466662,1.1176897193112298,0.35294117647058826,0.8371410228230158,1.0,1/15,1.38%,LRRC7
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.5605686441176261,1.1176516971420383,0.33766233766233766,0.8363231208721283,1.0,9/29,21.67%,BCAP31;ZDHHC6;LAMP2;ZDHHC14;PIKFYVE;TRAK1;SDCBP;VPS37A;CDC37
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.7462029564719139,1.117500408678002,0.39344262295081966,0.8359084066238808,1.0,1/6,1.54%,SUN2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.6622154118885607,1.1171611904815864,0.38461538461538464,0.8360247743835036,1.0,6/14,22.15%,MAP2;NAV3;ARHGEF2;TBCD;TAOK1;CDH5
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.6308240723777356,-1.116597640747749,0.3939393939393939,1.0,1.0,3/10,9.93%,COL8A1;LAMA3;FN1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.7090806007296281,-1.1160034056045085,0.4,1.0,1.0,3/7,11.37%,ATM;LDB2;NLRC5
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5838175982848823,1.115079974365913,0.3835616438356164,0.8424691091432309,1.0,3/20,15.30%,ADM;GGT5;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7479363516474912,1.1145913335974797,0.2807017543859649,0.8429259092967726,1.0,2/5,13.78%,CD81;CD55
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7222177817267187,1.1144240134356274,0.37333333333333335,0.8424797097048546,1.0,4/9,22.15%,JAK1;PAK2;ACTB;CDH5
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.6207091215610052,1.1139180066305159,0.38961038961038963,0.8434373737967056,1.0,3/21,5.15%,ITPR1;SLC8A1;CACNA1C
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.7590847552965443,1.1134864597934742,0.3770491803278688,0.8440200283782779,1.0,2/5,14.82%,ATG12;AGTPBP1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.542722599364886,1.113059596480502,0.3108108108108108,0.8446783826872313,1.0,7/29,13.31%,ERBB4;PRKAG2;FGFR1;RAP1A;CDKN1A;FLT1;TAB2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.5077273254133878,1.1129525955229793,0.25,0.8441680922988448,1.0,25/90,24.78%,BCL6;BNIP3L;MAP3K5;DUSP6;RPS27A;ARHGEF4;JUN;GNA13;REST;ANO6;ITGB1;HIP1R;ECT2;TGM2;ARHGEF2;KALRN;BCLAF1;TNFRSF10B;DNM2;TNFAIP8;UBC;PREX1;ATF6;RACK1;FGD4
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.6299313556805367,1.1128274120204253,0.40540540540540543,0.8436974075622306,1.0,3/11,18.57%,ANXA1;GGT5;STAT3
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.7017067723969503,1.1126028342696164,0.3472222222222222,0.8433813574002812,1.0,2/8,8.82%,SMAD7;CDKN1B
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.5078258817377,-1.1123280011374497,0.34615384615384615,1.0,1.0,3/14,11.21%,SLC38A3;SLC16A2;SLC38A6
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.7179534141715425,1.1122449703637496,0.38181818181818183,0.8436539799329645,1.0,4/8,17.21%,BCAP31;MICU2;PDZD8;TGM2
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.688508659805907,1.112016890660953,0.42857142857142855,0.8435940402365204,1.0,2/7,11.47%,ANXA1;REST
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.7235398829565325,1.111943023743378,0.40625,0.8428328652782937,1.0,3/6,25.13%,FGFR1;STOX2;USP22
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.5483577286280855,1.1117013360663555,0.3108108108108108,0.8428631645669915,1.0,6/38,9.85%,PLS3;TBX3;HYAL2;FGFR1;ALPL;GJA1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.7107796704020968,1.1114856980280596,0.36923076923076925,0.8424989782316612,1.0,3/8,16.18%,KCNMB4;ANK3;DMD
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.7230561773444564,1.1109658856602067,0.34375,0.8432921053581791,1.0,1/6,2.52%,TRIM5
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.5695494097271694,-1.110577226559031,0.375,1.0,1.0,1/9,0.24%,CEMIP
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.607899001382022,1.1105388404425551,0.36231884057971014,0.8438041549749826,1.0,10/22,26.40%,DPP10;PRKCE;PIK3R1;CNST;ITGB1;LGALS3;ATP2B4;PRKCH;RACK1;EGFR
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.6881229570280435,1.1099832979142652,0.3333333333333333,0.8445939926464422,1.0,3/12,4.78%,SERPINE1;ANXA1;PRKCE
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.6294369889045113,1.1095712687563948,0.36619718309859156,0.8450400727023023,1.0,5/17,19.76%,ANK3;MYH10;RASA1;ECT2;CHMP4B
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.6526958616473707,1.1094882116611862,0.4,0.8442453516101107,1.0,7/12,27.14%,EDEM3;RPS27A;AMFR;UGGT2;UBC;SEL1L;UGGT1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.6925238430853317,1.1093146575237882,0.40298507462686567,0.8439326218650928,1.0,4/8,24.65%,MT1M;MT2A;SLC30A1;MT1E
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.6826195284376265,1.1088322039798664,0.36764705882352944,0.8448197140618039,1.0,3/13,13.94%,PIK3R1;DLC1;PAK2
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.6125588205939457,1.108708333948518,0.37333333333333335,0.8442927066299877,1.0,5/21,20.98%,PSMC6;REL;PSMA7;MALT1;TNFRSF10B
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.5460060510551882,1.10843623285947,0.2948717948717949,0.8442328579501088,1.0,16/32,22.66%,GRIA2;CADM2;S1PR1;GPM6B;NFASC;SNAP25;GJA1;NRXN1;TMEM132C;ADGRB3;SLC1A2;SOCS3;GRM5;GPRC5B;PLP1;ETS1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.5007716541989822,-1.1081999864113468,0.2692307692307692,1.0,1.0,3/20,4.38%,BABAM2;ATM;ATR
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.4920302646985603,1.1080428924221346,0.3176470588235294,0.8446763247490403,1.0,26/113,18.17%,CCDC3;PPM1D;CALR;GAPDH;PPHLN1;REL;PINK1;SRGN;ATP2B1;PICALM;KLF4;PTBP2;HIF1A;REST;DCP2;AGO2;GIGYF2;CLDN5;RPL13A;NDFIP1;NCOR2;ATOH8;DIP2A;GATA2;BTG2;TMBIM6
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.7541362562787695,1.1077629389422927,0.4166666666666667,0.8446664398357085,1.0,3/5,18.57%,PIK3R1;PXN;STAT3
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.7208470402490688,1.1075663281691295,0.3380281690140845,0.8434933272989081,1.0,4/6,22.87%,SLC8A1;ATP1A1;GSN;ATP1B1
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.7208470402490688,1.1075663281691295,0.3380281690140845,0.8434933272989081,1.0,4/6,22.87%,SLC8A1;ATP1A1;GSN;ATP1B1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.6085310363905256,1.1075509444170748,0.36764705882352944,0.8425956738768717,1.0,7/19,26.16%,MYO1B;PPFIA2;MYO1E;TRAK1;PAFAH1B1;TANC2;WASL
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.6576432163715534,1.1075029480107281,0.4117647058823529,0.8417750888940881,1.0,1/8,1.27%,NEDD9
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.5188996651508405,1.107301514744998,0.34615384615384615,0.8415810884864704,1.0,10/47,13.71%,CHPT1;SPOCK1;PINK1;HSP90AA1;PICALM;NRG3;RAP1A;STK38L;BCAR1;HIP1R
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.4951649456515485,1.107267647361794,0.3253012048192771,0.8408134010815619,1.0,18/82,17.10%,NRCAM;DOK5;MAP1B;LAMA5;ROBO2;PIK3R1;HSP90AA1;SEMA6B;GRB2;NRXN3;ANK3;UNC5C;NRXN1;S100A6;GRB10;FEZ2;SEMA3F;DAG1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.6232804446746076,1.106921298320811,0.36363636363636365,0.8410697202755182,1.0,3/16,9.83%,PCK1;PIK3R1;HIF1A
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.5298300967962618,1.106513941931771,0.32051282051282054,0.8413005606658643,1.0,5/48,5.10%,DDIT4;PBX3;NES;GRIN2B;ROBO2
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.5418891168040731,1.1060860882372685,0.3291139240506329,0.8417796680513581,1.0,9/47,15.25%,ERBB4;CACNA1C;ZFPM2;DLC1;CDKN1B;CDKN1A;FOXF1;TAB2;FOXC1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.657629493627798,1.1059545407055964,0.3968253968253968,0.841325813763056,1.0,3/13,10.46%,RAPGEF3;RAP1A;PECAM1
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.7196246103721551,1.1056245284391781,0.29310344827586204,0.8414563065163957,1.0,2/5,11.16%,ATP2B1;SETD3
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.6128629315553589,1.1050432445339653,0.4,0.8423303651649438,1.0,4/15,9.03%,SPOPL;UFL1;SMAD7;OGT
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.65916915949904,1.1047291214125496,0.38571428571428573,0.842422300281424,1.0,5/8,29.24%,OGT;SETD3;WDR82;TET2;KMT2A
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.5873468484177118,1.1043446796447571,0.33783783783783783,0.84083313832182,1.0,6/29,17.13%,PSMC6;TAB2;KRAS;PAK2;PSMA7;MALT1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.5873468484177118,1.1043446796447571,0.33783783783783783,0.84083313832182,1.0,6/29,17.13%,PSMC6;TAB2;KRAS;PAK2;PSMA7;MALT1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.5873468484177118,1.1043446796447571,0.33783783783783783,0.84083313832182,1.0,6/29,17.13%,PSMC6;TAB2;KRAS;PAK2;PSMA7;MALT1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.5706553340936876,1.103970884950673,0.3116883116883117,0.8414071551394302,1.0,9/25,22.18%,PPM1D;CBFB;JUN;CCNC;CDKN1A;BCLAF1;CDK8;MED4;SETX
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.5809229527856818,1.10380682285991,0.3382352941176471,0.8409946706671318,1.0,5/27,9.83%,PDK4;PCK1;PIK3R1;BACE2;HIF1A
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.7578659669020243,1.1037218294218034,0.4426229508196721,0.8403001549853927,1.0,2/5,16.10%,UNC5C;SEMA3F
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.46254728206923396,1.1034382301370707,0.2553191489361702,0.8404919249725866,1.0,47/199,19.55%,ZEB2;BCL6;ATF3;MAFK;KLF2;TBX3;BHLHE40;CALR;ZBTB1;ZFPM2;PURA;SMAD7;SIN3B;ESR2;CBFB;KDM1A;ARID5A;RPS27A;RPL23;KLF4;JUN;ZNF366;CREM;SPEN;OTUD7B;CNBP;REST;PPM1A;NEDD4L;LRRFIP1;FOXC1;NCOR2;MTDH;NR2C1;MCPH1;SDCBP;TPR;RIF1;CRY1;STAT3;DUSP22;NFIB;MBD2;NACC2;NR1D2;NFIC;NOTCH4
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.7398084657432438,1.103402445735536,0.37037037037037035,0.8397258444279928,1.0,2/5,22.39%,AGO2;PLCB1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.6460657563182253,1.1029291267140477,0.4383561643835616,0.8404818402237445,1.0,2/12,5.31%,INPP5F;MTMR12
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.6184666061338064,1.1024344581300516,0.375,0.8411749357791668,1.0,5/12,21.67%,HSP90AA1;OGT;PELI1;SDCBP;CDC37
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.5898105203219864,1.1023714892354763,0.34328358208955223,0.8404962683506858,1.0,8/16,33.33%,TAF1D;ZMIZ1;ACTB;SMARCA5;ATAD2B;ARID1A;DEK;EP300
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.5378476275535766,1.102046930198747,0.3076923076923077,0.8406623301644757,1.0,9/31,26.06%,PSMC6;RPS27A;CCNH;PSMA7;NPM1;UBC;NAP1L4;PSMB9;SMARCA5
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.590000842240477,1.1011274081701994,0.288135593220339,0.8429155103172303,1.0,3/19,7.81%,PDK4;PCK1;BACE2
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.6825446924268511,1.1007371382716022,0.4383561643835616,0.8433956095657782,1.0,2/8,7.04%,BCAP31;PINK1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.751427078582946,1.1002032973086908,0.3225806451612903,0.8442035414131102,1.0,1/5,7.38%,KDM1A
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.6066866791241252,1.0998435850504156,0.352112676056338,0.8446690187457032,1.0,2/17,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.7137679164990979,1.099761709081243,0.3787878787878788,0.8440274442919979,1.0,1/6,12.91%,AGO2
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.7161001230304032,1.099739439032685,0.3088235294117647,0.8431930114746337,1.0,4/8,23.03%,RFTN1;BCAR1;TEC;MEF2C
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.5924387380307544,-1.0994666192846845,0.4117647058823529,1.0,1.0,1/7,1.46%,CPQ
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.7316489361702128,1.0994609529417052,0.40625,0.8432578515918036,1.0,5/5,26.93%,HSP90B1;NPLOC4;HERPUD1;SEL1L;VCP
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.5930637104602747,-1.099343723462584,0.34146341463414637,1.0,1.0,1/7,12.35%,PTPN2
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.5866537037218335,1.0983359811820328,0.38235294117647056,0.8458060467428911,1.0,5/21,19.10%,ITPR1;SCARB2;DEPP1;PSAP;ABL2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.6890342098086761,1.098288522283147,0.47058823529411764,0.8450934153915612,1.0,2/7,16.33%,PRNP;TRAM1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.6149756530735121,1.098244867986503,0.34328358208955223,0.8443460648715087,1.0,9/23,21.14%,YBX3;NFE2L2;PINK1;PTTG1IP;ARHGEF2;HERPUD1;TMBIM6;BCL2L1;MCL1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.566172697581595,1.0981851861962837,0.3380281690140845,0.8436365594622959,1.0,10/29,20.56%,MYO9B;EPS8;BCR;DLC1;PRAG1;ADGRG1;RAC1;ARHGEF2;ABL2;RASIP1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.6563827615859468,1.0981269468874897,0.4126984126984127,0.8428562167568585,1.0,4/7,25.87%,GJA1;ITGB1;PAFAH1B1;CDK5RAP2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.5111422454092253,1.0976272460744672,0.2894736842105263,0.8436318990728309,1.0,15/51,21.83%,NEDD9;PRKAG2;CCDC88A;PRNP;HSP90AA1;RAP1A;CDKN1A;TAB2;PAK2;ECT2;PTPN1;CAB39;GRM5;TAOK1;GPRC5B
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.6499916831926906,1.0974465661065607,0.3194444444444444,0.8433828360049238,1.0,4/10,19.39%,SNAP25;DNAJC5;SYT1;RIMS2
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.7431449473113916,1.096910133123983,0.41333333333333333,0.844252461772345,1.0,3/5,19.04%,SLC8A1;TGM2;RYR3
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.5096427772918178,-1.0968198359319514,0.3333333333333333,1.0,1.0,5/28,9.19%,CEMIP;TPD52L1;PKD2;PDGFC;PDGFB
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.6801445613455177,1.0966768807050156,0.4262295081967213,0.8441593990858148,1.0,3/8,22.15%,FOXF1;NOTCH4;CDH5
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.7148412990666151,1.0964907449823915,0.4067796610169492,0.8438385889960142,1.0,3/7,4.94%,SCP2;MGLL;ACOX1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.6747313217268008,1.096394002721942,0.4166666666666667,0.8432907661719856,1.0,3/7,17.85%,ANXA1;FLT1;LGALS3
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.6698783214389026,1.0963826911113121,0.43283582089552236,0.8424208903074238,1.0,2/10,7.04%,CCDC88A;PINK1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.6288208695154898,1.0960900531090312,0.4032258064516129,0.8424856544585465,1.0,3/15,10.46%,RAPGEF3;RAP1A;PECAM1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.6601046729901218,1.0955328987690258,0.35294117647058826,0.8432909203115344,1.0,3/8,12.40%,SLC4A10;ANO5;ANO6
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.6386470852754967,1.095201188602246,0.373134328358209,0.8433307482215975,1.0,4/11,20.37%,HIF1A;GRB10;PTPN1;NEDD4
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.6636753576894013,1.094691266840111,0.352112676056338,0.8440261053748378,1.0,3/8,9.85%,ADAMTS9;SMAD5;GJA1
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6904501478044839,-1.0941336833237472,0.40625,1.0,1.0,2/5,21.73%,RPS8;RPS16
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.7128483259416017,1.09411745169102,0.39344262295081966,0.8448033294123145,1.0,3/6,11.63%,RAP1A;MAGI2;ACAP2
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.559844919032934,-1.0940627356902057,0.2916666666666667,1.0,1.0,4/13,16.15%,SHLD1;MSH3;SHLD2;POLR2A
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.48894561239479734,1.0939749669227672,0.345679012345679,0.8442942540329145,1.0,18/73,21.14%,ITPR1;PRKAG2;TRIM5;GAPDH;UFL1;PINK1;RB1CC1;DEPP1;EEF1A1;TAB2;TMEM59;MTDH;PSAP;STAT3;ABL2;NEDD4;RASIP1;MCL1
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.6343749581552195,1.0938029036162578,0.3770491803278688,0.8439050854818464,1.0,2/17,4.46%,PNP;LBR
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.5784337548392734,1.093334682599895,0.3783783783783784,0.8447036942249926,1.0,11/34,22.87%,LAMA5;SCARB2;CTNNA1;ATP1A1;BCAR1;CADPS2;DAG1;HDLBP;EPAS1;COL18A1;ATP1B1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.5792559340800765,1.0929977286572063,0.2972972972972973,0.8446587669655606,1.0,2/19,7.01%,B3GNT2;CHST11
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.5873027646127993,-1.0929605954428516,0.3793103448275862,1.0,1.0,5/11,17.34%,STAT1;PLXND1;MAML3;MAML2;PBX1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.6379551725104665,1.0923820581004595,0.37681159420289856,0.8456325412584994,1.0,5/17,19.55%,TBX3;FGFR1;HIF1A;LIMS1;NOTCH4
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.7284765031971159,1.0920970278150222,0.4393939393939394,0.8457287035452938,1.0,1/5,11.85%,IFNGR1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.6948031402194565,1.092057217682971,0.39344262295081966,0.8440195517559516,1.0,2/7,10.23%,RPS27A;RFC3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.6948031402194565,1.092057217682971,0.39344262295081966,0.8440195517559516,1.0,2/7,10.23%,RPS27A;RFC3
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.7009541624002259,1.0916246909623446,0.35714285714285715,0.8443058215870725,1.0,5/9,23.03%,TBX3;BOC;BTG1;PLCB1;MEF2C
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.47788876870838587,1.0915001905791888,0.27848101265822783,0.8438845869097774,1.0,8/53,9.85%,AKAP12;TIMP3;PLSCR4;DLC1;COL4A2;OGT;MIB1;GJA1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.7028574988623466,1.0904297769382953,0.40625,0.8461829302280011,1.0,2/5,26.85%,AHCYL1;PAPOLA
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.7288722461131584,1.0902738905264295,0.42857142857142855,0.845737090561118,1.0,3/5,14.74%,CFH;CD55;RAC1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.6522418332972514,-1.0897711037383908,0.4117647058823529,1.0,1.0,2/5,4.65%,SLCO1A2;ABCG2
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.5350681648868312,1.0897470321258758,0.36363636363636365,0.8465136091694567,1.0,7/33,17.18%,TBX3;NES;TIMP3;COL4A2;BCAR1;WWTR1;AFAP1L1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.5348156051032297,1.0896247887823574,0.3902439024390244,0.8461035561727391,1.0,14/53,19.42%,PPP2R3A;PPM1D;PTPRD;DUSP6;ALPL;DUSP1;SSH1;PPM1A;DUSP16;CTTNBP2NL;PLPP1;PPP1CB;MTMR6;PTPN1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.6586179560662512,1.0892370319895186,0.43478260869565216,0.8464795861931026,1.0,1/9,2.74%,BHLHE40
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.5228882515742925,1.0889954083277458,0.35443037974683544,0.8463397006056999,1.0,18/52,23.48%,HYAL2;SMAD7;SMAD5;RPS27A;JUN;LRRC32;FOS;CLDN5;ITGB1;LIMS1;PXN;ZMIZ1;DUSP22;SMAD6;CDH5;UBC;MEF2C;ADAM9
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.5173344039718206,1.0887945905920844,0.37333333333333335,0.8461884134713434,1.0,14/65,17.45%,CCDC3;REL;PINK1;PICALM;KLF4;HIF1A;REST;AGO2;CLDN5;NDFIP1;ATOH8;SDCBP;DIP2A;GATA2
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.6120525898881968,1.0881982271001165,0.3888888888888889,0.8472407777549104,1.0,9/19,26.29%,ARF1;JAK1;HSPA9;ANXA2;PAK2;CFL1;PLCB1;MSN;CDC42
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.5969249002919184,1.088175814005797,0.37681159420289856,0.8464119677542333,1.0,2/22,9.19%,PDK4;LAMP2
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.6482078381884859,-1.0877604071926972,0.4117647058823529,1.0,1.0,1/6,0.24%,CEMIP
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.6482078381884859,-1.0877604071926972,0.4117647058823529,1.0,1.0,1/6,0.24%,CEMIP
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.6577363584016518,1.0876544002263167,0.47761194029850745,0.8470538520455325,1.0,2/10,20.19%,ROBO2;SMAD6
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.6699139544582873,1.0873709020715825,0.4,0.8471470219132162,1.0,1/5,6.75%,ENPP2
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.6799140537680949,1.087367982612588,0.4307692307692308,0.8462743689106154,1.0,1/6,2.82%,NES
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.6818313271991876,1.086456767597674,0.42424242424242425,0.8483090221243005,1.0,3/6,13.52%,SMAD7;MAGI2;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.701332979470459,1.086454602666071,0.373134328358209,0.847425366892921,1.0,3/11,13.94%,PIK3R1;DLC1;PAK2
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.6424424734956469,1.086429282372171,0.40350877192982454,0.846647930516128,1.0,1/10,4.14%,TIMP3
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.5266569273023892,1.0861289633506825,0.358974358974359,0.8468684808119084,1.0,8/45,15.25%,ERBB4;CACNA1C;ZFPM2;CDKN1B;CDKN1A;FOXF1;TAB2;FOXC1
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.6079909586824164,1.08598226088356,0.32,0.8464635948113641,1.0,1/17,0.88%,PSMC6
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.662517838246422,1.085844925003277,0.3793103448275862,0.8459208088387672,1.0,4/8,25.95%,RAB21;DNAJC13;MSN;MAP2K1
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.4647286738382818,1.085828421218867,0.32941176470588235,0.8451019553861967,1.0,27/105,22.42%,ANGPTL4;HSPA5;BNIP3L;TBX3;ANXA1;PIK3R1;RPS27A;HSP90B1;HSPA9;NAA16;PAK2;RASA1;MTDH;GOLPH3;GRK5;MALT1;TMBIM6;CFL1;NPM1;SMAD6;BCL2L1;MCL1;TNFAIP8;AVEN;RPL10;SETX;UBC
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.6524704272863198,-1.085798874599467,0.3870967741935484,1.0,1.0,2/5,9.19%,PDGFC;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.6403328493788891,-1.085691900296921,0.46153846153846156,1.0,1.0,3/10,3.40%,EIF2AK2;CD74;OAS3
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.5301791678659409,1.0855913546837856,0.4,0.844930910060456,1.0,4/42,7.04%,MTFR1;BCAP31;BNIP3L;PINK1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.4531029897396637,1.0853198285541346,0.3563218390804598,0.8448754764667402,1.0,30/135,21.59%,ERBB4;TBX3;CALR;CD81;UFL1;FGFR1;RPS9;RPL23;CDKN1B;SMC6;CNBP;FLT1;CNOT6L;CLDN5;ADGRG1;KRAS;WWTR1;RAC1;SDCBP;GRK5;TGM2;GATA2;NAMPT;DYNC1H1;CSPP1;BCLAF1;NPM1;SLFN11;VEGFC;ZFP36
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.650044830799906,1.0846537949412518,0.4153846153846154,0.8460406297344734,1.0,6/9,27.14%,RPS27A;AMFR;UGGT2;UBC;SEL1L;UGGT1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.6798639852535955,1.084506577578454,0.44285714285714284,0.8456391051034652,1.0,5/8,27.49%,ANXA1;REST;ZFP36;ADAM9;HNRNPU
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.5959099342913596,1.0844288076501793,0.3972602739726027,0.8450775462594253,1.0,9/20,26.29%,ARF1;JAK1;HSPA9;ANXA2;PAK2;CFL1;PLCB1;MSN;CDC42
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.6883688498745404,1.0840295050971342,0.36923076923076925,0.8453206262384579,1.0,6/10,23.88%,WNT2B;HYAL2;NFIB;SULF2;MEF2C;CREB3L2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.6111288255146831,1.0839867608007323,0.41333333333333333,0.8446458854420893,1.0,1/12,0.77%,ADAMTS9
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.725640827501373,1.0838845533757824,0.40625,0.8441099882496801,1.0,4/5,24.14%,ANK3;DMD;ATP1B1;WNK1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.639073443851226,1.0836949463925916,0.32857142857142857,0.8438383795984236,1.0,7/13,21.06%,BCL6;CDKN1B;TOM1L2;FOXC1;BTG2;BTG1;CHFR
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.7311656382436001,-1.083638415440543,0.42105263157894735,1.0,1.0,3/5,19.92%,PDGFB;PDCD4;NFATC3
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.6095887146823799,1.0832652586722975,0.4266666666666667,0.8445961384397325,1.0,3/16,7.33%,MAP2;FES;NAV3
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.5926895827236778,1.083227205853222,0.4126984126984127,0.8438563881950587,1.0,8/19,27.33%,RFTN1;SDCBP;PLCB1;CSNK2A1;RPS6KA3;CDC42;EGFR;AKAP6
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.6305567471437857,1.0831177798010116,0.3880597014925373,0.8432208227091201,1.0,3/15,9.83%,PRKAG2;OGT;HIF1A
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4922167307222165,1.0829386677671284,0.40229885057471265,0.8429626302598752,1.0,16/66,17.10%,DOK5;LAMA5;ROBO2;PIK3R1;SEMA6B;GRB2;NRXN3;UNC5C;NRXN1;GRB10;RAC1;ALCAM;FEZ2;SEMA3F;PLXNA2;DAG1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.6257300869743022,1.0826730193825824,0.3835616438356164,0.8430009628012956,1.0,6/12,24.73%,BCAP31;NACC2;BCLAF1;BCL2L1;NCK1;RACK1
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.5608351768134111,1.0823774768857162,0.37662337662337664,0.843096081630497,1.0,9/21,21.49%,HSPA5;HSPH1;HSP90AA1;HSPA9;HERPUD1;TMBIM6;PTPN1;HSPA8;SERPINH1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.7534699451335667,1.0821654819615454,0.41379310344827586,0.8431114773652948,1.0,2/5,17.29%,GJA1;SLC1A2
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.5861623279329742,-1.0817627954306268,0.4117647058823529,1.0,1.0,1/9,0.56%,PRIMPOL
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.6736013971445911,1.0816349508810572,0.43283582089552236,0.8437170282634903,1.0,5/8,27.22%,RAC1;PARVB;GSN;CDC42;RHOJ
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.6598130872526979,1.0815446288388644,0.41935483870967744,0.8432782331997443,1.0,1/9,0.74%,MTFR1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.679933593882283,1.0814052433172736,0.41935483870967744,0.8430102300785309,1.0,2/8,20.61%,CSNK1D;CEP290
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.5882479890249275,1.081307298886432,0.43661971830985913,0.8425956738768718,1.0,3/17,7.84%,LAMC1;BCR;DLC1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.685907566047205,1.0807924650683625,0.4375,0.843120165426126,1.0,4/9,18.43%,PECAM1;PIKFYVE;LGALS3;PDE4B
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.5805735555424448,1.0804118792743216,0.32,0.843417749283859,1.0,5/27,9.93%,PSMC6;HSPA5;UBE2J1;HSP90B1;NPLOC4
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6243829463050422,1.0803462754835815,0.4166666666666667,0.8426881765615455,1.0,5/13,19.39%,GRIK2;INPP5F;ANXA2;SYT1;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6700081329974542,-1.0799986378559134,0.4,1.0,1.0,3/7,11.42%,SHLD1;PARP9;SHLD2
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),-0.6413100255278728,-1.0796060898264157,0.38461538461538464,1.0,1.0,1/5,3.13%,GMDS
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.6490278202259865,1.0795521443274898,0.3561643835616438,0.8441801527709915,1.0,2/11,8.37%,PINK1;DUSP1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.7515957446808513,1.079288129059669,0.36666666666666664,0.844070475240747,1.0,5/5,24.94%,APOLD1;ATOH8;NOTCH4;BTG1;ZEB1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.647231708817148,-1.0790638964216432,0.475,1.0,1.0,1/5,4.20%,ARHGAP12
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6552749385035936,1.0785104273373578,0.38461538461538464,0.8455243055497256,1.0,2/9,10.31%,SCP2;PITPNC1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.7241735248929514,1.078418526994816,0.36065573770491804,0.8449528457009269,1.0,3/5,6.91%,RFTN1;VSIR;PRNP
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.5542330263549706,-1.0782687210085993,0.37142857142857144,1.0,1.0,5/12,6.72%,CEMIP;HOMER2;TBL1X;CLIC5;CDC14A
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5542330263549706,-1.0782687210085993,0.37142857142857144,1.0,1.0,5/12,6.72%,CEMIP;HOMER2;TBL1X;CLIC5;CDC14A
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.6971426480502836,1.0782623339760806,0.42028985507246375,0.8445621210449217,1.0,3/6,25.02%,RAPGEF3;TAOK1;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.7182596791849554,1.078251675096418,0.43478260869565216,0.843746099128644,1.0,4/5,28.18%,COMMD1;NEDD4L;CAB39;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.6416106132551485,-1.0781305502669583,0.36585365853658536,1.0,1.0,3/5,29.08%,RORA;THRAP3;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.6445136854579263,1.0776346944995672,0.4375,0.8449143745826829,1.0,5/14,19.76%,SEC22B;PINK1;FEZ2;LIMK2;CHMP4B
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.5499344132112436,-1.077016450519264,0.3333333333333333,1.0,1.0,4/13,10.81%,ALS2;CLCN3;TMCC1;EEA1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.6888057722853878,1.076635551077525,0.5151515151515151,0.8470314716330393,1.0,1/6,0.90%,CHPT1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.48019999058874685,1.0760052673031137,0.3333333333333333,0.8481493923176708,1.0,11/60,15.51%,RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.5317065314686744,1.0758112367647497,0.37662337662337664,0.8477574222475006,1.0,6/30,12.01%,SLC8A1;TIMP3;PLSCR4;COL4A2;GJA1;FOXF1
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.5747593114252523,-1.075347389131651,0.41025641025641024,1.0,1.0,5/12,20.82%,PDGFB;STX3;CDH13;PRKD1;IL6R
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.6224268226790483,1.0753399035198647,0.37681159420289856,0.8484261140944447,1.0,7/13,24.38%,CDKN1B;JUN;GJA1;CDKN1A;MEF2C;ADAMTS1;PPARG
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.5375806770622676,1.075256719125077,0.3484848484848485,0.8477894514433616,1.0,7/27,15.99%,POLA1;CDK6;CDKN1B;CCNH;CDKN1A;CRLF3;BRD4
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.678414333704516,1.074889789448209,0.4098360655737705,0.8480670743565918,1.0,4/5,31.98%,CFL1;PLCB1;RACK1;NR2C2
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.630905255288908,1.0747424834424886,0.45714285714285713,0.8476989975889017,1.0,5/11,25.66%,MAP1B;NAV3;ARHGEF2;TAOK1;HDGFL3
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.7138895917838476,1.0744024860604304,0.4126984126984127,0.8477983633548553,1.0,2/5,16.63%,KCNMB4;SYT1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.6015082705951355,-1.0741751044264762,0.375,1.0,1.0,1/12,0.16%,VCAM1
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.7194760528204432,1.0741268132254704,0.4126984126984127,0.8478864301397795,1.0,2/5,13.73%,RPL23;SMARCC1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.6755882160649549,1.0740886487321684,0.36363636363636365,0.8471869319908658,1.0,1/6,12.91%,AGO2
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.5230510263897381,1.0740050328218274,0.352112676056338,0.8465663772954802,1.0,14/42,29.22%,UFL1;SMAD7;OGT;TRIB2;COMMD1;SDCBP;HERPUD1;CSNK1D;XPO1;RACK1;EIF3H;VCP;TLK2;RNF19A
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),0.6747934800150016,1.0739633402150754,0.45454545454545453,0.8449530240394674,1.0,1/8,3.00%,PPA1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),0.6747934800150016,1.0739633402150754,0.45454545454545453,0.8449530240394674,1.0,1/8,3.00%,PPA1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.675519921684072,1.073876901145005,0.4189189189189189,0.8444028045716016,1.0,1/7,1.30%,CLIC2
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.6327537590304871,-1.0729212354465425,0.40540540540540543,1.0,1.0,3/6,18.65%,MRPS31;PTCD3;LARS2
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6945368993073742,1.0727701335630677,0.39436619718309857,0.8468772905339025,1.0,5/9,23.88%,WNT2B;NFIB;SULF2;MEF2C;CREB3L2
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.5611651445016029,1.0727553721482017,0.37333333333333335,0.8460837242541326,1.0,5/20,14.45%,PIK3R1;GRB2;BCAR1;KIF16B;ERBIN
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.5884089350743155,1.0726851478183634,0.36363636363636365,0.8454128724330562,1.0,7/21,20.69%,IPO7;CDK6;DUSP1;CDKN1B;FOXC1;BTG2;BTG1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),0.5998888764260497,1.0726692034656367,0.4375,0.844622318542882,1.0,2/16,22.18%,YTHDC1;SETX
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.564520408696612,1.0725799048564526,0.43478260869565216,0.8441081130189027,1.0,2/24,7.99%,SEC22B;TMED10
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.7177432859430914,1.0721709817444163,0.453125,0.8443416106473572,1.0,2/5,6.27%,NFKBIZ;SMAD7
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.5183637483889901,-1.0718983913647202,0.3870967741935484,1.0,1.0,3/11,7.99%,TPD52L1;DEPTOR;SGMS1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5877943898799064,1.0717305371878563,0.3770491803278688,0.844783077240137,1.0,4/17,12.54%,TSG101;GRB2;ITGA1;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.4774546039978618,1.071525024359268,0.3780487804878049,0.8445880455363176,1.0,19/76,19.26%,TBX3;CALR;JUNB;JUND;RASSF1;RPL23;CDK6;DUSP1;CDKN1B;JUN;MAGI2;CDKN1A;UHRF2;CRLF3;SND1;SDCBP;GRK5;STAT3;HBP1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.624334348110488,1.0709671636922111,0.4626865671641791,0.845532027965366,1.0,1/10,0.74%,MTFR1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.49439745962147785,1.069852527988351,0.32894736842105265,0.8483116795465041,1.0,17/56,23.03%,ANXA1;HYAL2;SMAD7;KLF4;RAP1A;MAGI2;ACAP2;FLT1;BCAR1;EEF1A1;ACVR2A;FOXC1;LIMS1;DUSP22;ZFP36;SETX;MEF2C
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5425785927193707,1.0693734771211847,0.3466666666666667,0.8489332800970268,1.0,4/27,8.79%,NRCAM;MAP2;MAP1B;ANK3
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.6668111241041575,1.0691054577277734,0.4411764705882353,0.8489423555302983,1.0,3/7,21.22%,SYT1;RIMS2;PPP3CB
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.5718758791839099,1.068981423858359,0.42028985507246375,0.8485697198670684,1.0,5/19,9.03%,INPP5F;FGFR1;PIK3R1;PLCL1;OGT
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.5801130474056175,1.0688433072349541,0.3380281690140845,0.8481433384015103,1.0,3/18,8.82%,TBX3;CALR;CDKN1B
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.7056567395488802,1.068561908092262,0.44776119402985076,0.8480552006576341,1.0,3/5,24.14%,GPM6B;NEDD4;WNK1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.6147631572874093,1.0685582947614372,0.4852941176470588,0.8472387033354527,1.0,4/15,9.03%,SPOPL;UFL1;SMAD7;OGT
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.6532958529276601,1.068481459242629,0.4142857142857143,0.8465541537127879,1.0,5/11,19.42%,DUSP6;DUSP1;DUSP16;DUSP22;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.5166832761718589,1.0682884106512647,0.3974358974358974,0.8463267392478202,1.0,19/48,27.76%,ZEB2;PSMC6;GPC5;PPM1A;UBE2B;PSMA7;TNKS;CSNK1G3;CSNK1D;USP34;SULF2;GPRC5B;CSNK2A1;WNK1;PSMB9;EGFR;VCP;SPIN1;XIAP
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.6912153634878216,1.0674721181494775,0.4838709677419355,0.8479970949946413,1.0,4/7,25.02%,RAPGEF3;DIP2A;TAOK1;TERF2IP
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.5495219255686081,1.0671382859045395,0.391304347826087,0.8480828290280953,1.0,5/22,5.68%,GRIA2;MAP2;GPM6B;NPAS3;CTNND2
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.5783900698456712,-1.0670148802711559,0.3870967741935484,1.0,1.0,2/15,2.87%,VCAM1;LEPR
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.6201274327148466,1.0666992132894066,0.43243243243243246,0.8482874256164727,1.0,4/18,11.47%,BCAP31;MAP3K5;GRIN2B;REST
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.5371311588530899,1.0663727884961438,0.45121951219512196,0.848491625315251,1.0,7/33,10.23%,PSMC6;BAZ1A;PURA;POLA1;RPS27A;NOC3L;RFC3
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.5482460056948599,1.0660202907001373,0.37142857142857144,0.848695429278179,1.0,7/28,7.36%,LDHA;HSPH1;MGLL;GLUL;ACOX1;ACSL5;HSP90AA1
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.5768968925542908,1.065456208056407,0.4057971014492754,0.8496433069353645,1.0,8/14,33.94%,EEF1A1;FOXC1;DUSP22;ZFP36;EGFR;DAB2IP;GAREM1;IQGAP1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.6350839961075998,1.0649832989060442,0.4305555555555556,0.8486353003823885,1.0,4/12,19.76%,LBR;AHCTF1;REEP3;CHMP4B
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.6350839961075998,1.0649832989060442,0.4305555555555556,0.8486353003823885,1.0,4/12,19.76%,LBR;AHCTF1;REEP3;CHMP4B
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.6350839961075998,1.0649832989060442,0.4305555555555556,0.8486353003823885,1.0,4/12,19.76%,LBR;AHCTF1;REEP3;CHMP4B
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.5970431644644655,1.0649776219495362,0.43283582089552236,0.8478169442585868,1.0,5/15,21.22%,MAP1B;HSP90AA1;ALCAM;SEMA3F;PPP3CB
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.6654009652266616,-1.0649638615512986,0.4864864864864865,1.0,1.0,1/5,1.81%,PLA2G4A
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.5939489491770581,1.064753738435716,0.38571428571428573,0.8476014606356137,1.0,3/16,11.05%,RPS27A;RFC3;CCNH
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.49605535358279523,1.0647290792492705,0.3181818181818182,0.8469573082449601,1.0,14/63,18.80%,ARHGAP23;MYO9B;BCR;ARHGAP21;SRGAP1;DLC1;ARHGEF4;GNA13;ECT2;RAC1;TGM2;ARHGEF2;KALRN;FAM13A
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6516025235776759,1.0644505416090677,0.4603174603174603,0.8470752855944204,1.0,5/8,33.81%,PINK1;DCUN1D4;ARRDC3;CDC14B;RAB1A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.7072566678817858,1.064438589407116,0.4406779661016949,0.8463043984629047,1.0,2/6,10.23%,RPS27A;RFC3
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.465609993744952,1.0643108139906492,0.3132530120481928,0.8458879657202351,1.0,19/106,14.74%,PIK3R3;ERBB4;PRKAG2;CD81;RAPGEF3;ENPP2;PRNP;PINK1;HSP90AA1;RB1CC1;RAP1A;PECAM1;CDKN1A;TAB2;ACVR2A;KRAS;PAK2;SH2D3C;RAC1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.5950392277152081,-1.0642173115356397,0.38235294117647056,1.0,1.0,1/10,0.77%,HOMER2
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.5106134914727274,1.0636613653997256,0.345679012345679,0.8469576784992288,1.0,9/46,16.68%,DDIT4;PRKAG2;SMAD7;PRNP;TRIB2;PAK2;WWTR1;DMD;SPRED1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5781780722904154,1.0634966638462653,0.37662337662337664,0.8466588506273323,1.0,7/25,22.42%,SMAD7;RPS27A;PPM1A;STRAP;SPRED1;SMAD6;UBC
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.5582599670397754,-1.063467495014402,0.42424242424242425,1.0,1.0,1/15,0.13%,GBP1
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5365828311274209,-1.0633410396284173,0.4074074074074074,1.0,1.0,4/14,8.50%,CD74;ATM;ATR;MDM2
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.5004395573842187,1.0626931896583407,0.3698630136986301,0.8482483878227813,1.0,9/48,17.00%,PRKAG2;CCDC88A;CDKN1B;OGT;HIF1A;CDKN1A;BTBD10;SDCBP;TPR
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.6331831131595582,1.0618748467506085,0.45714285714285713,0.8498135751470697,1.0,4/12,26.29%,PIK3R1;FSCN1;WASL;CDC42
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.6341244523827408,1.0618218959547412,0.43548387096774194,0.8491509415852321,1.0,2/10,7.38%,NES;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.6383110906727368,1.0603731972363677,0.40298507462686567,0.8526265747563584,1.0,4/15,17.45%,ZFPM2;TRIB2;WWTR1;GATA2
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.684744329055344,1.0589553307889732,0.4406779661016949,0.855968083417092,1.0,3/5,17.58%,PPA1;SULT1C4;TPST2
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.6931272193118186,1.0585367469207592,0.48,0.8564690997493469,1.0,5/7,27.73%,SMAD7;PAK2;ACTB;TBCD;PIP5K1C
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.6163480551567022,-1.0583648970074129,0.4444444444444444,1.0,1.0,1/8,0.13%,GBP1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.46853185284229143,-1.0578519102935824,0.3333333333333333,1.0,1.0,3/26,5.92%,PGM5;TTN;EPB41L5
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.6399144040756175,1.057523060758141,0.46774193548387094,0.8585386449966732,1.0,2/6,15.19%,ESR2;PLPP1
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.683525737391519,1.0573825912709964,0.4375,0.8581251357581049,1.0,2/5,5.92%,CHPT1;DHRS7B
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.5062755990421903,1.0572030652755455,0.38666666666666666,0.8579664391582799,1.0,10/41,17.10%,LAMC1;PLS3;NES;TIMP3;COL4A2;BOC;BCAR1;WWTR1;DMD;DAG1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.6817981795182009,1.0568439660763962,0.45161290322580644,0.858061829924033,1.0,1/7,8.29%,CDK6
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.5892731074585472,1.0564350429745428,0.47058823529411764,0.8585162295644825,1.0,4/16,20.37%,TRIM5;PELI1;UBE2B;NEDD4
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.5008520868068485,-1.0561560262182255,0.3684210526315789,1.0,1.0,2/27,0.72%,GBP1;GBP2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.6699191440422962,1.0561438634319136,0.3442622950819672,0.8585581470356846,1.0,4/7,30.44%,ATP1A1;TFPI;ABHD2;UBE3A
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.685665725792381,1.0553167336853426,0.47058823529411764,0.8602554581646508,1.0,3/6,26.24%,REST;SYT1;STXBP3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.6568075613705386,-1.0546092394294566,0.40540540540540543,1.0,1.0,2/5,11.42%,SHLD1;SHLD2
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.5461058467821129,1.054081156834206,0.425,0.8631926255672439,1.0,5/31,16.02%,PSMC6;CDK6;KLF4;CDKN1A;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.4428394372371346,1.0540350609144669,0.4065934065934066,0.8625353914367032,1.0,33/129,22.42%,ANGPTL4;PDK4;HSPA5;BNIP3L;TBX3;ANXA1;PIK3R1;CPEB4;PINK1;RPS27A;KLF4;HSP90B1;HSPA9;ITGB1;NAA16;PAK2;RASA1;MTDH;GOLPH3;GRK5;MALT1;TMBIM6;CFL1;NPM1;SMAD6;BCL2L1;MCL1;TNFAIP8;AVEN;RPL10;SETX;YWHAE;UBC
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.5275803929290905,-1.0534301468076332,0.43478260869565216,1.0,1.0,1/9,1.27%,SLC38A3
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.674543254261221,1.0534083082913182,0.44285714285714284,0.8635722433261127,1.0,1/8,2.92%,ANK2
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.6649656685566524,1.0533527246007999,0.4838709677419355,0.862957908943158,1.0,4/8,28.95%,WAPL;TERF2IP;YLPM1;SMG1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5268813541904384,1.053156278366696,0.3950617283950617,0.862607100741284,1.0,10/39,19.44%,ZEB2;PSMC6;GPC5;PPM1A;UBE2B;PSMA7;TNKS;CSNK1G3;CSNK1D;USP34
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),0.5983896482333402,1.0530390505350162,0.41935483870967744,0.8621206489137485,1.0,4/15,12.54%,TSG101;GRB2;ITGA1;ZFYVE28
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.7178951871570285,1.0527057608094053,0.46153846153846156,0.8614016507996025,1.0,1/5,5.23%,PPHLN1
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.7178951871570285,1.0527057608094053,0.46153846153846156,0.8614016507996025,1.0,1/5,5.23%,PPHLN1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.5811970628623985,1.0523672721840651,0.391304347826087,0.8615659329510229,1.0,5/13,26.40%,AGO2;STAT3;ZFP36;MAP2K1;EGFR
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.4985518035173306,1.05228287534612,0.3950617283950617,0.861030052583649,1.0,12/46,22.15%,TIMP3;PLSCR4;ARID5A;COL4A2;VWF;TNS1;PARVB;PLXNA2;GSN;EPAS1;CALD1;CDH5
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.5623365585150045,1.0514491430182906,0.37662337662337664,0.8625927736118617,1.0,9/20,23.08%,TIMP3;MSRB3;COL4A2;FOXF1;PLAT;VEGFC;SERPINH1;CALD1;ADAMTS1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.5965191297445142,1.051380536422484,0.45714285714285713,0.8620360831689317,1.0,7/15,24.14%,ANK3;ATP1A1;NEDD4L;SYT1;TF;NEDD4;WNK1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.6421248536789689,1.051186212995333,0.36923076923076925,0.8616470941350036,1.0,1/11,4.20%,VAPB
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.5140188760386719,1.050636100100273,0.41025641025641024,0.8624972143291285,1.0,11/36,19.04%,MT1M;PRNP;MT2A;ANK3;CDKN1B;JUN;FOS;ECT2;SYT1;TF;RYR3
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.4044073921008862,-1.0504575415051678,0.2631578947368421,1.0,1.0,1/30,0.13%,GBP1
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.4201183889116999,-1.0502239439758068,0.36666666666666664,1.0,1.0,7/42,9.93%,PKHD1L1;GBP2;COBLL1;LAMA3;PTPN21;ST3GAL1;FN1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6625713049932576,1.0499696540989387,0.4461538461538462,0.8637928139194685,1.0,1/8,8.63%,KLF4
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.6407259109481993,-1.0497818371095045,0.5,1.0,1.0,1/5,1.89%,CWC27
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.6407259109481993,-1.0497818371095045,0.5,1.0,1.0,1/5,1.89%,CWC27
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.5393291208610872,1.0492814467013956,0.45569620253164556,0.8647951575256642,1.0,14/41,25.07%,KHDRBS3;PIK3R1;YTHDC1;PTBP2;SLC38A2;AHNAK;PRX;HNRNPH3;TRA2B;TMBIM6;ZNF326;SETX;PTBP3;CWC22
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5337012376414931,1.0486882157653925,0.4025974025974026,0.8656711044537665,1.0,10/35,22.12%,PLS3;NES;COL4A2;GJA1;WWTR1;CTTNBP2NL;PLAT;VEGFC;SERPINH1;CALD1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.6709891005566522,-1.0482033515617686,0.4594594594594595,1.0,1.0,2/6,11.45%,CD74;MCU
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.6765959472430331,1.0476619554677191,0.5,0.8680591287192688,1.0,2/7,22.47%,PINK1;SREBF2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.54540585205259,1.0474248105687864,0.484375,0.8679049502181951,1.0,7/25,26.40%,RAPGEF3;PINK1;HSP90AA1;SH2D3C;ATP2B4;TERF2IP;EGFR
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.5705678847714675,1.047274422416063,0.4166666666666667,0.8674612971444159,1.0,7/22,18.38%,SERPINE1;SPOCK1;DUSP1;RASA1;PLXNA2;FZD4;PODXL
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.47080786568355326,-1.0468245042757012,0.38095238095238093,1.0,1.0,3/21,8.53%,IRF1;PARP9;SAMHD1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.6010115516194058,-1.0467957928984966,0.48148148148148145,1.0,1.0,1/5,3.98%,BMP6
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.5542430417393822,1.0466410389777807,0.3972602739726027,0.8684762666222139,1.0,6/24,19.76%,ANK3;MYH10;SPIRE1;RASA1;ECT2;CHMP4B
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.6987193413233879,1.0460746854795757,0.5344827586206896,0.8684881947684684,1.0,1/5,6.93%,TUBB4B
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.6987193413233879,1.0460746854795757,0.5344827586206896,0.8684881947684684,1.0,1/5,6.93%,TUBB4B
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.5208110319376164,1.0460394550981482,0.4444444444444444,0.8678085066558794,1.0,7/29,24.30%,ADM;GGT5;ADCY2;LGALS3;ADCY9;FYN;FGR
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5995183462156286,-1.0456327222597903,0.41025641025641024,1.0,1.0,3/7,21.49%,HLA-F;HLA-A;NECTIN2
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.565935613643348,1.045316300783222,0.47560975609756095,0.8691490280431694,1.0,9/27,17.66%,DTNA;SLC8A1;TPM4;ITGA1;MYL6;DYSF;DMD;PXN;MYL12B
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.6387662592449941,1.0447286193062553,0.4090909090909091,0.8699828016295031,1.0,4/11,14.18%,NRCAM;FGFR1;REST;ECT2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6428856590927534,1.0440977004969634,0.463768115942029,0.8706813737973368,1.0,4/9,24.38%,CDKN1B;CDKN1A;MEF2C;PPARG
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.47575189892028247,1.043877002126507,0.3670886075949367,0.8704849681808207,1.0,21/53,31.39%,GLUL;RPS9;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS27;NPM1;RPL10;XPO1;RPL37A;RPL21;RPLP1;RPS15;WDR43;MTREX;XRN2;RPL24;RPS7
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4467615014956563,-1.0436236828943797,0.3076923076923077,1.0,1.0,2/23,5.42%,EIF2AK2;NOD1
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.6450636551968342,1.0432030689279757,0.5,0.8718283504321508,1.0,3/8,21.65%,CANX;SYT1;SYNJ2
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.6422930049462939,1.042860465104693,0.4931506849315068,0.8720003733986867,1.0,3/9,21.65%,CANX;SYT1;SYNJ2
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.6397766988349555,1.0424896450043972,0.43103448275862066,0.8723257397801051,1.0,3/6,24.14%,FOXC1;OXSR1;WNK1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5293636477209205,1.0423882949006382,0.4788732394366197,0.8717805702628977,1.0,2/24,2.84%,WNT2B;ZNF160
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.6774746914780236,1.0423654044005803,0.463768115942029,0.8710216722917268,1.0,2/7,16.68%,SMAD7;SPRED1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.6703880424675174,1.0422066380703094,0.4925373134328358,0.870723876831937,1.0,3/6,25.37%,GRIN2B;FYN;PSMB9
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.5875442045396283,1.0419643473684854,0.5128205128205128,0.8706001364665495,1.0,6/11,24.14%,ANK3;ATP1A1;NEDD4;ATP2B4;AHCYL1;WNK1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.6469284954449235,1.041751455699435,0.44285714285714284,0.8703440600446659,1.0,4/8,33.81%,RPL23;CDC14B;RPS7;RAB1A
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.5351719004415503,1.0416726396174087,0.425,0.8698643203262256,1.0,14/31,27.33%,RAPGEF3;CPEB4;SSH1;CTNNA1;HSP90B1;RAP1A;GOLPH3;RYR3;ACTB;MEF2C;MTOR;SLC38A9;CAPN2;AKAP6
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.6349610839259603,1.0414088477368508,0.42424242424242425,0.8696297405799834,1.0,2/5,16.79%,NAA16;NAA50
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.5175787889059391,1.0413541748047423,0.38028169014084506,0.8689583132118079,1.0,8/41,11.29%,LRRC7;FES;IL1RAPL1;PTPRD;ROBO2;SCARB2;RAP1A;MAGI2
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.5195295409647176,1.0398034447442486,0.45,0.8721692039893094,1.0,11/33,25.44%,CCDC88A;PINK1;PAK2;ECT2;ADCY2;MALT1;TNFRSF10B;TAOK1;ADCY9;EMP2;MTOR
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.6787387615570157,1.0395654535633685,0.5076923076923077,0.8721158782259133,1.0,2/5,19.12%,RAP1A;SLC30A1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.6244174290383755,1.0394026257833244,0.4925373134328358,0.8717279819007452,1.0,1/10,3.40%,MAP3K5
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.6406646471872622,1.039289508129664,0.48484848484848486,0.8711888074949639,1.0,4/7,29.99%,PRNP;TRAM1;EGFR;VAPA
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.6697320240217117,1.0390562617891457,0.44642857142857145,0.8712175016563253,1.0,3/6,29.75%,PLPP1;ACER3;SPTLC2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.6160404839061797,1.0386321542448924,0.49230769230769234,0.8716405832796846,1.0,5/12,20.66%,SMAD7;JAK1;ANK3;PODXL;AFDN
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.5116342179913024,1.0376034476513185,0.43243243243243246,0.8737402721349091,1.0,16/27,36.20%,NEDD4L;SYT1;SDCBP;RIMS2;CSNK2A1;RPS6KA3;CDC42;EGFR;CDKL5;AKAP6;ADAM17;RIMS1;MTPN;DDX3X;MAP3K13;EIF4G2
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.6891642325712283,1.03753184208041,0.5151515151515151,0.87305989136272,1.0,3/5,23.27%,ADGRB3;SCARF1;ANKS1A
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.4796102909084306,1.0373413340849114,0.44047619047619047,0.8727438515830411,1.0,21/65,22.20%,SUN2;VAPB;ATP8B1;ARHGAP21;SRGN;TMED10;ANK3;TOR1AIP2;NPLOC4;WASHC4;DYSF;REEP3;RAB30;GOLPH3;RAB2A;VMP1;ARFGEF2;CSNK1D;ARFGEF1;DNAJC13;CAV2
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.6291623036906943,1.0371055297973917,0.4225352112676056,0.872569464891484,1.0,5/10,16.18%,SLC8A1;ANK2;KDM1A;DYSF;DMD
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.5612521190410368,1.0370742852994799,0.48484848484848486,0.8718919856094123,1.0,8/22,23.24%,RFTN1;ZDHHC6;ZDHHC14;PIKFYVE;SDCBP;VPS37A;AFDN;RAB3GAP2
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.4245009138021909,1.0370061977771179,0.3402061855670103,0.8713263789430468,1.0,68/324,21.33%,LAMC1;B3GNT2;PSMC6;PDK4;PPP2R3A;FEM1C;PRKAG2;PKN3;PPM1D;MAP3K5;ANXA1;MGAT4A;PTPRD;PRKCE;PLOD2;DUSP6;UFL1;BCR;FGFR1;ERO1A;PINK1;JAK1;DCAF10;ZDHHC6;CDK6;DUSP1;SSH1;MACROD2;HSP90B1;MSRA;HIF1A;SIK2;TRIB2;SETD3;COMMD1;PPM1A;STK38L;STK38;PRAG1;MAPK10;ACVR2A;DUSP16;PAK2;CTTNBP2NL;TRIOBP;PSMA7;PLAT;TNKS;GRK5;TGM2;PPP1CB;RAB2A;TF;CSNK1G3;CSNK1D;MTMR6;ABL2;MGAT1;PTPN1;LIMK2;TEC;SOCS3;CDK8;PMM2;MORC3;PPP3CB;EPAS1;TAOK1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.6848293163710977,1.0369692827238675,0.4262295081967213,0.8707014923315077,1.0,3/5,29.03%,ATP1A1;TFPI;ABHD2
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.6681909650504045,1.0369238008947923,0.463768115942029,0.870027526932685,1.0,2/6,11.29%,ITGA1;MAGI2
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.6985185497353834,1.0368140374911836,0.48484848484848486,0.8694751576417445,1.0,2/5,13.04%,HIF1A;TRAK1
prerank,MSigDB_Hallmark_2020__Apoptosis,0.49103303939182574,1.0366287614098662,0.425,0.8692044225328082,1.0,12/57,11.87%,ATF3;NEDD9;BCAP31;BNIP3L;ANXA1;TIMP3;SMAD7;CDKN1B;EMP1;JUN;IFNGR1;CDKN1A
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.6375430686131782,-1.0366198802803168,0.4444444444444444,1.0,1.0,2/7,16.79%,ACVR1;MDM4
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.6029669384223071,1.036540869953042,0.4626865671641791,0.8687539241288385,1.0,2/9,19.39%,NRXN1;RIMS2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.47261262116590574,1.0364508392550231,0.4027777777777778,0.8682742198546199,1.0,8/58,10.09%,MAP2;GRM7;GPM6B;CTNND2;PPP1R9A;MICALL2;CNTNAP2;GAS7
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.5945759683038012,1.0358861961984371,0.4647887323943662,0.8688349512148413,1.0,6/15,20.16%,KDM1A;ALPL;RFC3;SMARCC1;GATA2;NPM1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.542191056671039,1.0356050148675422,0.4714285714285714,0.8689252906417847,1.0,3/20,11.55%,UFL1;RPL23;COMMD1
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.6125813156035527,1.0351427655999175,0.5070422535211268,0.8695243472018082,1.0,2/10,7.36%,BCAP31;HSP90AA1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.6158959398047128,-1.0344539172278715,0.5,1.0,1.0,1/9,0.16%,VCAM1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.42693856570293565,1.0343794012003644,0.3870967741935484,0.8710594267998594,1.0,57/272,20.58%,ZEB2;BCL6;ATF3;MAFK;KLF2;TBX3;BHLHE40;PHF10;CALR;ZBTB1;ZFPM2;PURA;SMAD7;SIN3B;ESR2;ATP8B1;CBFB;KDM1A;ARID5A;RPS27A;RPL23;KLF4;CDKN1B;JUN;ZNF366;CREM;SPEN;OTUD7B;CNBP;REST;PPM1A;NEDD4L;ZBTB38;LRRFIP1;FOXC1;NCOR2;MTDH;NR2C1;ATOH8;LIMS1;MCPH1;SDCBP;TPR;RIF1;CRY1;STAT3;DUSP22;MBD2;NACC2;NR1D2;NFIC;NOTCH4;BCLAF1;CREBZF;RCOR3;ELK3;HSPA8
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5706388369508718,-1.0343078421797318,0.4666666666666667,1.0,1.0,2/9,2.95%,BABAM2;ATM
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.6309981365020685,-1.0339754086074855,0.4722222222222222,1.0,1.0,1/6,1.09%,MSL2
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.6912124055047593,1.0339719248601735,0.4918032786885246,0.8713566999712075,1.0,2/6,19.39%,NRXN1;RIMS2
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.5794829311137183,1.033861268178383,0.47297297297297297,0.8708075826004278,1.0,6/19,23.03%,FGFR1;HIF1A;FOXC1;LIMS1;NOTCH4;MEF2C
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.6174997695351572,1.0336111536637775,0.4838709677419355,0.870488120429862,1.0,2/11,9.19%,TSG101;LAMP2
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.6570626322220932,1.0328807185103293,0.5151515151515151,0.8718281309061381,1.0,1/7,1.01%,RFTN1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.6339212985456976,-1.0323275624493027,0.5208333333333334,1.0,1.0,2/6,1.83%,PLA2G4A;CD74
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.5498097363936052,1.0317444988571902,0.4,0.8740887526052649,1.0,8/20,20.82%,CALR;ANXA1;ANXA2;NEDD4L;HIP1R;GATA2;DYNC1H1;ACTB
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.4224616772362682,1.0312466367064843,0.4659090909090909,0.874659652805211,1.0,39/179,21.33%,ERBB4;PDK4;PCK1;PRKAG2;FES;PKN3;MAP3K5;PRKCE;BCR;FGFR1;SMAD7;PINK1;JAK1;CDK6;SIK2;TRIB2;CCNH;STK38L;FLT1;STK38;PRAG1;MAPK10;ACVR2A;PAK2;TNKS;GRK5;PRKX;CRY1;CSNK1G3;CSNK1D;ABL2;ABI1;LIMK2;TEC;CDK8;CAB39;MORC3;PPP3CB;TAOK1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.5156939959720498,1.0312248806247213,0.391304347826087,0.8739019916834669,1.0,11/25,32.99%,FGFR1;HIF1A;GATA2;ATP2B4;ETS1;MEF2C;PPARG;MECP2;RGCC;ADAM17;ACVRL1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.5837258396658496,1.0309605728929254,0.5147058823529411,0.8738880461291009,1.0,6/10,32.19%,GJA1;ITGB1;PAFAH1B1;CDK5RAP2;NDEL1;KPNB1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.4721905806880107,1.030774066746894,0.3924050632911392,0.8735477724400357,1.0,12/56,10.97%,LAMC1;SERPINE1;ADAMTS9;GPM6B;LAMA5;PLOD2;P4HA1;COL4A2;ITGA1;VWF;PECAM1;ADAM15
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.5568299411456434,1.0305358333983181,0.4375,0.8733167899274036,1.0,6/19,16.68%,PRKAG2;CDKN1B;TRIB2;PAK2;WWTR1;SPRED1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.39994572143921703,-1.0304654842144383,0.3076923076923077,1.0,1.0,14/47,13.55%,GBP1;CD74;GCNT2;TGFBR3;PDGFC;PDGFB;FN1;SEMA6A;MFHAS1;SPRY3;PTPRR;PTPN2;RAPGEF2;GAS6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.5847926158155579,1.0303658630835841,0.38571428571428573,0.8728986493120376,1.0,2/12,6.06%,SERPINE1;HYAL2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.5983605023516012,1.0302911325951434,0.4788732394366197,0.8723135739259309,1.0,4/15,12.88%,ANK2;CTNND2;FGFR1;BCAR1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.5234586078161771,-1.0297523919598364,0.35135135135135137,1.0,1.0,3/14,5.55%,ATM;ATR;SP100
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.5527944894035984,1.0297207403329502,0.4675324675324675,0.8731879999307849,1.0,7/25,24.38%,ZFPM2;AAMDC;TRIB2;WWTR1;GATA2;ZFP36;PPARG
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.49287761526864476,1.0292964770830506,0.43478260869565216,0.8734307498234521,1.0,13/45,23.37%,RTN4;SGIP1;HSP90AA1;PICALM;AHCTF1;HIP1R;DMD;TPR;PXN;CHMP4B;TBCD;UVRAG;NCK1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.6481679101607974,1.0289487414886065,0.4383561643835616,0.8733582836938086,1.0,2/8,11.47%,ROBO2;REST
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.6029612647668601,1.0288406709833653,0.4827586206896552,0.8728338373550498,1.0,3/11,19.39%,RAP1A;PREPL;RIMS2
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.4868498933703923,1.0287056381815702,0.4430379746835443,0.872565629319058,1.0,9/50,15.75%,NES;ANK2;MAP1B;NFASC;COL4A2;GJA1;BOC;PCDH7;NAV2
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.5281223840908603,1.0285825753059599,0.47297297297297297,0.8721605376388484,1.0,14/25,30.36%,RAB11FIP3;AHCTF1;ECT2;SND1;DYNC1H1;BCL2L1;CAV2;UVRAG;CSNK2A1;IHO1;CDC42;PIK3C3;CALM1;PRPF40A
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6456632323533409,1.0285033307706266,0.42857142857142855,0.8715993184798474,1.0,3/6,26.40%,NCOR2;MAP2K1;EGFR
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.6230413586266224,1.0282273285613468,0.48484848484848486,0.871450428974649,1.0,7/10,30.17%,HSP90AA1;NOS1AP;DNM2;WASL;EGFR;CALM1;ZDHHC21
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.5093371981657393,-1.0280201188947564,0.41379310344827586,1.0,1.0,7/15,22.50%,BICD1;EFNA5;CLASP1;CYLD;PHLDB1;PHLDB2;MARK2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.6860752644578653,1.0279816340016614,0.5230769230769231,0.8713213714886374,1.0,1/5,3.90%,ANXA1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.46490958804839366,-1.0279543364365977,0.35714285714285715,1.0,1.0,3/26,6.40%,VCAM1;SNED1;PODN
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.687367325087662,1.0278462619205893,0.4423076923076923,0.8709676761695326,1.0,3/6,13.44%,INPP5F;ANXA2;KIF16B
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.5065712683239556,-1.0272983298546339,0.38461538461538464,1.0,1.0,6/13,12.32%,IFIH1;TAP1;IRF1;PARP12;HLA-F;HLA-C
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.5030178397609599,1.0272746536313615,0.4473684210526316,0.8718160817947764,1.0,9/32,24.38%,ADM;KLF4;GGT5;ADCY2;ADCY9;CDH5;FYN;FGR;PPARG
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.6389284378302232,1.0261873865674858,0.49230769230769234,0.8742733330271321,1.0,4/9,25.44%,LPGAT1;SCARB1;LDLR;MTOR
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.5038658332759882,1.0261847633171608,0.4861111111111111,0.8735181905182909,1.0,13/42,27.94%,NES;KDM1A;CDKN1A;CLDN5;HIP1R;CRK;AMFR;TMBIM6;ACTB;RACK1;ADD1;MARK3;SPPL3
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.6900463064475036,1.0260505328047584,0.47540983606557374,0.8730274162886476,1.0,1/5,22.26%,RAB8B
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.4417780393850661,1.0260376754275475,0.43373493975903615,0.8722649469294436,1.0,24/126,20.85%,MTFR1;NEDD9;VAPB;ATP8B1;PINK1;ARHGAP21;TMED10;TOR1AIP2;NPLOC4;LARP4;PIKFYVE;AGTPBP1;BRWD3;RAB30;PDZD8;GOLPH3;RAB2A;VMP1;CFL1;CSNK1D;CHMP4B;SH3KBP1;DPYSL2;ARFGEF1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.5637811507487956,-1.0259745931513529,0.45714285714285713,1.0,1.0,2/10,16.23%,COG3;TRAPPC10
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.5512603836474269,-1.0250474119783686,0.4482758620689655,1.0,1.0,3/12,9.35%,BABAM2;USP25;OTUD4
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.4699570880642794,1.024188827389281,0.48717948717948717,0.8762790383387817,1.0,11/49,9.83%,LAMC1;ZEB2;KLF6;KLF2;TIMP3;PLSCR4;P4HA1;COL4A2;KLF4;FOSL2;HIF1A
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.5836175632634634,1.0241736793784726,0.44,0.875544214710121,1.0,6/16,19.60%,GLUL;CTNNA1;OTUD7B;WWTR1;TPR;LIMK2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.7390665522381618,1.023908651044989,0.5076923076923077,0.875470854440284,1.0,2/5,11.47%,PINK1;REST
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.6686940124394852,1.0236896259422457,0.5,0.8752618200926721,1.0,1/7,10.23%,RFC3
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.6297513899003132,1.0234102084543113,0.4166666666666667,0.875353591724857,1.0,2/7,7.04%,HSPA5;PINK1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.6270725855450769,1.0232129784269923,0.49295774647887325,0.8750481897640341,1.0,2/9,18.57%,MALT1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.6633847791378396,1.0230830562272135,0.4647887323943662,0.874607869893505,1.0,7/7,33.78%,ITGA1;MAGI2;MEF2C;MTOR;CALM1;MTMR9;HSP90AB1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.6651860637275095,1.022833805995745,0.49230769230769234,0.8745259733710609,1.0,3/6,28.18%,GSN;EMP2;CAMK2D
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.4149465952602801,-1.0227271421820638,0.45454545454545453,1.0,1.0,8/54,7.28%,XAF1;EIF2AK2;CD74;ISG15;MX1;STAT1;SP100;GCH1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.47188757946766907,-1.0224180628489925,0.4418604651162791,1.0,1.0,4/18,13.73%,EIF2AK2;TGFBR3;FOXO1;ULK4
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5252542980677377,-1.0222781777606997,0.35714285714285715,1.0,1.0,3/15,9.72%,CD74;PARP14;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.4863193943782379,1.0222410915847617,0.43209876543209874,0.8755259257916586,1.0,13/58,14.74%,SERPINE1;CALR;HYAL2;SMAD7;NAV3;SRGAP1;DLC1;GJA1;ADAM15;MAGI2;CLDN5;ADGRG1;RAC1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.6278315348540383,1.0218324510804784,0.4931506849315068,0.8749945967098464,1.0,6/13,24.25%,INSIG1;CNBP;RALY;SCARB1;ABCG1;LDLR
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.6278315348540383,1.0218324510804784,0.4931506849315068,0.8749945967098464,1.0,6/13,24.25%,INSIG1;CNBP;RALY;SCARB1;ABCG1;LDLR
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.6703870828856829,1.0212402095522641,0.4262295081967213,0.8760878818647705,1.0,3/7,16.10%,ROBO2;SEMA6B;SEMA3F
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.3806654601163384,-1.0209340641065978,0.3333333333333333,1.0,1.0,7/87,4.20%,COL8A1;CARMIL1;RHOBTB1;PGM5;TLL1;EVL;ARHGAP12
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.5830441098124632,1.020417827250038,0.5217391304347826,0.8771215303678469,1.0,3/10,19.39%,PREPL;SYT1;RIMS2
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.6487471669183489,1.018933017300126,0.47540983606557374,0.8785030158709686,1.0,1/10,7.36%,HSP90AA1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.6487471669183489,1.018933017300126,0.47540983606557374,0.8785030158709686,1.0,1/10,7.36%,HSP90AA1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.6487471669183489,1.018933017300126,0.47540983606557374,0.8785030158709686,1.0,1/10,7.36%,HSP90AA1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.692395691271731,1.0188765083409088,0.5,0.877967596102317,1.0,3/5,24.49%,UPP1;DPYSL2;TET2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.6287998729211687,1.018592608030161,0.45714285714285713,0.8780655987217708,1.0,2/8,18.57%,MALT1;STAT3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.5719583385248428,1.0183627773347192,0.5,0.8779049045786613,1.0,3/24,6.11%,ERBB4;FES;FGFR1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6593925885439564,1.0181215582617333,0.5217391304347826,0.877754053211267,1.0,4/7,31.66%,SMC6;CSNK2A1;IHO1;ZNF207
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.6074724008410015,1.0179777936518166,0.484375,0.8774409626762623,1.0,4/10,28.95%,PPP1R10;TERF2IP;YLPM1;SMG1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.49411112556531744,1.0172969418523496,0.4875,0.8784654801447721,1.0,15/45,23.48%,SMAD7;SMAD5;RPS27A;JUN;LRRC32;FOS;CLDN5;ITGB1;PXN;ZMIZ1;DUSP22;SMAD6;CDH5;UBC;ADAM9
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.5047852466903169,1.0171444022160412,0.41975308641975306,0.8780187239575701,1.0,4/39,8.82%,SEC22B;KLF2;KLF4;CDKN1B
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.5362197153546703,-1.0161087425428275,0.5555555555555556,1.0,1.0,3/12,8.50%,ATM;ATR;MDM2
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.6718826336196662,1.0151474916907468,0.5538461538461539,0.8822826123817201,1.0,2/6,23.24%,ANXA2;RAB3GAP2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.6990500582611,1.0143985317564377,0.5357142857142857,0.8834337290244113,1.0,1/5,2.34%,BCAP31
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.5879852853292534,1.014202244683837,0.4861111111111111,0.8832598933640323,1.0,4/12,20.61%,TPR;DYNC1H1;NEDD4;CEP290
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.5056475030111137,1.0141193997344184,0.4444444444444444,0.8828010613799941,1.0,5/25,14.42%,TIMP3;PLSCR4;COL4A2;GJA1;TNS1
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.46574030403808725,1.0141175216913567,0.44047619047619047,0.8820484603046488,1.0,18/60,18.38%,CHPT1;BHLHE40;KAZN;INPP5F;DLC1;KLF4;SLC2A1;GJA1;FKBP5;FOS;SLC26A2;FOXC1;ADD3;NCOR2;NAV2;AMFR;TGM2;PODXL
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.5914051065622803,1.0139666330594426,0.4492753623188406,0.8816578968171855,1.0,7/19,29.93%,BCAR1;SHC2;CADPS2;EPAS1;ATP1B1;EFNB2;DAB2IP
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.5309881081378598,-1.0139444631369163,0.4117647058823529,1.0,1.0,2/14,2.12%,COL8A1;TLL1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5463692260842459,1.0136612157591338,0.4657534246575342,0.8816948449645727,1.0,8/17,30.44%,ESR2;TMF1;PLPP1;ZMIZ1;NEDD4;ARID1A;UBR5;UBE3A
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.5993512150670139,1.0134825961343898,0.4461538461538462,0.8813905431702301,1.0,5/7,36.07%,RAC1;ALMS1;CDC42;AKAP13;ACTG1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.5339740744378464,-1.0131490994384744,0.4634146341463415,1.0,1.0,2/12,2.87%,CD74;LEPR
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.47322475296943234,-1.0131122759352644,0.4375,1.0,1.0,2/13,3.27%,FAXDC2;STAT1
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.5229430210756094,1.0111905724720283,0.4444444444444444,0.8866736852181671,1.0,4/23,9.85%,DLC1;MSRB3;COL4A2;GJA1
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.5516031527482844,-1.0111236810472337,0.5517241379310345,1.0,1.0,3/9,15.86%,ISG15;HLA-A;HSPD1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.48888008691149515,1.0108515754778884,0.4878048780487805,0.8869617372649953,1.0,7/56,10.97%,DDIT4;RTN4;GAPDH;PRKCE;DLC1;OGT;ADAM15
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.4755413450549169,1.0107248160619338,0.44047619047619047,0.8865970226975844,1.0,16/63,17.50%,DOK5;TRIM5;MGLL;PRNP;CBFB;OGT;SIK2;PRAG1;RIC8B;CD55;WWTR1;VWA2;CRK;AMFR;GRK5;PXN
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.6507098205192261,1.0097553123836054,0.53125,0.8884053436184066,1.0,2/7,10.68%,HIF1A;LRRC32
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.5860966149639191,1.0096915777656608,0.5079365079365079,0.8878040919529774,1.0,5/10,29.61%,PICALM;COMMD1;TF;XIAP;FTL
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6785903204646542,1.0093467426369924,0.5,0.8880430662992721,1.0,2/5,11.24%,KCNMB4;ATP1B3
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.610860211670492,1.0089279658271404,0.5645161290322581,0.8884606420946953,1.0,7/9,27.33%,ANO6;NEDD4L;NEDD4;AHCYL1;YWHAE;WNK1;AKAP6
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.5585308821796945,1.0087190606006917,0.5303030303030303,0.8882279891015331,1.0,11/15,30.17%,HSP90AA1;HIF1A;NOS1AP;ATP2B4;DNM2;SCARB1;WASL;EGFR;PIK3CB;CALM1;ZDHHC21
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5934345377480702,-1.008115927403792,0.5357142857142857,1.0,1.0,1/8,0.24%,CEMIP
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6017775721574017,1.0081090638826904,0.43283582089552236,0.8889174618107409,1.0,2/7,20.64%,PKIG;ATP2B4
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.564890577911256,1.008032651330647,0.4626865671641791,0.8883559031653971,1.0,3/13,16.87%,ARF1;MAGI2;SDCBP
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.587210282212014,1.0069839042237123,0.40298507462686567,0.8903868180277759,1.0,2/8,11.05%,RPS27A;CCNH
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.5999473677571467,1.0067248318263289,0.5915492957746479,0.8902471438984657,1.0,5/10,28.95%,NPAS2;CRY1;BCLAF1;MCL1;SMG1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.5965880867236713,1.0064667211088782,0.4507042253521127,0.8901451999036764,1.0,2/8,10.54%,RPS27A;USP45
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.6738216031030364,1.005189541665498,0.5,0.892853203400051,1.0,3/5,22.39%,PIK3R1;GIGYF2;PLCB1
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.5668134934895392,1.0051468578707001,0.5373134328358209,0.8921690429588686,1.0,3/14,8.07%,ANXA1;PURA;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.4424581155457426,1.0047004360645035,0.4666666666666667,0.8927109074095642,1.0,20/136,14.29%,PIK3R3;ANK2;GAPDH;VSIR;PIK3R1;NFE2L2;RPL23;KLF4;ANK3;SLC38A2;HIF1A;GJA1;LARP4;IFNGR1;AGO2;CLDN5;TAF1D;NOS1AP;KRAS;TENT4A
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.6263720217555755,1.0046052921475024,0.5625,0.8921868334638056,1.0,3/8,14.74%,PRAG1;ADGRG1;RAC1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.6293587026477581,-1.0038829286599462,0.4594594594594595,1.0,1.0,2/6,11.42%,SHLD1;SHLD2
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.5596070745748051,1.0036676771716753,0.49295774647887325,0.8938572551813465,1.0,8/20,25.31%,FES;CBFB;CDK6;HSPA9;LGALS3;KMT2E;MEF2C;CREBBP
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.6622861115539922,1.0036633829248172,0.5087719298245614,0.8931185842108362,1.0,2/6,21.38%,HS6ST3;EXT1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.6345817542689154,1.0028799739373082,0.5147058823529411,0.8944033572189546,1.0,1/9,5.42%,DUSP6
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.6677102482328525,1.0022956865650414,0.5555555555555556,0.8950993811814749,1.0,2/5,13.47%,SMAD7;NEDD4L
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.4762717028047956,1.0019410221019978,0.4794520547945205,0.8952267371818536,1.0,11/44,20.85%,SEC22B;ATP8B1;ARHGAP21;TMED10;NPLOC4;RAB30;GOLPH3;RAB2A;VMP1;CSNK1D;ARFGEF1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.6737176665104867,-1.0018580930943703,0.6410256410256411,1.0,1.0,2/5,11.45%,CD74;MCU
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.6737176665104867,-1.0018580930943703,0.6410256410256411,1.0,1.0,2/5,11.45%,CD74;MCU
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.6737176665104867,-1.0018580930943703,0.6410256410256411,1.0,1.0,2/5,11.45%,CD74;MCU
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.4550115445550066,1.0018481384512643,0.5125,0.894740369988046,1.0,9/70,9.83%,PNP;SERPINE1;RFTN1;ANXA1;GAPDH;MBP;HYAL2;TMED10;HIF1A
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.6473615267193067,1.001759279415329,0.5396825396825397,0.8940876317249029,1.0,4/6,35.17%,ADAM9;MTOR;MAPRE2;IQSEC1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.5050749727451757,1.0013479179033484,0.4383561643835616,0.8944382353285915,1.0,10/28,31.69%,PPM1D;PPHLN1;TAF1D;CREBZF;ACTB;SMARCA5;MTF2;MECP2;DEK;AEBP2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.5522646245198468,1.001296985926566,0.4852941176470588,0.8938517414324513,1.0,3/15,9.03%,PCK1;ANXA1;OGT
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.6351651688844402,1.0011895664837276,0.5362318840579711,0.8933866638108531,1.0,2/6,17.37%,PPM1A;HDAC7
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5923426719923612,1.0001179655900816,0.5,0.8950885001293789,1.0,7/15,24.73%,BCAP31;PINK1;HERPUD1;BCLAF1;BCL2L1;MCL1;RACK1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.6861059712126969,1.0000416671804186,0.5283018867924528,0.8945491734066793,1.0,3/5,26.16%,DNM2;ASAP1;WASL
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.6244098821590498,0.9983091117251104,0.5147058823529411,0.8982619060101862,1.0,1/7,12.91%,AGO2
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.5734154721417849,0.9981648299599225,0.4852941176470588,0.8978870558949054,1.0,9/13,38.65%,NEDD4L;SYT1;RIMS2;PLCB1;CDKL5;RIMS1;INSR;MAP3K13;SMURF1
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.5917084388937071,0.9977374408993777,0.53125,0.8980664081186389,1.0,4/9,25.87%,GJA1;ITGB1;PAFAH1B1;CDK5RAP2
prerank,PanglaoDB_Augmented_2021__B Cells,-0.4804134016043254,-0.9976693551486271,0.4230769230769231,1.0,1.0,2/15,2.50%,CD74;EBF1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.5334244878040311,-0.9972064036927623,0.4666666666666667,1.0,1.0,1/11,1.27%,SLC38A3
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.48898002694718734,0.9961234854011174,0.42857142857142855,0.9013429571639007,1.0,6/34,9.19%,TSG101;PRKAG2;ATG12;PINK1;RB1CC1;LAMP2
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.4263895367017856,0.9954295106546145,0.48863636363636365,0.902163934655237,1.0,27/141,20.58%,BCL6;TBX3;BHLHE40;PHF10;CALR;ZFPM2;ATP8B1;KDM1A;ARID5A;KLF4;CDKN1B;JUN;SPEN;REST;ZBTB38;NCOR2;ATOH8;LIMS1;CRY1;MBD2;NACC2;NR1D2;BCLAF1;CREBZF;RCOR3;ELK3;HSPA8
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.6750904586306425,0.9952991337001986,0.515625,0.9017686935250699,1.0,1/5,6.75%,ENPP2
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.6069911599468972,-0.9951413113530491,0.5294117647058824,1.0,1.0,1/5,1.81%,PLA2G4A
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.6046496683204224,0.9950861629041216,0.5166666666666667,0.9015304351130777,1.0,1/8,3.59%,S1PR1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.5882562626588691,-0.9950120087915958,0.5161290322580645,1.0,1.0,2/7,16.79%,ACVR1;MDM4
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.6027033676895294,0.9949471874964557,0.6142857142857143,0.9011271795858629,1.0,5/10,21.89%,SLC25A16;SLC26A2;ADCY2;ADSS2;ADCY9
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.45834887877392694,0.9947405014602326,0.48,0.9008439383103247,1.0,12/52,17.45%,MAFF;FES;PRNP;VWF;PECAM1;LRRC32;ADGRG1;DYSF;TNS1;NCOR2;PLXDC2;GATA2
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.6148974985088206,0.9943213616730593,0.5166666666666667,0.9009372647260119,1.0,1/6,12.40%,ANO6
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.3751634305244477,-0.9939916131633675,0.4117647058823529,1.0,1.0,11/76,8.55%,PRIMPOL;MGMT;BABAM2;ATM;ASCC3;FAM111A;PARP9;ATR;RAD51B;HERC2;MSH3
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.5469731734159038,0.9938163922238424,0.5633802816901409,0.901222916553725,1.0,4/11,19.39%,PDE7A;RAPGEF3;ADCY2;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.6080926153937893,0.9937761507946108,0.5070422535211268,0.9005556533218592,1.0,2/10,16.49%,RAC1;LIMS1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.6711969275679017,0.9934440364420153,0.5555555555555556,0.9007221914527473,1.0,1/6,6.40%,ESR2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.6284077056140853,0.9934020649752954,0.609375,0.9001204354969409,1.0,3/6,17.58%,SULT1C4;SLC26A2;TPST2
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5175081103585538,0.9931580761666767,0.5373134328358209,0.9000129890203812,1.0,8/24,16.49%,NEDD9;CALR;IL1RAPL1;PTPRD;RAC1;TRIOBP;CRK;LIMS1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.6586337765334292,0.9926067921751681,0.49230769230769234,0.8998442269232089,1.0,3/6,19.39%,NEDD4L;SYT1;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.6586337765334292,0.9926067921751681,0.49230769230769234,0.8998442269232089,1.0,3/6,19.39%,NEDD4L;SYT1;RIMS2
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.6173868004456223,0.9921268927759626,0.4647887323943662,0.9004298731695016,1.0,4/8,25.44%,KIF16B;NEDD4;UVRAG;MTOR
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.4546748393631063,0.9916813588106363,0.5,0.900732284039517,1.0,11/55,10.46%,SERPINE1;CD9;TIMP3;SYTL4;SNAP25;DNAJC5;SRGN;TMED10;LAMP2;VWF;PECAM1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.5205908502227757,0.9916321358265215,0.5142857142857142,0.9000970739298016,1.0,3/25,8.63%,SERPINE1;INPP5F;KLF4
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.5987390310028876,0.9915927209105847,0.5147058823529411,0.8979435201882047,1.0,3/9,19.87%,PPM1D;FOS;KMT2E
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.5987390310028876,0.9915927209105847,0.5147058823529411,0.8979435201882047,1.0,3/9,19.87%,PPM1D;FOS;KMT2E
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.5987390310028876,0.9915927209105847,0.5147058823529411,0.8979435201882047,1.0,3/9,19.87%,PPM1D;FOS;KMT2E
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.62718286762989,0.9915803812252277,0.46296296296296297,0.8972219595089805,1.0,1/6,4.17%,LAMA5
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.6347432827879755,0.991560176680565,0.5074626865671642,0.8965559401256004,1.0,6/6,36.63%,UGGT2;VCP;UGGT1;DNAJB14;CUL3;ATXN3
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.5566584297977241,0.9915178268783177,0.5806451612903226,0.8958819488440443,1.0,3/13,10.49%,GLUL;ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.5131526694852416,0.9913521589267532,0.5633802816901409,0.8955166370486076,1.0,8/20,22.26%,ZDHHC6;ZDHHC14;PIKFYVE;TRAM1;SDCBP;CHMP4B;VPS37A;RAB8B
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.5168420713993015,0.9911999661312844,0.5454545454545454,0.8951338392294464,1.0,4/26,11.87%,PPM1D;CBFB;CCNC;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.531767785764104,0.9911393578366217,0.5373134328358209,0.8945619905527352,1.0,1/24,0.69%,SERPINE1
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.6220691503583325,0.9909500922172896,0.5245901639344263,0.8942979061203074,1.0,4/8,25.71%,CCDC60;VWA2;ATP1B1;NEBL
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.6066516698775535,0.9901870850546941,0.5238095238095238,0.8952966781020347,1.0,2/9,7.04%,CCDC88A;PINK1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.6110682225913935,-0.9898750589142307,0.4888888888888889,1.0,1.0,3/5,29.83%,PRKD1;HSPB1;PRKD2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5148445778723905,-0.9895695229548487,0.4230769230769231,1.0,1.0,4/17,4.62%,MGMT;SHLD1;PARP9;SLF2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.6541189153732287,0.989543244292045,0.5409836065573771,0.8960505636081374,1.0,2/5,14.10%,ZBTB1;AP1G1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.6255607390384716,0.9894027348333032,0.5573770491803278,0.8956238666253478,1.0,1/8,3.59%,S1PR1
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.46929752540382774,0.9886837187032972,0.4794520547945205,0.8959949410139953,1.0,9/43,10.97%,LAMC1;SERPINE1;ADAMTS9;LAMA5;COL4A2;ITGA1;VWF;PECAM1;ADAM15
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.46929752540382774,0.9886837187032972,0.4794520547945205,0.8959949410139953,1.0,9/43,10.97%,LAMC1;SERPINE1;ADAMTS9;LAMA5;COL4A2;ITGA1;VWF;PECAM1;ADAM15
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.5853408421043864,0.9876973902417735,0.5416666666666666,0.8977606891532246,1.0,5/11,27.49%,AAMDC;ZFP36;PPARG;ASXL2;HNRNPU
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.5028971729980303,0.9870619075355466,0.5675675675675675,0.8986531364050314,1.0,5/26,14.10%,CANX;ARF1;SEC24D;PIKFYVE;AP1G1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.557151044740283,0.9870164377646677,0.5211267605633803,0.8980287975178497,1.0,7/13,28.47%,DLC1;ITGA1;MAGI2;CDH5;MTOR;SPPL3;CALM1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.6083550542383669,0.9866412914403395,0.4925373134328358,0.8982207642666363,1.0,2/10,2.90%,DTNA;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.515705263291649,0.9864285233202147,0.4864864864864865,0.8980811925302032,1.0,8/28,17.61%,RTN4;CALR;GAPDH;PRNP;GIGYF2;RPL13A;RTN3;BTG2
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6019313463011693,0.9862665218280366,0.5454545454545454,0.89777189020024,1.0,5/15,20.32%,CDK6;KLF4;CDKN1A;NACC2;SLFN11
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.6003488800133363,0.9861124214412591,0.5625,0.897463083944583,1.0,6/9,37.66%,TGM2;PDE4B;ATP2B4;RYR2;PRKN;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.585289324907728,0.9860578406166477,0.5555555555555556,0.8968511306281689,1.0,4/10,19.39%,GRIK2;ANK3;SYT1;RIMS2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.5822105312286432,-0.9857145492241621,0.5,1.0,1.0,3/11,11.42%,SHLD1;PARP9;SHLD2
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.5828253415570783,-0.9853573448526648,0.45714285714285713,1.0,1.0,2/6,14.71%,MFF;PNPT1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.611230219114553,0.9845820693079426,0.5492957746478874,0.8995061564398232,1.0,3/6,18.38%,MYO1E;MAGI2;PODXL
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.5375472565044062,0.9843044071038021,0.4864864864864865,0.8994909436653197,1.0,7/19,22.28%,RAPGEF3;HYAL2;PIK3R1;ECT2;TPR;NEDD4;YWHAE
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.4655545069461781,0.9835537026455107,0.5142857142857142,0.9004735888546643,1.0,4/35,13.52%,IL1RAPL1;ROBO2;KLF4;ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.5298424666560855,0.983352650355101,0.4444444444444444,0.9000392283631614,1.0,5/17,19.39%,GRIK2;GRIN2B;NRXN1;SYT1;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.4611124697646795,0.9831229262557367,0.5185185185185185,0.8999346764922362,1.0,28/71,27.30%,NRCAM;FES;AAMDC;FGFR1;CTNNA1;GJA1;RAP1A;BOC;REST;ACVR2A;ECT2;WWTR1;FOXC1;SDCBP;ARHGEF2;BTG1;ZFP36;GPRC5B;PLCB1;MEF2C;PRKCH;PPARG;ZEB1;RPS6KA3;MTOR;CDC42;SLC6A6;ASXL2
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.6643919110359947,0.9824140827685645,0.6129032258064516,0.9009946082369236,1.0,3/6,27.07%,GJA1;SLC1A2;SLC6A6
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.5755169550309208,0.9819844791440515,0.42424242424242425,0.9013601458729433,1.0,5/10,37.24%,RAC1;ALMS1;CDC42;ACTG1;PRKN
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.6055060298613988,0.9815309394817684,0.547945205479452,0.9017517227294984,1.0,4/9,25.71%,KDM1A;DMD;MEF2C;NEBL
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.5906515518809563,-0.9813524040068349,0.5348837209302325,1.0,1.0,2/5,25.95%,GAS6;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.562063126878847,0.9809761383055572,0.4857142857142857,0.9024175443389244,1.0,2/20,6.24%,RTN4;CCDC88A
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.6635689535123283,0.9809194735082694,0.49206349206349204,0.9017887978443915,1.0,1/5,5.10%,ROBO2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4866760073578869,0.979871099331928,0.5783132530120482,0.9033830571432053,1.0,11/39,24.38%,SMAD7;SMAD5;RPS27A;MAGI2;PPM1A;STRAP;ACVR2A;SPRED1;SMAD6;UBC;PPARG
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.5797510704614849,0.9791675370341325,0.5571428571428572,0.9042229105853224,1.0,8/12,29.93%,HYAL2;DUSP1;STK38;PTPN1;HIPK3;PIK3CB;DNAJA1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.5009037794770593,0.9791085085104652,0.5,0.9036737754167466,1.0,11/31,21.33%,GPM6B;EPS8;RAPGEF3;CCDC88A;DLC1;HIP1R;RAC1;CRK;ABL2;ESAM;TAOK1
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.526907024515545,0.9779706813495109,0.6,0.9056866667478669,1.0,6/24,13.39%,PTPRD;NFASC;SNAP25;DEPP1;SHC2;MAPK10
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.5816461130587457,0.9777539418620341,0.4794520547945205,0.9054461025246059,1.0,5/11,22.84%,YBX3;SERPINB6;ARHGEF2;CAB39;OXSR1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.6462862660322665,0.9773557543712167,0.5238095238095238,0.90579669808908,1.0,1/5,17.08%,DIP2A
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.5883100617202427,0.977348227145984,0.5666666666666667,0.9050806532684562,1.0,3/7,21.89%,ADCY2;CRY1;ADCY9
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.508421084809549,0.9766842467290511,0.4444444444444444,0.905730308392538,1.0,5/17,22.12%,TIMP3;COL4A2;TNS1;RBPMS;CALD1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.6477820922759856,0.9765067125559509,0.5573770491803278,0.9054200954335826,1.0,2/6,19.76%,EPS8;CHMP4B
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.4901710829561467,0.9763749997001427,0.5466666666666666,0.9049961045845928,1.0,16/37,31.45%,GRIN2B;ANKS1B;ARPC2;RASA1;RAC1;CRK;SDCBP;KALRN;ACTB;ANKS1A;FYN;WASL;CDC42;EFNB2;ACTR2;PTK2
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.49990391530710365,0.9761637936191231,0.5652173913043478,0.9048099191005221,1.0,5/27,14.66%,MAP3K5;RPS27A;TAB2;MAPK10;SH2D3C
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.6042704298963948,0.9754766452837783,0.5873015873015873,0.9057385713641036,1.0,1/6,7.36%,HSP90AA1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.5756166001543229,-0.9751999279180936,0.5428571428571428,1.0,1.0,1/9,2.95%,ATM
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.6515181295118129,0.9741427747265197,0.5303030303030303,0.908016193958454,1.0,2/7,11.47%,JUN;REST
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6495015444048982,0.9739606119930136,0.5645161290322581,0.9076528304544503,1.0,4/5,34.77%,MYEF2;MEF2C;SORT1;AKAP13
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.5070266795531202,0.9739123866774073,0.525,0.9070536458197507,1.0,7/15,22.66%,CDK6;HIF1A;HSPA9;ACVR2A;STAT3;ZFP36;ETS1
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.5475148486660605,0.9738322247810564,0.547945205479452,0.9064641502075711,1.0,6/12,24.99%,RPS27A;HSP90B1;TAB2;ALPK1;UBC;RPS6KA3
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.38274013881978214,-0.9738102376186194,0.5,1.0,1.0,8/53,10.33%,MLLT3;MTERF1;NFX1;IVNS1ABP;RTF1;MLLT1;TAF3;RBMX
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.45370988543746155,0.9732490509808193,0.5131578947368421,0.9072305157966312,1.0,16/59,22.15%,TAMALIN;PKN3;TIMP3;HYAL2;TMEM184B;PLSCR4;BACE2;COL4A2;TMTC1;WWTR1;AFAP1L1;FZD4;SMAD6;EPAS1;CALD1;CDH5
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.32914804724936814,-0.9732280402255875,0.35,1.0,1.0,8/128,3.61%,GBP1;VCAM1;GBP4;GBP2;IL32;LEPR;STAT1;IRF1
prerank,PanglaoDB_Augmented_2021__Neurons,0.4755207731559835,0.973035469376731,0.582089552238806,0.906903845798791,1.0,9/61,11.58%,GRIA2;CADM2;SGIP1;SNAP25;RB1CC1;PPFIA2;PPP1R9A;CNTNAP2;NRXN1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.4730008690592221,0.9719611096403357,0.5897435897435898,0.9085763616596463,1.0,9/47,9.85%,LAMC1;SERPINE1;SPOCK1;TIMP3;PLOD2;TPM4;COL4A2;JUN;GJA1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.6318578744077976,0.971837228930263,0.5294117647058824,0.9080921716903999,1.0,4/7,20.37%,PRKCE;COMMD1;NEDD4L;NEDD4
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.518587880951692,0.9716551252687149,0.5571428571428572,0.9078875928497162,1.0,9/20,27.38%,MYO9B;EPS8;GNA13;ADGRG1;CFL1;PHACTR4;CDC42;RHOJ;ARHGAP29
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.4532564349787508,0.9716249283932608,0.5774647887323944,0.9072305499432163,1.0,7/51,10.09%,NRCAM;MAP2;MAP1B;CTNND2;ANK3;CNTNAP2;GAS7
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.5906013821164262,0.9716181538092136,0.5285714285714286,0.9065397305372054,1.0,2/8,12.32%,CD81;FLT1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.590885681755196,-0.9711909844624392,0.5833333333333334,1.0,1.0,2/6,6.61%,IFI27;NUP214
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.518390185322913,0.9706044595520824,0.5384615384615384,0.9082842515031716,1.0,5/23,21.12%,FGFR1;HIF1A;GATA2;EGFL7;VEGFC
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.6312646289539297,-0.9705094175182346,0.5365853658536586,1.0,1.0,1/5,0.16%,VCAM1
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.6323630981423596,0.9704941900036046,0.625,0.9078456112510812,1.0,2/6,9.30%,PRKAG2;SLC2A1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.5869467644655137,0.9701595997779813,0.59375,0.908084714007864,1.0,4/9,30.17%,CLDN5;CDH5;ADD1;ZDHHC21
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.4388905129132559,0.9700180175687851,0.5058823529411764,0.9077162997334954,1.0,5/69,6.32%,PSMC6;SPOPL;FEM1C;TRIM9;NFE2L2
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.5732143102135081,0.969636746811058,0.5873015873015873,0.9077471290967202,1.0,3/6,23.03%,MYL6;CAV2;MEF2C
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.5521443168270691,-0.9695967650340925,0.5757575757575758,1.0,1.0,1/7,0.82%,EIF2AK2
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.4840285904407555,-0.9694897927534478,0.5625,1.0,1.0,1/12,1.27%,SLC38A3
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5363809856392162,0.9688587208879103,0.5074626865671642,0.9086698925855886,1.0,6/11,36.55%,TRAK1;DYNC1H1;PAFAH1B1;NDEL1;RAB1A;TRAK2
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.5398813212274719,0.9687439660391512,0.5616438356164384,0.9082326557187297,1.0,6/15,22.26%,CANX;ANXA1;GOLPH3;RIMS2;MIA2;RAB8B
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.5560775405016974,0.9683867342407873,0.5522388059701493,0.908193840080055,1.0,5/12,25.98%,RAB21;HIF1A;DYNC1H1;PAFAH1B1;KIF1B
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.4707999048859235,0.9682376064146722,0.5714285714285714,0.9078699685749951,1.0,7/52,11.00%,SEC22B;TSG101;ARF1;SEC24D;TMED10;LAMP2;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.5507896602533906,-0.9678152866508959,0.5666666666666667,1.0,1.0,4/15,7.22%,IFIH1;ISG15;HERC5;TRIM25
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.6357445953505038,0.9673917787918325,0.5416666666666666,0.9092905027385514,1.0,2/6,7.09%,CANX;JAK1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.4614772562406295,-0.9671815332053595,0.5,1.0,1.0,4/22,9.93%,ATG10;WARS1;STAT2;FN1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.5654725016046567,-0.9666228459547045,0.5625,1.0,1.0,3/6,14.48%,NNT;ATP6V1H;SLC25A27
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.3623844602188018,-0.9663399878066452,0.45,1.0,1.0,8/52,7.28%,CD74;IFIH1;ISG15;IFI27;MX1;SP100;TRIM25;GCH1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.5781540007535333,0.966253221458195,0.5571428571428572,0.9111401632200301,1.0,4/10,17.00%,HYAL2;PIK3R1;ECT2;TPR
prerank,MSigDB_Hallmark_2020__Androgen Response,0.471460372452175,0.9660116978627389,0.5903614457831325,0.911047500004034,1.0,14/50,16.73%,AKAP12;ELL2;SEC24D;NDRG1;INSIG1;CDK6;UBE2J1;SLC38A2;FKBP5;MAP7;SLC26A2;ZBTB10;PLPP1;ACTN1
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.546556849032821,-0.9657899659908136,0.5151515151515151,1.0,1.0,3/9,5.74%,CD74;ATM;RC3H1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.5684913142331803,-0.9656567697576287,0.5263157894736842,1.0,1.0,1/8,5.95%,TMEM106B
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.677367187138764,0.9656414072495083,0.6296296296296297,0.911170309324339,1.0,1/5,4.91%,GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.5670420981986103,0.9652612660266197,0.5671641791044776,0.9112412898483735,1.0,3/13,16.60%,HSP90AA1;KLF4;TNKS
prerank,PanglaoDB_Augmented_2021__Microfold Cells,0.47148985145580163,0.9651581432985908,0.5671641791044776,0.9107961679909667,1.0,13/30,21.70%,EHD4;BHLHE40;JUNB;NFE2L2;KLF4;FOSL2;SUSD6;LGALS3;NFIB;MGAT1;NFIC;ZFP36;B4GALT1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.4158687609693964,0.9649854571400217,0.5180722891566265,0.9104634447721079,1.0,7/91,9.30%,LAMC1;SEC22B;SEC24D;MCFD2;TMED10;PICALM;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.6010805995152946,0.9648165234720042,0.5625,0.910105474334584,1.0,2/6,18.27%,ZBTB1;ZMIZ1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.48486458745243327,0.9644266024963162,0.5432098765432098,0.91025427619941,1.0,5/42,18.11%,KHDRBS3;YTHDC1;REST;SRSF7;TRA2B
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.5792885533908607,0.9643986713485189,0.6086956521739131,0.9096826818956603,1.0,2/9,6.06%,GPC5;HYAL2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.6288915101403374,0.9642343732903418,0.6,0.9093689711824233,1.0,3/8,18.43%,PIKFYVE;LGALS3;PDE4B
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.5664118510099101,0.964149393704927,0.6527777777777778,0.9089187783606455,1.0,4/10,7.25%,SCP2;PRKAG2;LBR;INSIG1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5753592687222359,0.9639195982961316,0.618421052631579,0.9086489038347223,1.0,6/12,27.76%,KLF4;PAK2;YWHAE;CSNK2A1;RPS6KA3;XIAP
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.6576870514681452,0.963859112075052,0.5614035087719298,0.9081059353636755,1.0,2/5,11.29%,RAP1A;MAGI2
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.6334388600318003,0.9638405525372088,0.6206896551724138,0.9074783933161733,1.0,3/9,18.09%,BCAP31;TGM2;HERPUD1
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.6125212946406969,0.9637884969343489,0.6031746031746031,0.9068944824411085,1.0,1/7,11.16%,SETD3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.5467017278837378,0.9636813341480001,0.5507246376811594,0.906490542626185,1.0,5/16,31.39%,GLUL;NPM1;XPO1;RPS15;RPS7
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.557229219496495,0.9630621548053996,0.5194805194805194,0.9071182593675686,1.0,5/18,21.83%,TMEM45B;ADGRG1;VWA2;LGALS3;GPRC5B
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.5518419639460269,0.9629710742824684,0.5466666666666666,0.9066211065679737,1.0,2/12,8.50%,IL1RAPL1;PPFIA2
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.5215689321937408,0.9622222130533801,0.5142857142857142,0.9075965922138332,1.0,2/25,7.04%,BNIP3L;PINK1
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.6177104650715087,0.9621386870350251,0.5555555555555556,0.9071168359539761,1.0,1/8,3.82%,TRMT9B
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.5247204893271694,-0.9616465861303726,0.5666666666666667,1.0,1.0,3/10,12.48%,SHLD1;SHLD2;RNF169
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5277397939687044,-0.9615072306288954,0.5172413793103449,1.0,1.0,2/11,2.95%,BABAM2;ATM
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.5215600480652529,0.9611239227474648,0.5333333333333333,0.9089314621456174,1.0,3/19,17.13%,BNIP3L;DENND3;MALT1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.4088349720979204,0.960953248118636,0.5568181818181818,0.9085702594870483,1.0,33/149,17.21%,RTN4;ERBB4;BCAP31;TRIM5;GAPDH;NRG2;FGFR1;PIK3R1;REL;PINK1;HSP90AA1;RPL23;GRB2;VWF;GJA1;PPM1A;FLT1;PELI1;RPL37;TAB2;NOS1AP;ITGB1;SLC20A1;ECT2;RAC1;NDFIP1;MTDH;ALPK1;BRD4;LIMS1;GOLPH3;MALT1;TGM2
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.5067531726576535,0.960861318477128,0.5333333333333333,0.9080230009731071,1.0,3/12,26.40%,PRNP;LDLR;EGFR
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.60663321477208,0.9608101963006631,0.578125,0.9074257210481373,1.0,1/6,7.36%,HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.6489330142568521,0.9605092228147967,0.5932203389830508,0.9074730067857024,1.0,4/5,35.17%,ADAM9;MTOR;MAPRE2;IQSEC1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.529296438776103,0.9600406440375012,0.5555555555555556,0.9078248798153741,1.0,4/24,11.47%,BCAP31;MAP3K5;KLF4;REST
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.6495465148941115,0.9597571364600112,0.5806451612903226,0.9077956839603463,1.0,2/5,16.10%,SEMA6B;SEMA3F
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.42364054062689327,-0.9591730514344488,0.5263157894736842,1.0,1.0,2/33,0.64%,VCAM1;THSD1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.5697195517177138,0.9591096849866819,0.5373134328358209,0.908467875794255,1.0,2/8,3.90%,PCK1;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.5527246106554593,0.9590167163059341,0.6142857142857143,0.9079653999787112,1.0,1/16,4.20%,VAPB
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5481555423704789,0.9589640450999533,0.5285714285714286,0.9073961878938698,1.0,3/15,15.67%,AGO2;ZC3H7A;TUT7
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.5284554790525386,0.9587949031504857,0.5151515151515151,0.9071650667629129,1.0,6/15,35.67%,RPS27;NPM1;RPL10;RPS15;RPL24;DDX3X
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.46940524570227354,0.9586820342435484,0.5822784810126582,0.906816353800028,1.0,12/44,22.28%,ATF3;HSPH1;PINK1;HSP90AA1;SLC38A2;AMFR;TPR;NPAS2;NPM1;HSPA8;MCL1;YWHAE
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.596335362874223,0.9585868003922267,0.5671641791044776,0.9063924055026497,1.0,3/7,18.27%,TMF1;PLPP1;ZMIZ1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.6023610481014194,0.9585161874270747,0.5652173913043478,0.9058513339303218,1.0,4/6,39.07%,TRAK1;MTM1;TRAK2;MEF2A
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.599799479252711,0.9582529137578625,0.5862068965517241,0.9056641016120316,1.0,1/7,4.14%,TIMP3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6413851635212173,0.9576997319577435,0.6376811594202898,0.9062246606329755,1.0,3/6,21.14%,FGFR1;BCL2L1;MCL1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.6140773002399974,0.9575286685788426,0.5714285714285714,0.9058863613872336,1.0,1/5,7.14%,ARHGAP21
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.517880536816894,0.9575085123039622,0.5540540540540541,0.9052718220358308,1.0,11/24,24.38%,PGK1;COL4A2;KLF4;CLDN5;FOXC1;ATF2;SPRED1;ATP2B4;SPARC;ADAMTS1;PPARG
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.6311627667012838,-0.9570194742671757,0.5,1.0,1.0,2/5,11.42%,SHLD1;SHLD2
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.6311627667012838,-0.9570194742671757,0.5,1.0,1.0,2/5,11.42%,SHLD1;SHLD2
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.5940421620045294,0.9569862233955637,0.6153846153846154,0.9056302907653414,1.0,4/8,7.25%,SCP2;PRKAG2;LBR;INSIG1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.48297668579994196,0.956898011709527,0.5822784810126582,0.9052680793718457,1.0,6/27,14.18%,ERBB4;FGFR1;CDKN1B;FLT1;EEF1A1;ECT2
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.4810596300300837,-0.9564731619283259,0.5333333333333333,1.0,1.0,2/16,6.61%,IFIH1;NUP214
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.6121557787124765,0.9559946048136075,0.5901639344262295,0.9067221488186546,1.0,4/6,24.38%,SREBF2;SCARB1;ABCG1;PPARG
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,0.5865777129987358,0.955727275491063,0.6521739130434783,0.9067275534516305,1.0,1/11,3.59%,S1PR1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.6295899968457894,0.955699219510253,0.5970149253731343,0.9060896221725125,1.0,4/6,29.24%,OGT;WDR82;TET2;KMT2A
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.6306414222367425,0.9556964609519711,0.6271186440677966,0.9054192520026617,1.0,3/5,32.19%,SREBF2;ABCG1;KPNB1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.6510318716509274,0.955461952427034,0.671875,0.9052170597399608,1.0,3/6,30.23%,SCARB1;ABCG1;ABCA5
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.42800514077058505,0.955239970260254,0.5609756097560976,0.9050818592109161,1.0,17/89,16.52%,RRBP1;RPS11;POLA1;RPS18;RPS9;RPS27A;RPL23;RFC3;RPL8;RPL34;RPL37;RPLP2;AGO2;EEF1A1;RPL13A;RPS12;GOLPH3
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.6658273152631822,0.9551460105149306,0.5964912280701754,0.9046053336734787,1.0,1/5,7.60%,RAB21
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.5563384362231595,0.9545341501174388,0.5571428571428572,0.9051866308542076,1.0,3/16,9.03%,WDR48;PINK1;OGT
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.6144906844899166,0.9541054926599191,0.5757575757575758,0.905484265543371,1.0,2/6,27.49%,REST;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5845740857195956,0.9539122264570021,0.6060606060606061,0.9051996657441722,1.0,3/14,11.87%,CDK6;KLF4;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.589651416531561,-0.9538535213154083,0.5806451612903226,1.0,1.0,1/5,2.95%,ATM
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.608014450533509,0.953757653290701,0.6129032258064516,0.9047992186749995,1.0,2/7,24.38%,FOXC1;PPARG
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.5048214614689592,0.9537251649592009,0.515625,0.9041835961130313,1.0,8/24,23.82%,BNIP3L;PINK1;BTBD10;NPAS2;INPP5A;CHMP4B;NCK1;FYN
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.5208131538632844,0.9534743135487506,0.5714285714285714,0.9040415759574304,1.0,3/19,9.03%,VSIR;SRGN;OGT
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.5362894468946587,0.9533131319287256,0.625,0.9036843159946538,1.0,5/17,17.85%,PPP2R3A;PGK1;HNRNPH3;DAG1;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.643483899944842,0.9529193486341625,0.6666666666666666,0.903791290403005,1.0,2/6,17.00%,PPHLN1;TPR
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5638825527841999,0.9528551523360663,0.6268656716417911,0.903277535520012,1.0,1/14,0.69%,SERPINE1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.4205981642976414,-0.9528042658423731,0.5238095238095238,1.0,1.0,3/29,5.39%,PRIMPOL;ATR;RHBDD1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.6130665019088579,0.9527504883916712,0.5660377358490566,0.9028554923650634,1.0,1/5,3.27%,GLUD1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.5108019163730262,-0.9526906538706812,0.5666666666666667,1.0,1.0,2/11,10.41%,TCF7L1;TLE4
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5669246038531986,0.9523572590360653,0.6029411764705882,0.9031446073958616,1.0,5/10,25.23%,CANX;GOLPH3;MIA2;RAB8B;SEL1L
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.5166981000039008,0.9518262259254772,0.5555555555555556,0.9037305059860061,1.0,5/27,11.85%,SLC2A13;PICALM;LARP4;NSMAF;IFNGR1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.5641729710982142,0.9517763754361606,0.5882352941176471,0.9031688185578013,1.0,2/13,5.21%,S1PR1;CHSY1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.5454807831719384,0.9505172308550762,0.5789473684210527,0.9050975511682027,1.0,4/10,20.85%,SSH1;HIP1R;GSN;ARFGEF1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.6323852480706771,0.950500517457232,0.6153846153846154,0.9038017846429234,1.0,2/6,19.50%,HIF1A;SULF2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.6323852480706771,0.950500517457232,0.6153846153846154,0.9038017846429234,1.0,2/6,19.50%,HIF1A;SULF2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.5798513217635614,0.95044356926849,0.6176470588235294,0.9032252518864623,1.0,4/10,24.38%,CDKN1B;CDKN1A;MEF2C;PPARG
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.46507145179273324,0.950371363160597,0.5512820512820513,0.9026824468934228,1.0,5/35,16.95%,CLIC2;CLDN5;HIP1R;FOXC1;AMFR
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.6165416315039146,0.9500455262758382,0.6268656716417911,0.9026743062794497,1.0,1/7,1.54%,SUN2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.5845308945650076,0.9495941326060315,0.5970149253731343,0.9022808052974846,1.0,2/9,18.78%,DLC1;DUSP22
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.5845308945650076,0.9495941326060315,0.5970149253731343,0.9022808052974846,1.0,2/9,18.78%,DLC1;DUSP22
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.6252605852889391,0.9488171480124643,0.5818181818181818,0.9032973755225884,1.0,4/6,23.03%,BOC;BTG1;PLCB1;MEF2C
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.5425810214481851,-0.9488134171162145,0.5588235294117647,1.0,1.0,3/10,8.50%,ATM;ATR;MDM2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5332153171957192,0.9486449318705112,0.6086956521739131,0.9030267539242904,1.0,8/16,35.33%,KLF4;ATP2B4;MEF2C;PPARG;MECP2;RGCC;ACVRL1;DLL4
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.5818233802561715,0.9481760797696843,0.5352112676056338,0.9033457162566503,1.0,4/9,23.69%,PTBP2;SRSF7;TMBIM6;PTBP3
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.6113961639057062,0.9481759408182873,0.6231884057971014,0.902682953442082,1.0,3/8,23.03%,REST;PDE4B;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5870915057057258,0.9480573357856181,0.6101694915254238,0.9022417834075822,1.0,2/8,11.87%,GRB2;CDKN1A
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.5530780952575927,-0.9478908434259452,0.4666666666666667,1.0,1.0,2/6,10.36%,PGM5;CFLAR
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5903201721436703,0.9477180336005148,0.6060606060606061,0.9023156649493708,1.0,4/9,27.81%,BRD4;RNF168;HNRNPU;WDR43
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5082589683101587,-0.9476377093897503,0.5151515151515151,1.0,1.0,3/16,2.15%,VCAM1;CD74;IL15
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.6242021276595746,0.9475279766391671,0.576271186440678,0.9020304342205614,1.0,5/5,37.66%,LGALS3;MSN;STK10;PTK2;MAPK1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.6703430556994623,0.9461261277127251,0.640625,0.9042975772140893,1.0,1/5,5.26%,WDR48
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5393896423108158,0.9448928149463462,0.5352112676056338,0.9062192209432188,1.0,3/14,13.68%,ROBO2;PECAM1;ITGB1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.4947153864435511,0.9445948821853686,0.5609756097560976,0.9062899812551295,1.0,7/38,20.82%,PBRM1;BAZ1A;ZBTB1;SMARCC1;MBD2;NPM1;ACTB
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.5254796074063011,0.9437525287955485,0.5492957746478874,0.9074100999165066,1.0,7/15,13.52%,SLC8A1;S1PR1;GPM6B;SRGN;ATP2B1;ANO6;ACVR2A
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.5986839556682024,0.9433628239403549,0.6166666666666667,0.9074798883833426,1.0,1/6,1.91%,PRKAG2
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.5450284643517787,0.9433392218538312,0.6197183098591549,0.9069078184207001,1.0,3/12,14.32%,PRKAG2;PIK3R1;GRB10
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.5753249948245968,0.9429535570897821,0.6515151515151515,0.9070590469157801,1.0,1/11,2.55%,TBX3
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3815271039765966,-0.9422391960034251,0.5416666666666666,1.0,1.0,4/42,3.56%,MLLT3;ANKRD6;ZNRF3;NKD1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.42181129176153365,-0.9418667573324252,0.5882352941176471,1.0,1.0,4/24,9.35%,BABAM2;TOX;PDGFB;OTUD4
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.5412909730171294,0.9418099534137769,0.59375,0.9089053959611765,1.0,3/13,17.13%,ZBTB1;CD55;MALT1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.41216878972207616,-0.940990443643098,0.5142857142857142,1.0,1.0,2/20,1.86%,CD74;IFIH1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.6044796321393546,0.9409712678627572,0.6268656716417911,0.9098493179957405,1.0,3/7,23.27%,ADGRB3;SCARF1;ANKS1A
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5402290507664375,0.9409047014807352,0.6307692307692307,0.9093662878222528,1.0,1/11,1.38%,LRRC7
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.602804788049824,0.9405662023469156,0.5633802816901409,0.9095152916380428,1.0,2/6,21.59%,STAT3;ZFP36
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.5789860407252944,0.9402448094346431,0.639344262295082,0.9094214352431789,1.0,4/9,29.93%,ARFGEF1;LRCH1;WNK1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4817720951636986,0.93969416249761,0.5945945945945946,0.9097964864242725,1.0,8/30,23.08%,ANXA1;CDK6;KLF4;CDKN1A;KMT2E;SLFN11;PLCB1;ADAMTS1
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.6522580134508855,0.9395348017102055,0.6417910447761194,0.9094118115387015,1.0,1/5,7.28%,SMAD5
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.5257792779164931,0.9393588151746852,0.5846153846153846,0.9090519054337501,1.0,9/14,33.09%,GGT5;PELI1;TAB2;ERBIN;SMAD6;RPS6KA3;IFNAR1;ADAM17;CYRIB
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.6018384277106736,0.9392336845559887,0.546875,0.9087005848987206,1.0,1/5,11.37%,ANXA2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.6052273865888917,0.9392285522026569,0.5789473684210527,0.9067322803826946,1.0,3/5,32.24%,OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.6052273865888917,0.9392285522026569,0.5789473684210527,0.9067322803826946,1.0,3/5,32.24%,OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.6052273865888917,0.9392285522026569,0.5789473684210527,0.9067322803826946,1.0,3/5,32.24%,OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.5999680167759842,-0.9388742524275705,0.6388888888888888,1.0,1.0,2/5,9.38%,ALS2;AUTS2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5715898624729367,0.9378684811860892,0.6176470588235294,0.9090534077460628,1.0,6/8,28.90%,ANK2;VMP1;ATP1B1;AKAP6;CALM1;RYR2
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.4207532874378679,0.9376444029533827,0.5974025974025974,0.9088962081847048,1.0,20/71,25.44%,PCK1;PKN3;PRKCE;PINK1;PIKFYVE;STK38L;STK38;PAK2;TNKS;PRKX;CSNK1G3;CSNK1D;CAB39;MORC3;PRKCH;CSNK2A1;WNK1;HIPK3;RPS6KA3;MTOR
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4710519472160298,0.9376063144868101,0.6388888888888888,0.9082895629861062,1.0,5/29,14.10%,CANX;ARF1;SEC24D;PIKFYVE;AP1G1
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.5101471619058792,0.9375695980870796,0.5714285714285714,0.9077720561532638,1.0,8/17,28.47%,DLC1;HSP90B1;ENSA;ARPP19;YWHAB;CDH5;SPPL3;CALM1
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.4634877958089163,0.9373699610070239,0.5492957746478874,0.9075680078708603,1.0,7/23,21.30%,KDM1A;OGT;GJA1;GRB10;ALMS1;DYNC1H1;EPAS1
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.41081452864533696,0.937224717404872,0.6022727272727273,0.9071879770559541,1.0,29/123,25.74%,RRBP1;RPS11;RPS18;RPS9;RPS27A;RPL23;YTHDC1;RPL8;RPL34;RPL37;RPLP2;AGO2;EEF1A1;RPL13A;SRSF7;RPS12;HNRNPH3;GOLPH3;TPR;RPS27;RBMS2;RBPMS;RPL10;SETX;RPL37A;THOC2;RPL21;RPLP1;SRSF11
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.48868744081927595,0.9371098210701084,0.5230769230769231,0.9068084922623335,1.0,7/19,21.30%,KDM1A;OGT;GJA1;GRB10;ALMS1;DYNC1H1;EPAS1
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.6030613259681776,0.9370563535463049,0.6451612903225806,0.9062615305237973,1.0,4/8,30.23%,ABCG1;PRKCH;PPARG;ABCA5
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.6246331680989627,0.9367961279253462,0.5833333333333334,0.9061231137206853,1.0,2/6,8.63%,MBP;KLF4
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.46167591199533226,0.9366030547491723,0.620253164556962,0.9058810309986665,1.0,13/36,25.37%,PSMC6;SIN3B;LSS;PLPP1;NCOR2;PSMA7;PSAP;NR1D2;SREBF2;LDLR;PPARG;CREBBP;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5404520992562296,0.9362825906317568,0.5636363636363636,0.9059107457764902,1.0,3/11,26.40%,BTBD10;SDCBP;EGFR
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.45325980981502023,-0.9361942197672916,0.6129032258064516,1.0,1.0,3/18,6.16%,SLCO1A2;BMP6;OPTN
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.4890109468636661,-0.9361137251821328,0.5714285714285714,1.0,1.0,2/16,0.77%,GBP1;HOMER2
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.5498526608365981,0.9358750463589356,0.6533333333333333,0.9062196525086459,1.0,3/13,5.02%,TBX3;ANXA1;ZBTB1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.48687993819664244,0.9355838837321143,0.6216216216216216,0.9061294962332576,1.0,5/20,24.38%,SMAD7;SMAD5;ACVR2A;SMAD6;PPARG
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.5341688649460149,0.9349938024225896,0.5942028985507246,0.9066130728977616,1.0,2/12,3.80%,GLUD1;GLUL
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.47354528476680013,0.9348778385343883,0.573170731707317,0.9062202451696153,1.0,4/30,14.08%,GPM6B;CDK6;ADAM15;RASA1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.6336345414925398,0.9348217776737643,0.6612903225806451,0.9056927372725097,1.0,2/5,19.50%,CHST11;SULF2
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.42663924657526375,-0.9346037083411967,0.5862068965517241,1.0,1.0,5/33,5.82%,SLC22A5;SLC38A3;ABCG2;SLC25A29;MIA3
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.5784578893421091,0.9342420679091606,0.6428571428571429,0.9054979304254982,1.0,4/9,17.00%,HYAL2;PIK3R1;ECT2;TPR
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.5784578893421091,0.9342420679091606,0.6428571428571429,0.9054979304254982,1.0,4/9,17.00%,HYAL2;PIK3R1;ECT2;TPR
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.4115714844112941,0.9330298534292119,0.6375,0.9069566520111908,1.0,24/70,29.69%,PCK1;PKN3;PRKCE;PINK1;STK38L;STK38;PAK2;TNKS;PRKX;CSNK1G3;CSNK1D;CAB39;MORC3;PRKCH;CSNK2A1;WNK1;HIPK3;RPS6KA3;MTOR;MARK3;CAMK2D;TLK2;SMG1;RPS6KA2
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.4277124155728722,-0.933008278540949,0.5,1.0,1.0,5/17,13.81%,SLC38A3;SLC25A29;SLC16A2;SLC38A6;SLC23A2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.6069653522456513,0.932897312102739,0.6197183098591549,0.9065491123034599,1.0,5/8,22.28%,PRKCE;NEDD4L;CAB39;NEDD4;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5153621849504199,0.9320502388151892,0.5573770491803278,0.9076245124060169,1.0,3/15,12.32%,MAP3K5;FGFR1;FLT1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.48506274251571596,-0.9317132359129167,0.5428571428571428,1.0,1.0,1/11,2.95%,ATM
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.4674073704172513,0.9312548251515779,0.6376811594202898,0.9085478767848948,1.0,8/35,22.15%,TIMP3;PLSCR4;COL4A2;GJA1;FZD4;EPAS1;CALD1;CDH5
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.498851665831377,0.9312142120711381,0.5694444444444444,0.9079659276986648,1.0,7/20,23.98%,SPOCK1;RAC1;LIMS1;RSU1;FZD4;TBCD;EMP2
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.6246703078565423,0.9311971189880106,0.6349206349206349,0.9073373435703076,1.0,1/6,5.10%,ROBO2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4854707806788287,0.931136339384729,0.5714285714285714,0.9068282196189584,1.0,1/22,0.61%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5546366564653111,0.9307639773418241,0.6351351351351351,0.9068806441246186,1.0,3/10,14.74%,FES;NAV3;RAC1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.6373375805660701,0.9306493347403583,0.7258064516129032,0.9064436051280451,1.0,1/5,16.10%,SEMA3F
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.5207340949823668,0.9305848755359697,0.5303030303030303,0.9058652045323233,1.0,3/16,9.85%,TIMP3;COL4A2;GJA1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.5427746790012156,-0.9300350015789023,0.6,1.0,1.0,2/6,4.25%,STAT1;PARP9
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.5029621368355156,0.9300136830489488,0.625,0.9064857180138877,1.0,1/23,1.01%,RFTN1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.4230768875123728,-0.9299636668301544,0.48,1.0,1.0,3/28,4.73%,EIF2AK2;ANKRD6;TPD52L1
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.47692769096873205,0.9289265192489001,0.6575342465753424,0.9080584278693438,1.0,10/26,30.81%,TSG101;SDCBP;TPR;LGALS3;CDH5;RACK1;VCP;RGCC;DAB2IP;RAB7A
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.6004801496478432,0.9286693864335693,0.6507936507936508,0.9079445058463079,1.0,3/7,35.09%,TRA2B;PRPF8;SRRM1
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.5426554158734799,0.9286052492303475,0.6,0.9074374684901483,1.0,4/12,25.66%,NAV3;ARHGEF2;TAOK1;HDGFL3
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.43370793607617514,-0.9280589887723445,0.5416666666666666,1.0,1.0,5/30,7.22%,IFIH1;ISG15;HERC5;IRF1;TRIM25
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.48451490865410896,0.9277160292244753,0.5584415584415584,0.90880968045027,1.0,7/20,25.68%,CCDC88A;CNOT6L;SDCBP;DYNC1H1;RAB3GAP2;ASAP1;FSCN1
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5870505876782344,0.9274506406696221,0.609375,0.9086719065436706,1.0,2/7,13.78%,TRIM5;CD55
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.5745981876747301,0.927316897603081,0.5909090909090909,0.908243917191446,1.0,3/7,33.25%,RPS27;RPS15;PRKDC
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.5442383366084149,0.9271050683751346,0.6231884057971014,0.9079890846147178,1.0,3/11,16.52%,ANK3;PREPL;GOLPH3
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5169017286321159,0.9269723928219467,0.5833333333333334,0.90757785313273,1.0,5/14,27.76%,KLF4;YWHAE;CSNK2A1;RPS6KA3;XIAP
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.5965980174992863,0.9267472225276793,0.589041095890411,0.9073786732946976,1.0,2/7,16.02%,NFE2L2;PSMA7
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.6251708633199782,0.9266568989499878,0.6060606060606061,0.9069371406136909,1.0,2/5,23.77%,EIF3A;EIF5
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.5533442799627801,0.9265667506911334,0.609375,0.906488406262467,1.0,3/8,25.31%,NAA16;NAA50;CREBBP
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5571241954045149,0.9262299810556067,0.6065573770491803,0.9065483334968742,1.0,1/9,13.01%,GIGYF2
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.5929817537609783,0.9257618440570211,0.5967741935483871,0.9067878160152539,1.0,1/5,17.37%,HDAC7
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.4827039393966645,0.9253639759114337,0.6,0.9070581828590191,1.0,6/20,23.03%,ROBO2;ARID5A;ATP1A1;STAT3;TFPI;MEF2C
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.4929506464374998,0.9252215172459206,0.6301369863013698,0.9067432109062048,1.0,7/26,13.94%,CD9;CTNND2;SMAD7;CTNNA1;GJA1;CLDN5;PAK2
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.4758585063763409,0.9252166074679118,0.6144578313253012,0.9061169187625094,1.0,5/33,18.78%,GPM6B;DLC1;RAC1;LIMS1;DUSP22
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.430952439303778,0.9235476877225632,0.5945945945945946,0.9090275132754998,1.0,15/52,19.81%,ADM;SERPINE1;KLF6;ATP2B1;HIF1A;CDKN1A;ACVR2A;CD55;PCDH7;SLC1A2;BTG2;NAMPT;PDE4B;ABI1;IFNGR2
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.5531235978724746,0.9233585724583538,0.6086956521739131,0.9086884765525578,1.0,1/12,5.10%,ROBO2
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.4886757311002644,0.9232554426925937,0.5942028985507246,0.9082876914067778,1.0,5/27,12.19%,NES;KDM1A;JUN;CDKN1A;WAPL
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.431435042861309,-0.9227631873326606,0.5151515151515151,1.0,1.0,3/16,6.11%,DCP1A;RC3H1;PARN
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.6382584357603815,-0.9224504696983048,0.5853658536585366,1.0,1.0,2/5,12.06%,TNFRSF1B;PARD3
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.46997322688700804,-0.9220539834373263,0.4642857142857143,1.0,1.0,2/16,2.18%,PRIMPOL;ISG15
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.6139723223661159,-0.9212982363275319,0.5945945945945946,1.0,1.0,3/5,16.76%,GSPT1;CLEC16A;IGF1R
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.4604887636073126,0.921140362881236,0.625,0.9121078117242112,1.0,9/42,12.96%,NES;ANK2;MAP1B;NFASC;COL4A2;GJA1;BOC;BCAR1;SHC2
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.5900276693004158,0.9208597250059829,0.6349206349206349,0.9120391773716372,1.0,2/6,9.91%,ARID5A;ZNF366
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.550873914859894,0.920783398862518,0.6176470588235294,0.9115282358322045,1.0,2/11,12.01%,SMAD7;FOXF1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.5981621389869668,0.9203015856602238,0.6507936507936508,0.9119719996998299,1.0,4/5,39.26%,XIAP;DDX3X;PRKN;BIRC2
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6155643188984671,0.920242915025851,0.6229508196721312,0.9107741991504172,1.0,1/5,6.91%,PRNP
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.6155643188984671,0.920242915025851,0.6229508196721312,0.9107741991504172,1.0,1/5,6.91%,PRNP
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.5915247855197534,0.9201216284075323,0.6666666666666666,0.9103352143840219,1.0,1/7,4.86%,SYTL4
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.43051153019411936,0.9195412717343557,0.5697674418604651,0.9108636540778898,1.0,16/52,23.98%,BCL6;PPFIA2;LRRC4C;LARP4;NEDD4L;PAK2;ADGRB3;PDZD8;DAG1;CFL1;NEDD4;SPARC;ETS1;MEF2C;TANC2;EMP2
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.5090040525694511,0.9182722055031378,0.6052631578947368,0.9126048386065787,1.0,4/17,23.98%,CDK6;RAC1;LIMS1;EMP2
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.42357106703859887,0.9181020420303911,0.6493506493506493,0.9123276976854348,1.0,19/52,31.39%,RPS9;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS27;RPL10;RPL37A;RPL21;RPLP1;RPS15;WDR43;RIOK3;MTREX;XRN2;RPL24;RPS7
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.5829466405820428,0.9177310340384264,0.671875,0.9125063293139584,1.0,3/8,22.28%,RAPGEF3;TPR;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),-0.5733273041210719,-0.9172760836283027,0.6,1.0,1.0,1/5,7.70%,TAPT1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.45007241835657785,0.9165484002019598,0.6585365853658537,0.9142813276822914,1.0,11/46,18.78%,SERPINE1;SMAD7;NAV3;SRGAP1;DLC1;ADAM15;MAGI2;CLDN5;CRK;DAG1;DUSP22
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5522738605568045,0.9162480338847799,0.6865671641791045,0.914134634552196,1.0,1/10,6.27%,SMAD7
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.44619486631640615,0.9160163117997431,0.6626506024096386,0.9140266564278835,1.0,14/37,21.83%,ERBB4;NEDD9;CD81;ENPP2;PRNP;PECAM1;PAK2;ARHGEF2;STAT3;PTPN1;TEC;SOCS3;GRM5;GPRC5B
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4911815645172737,0.9158636850230913,0.6301369863013698,0.9136494278660651,1.0,8/17,33.78%,RPL23;OGT;SDCBP;CSNK2A1;EIF3H;TLK2;RPS7;HSP90AB1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.5361123015898009,-0.9157202371855055,0.5714285714285714,1.0,1.0,1/6,9.54%,ATP6V1H
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5090167766323628,0.915194154149099,0.6212121212121212,0.9144418764341391,1.0,7/13,32.24%,ANXA1;KMT2E;PLCB1;ADAMTS1;EGFR;RGCC;ADAM17
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.4604896740229545,0.9143915948952646,0.5802469135802469,0.9154100217936353,1.0,3/46,5.02%,PBRM1;BAZ1A;ZBTB1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.4284699800221492,-0.9143742131834398,0.52,1.0,1.0,2/17,2.18%,PRIMPOL;ISG15
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.5150476867739455,-0.9142669734443608,0.6285714285714286,1.0,1.0,1/10,1.17%,MLLT3
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.4933004980955435,-0.9137184735275922,0.5,1.0,1.0,1/11,1.06%,CTNNA2
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.43947440903456947,0.9136417303485342,0.6410256410256411,0.916200164716593,1.0,14/51,14.87%,PLS3;NEDD9;EPS8;MYO1B;TPM4;PPP1R9A;MYO1E;DSTN;SPIRE1;BCAR1;HIP1R;MPRIP;RAC1;TRIOBP
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.5133633202220796,-0.9136278783835822,0.59375,1.0,1.0,4/9,15.75%,RBMX;TRA2A;CIRBP;NCL
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5390399090414777,0.9131916579963436,0.6212121212121212,0.9164826081328881,1.0,3/9,22.42%,RPS27A;TAB2;UBC
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.48726955592933713,0.9131041541327007,0.640625,0.9159822571102006,1.0,7/27,19.12%,ARF1;MT1M;PRNP;MT2A;NDFIP1;TF;SLC30A1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.523869819574281,-0.9128361979253994,0.5,1.0,1.0,1/8,3.67%,PATJ
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.5260370744356456,0.9127246639892624,0.5714285714285714,0.9160115047368524,1.0,3/11,31.18%,NPM1;RPL10;RPL24
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),-0.5026635301556649,-0.9126398572620326,0.6071428571428571,1.0,1.0,1/11,0.64%,THSD1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.5497661792203683,0.9125466942186242,0.6428571428571429,0.9157113278628967,1.0,4/10,25.66%,NAV3;ARHGEF2;TAOK1;HDGFL3
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.4574655145962019,0.9123178055338584,0.5555555555555556,0.915495766547585,1.0,9/42,26.29%,PSMC6;AGO2;RAC1;PSMA7;FZD4;PPP3CB;PLCB1;PSMB9;CDC42
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.4664620634927509,0.9123006669246658,0.6142857142857143,0.9148980218771245,1.0,5/22,15.35%,CDK6;CDKN1B;CCNH;CDKN1A;CRLF3
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.4962360028964656,0.9122597943930584,0.5945945945945946,0.9143240301734716,1.0,5/26,14.48%,PCK1;SLC8A1;CPEB4;MAP7;LARP1B
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.463113866626664,0.9120207128181609,0.6351351351351351,0.914163336644032,1.0,8/28,20.64%,SMAD7;SMAD5;ACVR2A;PTPN1;SULF2;SMAD6;NEDD4;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3893175602294933,0.9116256239631385,0.6923076923076923,0.9143005840450739,1.0,34/168,20.58%,BCL6;TBX3;BHLHE40;PHF10;CALR;GAPDH;ZFPM2;ATP8B1;KDM1A;ARID5A;KLF4;CDKN1B;JUN;SPEN;REST;CDKN1A;WAPL;GIGYF2;ZBTB38;RPL13A;NCOR2;ATOH8;LIMS1;BTG2;CRY1;MBD2;NACC2;NR1D2;BCLAF1;CREBZF;SLFN11;RCOR3;ELK3;HSPA8
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.610104527981204,0.9104739519363372,0.6515151515151515,0.9159023427576523,1.0,1/7,7.38%,KDM1A
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.5259113840094644,0.9103326858648276,0.5769230769230769,0.9155579372431814,1.0,7/11,30.39%,SAMD8;NSMAF;PLPP1;ST6GALNAC3;ACER3;SPTLC2;CERK
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.5635223557249098,0.910046359443753,0.696969696969697,0.9153968396584088,1.0,4/8,36.07%,TF;ACTB;POC1B;ACTG1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.4733145906231123,0.9098031759997561,0.6341463414634146,0.915228349143136,1.0,4/27,13.47%,SEC22B;VSIR;CDKN1B;NEDD4L
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.4820134583497059,0.9092278500505949,0.5789473684210527,0.915699144905303,1.0,2/21,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5378009001254324,0.9089792553424876,0.6617647058823529,0.9156675252586343,1.0,6/9,36.63%,UGGT2;VCP;UGGT1;CUL3;NGLY1;ATXN3
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.5103265086397265,0.9088992258550073,0.6086956521739131,0.9151497125187872,1.0,7/18,31.29%,PBRM1;SMARCC1;MBD2;ACTB;SMARCA5;ARID1A;SMARCA1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.46295291185748644,0.9088160451468735,0.5903614457831325,0.9146629743069827,1.0,6/29,18.22%,BCR;TBC1D15;TBC1D9;ECT2;RALGAPB;RALGAPA1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.5614383311671738,-0.9087711157694768,0.5714285714285714,1.0,1.0,2/8,12.40%,RHBDD1;SPPL2A
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.5248882032022394,0.9087491732556986,0.6197183098591549,0.9141617245809374,1.0,1/10,1.49%,TSG101
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.5722796864776777,0.9083044617325,0.6349206349206349,0.9144041865220853,1.0,3/9,17.88%,PINK1;SPIRE1;DDHD1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.40376184149887095,0.9081931199280425,0.6024096385542169,0.9139871388265465,1.0,16/72,19.31%,RTN4;SERPINE1;GAPDH;KDM1A;OGT;GJA1;REST;AGO2;GRB10;WWTR1;FOXC1;SDCBP;RIF1;CFL1;ALMS1;DYNC1H1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.6204039997729862,0.9079260252821468,0.6964285714285714,0.913964382746033,1.0,2/5,23.67%,NPM1;XPO1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.5705692631462898,0.9076540964121774,0.6119402985074627,0.9138735591185851,1.0,2/5,8.29%,FES;CDK6
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5333303419089872,0.9061774797417617,0.6086956521739131,0.9162251781766522,1.0,2/13,4.36%,ERBB4;INPP5F
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.4201193066478136,0.9057703190648275,0.65,0.9163218508118253,1.0,18/49,31.39%,RPS9;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS27;RPL10;RPL37A;RPL21;RPLP1;RPS15;WDR43;MTREX;XRN2;RPL24;RPS7
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.5464246119736398,0.9055321891318929,0.6571428571428571,0.9161541034368165,1.0,4/9,26.93%,HSP90AA1;TPR;YWHAE;VCP
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.5270749437642199,-0.905492998902647,0.6285714285714286,1.0,1.0,3/7,20.88%,MOB3B;WWC3;MAPK14
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.6113776405069786,0.9048105351679196,0.6557377049180327,0.9169751095113586,1.0,3/5,30.23%,SCARB1;ABCG1;ABCA5
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.5461417391665467,0.9045517177906636,0.6666666666666666,0.9167769835533756,1.0,1/12,7.38%,KDM1A
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.4642191786670371,-0.9041896572359533,0.6129032258064516,1.0,1.0,3/12,11.90%,ATP10D;ATP9A;ATP9B
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.40127797353213096,0.9038705565534524,0.6511627906976745,0.9174231349038043,1.0,20/63,31.39%,RPS9;RPL23;RPL8;RPL34;RPL37;RPLP2;AGO2;RPL13A;TUT7;RPS27;RPL10;RPL37A;RPL21;RPLP1;RPS15;WDR43;MTREX;XRN2;RPL24;RPS7
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.6072020108338156,0.9037610266089454,0.6166666666666667,0.9170291755982272,1.0,1/6,9.14%,YTHDC1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5028301873607737,0.903547498218674,0.6493506493506493,0.9168314144692699,1.0,7/15,16.52%,S1PR1;CCDC88A;ARHGEF4;ITGB1;RAC1;PARVB;GOLPH3
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5883113703460696,0.9033233136683302,0.5967741935483871,0.916573755876672,1.0,5/6,26.93%,HSP90B1;NPLOC4;HERPUD1;SEL1L;VCP
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.5430485246765903,0.9032864588542561,0.6666666666666666,0.916030856819585,1.0,4/13,28.98%,RPS27A;DYNC1H1;UBC;DYNC1I2
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.5637945340521466,0.9031080691728404,0.6,0.9157740849350968,1.0,2/7,6.27%,S1PR1;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.5175076554454666,-0.9026169860907397,0.5909090909090909,1.0,1.0,2/11,2.55%,CARMIL1;EVL
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.4686075847226298,0.902535746616673,0.6419753086419753,0.9161255922579642,1.0,6/29,14.71%,NFE2L2;ERO1A;PINK1;SERPINB6;MSRA;TXNRD1
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.48046895603813095,0.9021801824233514,0.6052631578947368,0.9160716103026249,1.0,3/21,8.23%,UFL1;RPS27A;RB1CC1
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.5932195067839681,0.9019428519168822,0.640625,0.9158378148125118,1.0,3/6,19.10%,FGFR1;FLT1;ABL2
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.5872464899140735,-0.9007206496588649,0.6388888888888888,1.0,1.0,2/6,3.85%,ATM;TENT2
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.5872464899140735,-0.9007206496588649,0.6388888888888888,1.0,1.0,2/6,3.85%,ATM;TENT2
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.5999689369695006,0.9005577841907567,0.6865671641791045,0.9177465361110899,1.0,2/7,25.13%,UBE2B;USP22
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.551696173868458,-0.9001098662910414,0.6666666666666666,1.0,1.0,1/8,1.06%,CTNNA2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.5578024101920752,0.8998865256985817,0.7424242424242424,0.9185374005860122,1.0,1/10,5.79%,NDUFA12
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.6005883928228053,-0.8992786651758884,0.5625,1.0,1.0,2/6,11.42%,SHLD1;SHLD2
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.5516495032579706,0.8992782366023762,0.6176470588235294,0.9191626398742057,1.0,1/6,0.35%,SLCO4A1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.5252863701931585,-0.8991926212487388,0.6341463414634146,1.0,1.0,1/6,4.36%,EZH1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.60554720540931,0.8991244606965273,0.7076923076923077,0.9188152712593868,1.0,2/6,21.38%,CHST11;EXT1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.5301156778746039,-0.8985966191672242,0.65625,1.0,1.0,1/5,6.00%,IMMP2L
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.5194787882162999,0.898222289628031,0.746031746031746,0.9197980527935519,1.0,5/16,17.88%,PINK1;ZDHHC6;SPIRE1;HIP1R;DDHD1
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.5624563314387165,0.8975670666612702,0.6935483870967742,0.9205779591840777,1.0,2/10,10.07%,RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.5380604196777791,0.8973422008653864,0.6461538461538462,0.9203795435110046,1.0,1/9,1.49%,TSG101
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.4870033049242758,-0.8971910089291151,0.5588235294117647,1.0,1.0,2/8,4.25%,IFIH1;PARP9
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),-0.5115237505608695,-0.8970326813310132,0.5945945945945946,1.0,1.0,1/5,7.70%,TAPT1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.4879546659701114,0.8969615146774392,0.6666666666666666,0.9204423234373318,1.0,6/26,17.10%,SMAD7;WWTR1;FOXC1;SPRED1;SDCBP;DAG1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.5597669112053029,0.8968098747074376,0.6714285714285714,0.9200729099182657,1.0,5/10,26.45%,CPEB4;TMBIM6;MTOR;SLC38A9;CAPN2
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4322790562532361,0.8965379441965661,0.620253164556962,0.9199347907446299,1.0,5/31,14.74%,EPS8;PIK3R1;CCDC88A;ARPC2;RAC1
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.5388407713721767,0.8964437316224048,0.6,0.9195141277207438,1.0,3/7,26.29%,ARHGAP21;UVRAG;CDC42
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.6075133961355437,0.89594544735471,0.6557377049180327,0.91991190387126,1.0,1/5,15.99%,BRD4
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.4490601028245872,0.8952685130951713,0.6626506024096386,0.9205617797497997,1.0,5/42,6.32%,ST18;PSMC6;YBX3;HYAL2;NFE2L2
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.5031426954998239,0.8948802181667044,0.6376811594202898,0.920653888700704,1.0,4/15,8.42%,SLCO4A1;SLC52A3;SLC4A10;SLC4A7
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.43173201351142776,0.8942041781641656,0.5915492957746479,0.9214433928924425,1.0,8/42,10.46%,SERPINE1;CD9;TIMP3;SYTL4;SRGN;LAMP2;VWF;PECAM1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.5179690868674132,0.8941400371873904,0.6712328767123288,0.9209934636884399,1.0,5/12,13.52%,SLC8A1;GPM6B;ATP2B1;ANO6;ACVR2A
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.4385518842854038,-0.8935648887300702,0.5,1.0,1.0,1/10,1.06%,CTNNA2
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.41528037491020214,0.8933623604807795,0.627906976744186,0.9218780291880975,1.0,10/56,17.05%,ERBB4;FES;FGFR1;PINK1;SIK2;PIKFYVE;FLT1;PAK2;GRK5;PRKX
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.42009748737677344,-0.8932733968232238,0.52,1.0,1.0,2/20,2.55%,CARMIL1;EVL
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.5353804757551882,0.8931576342847978,0.6470588235294118,0.921746850399539,1.0,3/12,14.18%,GRB2;CDKN1A;ECT2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5729493928511047,0.8931195776825208,0.6714285714285714,0.9212014069456181,1.0,2/6,20.40%,NACC2;BCL2L1
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.4364011156756744,-0.8929544099984129,0.6129032258064516,1.0,1.0,1/14,1.46%,CPQ
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.5871472936516402,0.8927080099197341,0.6935483870967742,0.9214110572673553,1.0,3/6,30.23%,ABCG1;PPARG;ABCA5
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.5584391850940219,0.8926359265710516,0.6428571428571429,0.9209109051612924,1.0,2/6,29.93%,MORC3;DAB2IP
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.6010984609698283,0.8925430660654813,0.6617647058823529,0.9204409598715972,1.0,1/6,6.99%,BACH2
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.5789024805629296,0.8923543035084633,0.6964285714285714,0.9196135784603493,1.0,1/6,10.07%,RAP1A
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.5789024805629296,0.8923543035084633,0.6964285714285714,0.9196135784603493,1.0,1/6,10.07%,RAP1A
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.5547486348269379,0.8918868681942117,0.7058823529411765,0.9198751849294596,1.0,1/7,17.00%,TPR
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.5965756616630827,0.8918051675026215,0.6774193548387096,0.919443998878693,1.0,2/6,18.57%,HIF1A;STAT3
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.5591984185448879,0.8910301207313616,0.6923076923076923,0.9202280445760599,1.0,3/7,21.73%,OGT;CRY1;ARPP19
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.5577439384799627,0.8908582281039261,0.6666666666666666,0.9199149025115648,1.0,3/9,11.24%,SLC12A6;ATP1A1;ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.49034281237751226,0.8900570019034031,0.6323529411764706,0.9207858257485307,1.0,6/18,16.49%,NEDD9;CALR;RAC1;TRIOBP;CRK;LIMS1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.5075608449809581,-0.889808721222057,0.5263157894736842,1.0,1.0,1/7,1.12%,SLC4A4
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.3802792360622399,-0.8896183465492319,0.6857142857142857,1.0,1.0,6/25,15.54%,EZH1;TCF7L1;MSH3;XPC;HMGN3;UBB
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.5359486814933835,0.8895954004289807,0.6865671641791045,0.920920897707554,1.0,3/8,9.83%,ARF1;HSP90AA1;HIF1A
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.37614966565336266,0.8895006208229211,0.6989247311827957,0.9205638649319471,1.0,15/146,11.02%,DDIT4;AKAP12;PRKAG2;ARHGAP23;MYO9B;UFL1;BCR;ARHGAP21;SRGAP1;DLC1;ARHGEF4;VWF;RFC3;GNA13;PHLPP1
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.5867453412660658,-0.8894669175183678,0.6666666666666666,1.0,1.0,2/5,14.71%,MFF;PNPT1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.47342187326595225,0.8888114287405376,0.6710526315789473,0.9210951224536219,1.0,4/24,16.02%,PSMC6;CDKN1B;CDKN1A;PSMA7
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.6304432396753039,0.8886144577003187,0.7213114754098361,0.9208777629042101,1.0,3/5,27.33%,NEDD4L;YWHAE;AKAP6
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.5580756400087706,0.8885944803262072,0.647887323943662,0.919718934121124,1.0,1/7,11.05%,CCNH
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.5580756400087706,0.8885944803262072,0.647887323943662,0.919718934121124,1.0,1/7,11.05%,CCNH
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.47244258694379737,-0.8884474852056421,0.6388888888888888,1.0,1.0,1/11,1.12%,SLC4A4
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.5093280176919491,-0.8879476164592459,0.5833333333333334,1.0,1.0,2/11,2.15%,VCAM1;IL15
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.37734444718467053,-0.8879244704126925,0.6896551724137931,1.0,1.0,6/35,8.15%,SLC38A3;ARNT2;ZNRF3;ABCG2;SHROOM2;PTPN21
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.471616962343119,-0.8878109180305276,0.56,1.0,1.0,2/11,6.72%,ANAPC16;CDC14A
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5271477904191101,0.8877228804310369,0.6811594202898551,0.9205713469279445,1.0,3/13,6.27%,DDIT4;PRKAG2;SMAD7
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.5536859250707558,0.8876953291187483,0.6666666666666666,0.9200477436160746,1.0,3/5,41.65%,ABCG1;ADAM17;ADAM10
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.48175847633974994,-0.8875871880189573,0.5806451612903226,1.0,1.0,1/7,4.38%,ATR
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5603486191734771,0.887113950417645,0.6774193548387096,0.9204310796084071,1.0,3/7,30.62%,RAB3GAP2;RYR2;SPCS3
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.600283900857102,0.887070304085781,0.6896551724137931,0.9193131249167521,1.0,2/5,10.49%,ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.600283900857102,0.887070304085781,0.6896551724137931,0.9193131249167521,1.0,2/5,10.49%,ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.5115514251005551,0.8869523956672042,0.6621621621621622,0.9189157161123604,1.0,3/12,14.74%,FES;NAV3;RAC1
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4233142920691888,0.8868979662351006,0.6823529411764706,0.918424065337483,1.0,16/54,23.48%,SMAD7;SMAD5;RPS27A;JUN;LRRC32;FOS;CLDN5;ACVR2A;ITGB1;PXN;ZMIZ1;DUSP22;SMAD6;CDH5;UBC;ADAM9
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.5218000031212431,-0.886833297964046,0.7037037037037037,1.0,1.0,4/11,7.30%,HOMER2;STIM2;HOMER1;PKD2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.5730135783653335,0.8860553253153628,0.6379310344827587,0.9191860092776865,1.0,4/6,29.51%,MEF2C;AKAP6;EFNB2;ATP11A
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.3189224375386283,-0.88594283916573,0.7,1.0,1.0,22/174,11.39%,RNF213;MSL2;UBE3D;ANAPC16;ISG15;MARCHF8;HERC5;ZNRF3;HERC6;NFX1;RC3H1;RTF1;TRIM25;HECW2;HERC2;MDM2;PSMF1;UBE2E2;WSB1;PSMB1;FBXW4;FBXO9
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.5745317224387316,0.8857346061110212,0.6857142857142857,0.9192116933384209,1.0,4/7,39.81%,NOTCH4;DLL4;TGFBR2;NRP1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.4985585737381808,0.885332657198097,0.6883116883116883,0.9193319201030457,1.0,1/16,4.06%,GPM6B
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.5504573035649151,0.8852901422031898,0.6153846153846154,0.9188049289315606,1.0,1/6,4.99%,SEC24D
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4467230834668979,0.8852429711456697,0.7162162162162162,0.9182713592313412,1.0,6/28,14.10%,CANX;ARF1;SEC24D;PIKFYVE;MARCHF1;AP1G1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3889785141714372,0.8846403368396877,0.7045454545454546,0.918624311668478,1.0,10/108,9.93%,PSMC6;SPOPL;FEM1C;HSPA5;TRIM9;NFE2L2;RPS27A;UBE2J1;HSP90B1;NPLOC4
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.5741242114289613,0.8845010098660152,0.6956521739130435,0.9182439334464606,1.0,4/8,22.28%,ENSA;ARPP19;YWHAB;YWHAE
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.4066171056525549,-0.8835641893174859,0.7096774193548387,1.0,1.0,1/24,0.13%,GBP1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.42863398178540835,-0.8832900088420448,0.56,1.0,1.0,5/19,10.07%,GEMIN5;PARP9;GCNT2;RC3H1;LARP1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.36359198102567386,-0.8832271116666912,0.7307692307692307,1.0,1.0,3/36,6.40%,VCAM1;NOD1;PODN
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.48166120506529403,-0.8832268880092544,0.5769230769230769,1.0,1.0,2/10,1.41%,FAXDC2;STARD3
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.5242325977903021,0.8830918853939187,0.6567164179104478,0.9200974901277044,1.0,3/16,17.82%,ATG12;RB1CC1;VMP1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.5290116139571114,0.8830281769386236,0.6349206349206349,0.9196586749841079,1.0,5/12,20.37%,IL1RAPL1;PTPRD;NEDD4L;ADGRB3;NEDD4
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.452605180185783,-0.8827126347665757,0.6206896551724138,1.0,1.0,2/15,2.18%,PRIMPOL;ISG15
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.5922059329843777,-0.8821652130589414,0.7,1.0,1.0,2/5,5.34%,CHKA;PLAAT3
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.5447915751168192,0.8817563307000025,0.65,0.9214654515955466,1.0,1/6,9.83%,HIF1A
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.45456134264987547,0.8816893612126018,0.6666666666666666,0.9209901315439704,1.0,6/33,14.45%,NEDD9;LAMA5;ADAM15;BCAR1;ITGB1;ERBIN
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.5136352977780202,-0.881443505952025,0.59375,1.0,1.0,4/7,15.75%,RBMX;TRA2A;CIRBP;NCL
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.5271598267463681,0.88134712297344,0.6666666666666666,0.9209855477626799,1.0,5/10,29.40%,DUSP1;TOM1L2;CAV2;CDK5RAP2;RGCC
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.5083606607861025,-0.8812998367747865,0.6666666666666666,1.0,1.0,4/7,24.81%,SMYD3;NSD1;SMYD2;PRMT2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5929454908426812,0.8809723612920805,0.7611940298507462,0.9209376024347181,1.0,3/6,20.37%,PRKCE;NEDD4L;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.5696953127746229,0.8802364215595707,0.7619047619047619,0.9216987211235296,1.0,2/8,20.40%,PINK1;BCL2L1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.5791467180760604,0.8802136596669131,0.6727272727272727,0.9211234216514708,1.0,4/5,42.12%,SULF2;PCSK5;KIAA1217;DYNC2I1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.4836715042867752,-0.8799480595518338,0.5517241379310345,1.0,1.0,2/10,4.20%,RHOBTB1;ARHGAP12
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.5117787911894977,-0.8798795527624579,0.6153846153846154,1.0,1.0,4/7,27.22%,SRPK1;SAFB2;DHX9;SLTM
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.47290051632496455,0.8796785630728723,0.6933333333333334,0.9214001048064019,1.0,3/14,20.85%,SSH1;HIP1R;ARFGEF1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.4674210646372552,-0.8794640412252905,0.5161290322580645,1.0,1.0,2/9,10.25%,TNRC6C;CPEB3
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.4674210646372552,-0.8794640412252905,0.5161290322580645,1.0,1.0,2/9,10.25%,TNRC6C;CPEB3
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.5727899355648383,0.8793828425142343,0.6666666666666666,0.9207924647737845,1.0,3/5,37.66%,TGM2;PRKN;MAPK1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.5727899355648383,0.8793828425142343,0.6666666666666666,0.9207924647737845,1.0,3/5,37.66%,TGM2;PRKN;MAPK1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.5731218223802304,0.8788010754415474,0.7,0.9206900615001381,1.0,2/5,21.89%,ADCY2;ADCY9
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.5731218223802304,0.8788010754415474,0.7,0.9206900615001381,1.0,2/5,21.89%,ADCY2;ADCY9
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.47019671887410064,-0.8785545748333394,0.5714285714285714,1.0,1.0,1/13,1.06%,CTNNA2
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.4305567257499468,0.8785494462210206,0.64,0.9205922199985858,1.0,6/39,17.82%,NRCAM;CTNND2;NRXN1;CLDN5;LIMS1;VMP1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.5360612169769934,-0.8784988100141546,0.6571428571428571,1.0,1.0,1/5,5.74%,RC3H1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5379117519557371,0.878436151270706,0.6901408450704225,0.920257367526104,1.0,1/7,2.39%,FES
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.5491431378274031,0.8780344211368005,0.6231884057971014,0.9203969152487086,1.0,2/6,15.19%,HSP90AA1;PLPP1
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.49360766565890624,0.8774690281392004,0.7142857142857143,0.9207228779652075,1.0,2/17,7.04%,FES;PINK1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.47133636777083965,-0.8771156313760765,0.5588235294117647,1.0,1.0,2/6,13.81%,ABCG2;SLC23A2
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.5237706835691216,-0.8768007048281782,0.6578947368421053,1.0,1.0,2/7,7.62%,NKD1;SHROOM2
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.5453094032737064,0.8765135089426976,0.6527777777777778,0.9218947291207809,1.0,3/8,28.42%,HSPA9;SPG7;ATP5F1E
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.4064599065176948,0.8763797926749751,0.7317073170731707,0.9215455654006621,1.0,15/54,17.13%,TRIM5;GAPDH;REL;PINK1;GJA1;PPM1A;PELI1;TAB2;SLC20A1;ECT2;NDFIP1;MTDH;ALPK1;BRD4;MALT1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.5899994876507191,0.8760112932571232,0.7230769230769231,0.9214547142529212,1.0,3/5,27.81%,DDX18;NPM1;WDR43
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.507125487647855,0.8758972824095562,0.671875,0.9210275405409398,1.0,2/9,9.38%,ANXA1;JAG2
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.6139948094081356,0.875501394794035,0.6949152542372882,0.9210802122658486,1.0,2/5,28.02%,TMTC1;TMTC2
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.4840860245641615,-0.8753608883196161,0.7027027027027027,1.0,1.0,1/9,6.93%,PDE9A
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.571069212368435,0.87507769062899,0.7142857142857143,0.9212114565091589,1.0,1/6,12.01%,FOXF1
prerank,MSigDB_Hallmark_2020__UV Response Up,0.41986716924209533,0.8749679452136113,0.691358024691358,0.9208495608661998,1.0,7/40,12.91%,ATF3;JUNB;PTPRD;HYAL2;PLCL1;FOS;AGO2
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.5544261960404921,0.8748218779941421,0.6666666666666666,0.9205523883494936,1.0,2/7,10.07%,RAPGEF3;RAP1A
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.460064958743341,0.8742813972904048,0.684931506849315,0.9208478319115521,1.0,3/23,6.64%,MAP2;SPOCK1;ANO2
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.47736904778363143,-0.8740447597285375,0.59375,1.0,1.0,1/15,1.09%,MSL2
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.5374467965953631,0.8735192582863635,0.65625,0.9214709143746161,1.0,3/6,26.85%,CSTF3;SETX;PAPOLA
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.5410048325216344,0.8734790633978469,0.7076923076923077,0.9209672535246706,1.0,2/8,24.73%,DYSF;RACK1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.36709904522946063,0.8731197541483235,0.7380952380952381,0.9210410932503504,1.0,37/152,24.52%,PDK4;PRKAG2;PKN3;MAP3K5;PGK1;PRKCE;BCR;FGFR1;PINK1;JAK1;CDK6;SIK2;TRIB2;STK38L;STK38;PRAG1;MAPK10;ACVR2A;PAK2;DGKI;GRK5;STAT3;CSNK1D;LIMK2;TEC;CDK8;MORC3;PPP3CB;TAOK1;OXSR1;PRKCH;FYN;HK1;CSNK2A1;WNK1;FGR;HIPK3
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.5151300736120095,-0.8728882482422171,0.7073170731707317,1.0,1.0,1/8,1.94%,PLPPR4
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.5066682501533636,0.872235988689555,0.6716417910447762,0.9221539415022818,1.0,1/11,6.14%,PIK3R1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.5516723907475597,0.8718464381798827,0.6119402985074627,0.9222696052899277,1.0,4/7,27.49%,TPR;DYNC1H1;CHMP4B;HNRNPU
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.42021226308222337,-0.8717073102081252,0.6,1.0,1.0,2/19,2.55%,CARMIL1;EVL
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.36528037224774523,0.871329604643798,0.7647058823529411,0.9227192005872946,1.0,40/152,23.03%,ERBB4;KLF6;KLF2;MAP3K5;NPAS3;ESR2;SMAD5;PICALM;KLF4;JUN;HIF1A;CNBP;SETD3;REST;FOS;PPM1A;FOXF1;SMARCC1;NAA16;FOXC1;CRLF3;BRD4;ATOH8;NPAS2;FZD4;ZMIZ1;STAT3;NFIB;NR1D2;RLF;NOTCH4;KMT2E;NPM1;CEP290;DNM2;PPP3CB;MED4;PLCB1;ETS1;MEF2C
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5061592761332928,0.870902607962316,0.6521739130434783,0.9229693238244951,1.0,5/10,28.98%,CCDC88A;TUBA1B;TUBB;KIF1B;DYNC1I2
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.464373774128675,-0.8708463400243169,0.5909090909090909,1.0,1.0,2/15,4.65%,BMP6;ABCG2
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.4183459069547233,-0.8699824265707791,0.5483870967741935,1.0,1.0,1/14,2.15%,IL15
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.46543543787820496,0.8698925545987353,0.6811594202898551,0.9242200888183698,1.0,4/16,21.12%,ANXA1;FLT1;FOXC1;VEGFC
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.33937693580548983,-0.8693558133112189,0.7692307692307693,1.0,1.0,5/23,8.79%,ATM;PLK2;SP100;MDM2;HIPK2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.6094766477647433,0.8692425426617536,0.7611940298507462,0.9246959619720486,1.0,1/5,20.16%,NPM1
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.4712868722087883,0.8686651225481474,0.7313432835820896,0.9250010702170588,1.0,4/23,10.31%,SCP2;SCARB2;ATP8B1;PITPNC1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.5231572989551022,0.8684575452825801,0.6493506493506493,0.924703525520346,1.0,1/9,7.20%,NAV1
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.523979212684843,0.8682537990414855,0.704225352112676,0.923883122485452,1.0,5/10,13.52%,SLC8A1;GPM6B;ATP2B1;ANO6;ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.523979212684843,0.8682537990414855,0.704225352112676,0.923883122485452,1.0,5/10,13.52%,SLC8A1;GPM6B;ATP2B1;ANO6;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.5633035816666165,0.8681560837204488,0.703125,0.9234949177578635,1.0,2/7,7.76%,CHSY1;SRGN
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.4124331262712809,0.8678924565174386,0.7108433734939759,0.9233192303239371,1.0,7/49,9.48%,ADAMTS9;TINAGL1;SRGN;BACE2;OGT;GGT5;ATG4C
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.5898661923292507,0.8676430081315374,0.7076923076923077,0.9232002697203282,1.0,2/7,7.01%,CHSY1;CHST11
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.5206584421433536,0.8667361997317249,0.7142857142857143,0.9240555392556649,1.0,3/12,20.64%,CDKN1B;CDKN1A;ATP2B4
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5314958886764556,0.8651373802124857,0.7368421052631579,0.9261724063804985,1.0,6/8,36.52%,KPNA4;KPNA3;KPNA1;KPNB1;RANBP2;NUP54
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.5426710319343245,0.8651087257365632,0.6875,0.9256218401697,1.0,3/8,17.13%,SMAD7;CD55;MALT1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.5275724640824767,0.8647022566033705,0.6712328767123288,0.9256848990436712,1.0,1/6,1.43%,SCP2
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.5143782877331924,-0.8641788559659412,0.6923076923076923,1.0,1.0,1/7,0.19%,DDX60
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.4238852473109831,0.8638862477005917,0.7297297297297297,0.9263252165448231,1.0,3/40,9.30%,LAMC1;PICALM;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.558849206683743,0.8637554485194606,0.6557377049180327,0.9260007571155657,1.0,3/6,38.54%,ETS1;ADAM17;ACTN4
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.47201936570145575,-0.8625542160974959,0.6571428571428571,1.0,1.0,3/12,8.50%,CD74;THOC1;MDM2
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.5629038304663246,0.8624233367459849,0.7230769230769231,0.927582332152003,1.0,1/7,1.86%,PCK1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5331803043058221,-0.8616309881371197,0.6341463414634146,1.0,1.0,1/6,12.43%,MTERF4
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.503504593608716,0.8616186965977333,0.7230769230769231,0.9283607899575822,1.0,1/12,6.27%,SMAD7
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.4425575230074939,0.8614974644175858,0.6753246753246753,0.9279794774983952,1.0,1/27,0.88%,PSMC6
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.5349777445630506,-0.8609413188591551,0.6428571428571429,1.0,1.0,2/10,2.15%,VCAM1;IL15
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.5759283182748988,0.8608925809311943,0.7014925373134329,0.928342610782038,1.0,1/5,11.47%,REST
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.520921728684239,0.860306657940138,0.671875,0.9287543858853058,1.0,1/7,7.14%,ARHGAP21
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.5152497123223522,-0.8599579586059884,0.6511627906976745,1.0,1.0,1/5,2.20%,TTN
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.4605266112751997,0.8594702992317759,0.6956521739130435,0.9294530413106371,1.0,7/24,18.57%,IPO7;HSP90AA1;LAMP2;PTTG1IP;TPR;PPP1R10;STAT3
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.38730775549747415,0.8591207224273244,0.6842105263157895,0.9294012504940029,1.0,14/64,19.89%,CLIC2;ELL2;BNIP3L;DCAF10;PICALM;LAMP2;SLC2A1;TNS1;LPIN2;AGPAT4;SDCBP;BTG2;SLC30A1;FBXO34
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.5709823360526254,0.8591164895584764,0.703125,0.9288314575545237,1.0,4/6,35.62%,JUN;CHD1;EP300;SMARCA4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.566221339600284,0.8587623650456719,0.7288135593220338,0.9288570836023137,1.0,2/6,8.45%,ANK2;ATP2B1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.4579034262820031,0.8577789018480504,0.6455696202531646,0.9298615748363868,1.0,12/25,30.65%,RAB11FIP3;PRKCE;AHCTF1;ECT2;CSPP1;BCL2L1;UVRAG;CDC42;PIK3C3;CALM1;PRPF40A;CDC14B
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.49062461002122637,-0.8577282770683544,0.5789473684210527,1.0,1.0,1/7,8.79%,HIPK2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.4390321593288796,0.8576314660142199,0.7205882352941176,0.9295091849455267,1.0,6/29,23.37%,BNIP3L;CDKN1B;NPAS2;CHMP4B;SLFN11;NCK1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.46084951850190625,-0.8574999198990352,0.6774193548387096,1.0,1.0,2/13,2.95%,BABAM2;ATM
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5271322805395534,0.8573255936156879,0.6825396825396826,0.9294994213738662,1.0,2/7,6.06%,INPP5F;HYAL2
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.4071347993816854,-0.8569078589156262,0.5357142857142857,1.0,1.0,2/10,5.42%,IFIH1;NOD1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.43897400817558657,0.8568384653730079,0.64,0.9296152918314688,1.0,4/34,11.87%,ITPR1;MAP3K5;ERO1A;CDKN1A
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.4465178893153039,0.8565611576634599,0.6842105263157895,0.9294590070247661,1.0,4/22,7.01%,B3GNT2;GPC5;CHSY1;CHST11
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3912360208681167,0.856481804537976,0.7160493827160493,0.9289822857454042,1.0,15/88,16.87%,EHD4;RAB11FIP3;S1PR1;NUDCD3;CCDC88A;ARHGEF4;EMP1;RAP1A;ANO6;ITGB1;RAC1;BBS9;PARVB;GOLPH3;SDCBP
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.4102926249023984,0.8561925971343937,0.7532467532467533,0.9288544555370679,1.0,9/44,17.10%,TRIM5;FGFR1;DUSP1;PEBP1;PHLPP1;FLT1;PAK2;SPRED1;DAG1
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.4548325803674311,0.8561420268060655,0.6875,0.9283717458433551,1.0,5/21,7.36%,FES;PRKCE;PINK1;NAV3;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.42519900655294585,0.8554844167720178,0.7,0.9288914765741777,1.0,1/28,0.72%,ERBB4
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.39837772802199095,0.8554837553388271,0.6794871794871795,0.9283120059088164,1.0,5/42,9.59%,MAP2;GPM6B;PPP1R9A;MICALL2;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.558143093479248,0.8552915758238926,0.6666666666666666,0.9280389931860258,1.0,1/6,3.27%,GLUD1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.4878613112414961,-0.8551921395459137,0.6285714285714286,1.0,1.0,1/8,1.83%,CD74
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.5241510572748113,0.8550297174653037,0.6865671641791045,0.9278982605183486,1.0,4/6,35.59%,PRKX;ACVRL1;DLG1;CD34
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.417130983652339,0.8548845920007926,0.6710526315789473,0.9275772662593714,1.0,9/28,26.93%,RAPGEF3;NRXN1;NEDD4L;LGALS3;CDH5;RACK1;ADD1;ASAP1;VCP
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.45279051206387233,0.8546409809418937,0.7368421052631579,0.9274300605032314,1.0,6/29,8.45%,BCL6;ANXA1;GAPDH;POLA1;SRGN;ATP2B1
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.3285967894389101,-0.8543687248135003,0.8421052631578947,1.0,1.0,8/79,9.24%,RNF213;ANAPC16;ISG15;ZNRF3;RC3H1;TRIM25;MDM2;PSMF1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.5248095497048064,0.854340205390634,0.6911764705882353,0.9274147315347305,1.0,4/8,16.36%,SEMA6B;RAC1;SEMA3F;PLXNA2
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.38629731635766085,0.853428846185581,0.7647058823529411,0.9283137776150767,1.0,17/74,17.13%,TRIM5;GAPDH;UFL1;REL;PINK1;GJA1;OTUD7B;PPM1A;PELI1;TAB2;SLC20A1;ECT2;NDFIP1;MTDH;ALPK1;BRD4;MALT1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5018578570397214,0.8523341049220132,0.7323943661971831,0.9293432369692434,1.0,8/14,29.14%,PRKCE;ANK3;NEDD4L;DMD;NEDD4;WNK1;CAMK2D;FGF12
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.45310855238405584,0.8515876421768943,0.71875,0.9298456244607446,1.0,6/23,13.71%,TSG101;CCDC88A;GRB2;ITGA1;ZFYVE28;HIP1R
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.5186999433355839,-0.8511809189071186,0.6363636363636364,1.0,1.0,1/5,3.90%,DISP1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.5925585794229853,0.8511185836285415,0.7101449275362319,0.9300639126735418,1.0,2/5,39.95%,MTM1;DNAJB6
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.4471257868409142,-0.850952719711574,0.6388888888888888,1.0,1.0,1/12,6.93%,PDE9A
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.48089723697766096,-0.8505763215043909,0.6857142857142857,1.0,1.0,1/8,2.95%,ATM
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.35536388557441706,-0.8504664573367787,0.7037037037037037,1.0,1.0,8/29,19.97%,SNX2;TBC1D5;ANKFY1;EVI5;TRAPPC10;VPS50;TMEM87A;GBF1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.5452713145743517,0.8503444134924942,0.676056338028169,0.9307587037739202,1.0,3/6,30.23%,SREBF2;PPARG;ABCA5
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.3916279329885074,-0.8503234872728406,0.5833333333333334,1.0,1.0,4/24,10.25%,TNRC6C;RC3H1;ZC3HAV1;CPEB3
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.412180934324253,-0.8498865135415751,0.6571428571428571,1.0,1.0,3/13,11.55%,ATM;PDGFB;DACH1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5078447559539525,0.8491887524133412,0.6756756756756757,0.9321708038839956,1.0,1/11,0.72%,ERBB4
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.49422992572957614,-0.8490088782781349,0.5,1.0,1.0,1/10,3.69%,TNRC6C
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.4423589757144999,-0.8478830750501851,0.6551724137931034,1.0,1.0,1/12,3.93%,ZIC1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5642476942464428,0.8472469343016343,0.75,0.9346646443847704,1.0,3/7,27.49%,DCP2;TNKS;HNRNPU
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.5557158380639231,0.8467071584675243,0.676056338028169,0.9349966580922413,1.0,3/5,40.42%,KPNA1;KPNB1;DICER1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.43148923729720917,0.8466566090672936,0.6266666666666667,0.9344942482230676,1.0,6/30,25.74%,DCP2;SRSF7;CSTF3;ZFP36;HIPK3;SRSF11
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.5448261361261624,0.8465770800407384,0.71875,0.9340269014236382,1.0,3/6,29.99%,CFL1;CAV2;VAPA
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.5077733697332081,0.8465005911842569,0.7,0.9335532477978823,1.0,6/14,26.45%,CPEB4;UBR1;FYN;MTOR;SLC38A9;CAPN2
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.3895574451893533,-0.846276773175235,0.6470588235294118,1.0,1.0,3/25,2.76%,CARMIL1;EVL;OCLN
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.46541957273504053,0.845643205546155,0.7162162162162162,0.9343529612772233,1.0,3/20,4.78%,FES;NES;PRKCE
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4729764761788028,-0.8452358916965818,0.6153846153846154,1.0,1.0,1/9,3.98%,BMP6
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.4934229604138781,-0.8447086253551309,0.6176470588235294,1.0,1.0,1/8,2.05%,ZC4H2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4531134972878002,0.8442230264278592,0.68,0.9360592752307774,1.0,9/22,28.47%,MGLL;RIC8B;GRK5;CRY1;YWHAB;PLCB1;CAMKMT;GIT2;CALM1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.4413611702338949,0.8441187357153025,0.6842105263157895,0.9357089302392136,1.0,5/23,19.55%,ROBO2;JAG2;ZMIZ1;STAT3;NOTCH4
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.56953495987657,0.8440109202666014,0.6833333333333333,0.9353658841604071,1.0,1/5,32.99%,ACVRL1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.5034753421794824,0.8427891454425454,0.7121212121212122,0.9369448890731155,1.0,5/12,31.39%,RPS27;NPM1;RPS15;RIOK3;RPS7
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.35025293961687504,-0.8425602189046054,0.7727272727272727,1.0,1.0,4/24,4.54%,TLN2;OCLN;LIMS2;SDK1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.4930327044731694,0.8424392730207577,0.6716417910447762,0.9369238651900881,1.0,7/13,33.04%,NEDD4L;ADGRB3;CSMD3;NEDD4;CDKL5;DAB2IP;CAMSAP2
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.5404819389239977,0.8424011109890486,0.75,0.9363956328732134,1.0,2/7,18.88%,BBS9;CSNK1D
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.44631607105427645,0.8423078359587853,0.7183098591549296,0.9359160020207424,1.0,8/29,17.74%,NEDD9;CALR;CDK6;RAC1;TRIOBP;CRK;LIMS1;RSU1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.4029548450185434,-0.8418258530309926,0.5714285714285714,1.0,1.0,2/20,2.76%,CARMIL1;OCLN
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.4554112603265433,-0.8416767203303106,0.6296296296296297,1.0,1.0,1/10,1.83%,CD74
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.4643177861407907,0.8415574215501127,0.6612903225806451,0.9364912592866005,1.0,8/13,24.38%,SLC4A10;ACOX1;SLC4A7;NEDD4L;NR1D2;PNPLA8;WNK1;PPARG
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.5111714049958587,-0.8412677042975047,0.7272727272727273,1.0,1.0,1/6,0.13%,GBP1
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.4889602104288659,0.840118094212909,0.7575757575757576,0.9381878809076573,1.0,5/12,20.58%,HSPA5;HSPA9;TMBIM6;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.46064100396698304,0.8398280964335775,0.7058823529411765,0.9381182950673473,1.0,4/16,23.53%,CDK6;KLF4;PTPN1;KLF7
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.4782296596784398,-0.839704086323906,0.6285714285714286,1.0,1.0,1/7,2.26%,ARNT2
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.5435160082882736,0.8380398153145643,0.7457627118644068,0.9403311849735192,1.0,1/8,10.73%,RBM17
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.5662820745930196,0.8376835221087585,0.7719298245614035,0.9402672004279619,1.0,3/6,31.10%,DGKI;PGS1;DGKG
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.39739423929445944,-0.8375083332108504,0.76,1.0,1.0,7/23,17.34%,GMDS;STAT1;PLXND1;MAML3;MAML2;ZNF423;PBX1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5411359437997255,0.8372616415076394,0.6865671641791045,0.9404285237011465,1.0,3/7,20.40%,HERPUD1;TMBIM6;BCL2L1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.35952000061592726,0.8372463192385304,0.7764705882352941,0.9398734489230337,1.0,20/104,14.42%,SPNS2;APOLD1;CD9;MGLL;TIMP3;HYAL2;PLSCR4;SRGN;EMP1;SLC2A1;GGT5;VWF;PECAM1;LRRC32;CFH;FOXF1;FLT1;CLDN5;CD55;TNS1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.39731039161627724,-0.8366739546024801,0.6944444444444444,1.0,1.0,3/19,8.13%,BABAM2;ATM;HERC2
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.480067069946334,0.8361953759190259,0.7297297297297297,0.940627876084073,1.0,4/14,20.66%,ANK3;PREPL;GOLPH3;AFDN
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.5104313063488172,-0.8359499435571445,0.7352941176470589,1.0,1.0,2/8,14.82%,LARP1;CIRBP
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.4817786270126121,0.8354402497406141,0.7272727272727273,0.9412519411929522,1.0,8/18,33.84%,CCDC88A;DYNC1H1;LIMK2;KPNB1;DST;CAMSAP2;DLG1;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.44872501290781314,0.8354163712303098,0.6933333333333334,0.9406905721945714,1.0,6/24,19.58%,PRKCE;RAD21;ECT2;TPR;DYNC1H1;CSPP1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4204743490836104,0.8350816056966993,0.7123287671232876,0.9406742327271604,1.0,11/23,33.84%,ANXA1;BRD4;KMT2E;PLCB1;ADAMTS1;EGFR;MECP2;RGCC;ADAM17;CUL3;RAB11A
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.36996882141757415,0.8350388821841933,0.8372093023255814,0.9401615022671651,1.0,14/85,15.67%,RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;CNOT6L;DCP2;RPLP2;RPL13A;RPS12;TUT7
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.4189084840926424,-0.8341953668597158,0.5853658536585366,1.0,1.0,3/21,7.52%,ALS2;SNX2;SRGAP2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.5439576385917475,0.8341712696817324,0.7301587301587301,0.9410629657758426,1.0,3/5,27.49%,TPR;CHMP4B;HNRNPU
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.4399085963682336,-0.8334213208706805,0.6875,1.0,1.0,2/13,1.86%,CD74;IFIH1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.5050503907279805,0.8331269738074768,0.7297297297297297,0.9420787922614555,1.0,4/10,18.57%,ANXA1;PRNP;ERBIN;STAT3
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.47241218750553704,0.8329952341863395,0.7647058823529411,0.9416543836177375,1.0,2/20,3.80%,PCK1;GLUL
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.3810586496102647,0.8323028982373837,0.7808219178082192,0.9422073291785265,1.0,18/62,27.62%,DDIT4;CALR;GRB10;GATA2;CRY1;TMBIM6;EGFL7;PTPN1;SULF2;NEDD4;YWHAB;NCK1;PHACTR4;CSNK2A1;RACK1;EGFR;VCP;PIK3CB
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,0.48635963630051327,0.8318216401757093,0.7619047619047619,0.9423324955710152,1.0,3/13,9.83%,CD9;ANXA1;HIF1A
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5618350009500072,0.8304849651715157,0.75,0.9438329051779785,1.0,4/5,43.80%,GATA2;DLL4;PDCD10;PPP1R16B
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.42284004759043914,0.8297901526793621,0.7638888888888888,0.9443835194154125,1.0,7/25,24.04%,PINK1;LGALS3;HERPUD1;TMBIM6;BCL2L1;MCL1;CSNK2A1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.4468921246785643,0.8295168519874967,0.7428571428571429,0.9442364517421571,1.0,7/23,18.57%,IPO7;PINK1;LAMP2;PTTG1IP;TPR;PPP1R10;STAT3
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5281879108345889,0.8292793130256101,0.7796610169491526,0.9440219324191021,1.0,2/10,13.28%,PINK1;TMF1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.4144253952174991,0.8291300567784575,0.7682926829268293,0.9436995306896796,1.0,5/37,14.24%,SEC22B;HSP90AA1;CDKN1B;NEDD4L;PTTG1IP
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.5295993804958301,0.8265957860641171,0.765625,0.9469170430235322,1.0,2/5,23.98%,RAP1A;EMP2
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.4906798005317112,-0.8262088753372295,0.6842105263157895,1.0,1.0,2/8,16.87%,TRIP11;DYNC2H1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.42991276899406183,-0.8261567000637622,0.6521739130434783,1.0,1.0,1/11,2.97%,ZNRF3
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.4756709863074048,0.8257161741504339,0.704225352112676,0.9477273999395922,1.0,1/11,7.04%,PINK1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4327071423950096,0.8251861869841132,0.704225352112676,0.9479633115925333,1.0,7/16,32.24%,ANXA1;KMT2E;PLCB1;ADAMTS1;EGFR;RGCC;ADAM17
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.4896687592684379,-0.8241482338788648,0.6666666666666666,1.0,1.0,3/11,6.69%,IFI27;TNFSF10;SAT1
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.458251244618335,0.823970737742886,0.72,0.9492979744738006,1.0,8/24,25.50%,ATF3;AGO2;TPR;NPM1;CTIF;NCK1;EIF5;EIF3H
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.37941511129675415,-0.8237410232228137,0.7272727272727273,1.0,1.0,3/32,6.83%,VCAM1;SDK1;ACVR1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4627144580779856,0.8236169822343058,0.7808219178082192,0.949263112115432,1.0,7/12,38.49%,OGT;SDCBP;EIF3H;TLK2;HSP90AB1;USP7;RYBP
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.4481805288512998,0.8233987349466275,0.7974683544303798,0.9489387123380819,1.0,10/21,22.15%,MICALL2;CTNNA1;PECAM1;CLDN5;PAK2;ECT2;ESAM;AFDN;TBCD;CDH5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5015871350850123,0.8233939126295309,0.7424242424242424,0.9477933427396051,1.0,2/6,22.42%,RPS27A;UBC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.5015871350850123,0.8233939126295309,0.7424242424242424,0.9477933427396051,1.0,2/6,22.42%,RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.5695107818392324,0.8228197827016558,0.8301886792452831,0.9476315876739524,1.0,3/5,33.86%,AKAP6;SPPL3;PTBP1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.5695107818392324,0.8228197827016558,0.8301886792452831,0.9476315876739524,1.0,3/5,33.86%,AKAP6;SPPL3;PTBP1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.36293438022301605,0.8217721653659128,0.8313253012048193,0.9485714031150352,1.0,25/104,22.55%,BCL6;ZBTB1;WDR48;UFL1;POLA1;GRB2;MACROD2;SMC6;RFC3;USP45;CDKN1A;ZBTB38;UBE2B;ATF2;SUSD6;RIF1;BTG2;CRY1;NPM1;SLFN11;BCL2L1;MCL1;TAOK1;SETX;UVRAG
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.5007022648273998,0.8215945988416311,0.7681159420289855,0.948215041194733,1.0,2/9,12.72%,CDKN1A;DCP2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.3048313998887496,-0.8214968763927449,0.75,1.0,1.0,15/119,11.39%,RNF213;UBE3D;MARCHF8;HERC5;IFI27;HERC6;RC3H1;HECW2;MDM2;PSMF1;UBE2E2;WSB1;PSMB1;FBXW4;FBXO9
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.4695288784110463,-0.821461097751668,0.7096774193548387,1.0,1.0,2/7,16.33%,BICD1;CLASP1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.4790801168002653,0.8214345993798383,0.6986301369863014,0.9478255778885896,1.0,3/13,22.28%,WWTR1;YWHAB;YWHAE
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.4815680871470757,0.8212870328893215,0.7142857142857143,0.947496901073972,1.0,5/13,20.58%,HSPA5;HSPA9;TMBIM6;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.5190838587259565,0.8208088599329075,0.8088235294117647,0.9475102164890018,1.0,3/6,29.40%,ANO6;GSN;RGCC
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.506300489291886,0.8207912366059061,0.75,0.9469746110899744,1.0,6/9,31.10%,MGLL;DGKI;PGS1;SEL1L;ABHD2;DGKG
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.3920886330061262,0.8207479334609924,0.7619047619047619,0.9464998581636916,1.0,7/44,13.31%,ST18;PSMC6;HYAL2;RPS27A;HIF1A;PELI1;TAB2
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.500108705983623,0.8201635340341111,0.7205882352941176,0.9467811849245713,1.0,3/5,13.36%,MGLL;GGT5;PON2
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.43697098463293566,0.8199637215985539,0.7236842105263158,0.9466211675299647,1.0,8/23,24.38%,CDK6;REST;ACVR2A;WWTR1;HDAC7;SMAD6;MEF2C;PPARG
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.4436966130603863,0.8199436919910938,0.7424242424242424,0.9460807005522274,1.0,6/24,8.84%,BCAP31;SLC8A1;ANK2;CACNA1C;PRNP;PPP1R9A
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.3039249203773671,-0.8192092468958502,1.0,1.0,1.0,17/101,11.95%,SCFD2;CD74;OCLN;VPS45;BICD1;WLS;TBC1D5;HERC2;STX17;ITSN1;PACS2;PIGU;COG3;CNTLN;CEP68;SEPTIN9;EVI5
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.5039975558569225,0.8189435285431661,0.7741935483870968,0.9468422951260935,1.0,3/7,39.81%,CDKL5;MAP3K13;NRP1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.43973662787659157,-0.8178999349223267,0.6551724137931034,1.0,1.0,1/14,2.58%,PLCB4
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.43973662787659157,-0.8178999349223267,0.6551724137931034,1.0,1.0,1/14,2.58%,PLCB4
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.4183552621022899,0.8178928755408215,0.6962025316455697,0.9479831639069534,1.0,11/27,24.73%,SYTL4;TMED10;CNST;MYH10;FRMD4A;GOLPH3;TPR;CEP290;ABCG1;ADAM9;RACK1
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.5104289674428198,0.8175240980448661,0.8,0.9479827929122964,1.0,3/10,22.79%,HSPA9;BCL2L1;SPG7
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.44763648148812335,0.8172306502647392,0.7916666666666666,0.9477958877097392,1.0,7/20,31.63%,DYSF;CTTNBP2NL;NDFIP1;LGALS3;RACK1;RAB7A;PXK
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.45781080863117524,0.8171364375557523,0.7746478873239436,0.947436098534328,1.0,4/20,11.87%,ZBTB1;HYAL2;KDM1A;CDKN1A
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.49178758130253775,-0.8169017892404327,0.717948717948718,1.0,1.0,1/6,2.20%,TTN
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.4582034039995939,-0.8166229748832136,0.7142857142857143,1.0,1.0,1/6,6.11%,PARN
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.5356946442318913,0.8165794377716632,0.75,0.9476889067064644,1.0,2/8,21.30%,REST;EPAS1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.41230460325315665,-0.8165430126936858,0.8076923076923077,1.0,1.0,5/14,12.35%,PARP14;STAT1;PARP9;NLRC5;PTPN2
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.48926286583391065,0.8164707025659879,0.7424242424242424,0.9472498103796775,1.0,3/13,10.04%,TMED10;PICALM;SAMD8
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.4582039379764105,0.8163021535630454,0.7837837837837838,0.9468843444001127,1.0,7/17,16.52%,S1PR1;CCDC88A;ARHGEF4;ITGB1;RAC1;PARVB;GOLPH3
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.47412556768874126,-0.8160737886624957,0.65625,1.0,1.0,2/11,8.53%,PKD2;SAMHD1
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.3907716518319373,-0.8158908064793133,0.75,1.0,1.0,1/15,2.79%,BABAM2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.3899967704324805,0.8157913999829792,0.7638888888888888,0.9470307557920773,1.0,8/45,23.77%,HSP90AA1;YTHDC1;STRAP;RPS27;EIF3A;RPL10;SETX;EIF5
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.40935820438995557,0.8156429271428376,0.7721518987341772,0.9466459411825434,1.0,8/34,17.61%,CALR;GAPDH;CPEB4;AGO2;GIGYF2;RPL13A;TPR;BTG2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.5193366212537571,0.8154411627262305,0.8064516129032258,0.9458445342481566,1.0,4/5,27.62%,HIF1A;NOS1AP;SCARB1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.5193366212537571,0.8154411627262305,0.8064516129032258,0.9458445342481566,1.0,4/5,27.62%,HIF1A;NOS1AP;SCARB1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.48028540889293053,0.8149786574351815,0.7391304347826086,0.9459779630442476,1.0,5/15,20.40%,BCAP31;HYAL2;PAK2;BCLAF1;BCL2L1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.45847417392885725,0.8145372914261594,0.8166666666666667,0.9459787859187553,1.0,2/11,6.75%,CHPT1;ENPP2
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.3743249142593131,0.8142278502026193,0.788235294117647,0.9458538575410298,1.0,14/68,18.22%,RAPGEF3;BCR;PICALM;RAP1A;TBC1D15;RGS7;TBC1D9;ITGB1;ECT2;LIMS1;RALGAPB;TGM2;RSU1;RALGAPA1
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.49052993733154315,-0.8139830839355346,0.7058823529411765,1.0,1.0,1/6,2.95%,ATM
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.49622588655466854,0.8135164143161961,0.8208955223880597,0.9462185510137242,1.0,1/14,3.19%,LRRC8B
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.42574140377874237,0.8132874761374568,0.6623376623376623,0.9459415851786811,1.0,6/25,15.72%,GPM6B;CCDC88A;DLC1;HIP1R;RAC1;CRK
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.45839390082601933,-0.8126090402912386,0.6170212765957447,1.0,1.0,2/8,8.50%,CD74;MDM2
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.45698469803044184,-0.8120420711823515,0.75,1.0,1.0,3/10,13.15%,PLA2G4A;GPD1L;AGPAT3
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.45698469803044184,-0.8120420711823515,0.75,1.0,1.0,3/10,13.15%,PLA2G4A;GPD1L;AGPAT3
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.45977969260144474,0.811436738877121,0.7123287671232876,0.9479046074465485,1.0,5/12,22.28%,ANK2;NEDD4L;NEDD4;AHCYL1;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),-0.39669461907141285,-0.8102731143869364,0.7,1.0,1.0,2/13,6.83%,BMP6;ACVR1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.5066374146172491,0.8095677883558514,0.75,0.9501822359559464,1.0,3/5,20.48%,NRXN1;AGTPBP1;PAFAH1B1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.4907311296290644,0.8091895730248398,0.7014925373134329,0.9503059447113613,1.0,3/7,18.65%,PSAP;ESYT2;ST6GALNAC3
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.43340356968390525,-0.8086903095191275,0.6551724137931034,1.0,1.0,2/18,5.07%,STAT1;PLXND1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.3711702000885393,-0.8085323315998275,0.8,1.0,1.0,1/14,3.05%,IFI27
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.4486664205243779,0.8080836659799733,0.796875,0.9514978870412123,1.0,4/16,5.02%,PNP;CD81;ANXA1;ZBTB1
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.4993135628057143,-0.8077786834893731,0.7727272727272727,1.0,1.0,1/5,7.28%,GCH1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.34571863736967295,0.8071159361452895,0.8452380952380952,0.9522468200701109,1.0,20/105,21.09%,BHLHE40;CALR;ZNF280D;ESR2;HIF1A;CREM;CNBP;REST;SBNO1;ZBTB38;WWTR1;RALY;FOXC1;ATF2;ZMIZ1;STAT3;NR1D2;BTG1;DENND4A;DNM2
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.46462810822307565,0.8061974065995733,0.7164179104477612,0.9530739135475923,1.0,2/12,16.87%,PINK1;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.46439544623662155,0.8061866828221675,0.8227848101265823,0.9525307135610105,1.0,6/17,19.60%,HYAL2;PIK3R1;ECT2;WWTR1;TPR;LIMK2
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.4231291824590423,0.805035228852695,0.8421052631578947,0.95344877407241,1.0,4/27,10.31%,SPNS2;SCP2;ATP8B1;PITPNC1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.4942579717130137,0.804057759805868,0.7368421052631579,0.9542013642259545,1.0,5/9,22.52%,ANXA1;PRKCE;ITGB1;ARFGEF1;SCARF1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.5169374142433365,0.8035453609680557,0.734375,0.9544667679753073,1.0,2/6,19.31%,CFL1;DYNC1H1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.4933031803634825,0.8031421586322999,0.7384615384615385,0.9543509303328186,1.0,2/10,13.49%,BCAR1;DOCK4
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.30928330954849403,-0.8025203940121316,0.85,1.0,1.0,7/58,9.75%,RTTN;EXOC5;CDC14A;PKD2;OFD1;TTC17;RFX3
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.46364858735928527,0.8016676853484965,0.7384615384615385,0.9559221428367668,1.0,4/12,25.98%,RAB21;TRAK1;MAPK8IP3;KIF1B
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.49665548520808006,0.8010428211151839,0.7611940298507462,0.9563107051930368,1.0,4/7,27.52%,SDCBP;VEGFC;ANKS1A;ITGA2
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.304046465110509,-0.800728514329373,0.8666666666666667,1.0,1.0,9/54,16.15%,TENT2;THOC1;PARN;BICD1;RBMX;DDX17;FASTKD1;PNPT1;POLR2A
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.4649670031282719,0.8002224566784617,0.7384615384615385,0.9571184036565263,1.0,4/15,25.31%,PRNP;SERF2;GSN;CREBBP
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.47655539048138884,0.8001170179457505,0.734375,0.9561246739862092,1.0,1/11,8.07%,RPS27A
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.47655539048138884,0.8001170179457505,0.734375,0.9561246739862092,1.0,1/11,8.07%,RPS27A
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.4159132488263637,0.7997800804584603,0.7205882352941176,0.956040993916799,1.0,5/33,16.57%,SLC4A10;SCARB2;BCAR1;SHC2;CADPS2
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.4810127045347303,0.7996516903443107,0.75,0.9556892411348599,1.0,1/9,4.54%,ARF1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4985950616208638,0.798926044653575,0.7702702702702703,0.9560896465517795,1.0,5/8,40.11%,TNFRSF10B;SORT1;DAB2IP;DDX3X;BAG3
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.4772324027985747,-0.7984540494142975,0.7567567567567568,1.0,1.0,3/7,13.09%,SRGAP2C;SEMA6A;RAPGEF2
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.46920435192627225,0.7980091181961375,0.7761194029850746,0.9569207662635381,1.0,2/12,8.07%,WDR48;RPS27A
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.44809696480365824,0.7973763443786832,0.6571428571428571,0.9573722151645881,1.0,2/19,8.23%,ATG12;RB1CC1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.41666394660746964,-0.7972102483537614,0.6206896551724138,1.0,1.0,2/9,9.35%,USP25;OTUD4
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.36684766174032274,-0.7967463615806497,0.7666666666666667,1.0,1.0,5/17,13.55%,CD74;PDGFC;PDGFB;FN1;GAS6
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.5010392357425145,0.7963025253268704,0.75,0.9584495773341842,1.0,1/6,16.60%,TNKS
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.44849186887018094,0.7958299432993307,0.8289473684210527,0.9586843899521522,1.0,7/18,17.29%,SLC8A1;SLC20A2;SLC12A6;ANO6;SLC26A2;SLC20A1;SLC1A2
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.3728127688831424,0.7955300640270279,0.7777777777777778,0.9585148240663901,1.0,15/46,22.39%,PPA1;PTPRD;PGK1;ALPL;PPM1A;DUSP16;SLC20A1;PAK2;PLPP1;STAT3;INPP5A;LIMK2;PPP3CB;TAOK1;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4224314066282176,0.7951736801050913,0.7671232876712328,0.9584431663121865,1.0,10/21,32.91%,PINK1;MICALL2;YWHAB;YWHAE;SREBF2;PPP3CC;NPEPPS;YWHAQ;YWHAZ;MAPK8
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.4599267409699883,0.7947678382770731,0.7878787878787878,0.9584952858818845,1.0,2/13,2.18%,PCK1;AFF3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.5269568048081504,0.7945501495275006,0.8115942028985508,0.9582480506771895,1.0,2/5,27.49%,DCP2;HNRNPU
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.4002948624385609,0.7942992162951847,0.8125,0.9580076065552431,1.0,8/34,18.38%,RAPGEF5;ANK3;PPP1R9A;SLC12A6;SHC2;HIP1R;KALRN;PODXL
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.5355642253587641,0.7942466269567698,0.8461538461538461,0.957526987160785,1.0,3/6,21.99%,ENSA;ARPP19;YWHAB
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.4986245272054944,-0.793816839583782,0.7631578947368421,1.0,1.0,3/5,26.00%,CYLD;TRPM7;RIPK1
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.4986245272054944,-0.793816839583782,0.7631578947368421,1.0,1.0,3/5,26.00%,CYLD;TRPM7;RIPK1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.49847287912118793,-0.7934352499843916,0.7777777777777778,1.0,1.0,2/6,3.40%,CD74;OAS3
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.42928812393981525,0.7931475212856369,0.8181818181818182,0.9586122264990817,1.0,3/23,9.83%,PRKAG2;OGT;HIF1A
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.338901994670592,-0.7929095612817046,0.782608695652174,1.0,1.0,3/26,4.54%,OCLN;LIMS2;SDK1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.3914164023208923,0.7925507080498283,0.759493670886076,0.9589367275770349,1.0,12/42,27.49%,PSMC6;CDKN1B;FOXC1;PSMA7;SDCBP;BTG2;BTG1;CAV2;USP22;PSMB9;HECA;HNRNPU
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.43387412195694375,0.7919143260722064,0.7857142857142857,0.9592868007036089,1.0,6/17,23.37%,OGT;SIK2;GRB10;VWA2;PTPN1;NCK1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.45220019499648106,0.791893233368375,0.7727272727272727,0.9587482024113235,1.0,2/12,18.75%,PPP1R9A;INPP5A
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.4041306869750019,-0.7904210575871898,0.7419354838709677,1.0,1.0,2/15,9.59%,MX1;DNM3
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.3651701922254953,-0.7903151963567198,0.7692307692307693,1.0,1.0,1/23,0.82%,EIF2AK2
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.40465587538371944,0.7902384839791659,0.8181818181818182,0.960562437772901,1.0,9/29,23.67%,SUN2;AHCTF1;TNKS;RPS27;DYNC1H1;PAFAH1B1;TAOK1;SPC25;XPO1
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.37038467589662494,-0.7898586858523745,0.75,1.0,1.0,2/21,2.55%,CARMIL1;EVL
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.4152010077246241,0.7895386494237555,0.8157894736842105,0.9611376211029509,1.0,6/24,19.55%,RAPGEF3;PINK1;CDK6;FOXC1;NFIB;NOTCH4
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.46206149744465963,0.7893017755342545,0.6811594202898551,0.9609095607634629,1.0,5/8,20.61%,HYAL2;FOXF1;FOXC1;SULF2;CEP290
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.43519731567711384,0.7890436334066002,0.7567567567567568,0.9607593886803523,1.0,2/15,5.68%,MAP2;CTNND2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.5552511068051487,-0.7889712547510438,0.7608695652173914,1.0,1.0,1/5,3.43%,DCP1A
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.38733316624836583,0.788729703848197,0.7671232876712328,0.9605899961841915,1.0,10/32,26.40%,JAG2;PRAG1;GATA2;ZMIZ1;STAT3;EGFL7;NOTCH4;SREBF2;CREBBP;EGFR
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.36822384676658154,-0.7883692121423475,0.7027027027027027,1.0,1.0,2/19,4.41%,MLLT3;PLK2
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.35011535659292714,0.7881284150841404,0.8,0.9608989235408971,1.0,15/72,15.48%,ADAMTS9;PDK4;GRIK2;LSAMP;ENPP2;PLSCR4;DUSP1;VWF;LRRC32;CFH;CD55;TNS1;DGKI;PCDH7;KCTD12
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.3892638558663661,0.7878822541204886,0.7875,0.9607619334069842,1.0,8/42,15.72%,GPM6B;CCDC88A;DLC1;KATNBL1;HIP1R;PAK2;RAC1;CRK
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),0.48583317793780956,0.7878471206490892,0.828125,0.9602572441365537,1.0,3/9,11.31%,GLUD1;SLC2A1;SLC2A3
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.4878393540623973,0.7877047059864258,0.8166666666666667,0.9599079368503014,1.0,5/8,33.84%,CHMP4B;KPNB1;CUL3;EML4;RAB11A
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.521351422106358,0.7873459324985238,0.7727272727272727,0.9598426655461922,1.0,2/6,28.15%,CEP290;DNAJA1
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.45864908705571794,0.7871877628437979,0.7272727272727273,0.9588946301934765,1.0,3/12,19.58%,PRKCE;ECT2;CSPP1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.45864908705571794,0.7871877628437979,0.7272727272727273,0.9588946301934765,1.0,3/12,19.58%,PRKCE;ECT2;CSPP1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.4375956916620378,-0.7870465318589567,0.7,1.0,1.0,2/8,6.83%,BMP6;ACVR1
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.4212640102136772,0.7864142361366495,0.726027397260274,0.9593255531261088,1.0,7/23,19.10%,PLOD2;ERO1A;MSRA;STK38;PLAT;CSNK1G3;ABL2
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.4059859371798431,0.7864070910986607,0.7792207792207793,0.9587784209231632,1.0,6/30,20.29%,TSG101;TBC1D15;PIKFYVE;ALMS1;NPM1;GSN
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3428902419650883,-0.7863391802667214,0.8260869565217391,1.0,1.0,6/25,9.19%,CD74;IL15;BMP6;ACVR1;EFNA5;PDGFB
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.45286129709181216,-0.786025499179931,0.6756756756756757,1.0,1.0,1/8,7.28%,GCH1
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.4972581462820487,-0.786024674644218,0.7692307692307693,1.0,1.0,1/5,6.83%,ACVR1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),0.4883327838289705,0.784145415906022,0.746031746031746,0.9613942953014512,1.0,2/7,31.18%,RPL10;RPL24
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.3570377996169514,0.7840304465863005,0.8333333333333334,0.9610007747482753,1.0,5/52,12.32%,ERBB4;TRIM5;FGFR1;RAP1A;FLT1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.3993427459729894,-0.7836378410984053,0.6451612903225806,1.0,1.0,3/11,16.71%,TENT2;PNPT1;SCAF8
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.3993427459729894,-0.7836378410984053,0.6451612903225806,1.0,1.0,3/11,16.71%,TENT2;PNPT1;SCAF8
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4515357891244566,0.7833014771148262,0.7611940298507462,0.9615707356780223,1.0,5/12,30.70%,DCP2;SND1;ZFP36;MTREX;XRN2
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.5194192094946353,0.7824110833975113,0.8208955223880597,0.9621336238574635,1.0,5/6,26.93%,HSP90B1;NPLOC4;HERPUD1;SEL1L;VCP
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5182025906149852,0.7815521020032807,0.7777777777777778,0.9627535794893997,1.0,4/5,36.39%,FOXF1;PCSK5;GLI3;NIPBL
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.45187320921414087,0.7813155910309022,0.8115942028985508,0.9624755464667668,1.0,3/13,16.89%,DUSP1;PHLPP1;RELL1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.4652757179453473,0.7812584303885814,0.8153846153846154,0.9620376973122398,1.0,3/12,17.88%,PINK1;SPIRE1;DDHD1
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.507176717596329,0.780605157415083,0.8405797101449275,0.9623045435596028,1.0,2/7,7.09%,CANX;JAK1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.5218914234608675,0.7805503164430311,0.7536231884057971,0.9617969164496097,1.0,2/5,17.21%,SPEN;TGM2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.33291125257418125,-0.7789017869469999,0.7586206896551724,1.0,1.0,3/16,8.50%,ATM;PLK2;MDM2
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.4629827776518068,0.7785857223463803,0.765625,0.9640586485603825,1.0,6/10,33.86%,DLC1;CDH5;SPPL3;CALM1;MTMR9;PTBP1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.3812845625883006,0.7776024924857704,0.7733333333333333,0.9648606988934273,1.0,11/31,31.29%,LAMA5;TINAGL1;WWTR1;SEMA3F;EPAS1;EMP2;EGFR;TM4SF1;DAB2IP;DOCK1;SMARCA1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.5068924832377342,0.7774113606930448,0.7323943661971831,0.9645696401905012,1.0,1/6,10.68%,LRRC32
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.4814194117722883,0.7772526561327919,0.8235294117647058,0.9642023138886899,1.0,2/11,16.36%,ROBO2;PLXNA2
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.3666099946215934,-0.7766348607107948,0.8846153846153846,1.0,1.0,2/20,2.55%,PSTPIP2;EVL
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.4255571866969738,0.7762062924122487,0.7846153846153846,0.9650794618340599,1.0,3/15,22.47%,PINK1;GOLPH3;SREBF2
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.4081177971280611,0.775823395552271,0.7702702702702703,0.9649736847846787,1.0,9/25,23.64%,IPO7;RPL23;PTTG1IP;KPNA4;TPR;PPP1R10;STAT3;KPNA3;KPNA1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.3855636564914825,-0.7756182368565201,0.71875,1.0,1.0,3/17,8.21%,MLLT3;RTF1;MLLT1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.3855636564914825,-0.7756182368565201,0.71875,1.0,1.0,3/17,8.21%,MLLT3;RTF1;MLLT1
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.3464955260240019,0.7754509570086203,0.8809523809523809,0.9648871460945677,1.0,8/88,10.62%,PSMC6;WDR48;SMAD7;RPS27A;OGT;HIF1A;USP45;OTUD7B
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.4564944780041664,-0.7749247045867466,0.7419354838709677,1.0,1.0,2/7,11.69%,EEA1;MFF
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.469534557163385,-0.7748812607017999,0.6829268292682927,1.0,1.0,2/7,8.50%,CD74;MDM2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.38693147766304614,0.774091844672036,0.8421052631578947,0.9660489961930419,1.0,7/29,31.45%,SMAD7;TRIB2;CSNK1D;RACK1;VCP;RNF19A;PTK2
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.45651766313756525,-0.7736796733953744,0.75,1.0,1.0,4/7,27.86%,INO80;TOP2B;LATS1;NSL1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.4164486244129,-0.7731643498168609,0.7142857142857143,1.0,1.0,5/10,13.55%,CD74;PDGFC;PDGFB;FN1;GAS6
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.45906954856490334,-0.7728917396083675,0.78,1.0,1.0,2/7,8.50%,CD74;MDM2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.32763740295835697,-0.7718866292892467,0.8888888888888888,1.0,1.0,6/23,13.20%,EXOC5;STXBP6;OPTN;VPS35L;EXOC1;EXOC6
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4439528237072851,0.7709098812135297,0.76,0.9696728472498155,1.0,2/12,2.92%,CLIC2;ANK2
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.4231888612921709,0.7708697973022178,0.7647058823529411,0.9691511887908305,1.0,6/11,34.16%,GSN;ARFGEF1;CDH5;RACK1;CYRIB;RAP1B
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.34145386785962173,-0.7704391759773812,0.8461538461538461,1.0,1.0,7/28,9.72%,LEPR;STAT1;IRF1;STAM2;PDGFC;STAT2;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.38946712314049065,0.7702052899432636,0.863013698630137,0.9695202352240014,1.0,11/44,19.10%,FES;DUSP1;ADGRG1;RASA1;PLXNA2;PRKX;TGM2;PPP1CB;RSU1;PODXL;ABL2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.46235251822028417,0.7685899966133005,0.7777777777777778,0.970994509371255,1.0,3/12,11.42%,BCAP31;HSP90AA1;SLC25A16
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.479207267737803,-0.768251851332373,0.7333333333333333,1.0,1.0,2/5,23.82%,POLR2A;DHX9
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.34048660925624086,-0.7678578752772373,0.7878787878787878,1.0,1.0,4/20,9.19%,ATM;ATR;PARN;PDGFB
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.48286241707062943,0.767793958854867,0.7619047619047619,0.9715145012612197,1.0,1/7,16.52%,GOLPH3
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.4230079913595002,0.767645437700563,0.8533333333333334,0.9711389647979765,1.0,5/16,21.65%,CANX;PICALM;SYT1;DNM2;SYNJ2
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.389292355448546,-0.767549941769607,0.7096774193548387,1.0,1.0,1/10,5.23%,SLC25A29
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.44378981050039457,0.767389349423774,0.7794117647058824,0.9709668462780568,1.0,9/15,37.16%,ACTN1;ACTB;CLIC1;STXBP3;PIK3CB;MYL12A;MYH9;ACTG1;VCL
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.4646284022339481,0.7667378987056603,0.8059701492537313,0.971314790762469,1.0,1/12,5.55%,YBX3
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4844949409014515,0.7665856221352843,0.7164179104477612,0.9709843619955533,1.0,1/5,6.27%,SMAD7
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.3529341353739058,0.7663177769284827,0.8117647058823529,0.9707746288653111,1.0,14/78,19.44%,ZEB2;PSMC6;GPC5;CTNND2;PPM1A;WWTR1;UBE2B;PSMA7;TNKS;AMFR;FZD4;CSNK1G3;CSNK1D;USP34
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.452603302590013,-0.7660567386261168,0.6875,1.0,1.0,1/7,2.18%,ISG15
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.4992162552528177,0.7650252809392892,0.796875,0.9720081558272875,1.0,4/6,36.39%,FOXF1;PCSK5;GLI3;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.3753747382151701,0.764774979563223,0.7922077922077922,0.9719056123931842,1.0,6/36,8.79%,CD81;DPP10;PRKCE;PIK3R1;PRNP;ANK3
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.4669127604741475,0.763594445714311,0.7887323943661971,0.9726692805924527,1.0,3/7,16.73%,CD9;CRK;ACTN1
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.3487303356973575,-0.7632381947333255,0.84,1.0,1.0,1/24,0.82%,EIF2AK2
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.3867470550911777,-0.7625038920858747,0.8235294117647058,1.0,1.0,1/15,1.22%,ALS2
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.28528506887093336,-0.7624378795455578,0.9047619047619048,1.0,1.0,5/60,7.36%,TENT2;THOC1;IVNS1ABP;BICD1;WBP4
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.45083108870373756,-0.7622578988939437,0.6363636363636364,1.0,1.0,1/5,2.95%,ATM
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.4437916082545744,0.7619597826302289,0.7714285714285715,0.9741270937236844,1.0,4/10,20.82%,LAMA5;PRKX;DAG1;ACTB
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.47616843676908716,0.7618437120054099,0.7777777777777778,0.9737077890552034,1.0,3/7,7.25%,PRKAG2;LBR;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.35897187824577215,0.7610549541410382,0.8571428571428571,0.9742356278876199,1.0,8/52,9.16%,CD81;RAPGEF3;HYAL2;PIK3R1;PRNP;PINK1;ANK3;MICALL2
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.3100794525614653,-0.7600331644647189,0.9285714285714286,1.0,1.0,5/28,8.50%,GBP2;RANBP17;NUP214;TAF3;MDM2
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.4717943987804093,0.759778435754321,0.7575757575757576,0.9753683943277405,1.0,4/8,29.24%,OGT;RIF1;MTF2;KMT2A
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.44718264569868,0.7593023135389082,0.7910447761194029,0.9754282019134717,1.0,9/14,37.16%,ACTN1;ACTB;CLIC1;STXBP3;PIK3CB;MYL12A;MYH9;ACTG1;VCL
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.48980840319761254,0.7590365657563424,0.8169014084507042,0.9751918220769362,1.0,2/7,13.94%,HYAL2;PAK2
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.42256407892136955,0.7577916261210769,0.765625,0.9761710036675489,1.0,6/11,33.33%,NAA50;MORF4L1;CREBBP;PHF20L1;KAT6A;EP300
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.4065330068084061,0.7575939897575314,0.8082191780821918,0.9758841249007741,1.0,5/18,24.49%,UFL1;HSPA9;PRKX;KMT2E;TET2
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.4825965637319023,-0.7569977994732235,0.7804878048780488,1.0,1.0,1/5,9.19%,PDGFB
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.34477681093855894,-0.756576192701084,0.8095238095238095,1.0,1.0,2/27,3.40%,IFIH1;OAS3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4753465095383926,0.7552920593305202,0.8208955223880597,0.9782455566757876,1.0,3/7,23.08%,DOCK4;MEF2C;ADAMTS1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.5315589291924481,0.7537907765991807,0.8714285714285714,0.9796865384253579,1.0,4/5,40.74%,SPG7;ATP5F1E;CHCHD3;IMMT
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.4553225866176193,0.7534236221333971,0.7704918032786885,0.9795426643633408,1.0,5/9,35.59%,CRY1;ATP2B4;FYN;EP300;CD34
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.35957118121535364,-0.7533760504376311,0.8095238095238095,1.0,1.0,7/18,14.42%,CD74;GIMAP8;TNFRSF1B;HLA-C;SERPINB9;HLA-A;GIMAP4
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.3792683421014621,0.753231457069951,0.7837837837837838,0.9791666248182384,1.0,3/30,6.06%,SERPINE1;NFKBIZ;HYAL2
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.4274358967324882,0.7531888094247561,0.7681159420289855,0.9787094260887937,1.0,6/17,26.40%,CCDC88A;WAPL;ZBTB38;SLFN11;SMC3;EGFR
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.40466739774444294,-0.7530916448253642,0.7222222222222222,1.0,1.0,2/11,14.21%,EZH1;KAT6B
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.4517478583475939,-0.7521544683150769,0.7777777777777778,1.0,1.0,2/6,11.26%,LMO2;FOXO1
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.3639004523753523,0.7518637875583509,0.9,0.9798207562017083,1.0,7/35,14.42%,PCK1;TIMP3;PLSCR4;MT2A;PIKFYVE;CFH;TNS1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.336001469275016,0.7516491252180018,0.9146341463414634,0.9795705653265887,1.0,8/88,10.62%,PSMC6;WDR48;SMAD7;RPS27A;OGT;HIF1A;USP45;OTUD7B
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.43364503433378077,0.7513435411020638,0.8059701492537313,0.979496075886858,1.0,2/16,7.84%,TBX3;DLC1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.35193632349486853,-0.7511451041628225,0.88,1.0,1.0,3/24,5.23%,SLC4A4;ATP10D;SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.48654986564615144,0.7502359775103318,0.8484848484848485,0.9802669707790387,1.0,1/5,12.40%,ANO6
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.44285064576263744,0.7501902653440389,0.8428571428571429,0.9797728899469308,1.0,1/12,3.96%,SLC4A10
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.4631498224876819,0.7497196734026438,0.8225806451612904,0.9798360104639763,1.0,2/7,41.97%,IRAK3;IFI16
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.40237183003263427,-0.7493533273475191,0.813953488372093,1.0,1.0,3/10,17.53%,THOC1;SCAF8;CDK12
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.4685572242816693,0.7491628570415946,0.84,0.9799490677854743,1.0,2/9,8.63%,CD9;KLF4
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.4114822770560563,0.7483434832132356,0.7323943661971831,0.9804555875211659,1.0,4/18,25.15%,SYTL4;DYSF;SCARB1;PLEC
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.32508083592456505,-0.7478729687607708,0.8214285714285714,1.0,1.0,3/18,8.50%,ATM;PLK2;MDM2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5073970290429761,0.7476326236398386,0.84375,0.9808054410523683,1.0,2/6,33.39%,DIP2A;RPS6KA5
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.36553656581411076,0.7459946729812953,0.8625,0.9823593098463462,1.0,6/28,24.38%,SMAD7;SMAD5;ACVR2A;SMAD6;CDH5;PPARG
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.4222397805890798,0.7458778165372001,0.8472222222222222,0.981953034488121,1.0,7/17,24.73%,CALR;DYSF;TGM2;GATA2;SCARB1;FGR;RACK1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.3996000161210097,-0.745714482495397,0.7878787878787878,1.0,1.0,1/18,2.15%,IL15
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.4737460605030751,0.7455051175840265,0.782608695652174,0.9818401866945122,1.0,2/7,26.29%,MSN;CDC42
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.4090924790912879,0.7454851155723337,0.8428571428571429,0.9813412059100957,1.0,8/24,23.48%,SMAD7;ADGRG1;RAC1;LIMS1;TGM2;RSU1;AFDN;ADAM9
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.3685238808404607,0.7447705452013599,0.8809523809523809,0.9815650573214783,1.0,4/35,13.47%,SEC22B;CDKN1B;EEF1A1;NEDD4L
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.45109163831928484,0.744407579387344,0.859375,0.981483730324997,1.0,3/9,16.55%,AGO2;TUT7;SND1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.39590192731224694,-0.7432928944490745,0.7435897435897436,1.0,1.0,1/10,6.93%,PDE9A
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.5158231247432787,0.7432380227185081,0.8333333333333334,0.9824598187167269,1.0,3/5,29.93%,PTPN1;NEDD4;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.41874022193342797,-0.7431343790350208,0.7692307692307693,1.0,1.0,2/13,2.82%,CD74;SHLD1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.4173670766549703,0.7418976718642158,0.8421052631578947,0.9834596826828589,1.0,9/17,22.15%,MICALL2;PECAM1;CLDN5;PAK2;ECT2;ESAM;AFDN;TBCD;CDH5
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.4207504483114135,0.741791472642193,0.7746478873239436,0.983010890845659,1.0,2/12,19.12%,TF;SLC30A1
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.34579995706420086,-0.7417232147656756,0.84375,1.0,1.0,1/19,2.20%,TTN
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.48226233128813784,0.7416411882660289,0.8387096774193549,0.9826681548055859,1.0,1/5,5.92%,DHRS7B
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.46431835944984023,0.7416030747390685,0.8307692307692308,0.9821582464078823,1.0,5/7,47.62%,ABHD2;ACACA;ELOVL7;CBR4;ABCD3
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.4860869653121468,0.7412275349232345,0.8524590163934426,0.9822071081296802,1.0,1/7,9.59%,CNTNAP2
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.43159830324557663,0.7403591849367798,0.8676470588235294,0.982578253187675,1.0,5/15,21.65%,INPP5F;MTMR12;PLPP1;MTMR6;SYNJ2
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.4541695892501302,0.7398877315505397,0.765625,0.9826268271216889,1.0,1/8,3.90%,ANXA1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.42037065662789086,-0.7396749228769806,0.6785714285714286,1.0,1.0,2/7,12.14%,SPRY3;NTNG1
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.4378485343722839,0.739657038070909,0.8307692307692308,0.9824090947773699,1.0,3/9,23.16%,INPP5A;PPP3CB;PPP3CC
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.45313156872678495,0.7393484453746331,0.8088235294117647,0.9822163581278734,1.0,5/11,21.67%,CDKN1B;CCNH;CDKN1A;ACTB;CDC37
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.4662888503252103,-0.7387475711325516,0.775,1.0,1.0,1/5,10.31%,ATP9A
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.4541330022240051,-0.7386084508838617,0.7674418604651163,1.0,1.0,1/5,11.31%,MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.36441527858440076,0.7380125256433632,0.8767123287671232,0.9833536193912259,1.0,11/50,17.74%,RAPGEF3;PINK1;PICALM;RAP1A;RGS7;ITGB1;ECT2;PSAP;LIMS1;TGM2;RSU1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.40726895142332475,0.7373138545749879,0.7971014492753623,0.9836674648123122,1.0,8/17,36.39%,DAG1;CFL1;PLCB1;RAB14;TRIP12;NR2C2;INSR;NIPBL
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.41659098050396126,0.7371566611672522,0.8676470588235294,0.9833322528830016,1.0,3/11,36.39%,GRM5;FAM107A;NIPBL
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.374318699010891,0.7358674111737784,0.8648648648648649,0.9843620347830782,1.0,12/29,31.85%,FGFR1;PIK3R1;FLT1;NEDD4;DIPK2A;FGR;EGFR;PIK3CB;PIP5K1C;DAB2IP;PTK2;PPP2R5C
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.34325285786427473,-0.7357618226421454,0.7931034482758621,1.0,1.0,1/9,2.76%,OCLN
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.36239939762140005,0.7357485757471537,0.8780487804878049,0.9839404106821092,1.0,9/35,16.68%,PRKAG2;RAP1A;TRIB2;CDKN1A;TAB2;PAK2;ECT2;WWTR1;SPRED1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.4239656397739356,0.7355546209743155,0.8095238095238095,0.9836981231419757,1.0,3/13,18.88%,TMED10;GOLPH3;CSNK1D
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.4805203832465305,0.7352317885697062,0.8070175438596491,0.983499255232944,1.0,1/5,7.04%,PINK1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4257031060259898,0.7347815360074107,0.8289473684210527,0.9835162459892387,1.0,2/9,13.31%,RPS27A;TAB2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.4000095065957396,0.7344176568058444,0.9090909090909091,0.9833546445362847,1.0,4/21,11.87%,IPO7;CDKN1B;CCNH;CDKN1A
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.35255691415200363,0.7341873685902097,0.926829268292683,0.9830578268512099,1.0,8/44,20.42%,NEDD9;LARP4;RAC1;BRWD3;PDZD8;CFL1;SH3KBP1;DPYSL2
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.42887192863166157,0.732771428672376,0.8055555555555556,0.9841760456354235,1.0,4/12,12.40%,SLC8A1;ATP1A1;ATP1B3;ANO6
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.4757172742789334,0.7327615733925212,0.7592592592592593,0.9836393492205234,1.0,2/5,26.40%,TEC;EGFR
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.31892081289511237,0.7326379428387033,0.9634146341463414,0.9832629918209447,1.0,27/118,26.03%,BHLHE40;CALR;ZNF280D;CCDC88A;ESR2;HIF1A;CREM;CNBP;REST;SBNO1;ZBTB38;WWTR1;FOXC1;ATF2;STAT3;NR1D2;BTG1;DENND4A;GRM5;DNM2;RPL10;MEF2C;NSD2;TERF2IP;CREBBP;SMC3;ZNF718
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.40518362133627855,0.7323192404602558,0.8461538461538461,0.9831449602739877,1.0,5/16,29.43%,SMARCC1;NPM1;NAP1L4;SMARCA5;ARID1A
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.36694032552962674,-0.7319315486348309,0.8620689655172413,1.0,1.0,4/15,12.48%,MGMT;SLF2;SHLD2;RNF169
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.4281762553274184,0.7318306513080953,0.8732394366197183,0.983186630072877,1.0,2/8,13.31%,RPS27A;TAB2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3975375562665555,0.7299072934027129,0.855072463768116,0.984841491289651,1.0,3/19,12.32%,FGFR1;PIK3R1;FLT1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.44724489606332474,-0.7296720898535874,0.868421052631579,1.0,1.0,2/6,8.92%,NKD1;PROM1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.47201883056112237,-0.7292907833360889,0.78125,1.0,1.0,2/5,15.22%,OPTN;TRIP11
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.4108284122448541,-0.7290093310396455,0.8181818181818182,1.0,1.0,2/8,10.36%,DISP1;CFLAR
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.43243448555564873,-0.7281812212483374,0.7567567567567568,1.0,1.0,2/7,9.19%,PKD2;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3716671063305856,-0.7278753664757125,0.8387096774193549,1.0,1.0,2/9,10.25%,TNRC6C;CPEB3
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4196369860112199,0.727729003726324,0.8208955223880597,0.9867397562987421,1.0,5/12,22.02%,SMAD7;ACVR2A;SDCBP;SMAD6;RBPMS
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.31867312437156586,0.7274501589574085,0.898876404494382,0.9864975281895405,1.0,18/93,22.18%,ELL2;ZBTB1;AFF4;ESR2;CBFB;ELP4;CCNH;WWTR1;NCOR2;NR2C1;HDAC7;CSTF3;NR1D2;NFIC;NOTCH4;TFCP2;MED4;SETX
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.4223573527197635,-0.7271707519616918,0.8,1.0,1.0,2/7,16.79%,ACVR1;MDM4
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.347002519655681,0.7267693822072941,0.85,0.9865862553050572,1.0,12/57,23.67%,PSMC6;RPS27A;DCP2;GIGYF2;PSMA7;CARHSP1;NPM1;HSPA8;ZFP36;YWHAB;UBC;XPO1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.40911692631356844,0.7251357007468272,0.8133333333333334,0.988039758299101,1.0,4/14,23.45%,WAPL;TOM1L2;PPP1R10;MAX
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.43867244283962475,-0.724528569498827,0.8205128205128205,1.0,1.0,2/5,3.37%,PLA2G4A;GPCPD1
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.4675826686633343,0.7239508340182984,0.8636363636363636,0.9887331393182417,1.0,2/6,29.00%,ATP2B4;RIOK3
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.40947229800982327,0.7236698527266338,0.8933333333333333,0.9885576009671615,1.0,9/19,22.15%,MICALL2;PECAM1;CLDN5;PAK2;ECT2;ESAM;AFDN;TBCD;CDH5
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.3908771603779564,0.7234464998189202,0.8714285714285714,0.9883211506766546,1.0,3/20,10.23%,BAZ1A;POLA1;RFC3
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.42108266171940784,-0.7232391294585296,0.7222222222222222,1.0,1.0,1/5,4.94%,BCOR
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.37265096730692254,0.7229318141328005,0.8375,0.9883903141788402,1.0,8/33,18.73%,RAPGEF3;PIK3R1;CCDC88A;DLC1;PAK2;RAC1;PXN;ALMS1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.39807276860995094,0.7227725909441088,0.8636363636363636,0.9880809694974841,1.0,10/20,31.55%,TIMP3;TAB2;STAT3;RASIP1;MCL1;MTOR;TLK2;DAB2IP;MTMR9;FOXK2
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.48040520986561785,0.7221132793570589,0.8461538461538461,0.9883210001731677,1.0,2/6,26.29%,MSN;CDC42
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.34586690203821935,-0.7219478461755289,0.875,1.0,1.0,4/24,10.36%,CASP10;NOD1;TNFSF10;CFLAR
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.4434777961539955,-0.7217928358294601,0.7,1.0,1.0,1/5,5.82%,MIA3
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.3923812867152478,0.7214104190581005,0.8787878787878788,0.9886095447996293,1.0,7/22,23.48%,NDRG1;MT2A;HIF1A;NEDD4L;NEDD4;AHCYL1;ADAM9
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.4076266161765413,-0.7200413786045159,0.8108108108108109,1.0,1.0,1/9,1.43%,ARID5B
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.373963304811851,0.7198810848742305,0.85,0.9898666781263583,1.0,5/25,17.45%,PSMC6;CBFB;FOXC1;PSMA7;GATA2
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.3230551845642025,0.7195507026484143,0.9101123595505618,0.9895998357033244,1.0,16/109,20.61%,TSG101;EHD4;RAB11FIP3;NUDCD3;ATG12;RB1CC1;BBS9;TNKS;VMP1;CSNK1D;DYNC1H1;CHMP4B;VPS37A;NPM1;GSN;CEP290
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.34835250420154085,0.7187992940828064,0.8970588235294118,0.9898263383179747,1.0,4/39,12.51%,PRKAG2;RPL23;RFC3;RPL37
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.39467716672601005,0.7185581857103553,0.8309859154929577,0.9896206468113551,1.0,10/19,31.55%,PINK1;TAB2;STAT3;RASIP1;MCL1;MTOR;TLK2;SMG1;MTMR9;FOXK2
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.3720003498444495,0.7174057039953827,0.8313253012048193,0.9903576478433984,1.0,6/22,18.35%,ANK3;PPP1R9A;TMEM132C;SHC2;VWA2;KALRN
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.48844339539988857,0.7172262929173545,0.8035714285714286,0.9900546569620469,1.0,4/5,34.63%,SETX;UVRAG;CALCOCO2;INSR
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.45543402041895514,-0.716535161427756,0.8529411764705882,1.0,1.0,4/6,12.67%,FGD6;SRGAP2;DNM3;FGD5
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.3996690896725148,0.7158313612584045,0.8333333333333334,0.9912097112485203,1.0,4/16,22.34%,LARP4;PDZD8;CFL1;SPARC
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.3394075635667647,0.7157489277163827,0.8831168831168831,0.9907851762549271,1.0,3/33,7.36%,HSPA5;PINK1;HSP90AA1
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.39463639233197806,-0.7157169141373355,0.8,1.0,1.0,2/8,21.73%,RPS8;RPS16
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4343917457456079,0.7154664982345876,0.7702702702702703,0.9906037914447053,1.0,4/10,23.37%,HERPUD1;TMBIM6;BCL2L1;NCK1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3088252267623842,0.7153637330697026,0.9204545454545454,0.9901315368789781,1.0,15/131,16.02%,PSMC6;SPOPL;TSG101;FEM1C;TRIM9;NFE2L2;PINK1;MIB1;NPLOC4;OTUD7B;PELI1;NEDD4L;NDFIP1;UBE2B;PSMA7
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.4753179897590437,-0.7148940057098288,0.7567567567567568,1.0,1.0,1/5,1.35%,EYS
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.4620467644526298,0.7148878776529985,0.8181818181818182,0.9901567652027056,1.0,2/7,16.18%,SAMD8;DMD
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.4662255292836386,0.7140644656353529,0.8656716417910447,0.9906241495368313,1.0,1/6,6.24%,CCDC88A
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.4058310583492103,0.7139194664894075,0.8461538461538461,0.9901526534749636,1.0,3/15,13.12%,CBFB;RAP1A;CLDN5
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.3924232318349116,0.7138805061711132,0.8571428571428571,0.9896332635090513,1.0,6/14,28.90%,TOR1AIP2;ATP1B3;VMP1;ATP1B1;HNRNPU;RYR2
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.45611243893024794,0.7137640864964166,0.8253968253968254,0.9892414335723236,1.0,1/7,9.43%,GGT5
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.4376631398963863,0.7136044557096674,0.8181818181818182,0.9888500286138351,1.0,6/9,33.23%,COMMD1;NEDD4L;ATP2B4;CAMK2D;FGF12;DLG1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.42558793772503445,0.713395177430418,0.85,0.9885557022118039,1.0,1/8,11.16%,SETD3
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.42998927118218927,0.7129434081879841,0.8484848484848485,0.9879076620250643,1.0,4/6,22.39%,JAK1;GRB2;STAT3;PLCB1
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.42998927118218927,0.7129434081879841,0.8484848484848485,0.9879076620250643,1.0,4/6,22.39%,JAK1;GRB2;STAT3;PLCB1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.4099338313113244,0.7125117339576525,0.8260869565217391,0.9877892248346253,1.0,4/14,22.07%,SSH1;KLF4;GRM5;RPL10
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.38139472594566265,-0.7124558321139342,0.8235294117647058,1.0,1.0,1/7,11.37%,NLRC5
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.3631409955063934,0.7123167662069655,0.891566265060241,0.9874900810523699,1.0,2/27,7.07%,PSMC6;CBFB
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3600192637254326,0.7120793177778392,0.8205128205128205,0.9871972852338909,1.0,7/25,26.67%,ATP8B1;TBC1D15;RAC1;PODXL;FSCN1;CDC42;CDKL5
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.3863665223128508,0.7119687486811329,0.8387096774193549,0.9867843795738148,1.0,3/16,20.48%,ARHGAP21;TRAK1;PAFAH1B1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.3693577426664677,-0.7118522087457827,0.8,1.0,1.0,2/19,9.72%,IFI27;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4015419649638628,-0.7115262981953974,0.7906976744186046,1.0,1.0,3/9,12.35%,GRB14;KANK1;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.36743253041668467,0.710869044440938,0.922077922077922,0.9875514593964405,1.0,3/36,10.28%,HSPH1;KLF4;LARP4
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.4641306555149599,0.7105011702838189,0.9,0.9873433118483417,1.0,3/6,12.78%,SLC4A10;SLC4A7;TMEM165
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.4221244518115719,0.7095444106320339,0.8793103448275862,0.9880251007713867,1.0,1/10,2.52%,TRIM5
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.37423171833376734,-0.7090774691252572,0.8571428571428571,1.0,1.0,3/8,17.13%,PTPN2;OSBPL8;PPARD
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.42119005362969586,0.7086534552010543,0.8688524590163934,0.9884538049043746,1.0,3/9,19.42%,BCAR1;PLAT;PTPN1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.40395917517833974,0.7084695033269678,0.8382352941176471,0.988173446554593,1.0,4/14,13.47%,SLC8A1;ATP1B3;ANO6;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.38437720975936907,0.7081738233183451,0.8208955223880597,0.9880134272598099,1.0,6/20,16.52%,GLUD1;SYTL4;TMED10;MYH10;FRMD4A;GOLPH3
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.4616727341660536,0.7079747584907891,0.8923076923076924,0.9876916173365041,1.0,3/7,33.65%,RACK1;VCP;GLI3
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.3855428623170613,0.7079466583833325,0.8918918918918919,0.9871842962845138,1.0,11/21,42.52%,EIF3A;XPO1;UGGT1;KPNB1;PRPF8;PTBP1;POLR2B;UBAP2L;IMMT;NUP160;DHX15
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.3720189110191461,0.7073873599974858,0.9487179487179487,0.9872647538849031,1.0,5/25,17.45%,PSMC6;CBFB;FOXC1;PSMA7;GATA2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.40867842005546934,0.7072646405161306,0.9130434782608695,0.9868600196559778,1.0,2/16,7.38%,WDR48;KDM1A
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.40565214503321945,-0.705940265639512,0.8611111111111112,1.0,1.0,4/8,17.85%,AGPAT3;PPIP5K2;TPK1;ITPKB
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.40706957117868914,0.7041819617998905,0.8840579710144928,0.9896221759192712,1.0,4/17,10.49%,GLUL;ATG12;ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.46449503808423803,0.7032645132955553,0.8428571428571429,0.9899763915641907,1.0,1/6,20.29%,GSN
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.4343414391768421,0.7031087734346384,0.8970588235294118,0.9895887919389522,1.0,4/9,17.21%,ANXA1;XKR6;RAC1;TGM2
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.41727972069906605,0.7029076718812889,0.8285714285714286,0.9891896557498571,1.0,6/11,34.79%,BACE2;DAG1;ADAM9;SPPL3;ADAM17;MYH9
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.27304309104194324,-0.7028822139299435,0.9375,1.0,1.0,7/59,11.02%,EIF2AK2;GEMIN5;CAPRIN1;LARP4B;LARP1;CPEB3;GSPT1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.4445748346452479,0.7012304966762988,0.8769230769230769,0.9902841742380346,1.0,2/7,28.53%,DLGAP2;DLGAP1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.35828495025220775,0.7011338677123032,0.935064935064935,0.9898492749089014,1.0,19/42,33.84%,SUN2;AHCTF1;TNKS;RPS27;DYNC1H1;PAFAH1B1;TAOK1;SPC25;XPO1;SMC3;VCP;MECP2;DYNC1I2;ZNF207;NDEL1;KPNB1;RANBP2;EML4;RAB11A
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.46915655945362544,0.7011100628747508,0.8125,0.9893551760853581,1.0,4/5,33.84%,LIMK2;KPNB1;DLG1;RAB11A
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.44302531132469125,0.7008723254105271,0.7894736842105263,0.9890345422777993,1.0,1/8,13.04%,TRAK1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.3114564060804424,-0.7008382139610688,0.9032258064516129,1.0,1.0,1/17,1.04%,PSTPIP2
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.4353084028636745,-0.7003630186985138,0.75,1.0,1.0,2/5,13.68%,PARN;MCM9
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.42813590135566554,0.6993537487007324,0.8714285714285714,0.9900791214484079,1.0,1/9,2.90%,SLC8A1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.3988533330651563,0.6983804073738166,0.828125,0.9906698561452664,1.0,2/12,13.52%,KLF4;ACVR2A
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.39311282485379845,-0.6975498505042299,0.8888888888888888,1.0,1.0,1/11,1.67%,IL32
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.40817428157306135,0.6974259528001084,0.803030303030303,0.9911885145523526,1.0,3/8,30.81%,PIKFYVE;RAB14;RAB7A
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.4008782574994547,-0.6966087650797981,0.8108108108108109,1.0,1.0,2/8,9.19%,PKD2;PDGFB
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.47386601768780817,0.6965647536705986,0.8181818181818182,0.991462645154259,1.0,1/5,25.44%,MTOR
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.39006073175751266,-0.6959229695028738,0.8928571428571429,1.0,1.0,1/12,1.41%,STARD3
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.3740387609314585,0.6958862264416424,0.8307692307692308,0.9917067461466073,1.0,6/19,15.27%,GRB2;PRAG1;ADGRG1;ERBIN;RAC1;SHOC2
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.46591174881017644,0.6957923182924716,0.9076923076923077,0.9912848321580434,1.0,1/6,11.16%,SETD3
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.4476962705752755,0.6954530561912428,0.8461538461538461,0.991178244627542,1.0,4/8,23.82%,PRNP;LGALS3;SLC30A1;FYN
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.3490241730826874,-0.6952191818231652,0.8260869565217391,1.0,1.0,2/17,4.65%,BMP6;ABCG2
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.3485330830286258,-0.6951962599581777,0.8461538461538461,1.0,1.0,1/12,1.04%,PSTPIP2
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.3493661943683186,0.6951262606205945,0.9178082191780822,0.9909470746895852,1.0,2/26,5.50%,HSPA5;RAPGEF3
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.29325529261877514,-0.6949518197267923,0.9629629629629629,1.0,1.0,6/42,8.53%,BABAM2;ATM;PARP9;RAD51B;HERC2;SAMHD1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.40891176457802414,0.6945031257481094,0.85,0.9910484964893751,1.0,3/12,26.06%,NPM1;NAP1L4;SMARCA5
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.33554450176231165,0.6944735750276635,0.8947368421052632,0.990556651984873,1.0,9/36,25.84%,UFL1;SIN3B;UBE2B;NAA50;MORF4L1;RCOR3;USP22;CREBBP;PHF20L1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.4212475869689316,0.6944262519965013,0.8103448275862069,0.9900653307192054,1.0,1/7,7.76%,SRGN
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.3887407669126214,0.6944076724981655,0.88,0.9895626813045151,1.0,2/14,6.91%,VSIR;PRNP
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.46852119088322564,0.6941422488816892,0.8656716417910447,0.9893152175709938,1.0,2/6,11.18%,PINK1;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.4009873021819741,-0.6939705583225153,0.7105263157894737,1.0,1.0,2/6,10.49%,EVL;KANK1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.35980896872640555,0.6931526670795627,0.9090909090909091,0.9897013478829234,1.0,4/25,10.09%,SLC8A1;MGLL;CPEB4;GAS7
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.35895188055907357,-0.6929402595002636,0.8333333333333334,1.0,1.0,2/12,4.38%,ATM;ATR
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.4280477514029719,0.6910700063434407,0.8387096774193549,0.9910631821406857,1.0,3/10,17.45%,CALR;ANO6;GATA2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.44475733107738974,0.6907765451217985,0.828125,0.9907975781175621,1.0,1/7,2.90%,SLC8A1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.401731408630659,0.6907451004320168,0.9,0.9903017825974086,1.0,2/12,6.24%,IL1RAPL1;CCDC88A
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4043509713400977,0.6900923568712675,0.9054054054054054,0.9904089690719818,1.0,3/11,21.59%,CNOT6L;TUT7;ZFP36
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.4596637157741546,0.689410381108892,0.9166666666666666,0.9905396552333859,1.0,4/6,28.47%,PDZD8;VMP1;AHCYL1;CALM1
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.42307076176473946,0.6893264258973142,0.796875,0.9901332863891297,1.0,2/7,21.89%,ADCY2;ADCY9
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),0.41788904670304516,0.6889082693969102,0.8852459016393442,0.9900988624122026,1.0,2/12,10.70%,UFL1;HSPA9
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.4718395424848591,0.6888442581696678,0.9076923076923077,0.9896401109776315,1.0,1/5,23.24%,RAB3GAP2
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.3260493790709041,0.6887064254109446,0.9066666666666666,0.9892584252372202,1.0,9/44,21.09%,ARF1;MYO1B;COMMD1;KIF16B;ACBD3;AP1G1;ARFGEF2;HSPA8;DNM2
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.43875677079502384,0.6884834184267137,0.8461538461538461,0.988912469049905,1.0,3/5,47.52%,EGFR;LCOR;NRIP1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.4298228958444785,0.6882432318810802,0.8461538461538461,0.9886080704287599,1.0,3/7,26.40%,GATA2;EGFL7;EGFR
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4253003602646337,0.6879665870603313,0.863013698630137,0.9883745710911517,1.0,1/9,8.37%,DUSP1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.4763584434808634,0.6872012441325515,0.8307692307692308,0.9886057116200969,1.0,2/7,15.80%,SAMD8;AGPAT4
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.4485139056799412,0.6871112203764184,0.864406779661017,0.9881962006825066,1.0,2/7,14.10%,PIKFYVE;AP1G1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.348808332718694,0.6864709910909813,0.9012345679012346,0.9882862587031438,1.0,8/29,23.69%,PTBP2;AHNAK;PRX;RASA1;HNRNPH3;TRA2B;ZNF326;PTBP3
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.40902126457217725,-0.6843682348751123,0.868421052631579,1.0,1.0,1/8,5.39%,RHBDD1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.33622907899336063,-0.6841084499754433,0.8709677419354839,1.0,1.0,2/11,4.25%,STAT1;PARP9
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3926081365056697,-0.6824435688871167,0.7948717948717948,1.0,1.0,3/10,12.35%,GRB14;KANK1;PTPN2
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.43429063051587347,0.6821582791068385,0.8823529411764706,0.9918155220429208,1.0,1/5,18.27%,ZMIZ1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.43392613222338416,0.6819645065886496,0.9076923076923077,0.9914049683276411,1.0,4/7,27.49%,TPR;DYNC1H1;CHMP4B;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.3991113861762917,0.6814447501133106,0.8947368421052632,0.9914169780935762,1.0,4/13,19.55%,MBP;KLF4;PODXL;NOTCH4
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.4137581066018116,0.6814382768805204,0.8235294117647058,0.990895728367975,1.0,6/9,28.90%,SLC8A1;DMD;GSN;ATP1B1;CAMK2D;RYR2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.42895653374066234,0.681239401059831,0.8840579710144928,0.9905565865286177,1.0,2/5,23.08%,DOCK4;ADAMTS1
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.35453363116622777,0.68120026904608,0.9178082191780822,0.990083165823179,1.0,6/24,16.57%,SYTL4;TMED10;MYH10;FRMD4A;GOLPH3;CADPS2
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.33695000471092873,0.6807144536526785,0.948051948051948,0.9900724417212684,1.0,11/46,16.95%,CHPT1;CD9;JAK1;KLF4;FKBP5;FOS;SLC26A2;FOXC1;ADD3;NCOR2;AMFR
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.4225722883797153,-0.6802364220968056,0.7435897435897436,1.0,1.0,2/6,12.06%,TNFRSF1B;PARD3
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.38391347259404385,0.6795968234251688,0.8676470588235294,0.9906055517601856,1.0,2/17,7.38%,ZBTB1;KDM1A
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.37575495396029146,-0.6786403287957214,0.8064516129032258,1.0,1.0,1/6,6.11%,PARN
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.42317186907491616,-0.6786086543728667,0.8,1.0,1.0,2/5,11.61%,PARP12;PARP11
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.33688617216742245,0.6785633073489448,0.9066666666666666,0.9910621243001205,1.0,2/29,7.36%,PSMC6;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.30215052352911853,0.6781985082782611,0.9634146341463414,0.9908581368412467,1.0,18/69,25.02%,TRIM5;CRTC3;ESR2;KDM1A;RPS27A;TAB2;MTDH;ATF2;MALT1;ARHGEF2;FZD4;STAT3;NPM1;ANXA3;UBC;PRKCH;PPARG;TERF2IP
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.3216370793252146,-0.6776693224795812,1.0,1.0,1.0,8/17,21.54%,RAD51B;SAMHD1;INO80;MCM9;WRN;NSMCE2;NUCKS1;PSMD14
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.42670798574160934,-0.675998921864243,0.8787878787878788,1.0,1.0,1/5,4.41%,PLK2
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.41064625377206176,0.6757688006786005,0.9242424242424242,0.9925693479539914,1.0,1/14,6.29%,NDRG1
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.333100018889558,-0.6749464013783306,0.8846153846153846,1.0,1.0,5/22,8.34%,BMP6;ACVR1;HIVEP1;SMAD1;TGFBR3
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.333100018889558,-0.6749464013783306,0.8846153846153846,1.0,1.0,5/22,8.34%,BMP6;ACVR1;HIVEP1;SMAD1;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.43036147179182804,-0.6748606950540389,0.8918918918918919,1.0,1.0,2/5,15.14%,TNFRSF1B;SH3D19
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.4500549417332826,0.6745631505328838,0.8648648648648649,0.9931233754983003,1.0,1/5,2.90%,SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3896204442647665,0.6739565985314862,0.8701298701298701,0.9931402554581611,1.0,5/15,29.40%,WWTR1;FOXC1;SDCBP;MTOR;RGCC
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.43951240003950737,0.6725195958425118,0.8983050847457628,0.9938507934960847,1.0,1/7,1.49%,TSG101
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.3798339934023362,0.6724943167229754,0.8904109589041096,0.9933487472560267,1.0,5/12,26.85%,CCNH;TAF1D;CSTF3;SETX;PAPOLA
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.44742641619389617,0.6698243282740316,0.8888888888888888,0.995374458281108,1.0,2/5,27.78%,LIMK2;TCHP
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.3917048760596767,0.6695968431677753,0.9104477611940298,0.9950001823945599,1.0,3/11,17.00%,CALR;DUSP16;TPR
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.40730374423674603,-0.6687684478609255,0.8888888888888888,1.0,1.0,1/6,3.82%,LIMS2
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.30379235745270194,-0.6685458110027227,0.9259259259259259,1.0,1.0,4/21,11.31%,ANKRD6;TPD52L1;HIPK2;MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.3083963696615441,0.6682119454949709,0.974025974025974,0.99560937666878,1.0,7/49,15.70%,TRIM5;UFL1;HSP90AA1;HIF1A;TMEM59;PTTG1IP;MTDH
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.4032467852990182,-0.6678152573538959,0.8648648648648649,1.0,1.0,1/7,4.41%,PLK2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.44392701556138436,0.6676030571519334,0.8688524590163934,0.9950767567513381,1.0,1/5,4.36%,INPP5F
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.44392701556138436,0.6676030571519334,0.8688524590163934,0.9950767567513381,1.0,1/5,4.36%,INPP5F
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.3850975578377733,-0.6674859480815353,0.8444444444444444,1.0,1.0,2/5,20.88%,WWC3;MAPK14
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.38242544205747725,0.6667523827280464,0.9,0.9951854755365319,1.0,3/11,18.57%,VSIR;TRIB2;STAT3
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.40569740694746864,0.6661748480780549,0.875,0.9946947420219886,1.0,4/9,34.66%,ITGB1;FAM171A1;CUL3;PHACTR1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.40569740694746864,0.6661748480780549,0.875,0.9946947420219886,1.0,4/9,34.66%,ITGB1;FAM171A1;CUL3;PHACTR1
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.4215127323897232,-0.6656191127920356,0.7894736842105263,1.0,1.0,2/5,16.07%,LARP1;CLEC16A
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.32780570657889263,0.6656053784110916,0.9615384615384616,0.9946933111689735,1.0,10/49,23.67%,PSMC6;RPS27A;DCP2;PSMA7;CARHSP1;HSPA8;ZFP36;YWHAB;UBC;XPO1
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.2885153498976441,0.6647418834186654,0.9875,0.9949758791133411,1.0,11/109,11.13%,CANX;ARF1;LRP1B;RAB21;TMED10;ANK3;LAMP2;HSP90B1;TBC1D15;TBC1D9;PREPL
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.36618699262412874,0.6631545577628513,0.8840579710144928,0.9956984100078942,1.0,3/16,16.60%,HSP90AA1;KLF4;TNKS
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.35726933290264706,0.6631040420556003,0.9466666666666667,0.9952448523401696,1.0,6/19,18.57%,IPO7;BACH2;PTTG1IP;TPR;PPP1R10;STAT3
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.4031336474142468,0.6626124682242707,0.8904109589041096,0.9951910573149318,1.0,3/8,23.85%,PPFIA2;MEF2C;TANC2
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.38815365916014677,0.6613114389847595,0.8923076923076924,0.9955016995764685,1.0,2/13,10.23%,RPS27A;RFC3
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.4108524159591355,0.6607285665369458,0.8939393939393939,0.9954189229722401,1.0,5/9,36.87%,CSNK1D;HDGFL3;ZNF207;NDEL1;RANBP9
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.3356625871342112,0.6602508144343338,0.8933333333333333,0.9953362321913442,1.0,6/29,17.61%,CALR;GAPDH;GIGYF2;RPL13A;PLAT;BTG2
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.3792648037071792,-0.6600637362537424,0.8529411764705882,1.0,1.0,4/13,12.72%,FAM120B;CTBP2;FOXO1;OSBPL8
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.3146126515684761,-0.6595897150979352,0.84,1.0,1.0,4/25,12.01%,IFIH1;NUP214;SENP6;SENP7
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.43319185412391303,0.6595497012661705,0.828125,0.9953575742597495,1.0,5/7,20.82%,SLC2A1;NEDD4L;CTTNBP2NL;NEDD4;ACTB
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.4315605735541195,0.6582523226418516,0.9076923076923077,0.9959560793825454,1.0,1/7,3.75%,CD81
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.39976062761580267,-0.658239911122475,0.8055555555555556,1.0,1.0,2/8,9.88%,HOMER1;GNA14
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.4520376845484778,0.657042869756258,0.9444444444444444,0.996502045158012,1.0,2/5,8.42%,SLC4A10;SLC4A7
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.43242087721237255,0.6569550336817213,0.8615384615384616,0.9960499488592433,1.0,2/7,18.65%,SAMD8;ST6GALNAC3
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.3788972789840003,-0.6554117376674402,0.8809523809523809,1.0,1.0,2/5,17.13%,TNFRSF1B;PPARD
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.3962954070024683,0.6537433892490034,0.8529411764705882,0.9980475518866377,1.0,1/11,3.90%,ANXA1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.38092790855241876,-0.6537160278552654,0.9722222222222222,1.0,1.0,1/9,5.58%,THOC1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.3532406102328391,0.6530149230750822,0.9078947368421053,0.9981019971294578,1.0,3/17,14.74%,PIK3R1;ARPC2;RAC1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.40603403692988016,0.6526617393582833,0.90625,0.9979145944393258,1.0,2/7,22.79%,MICU2;SPG7
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.42860543255330635,0.652570424153729,0.8923076923076924,0.9974511945499895,1.0,4/5,55.06%,LRP6;CSNK1A1;CTNNB1;GSK3B
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.27639668537824114,-0.6524787160036137,1.0,1.0,1.0,24/24,72.56%,RBMX;POLR2A;WRN;TOPBP1;RBFOX2;HNRNPC;ATXN2;PCBP2;GTF2F2;HNRNPR;DDX24;WTAP;HNRNPM;HNRNPD;HNRNPA2B1;MMS19;HNRNPA3;POLR2B;PTBP1;HNRNPK;HNRNPF;HNRNPH1;XRN2;HNRNPU
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.4357489509340913,0.6524039448736255,0.9242424242424242,0.9965718130089184,1.0,3/7,16.18%,TPM4;MYL6;DMD
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.4357489509340913,0.6524039448736255,0.9242424242424242,0.9965718130089184,1.0,3/7,16.18%,TPM4;MYL6;DMD
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.37350296711443515,-0.651138983796626,0.8823529411764706,1.0,1.0,2/7,8.55%,RAD51B;MSH3
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.39482924393682034,0.6502023267209139,0.9014084507042254,0.9977758936110138,1.0,3/11,16.60%,KDM1A;JUN;TNKS
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.4168007238020716,0.6501085156499976,0.8727272727272727,0.997319262266658,1.0,2/6,20.48%,DYNC1H1;PAFAH1B1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.3661392311991029,-0.6498705821818633,0.8518518518518519,1.0,1.0,3/13,12.08%,EYS;ZIC2;PITPNA
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.3576999018361115,0.6497147439802584,0.8974358974358975,0.997104145840118,1.0,3/15,14.74%,PIK3R1;ARPC2;RAC1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.4129619328422077,0.649496419851675,0.8852459016393442,0.9967286371135505,1.0,2/8,19.28%,RASA1;ESAM
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.40361206307610975,0.6494543107084116,0.9411764705882353,0.9962388496364791,1.0,2/8,13.12%,CBFB;CLDN5
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.3296592848702954,-0.6488642435616035,1.0,1.0,1.0,1/11,2.76%,OCLN
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.37149189753592887,0.647964511620359,0.8904109589041096,0.9968497845737578,1.0,6/18,28.18%,ECT2;SYT1;RYR3;MEF2C;ADD1;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.43443329366551664,0.6478459228471665,0.8793103448275862,0.9964062571125483,1.0,3/6,24.38%,REST;NFIB;PPARG
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.391144924245146,0.646691020937669,0.8974358974358975,0.9967474307698229,1.0,3/12,14.21%,LBR;INSIG1;LSS
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.415568985978648,-0.6465803020142727,0.825,1.0,1.0,3/5,18.86%,NMT1;NMT2;METAP2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.4060907307335868,0.6449574915871138,0.9375,0.9975116437566085,1.0,2/9,17.13%,CD55;MALT1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.367475100191679,-0.6443314057646613,0.8292682926829268,1.0,1.0,3/6,18.27%,TNFRSF1B;HSPD1;CD47
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.38665091171965293,0.6443088915570108,0.8985507246376812,0.9975202245106433,1.0,2/12,10.07%,RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3394926208570868,0.6441688367381438,0.9315068493150684,0.997117272325259,1.0,6/22,22.10%,HYAL2;FGFR1;PAK2;LGALS3;TNFRSF10B;BCL2L14
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.3739026058778637,0.6439188803341943,0.9354838709677419,0.9967832854138011,1.0,3/8,32.24%,OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.3289215907632371,-0.6437754451034962,0.9565217391304348,1.0,1.0,2/23,5.58%,TENT2;THOC1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.29793407461768356,0.6437022046675525,0.9746835443037974,0.9964553504589237,1.0,13/68,17.61%,ZBTB1;PURA;POLA1;RPS27A;NOC3L;RAD21;RFC3;USP45;CNBP;UHRF2;UBE2B;RIF1;BTG2
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2867767965053783,-0.6422807257360448,0.9523809523809523,1.0,1.0,6/29,13.55%,CD74;STAT1;CFLAR;PTPN2;SPPL2A;GAS6
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.34078623930289803,0.6422128251430761,0.9358974358974359,0.9971093266573662,1.0,5/26,17.13%,CALR;WASHC4;SRSF7;TPR;MALT1
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.32847748083486983,0.6417136664421921,0.8888888888888888,0.9969811974437496,1.0,4/26,14.40%,PRNP;CDKN1B;CDKN1A;WWTR1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.3673505457124173,-0.6416619684144863,0.8947368421052632,1.0,1.0,1/8,2.18%,ISG15
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.3541301687923484,-0.6406423041105385,0.9166666666666666,1.0,1.0,2/7,17.42%,TMCC1;SPAST
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.32449126023236163,-0.640222250733181,1.0,1.0,1.0,2/14,6.77%,TBL1X;TBL1XR1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.3501574545761209,-0.6399723710199592,0.8387096774193549,1.0,1.0,2/12,4.62%,ATR;SLF2
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.4203110846046043,0.6392564506933204,0.9245283018867925,0.998221438132754,1.0,3/6,13.47%,SLC4A10;SLC4A7;NEDD4L
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.3256857987223721,0.6383660430011456,0.974025974025974,0.9983037003442666,1.0,12/34,28.90%,KCNMB4;ECT2;SYT1;RYR3;NEDD4;AHCYL1;MEF2C;ADAM9;ADD1;CAMK2D;CALM1;RYR2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.39928446643541177,-0.6370179066251289,0.8571428571428571,1.0,1.0,2/5,18.83%,HSPA1A;CASP4
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3882755633858669,-0.6369382481243967,0.9285714285714286,1.0,1.0,1/7,3.69%,TNRC6C
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.3882755633858669,-0.6369382481243967,0.9285714285714286,1.0,1.0,1/7,3.69%,TNRC6C
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.2834972232584268,-0.6367861176615482,0.9655172413793104,1.0,1.0,1/18,3.69%,TNRC6C
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.4125247699898186,-0.6364532728397141,0.7142857142857143,1.0,1.0,1/5,5.63%,ST3GAL6
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.4027787089692445,0.6354378270546833,0.9295774647887324,1.0,1.0,1/5,12.62%,CNOT6L
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.32813033129194935,0.6352237989712141,0.9625,0.9997885770474527,1.0,6/34,12.78%,SLC8A1;CACNA1C;ATP1A1;ATP1B3;ANO6;TMEM165
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.34946636902884415,0.6348946003359563,0.8831168831168831,0.999539930754624,1.0,1/15,2.52%,TRIM5
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.39476375794386886,0.6348142265522876,0.9242424242424242,0.9990981988231471,1.0,1/8,5.87%,POLA1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.36144878317807105,0.6346867707240426,0.9565217391304348,0.9986967022725036,1.0,3/17,15.25%,KDM1A;JUN;FOXC1
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3612460712561013,-0.6327339861785622,0.918918918918919,1.0,1.0,1/10,3.24%,USP25
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.4401374246240324,0.6313163731186621,0.8985507246376812,0.9999957080430023,1.0,2/5,21.14%,BCL2L1;MCL1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.4401374246240324,0.6313163731186621,0.8985507246376812,0.9999957080430023,1.0,2/5,21.14%,BCL2L1;MCL1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.3427361331282299,-0.6300482445205176,0.9032258064516129,1.0,1.0,2/11,5.55%,IFI27;SP100
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.3525117056184437,0.6298090078207103,0.9242424242424242,1.0,1.0,2/15,8.31%,NDRG1;GRB2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.41794675155179545,0.6294364466017396,0.9420289855072463,1.0,1.0,2/5,28.15%,NDFIP1;DNAJA1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.4027302747656097,0.6292352515004667,0.9285714285714286,0.9994637101805548,1.0,4/7,39.97%,UBR1;MTOR;SESN3;LARS1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.4027302747656097,0.6292352515004667,0.9285714285714286,0.9994637101805548,1.0,4/7,39.97%,UBR1;MTOR;SESN3;LARS1
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.36063836349928996,0.6271794349175783,0.92,1.0,1.0,4/16,21.59%,AGO2;ZC3H7A;NOTCH4;ZFP36
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.3986888926671323,-0.6266415456317066,0.8636363636363636,1.0,1.0,1/5,5.98%,ZNHIT6
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.4049148897133461,0.6261439525284359,0.8636363636363636,1.0,1.0,2/5,32.06%,ATP11A;HDAC9
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.3577449339495229,0.6258107837443175,0.9041095890410958,1.0,1.0,3/15,23.85%,PPFIA2;CFL1;TANC2
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.4001535292106262,0.6252804666278482,0.9682539682539683,0.999687675096814,1.0,2/6,23.16%,PPP3CB;PPP3CC
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.4001535292106262,0.6252804666278482,0.9682539682539683,0.999687675096814,1.0,2/6,23.16%,PPP3CB;PPP3CC
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.30291088628975305,-0.624676102957388,0.9615384615384616,1.0,1.0,2/15,9.24%,USP25;PSMF1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.3204920079543235,0.6246138879451897,0.9518072289156626,0.9997345914557725,1.0,5/33,14.24%,HSP90AA1;KLF4;OGT;LARP4;PTTG1IP
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.3331366361142988,0.6244930358153462,0.9473684210526315,0.9993015398848635,1.0,4/25,14.18%,ANXA1;GRB2;CDKN1A;ECT2
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.24397212741446064,-0.6242537945953726,1.0,1.0,1.0,23/104,17.24%,SCFD2;CD74;RANBP17;VPS45;NUP214;WLS;TBC1D5;HERC2;TECPR2;STX17;TNPO3;EVI5;VPS36;USP6NL;STX3;SNX13;XPO4;STX8;TBC1D4;SYNRG;GGA2;SEC31A;IPO8
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.279266285121284,-0.6242159270845445,0.9666666666666667,1.0,1.0,3/26,8.50%,ISG15;RHBDD1;MDM2
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.43193000924090313,0.6240223032462183,0.9047619047619048,0.9991228737048995,1.0,1/5,7.04%,PINK1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.41093630656837904,0.6239058911439246,0.9230769230769231,0.9987074912418639,1.0,4/7,36.02%,SND1;MTREX;XRN2;ENTPD4
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.37640348561497705,0.623350790080273,0.9166666666666666,0.9985744067231928,1.0,3/10,26.72%,KIF16B;SORT1;RAB14
prerank,PanglaoDB_Augmented_2021__Microglia,0.3655980178184258,0.6232701585704412,0.8852459016393442,0.9981259133194987,1.0,2/14,11.90%,PECAM1;FOS
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.3533335936006786,0.6232189254899948,0.9154929577464789,0.9976778731683603,1.0,4/11,22.66%,HIF1A;ACVR2A;STAT3;ETS1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.3099957277613292,-0.6214770802709139,0.9259259259259259,1.0,1.0,4/15,20.48%,THOC1;WDR70;SMARCAD1;NUCKS1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.2840505443772098,-0.6196045855328843,1.0,1.0,1.0,8/21,18.19%,PODN;ZNF521;LDB2;LAMA2;IGFBP7;CNRIP1;CXCL12;FAT4
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.2823890796372723,0.6193111660852318,1.0,0.9998421475404281,1.0,21/71,24.78%,RAPGEF3;PICALM;RAP1A;TBC1D15;RGS7;ITGB1;ECT2;CRK;PLXNA2;LIMS1;TGM2;RSU1;RASIP1;AFDN;ARFGEF1;CAV2;LRCH1;RAB3GAP2;WNK1;RACK1;FGD4
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.3339399819400575,0.6192298165749736,0.958904109589041,0.9993655625225422,1.0,1/22,5.37%,EPS8
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.2837655057445535,0.6185916097472564,0.9871794871794872,0.9992887150399604,1.0,9/47,19.55%,ESR2;CCNH;TAF1D;WWTR1;NCOR2;NR2C1;HDAC7;NR1D2;NOTCH4
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.3745141717033912,0.6185690416592932,0.9701492537313433,0.9987960282904916,1.0,4/9,23.67%,BACH2;MALT1;NPM1;XPO1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.3140157418511418,0.6171943428773655,0.8974358974358975,0.9992251351008261,1.0,4/24,14.18%,KDM1A;GRB2;CDKN1A;ECT2
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.32527280707732886,-0.616606825679744,0.9310344827586207,1.0,1.0,2/15,16.33%,OFD1;CLASP1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.3431327904748336,0.6165383360548962,0.9420289855072463,0.9991204003350007,1.0,3/17,22.42%,RPS27A;GSN;UBC
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.38351063829787235,-0.6153569678418781,0.8292682926829268,1.0,1.0,5/5,61.73%,UBN1;CABIN1;ATRX;NASP;RBBP4
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.33262373602980305,-0.6153546623742501,0.7804878048780488,1.0,1.0,7/7,66.83%,ROCK1;IKBKB;FMNL3;ROCK2;FMNL2;NCKAP1;DLG1
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.3842905344947676,0.6152913922621026,0.921875,0.99941422352208,1.0,2/7,15.67%,AGO2;TUT7
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.34445891671045636,0.6142554304536074,0.9583333333333334,0.9996180040452839,1.0,1/18,6.14%,PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.3182192945376224,0.6142024115353836,0.9166666666666666,0.9991488162527712,1.0,6/28,27.94%,CLDN5;HIP1R;AMFR;ADD1;MARK3;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.27409311718756024,0.6140880795413337,1.0,0.9987249285803982,1.0,14/82,19.55%,KLF2;PIK3R1;JAG2;VWF;HIF1A;NRXN1;GRB10;MGAT5;LIMS1;ZMIZ1;STAT3;RIMS2;SULF2;NOTCH4
prerank,PanglaoDB_Augmented_2021__Basophils,0.3350240183179069,0.6114747056529652,0.9090909090909091,0.9997184506904488,1.0,4/18,24.30%,LAMA5;GATA2;TEC;FGR
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.38052916343058074,0.6114555164647232,0.9384615384615385,0.9992331256706468,1.0,2/6,24.73%,DAG1;RACK1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.3414360946938009,-0.6098545921586289,0.8648648648648649,1.0,1.0,1/6,9.08%,SLC16A2
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.3349341138801888,0.6057875926843768,0.9857142857142858,1.0,1.0,3/16,12.40%,ATP8B1;PLSCR4;ANO6
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.34027644886216224,-0.6048598954433093,0.8666666666666667,1.0,1.0,1/10,6.61%,NUP214
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.34027644886216224,-0.6048598954433093,0.8666666666666667,1.0,1.0,1/10,6.61%,NUP214
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.34027644886216224,-0.6048598954433093,0.8666666666666667,1.0,1.0,1/10,6.61%,NUP214
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.3403819629041472,0.6033864415405265,0.948051948051948,1.0,1.0,9/19,30.94%,CDK6;ATOH8;NFIB;CAV2;SPARC;MTSS1;RGCC;DAB2IP;CASK
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.3535698180920167,-0.6033854070838118,0.9230769230769231,1.0,1.0,2/6,12.06%,ADGRG6;PARD3
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.3568391113283369,0.6030570672959424,0.9285714285714286,1.0,1.0,6/12,24.38%,FLT1;ATOH8;CAV2;SPARC;MEF2C;PPARG
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.3531293268146701,0.602895318380845,0.9701492537313433,1.0,1.0,1/14,4.91%,GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.3719385058244826,0.6023042673584453,0.9402985074626866,1.0,1.0,2/9,9.85%,JUN;GJA1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.33532392360892693,0.6022559858925013,0.948051948051948,1.0,1.0,2/18,9.35%,PIK3R1;SLC38A2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.2942066581998712,-0.6006704632963717,1.0,1.0,1.0,3/12,11.42%,THOC1;MSH3;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.40656784383678357,0.5998241896407589,0.9230769230769231,1.0,1.0,4/5,35.62%,MTOR;WDR43;EIF2AK3;SMARCA4
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.3445685824227279,-0.5995327799942253,0.9565217391304348,1.0,1.0,1/11,6.80%,MGA
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.3445685824227279,-0.5995327799942253,0.9565217391304348,1.0,1.0,1/11,6.80%,MGA
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.3496544733735783,0.5977990256887146,0.9516129032258065,1.0,1.0,4/15,20.58%,STXBP5L;NDFIP1;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.3694573491360442,-0.5975888910573127,0.8717948717948718,1.0,1.0,1/5,9.43%,PIK3C2B
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.282829835207152,-0.5966757840864503,1.0,1.0,1.0,4/17,14.71%,RC3H1;NBDY;HSPA1A;PNPT1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.36264345814969134,-0.5964070205758336,0.975,1.0,1.0,1/5,5.07%,PLXND1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.33813178442707204,0.5961757868605938,0.9565217391304348,1.0,1.0,5/11,33.33%,NAA16;NAA50;CREBBP;KAT6A;EP300
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.3124000884868578,0.5960623130351146,0.8904109589041096,1.0,1.0,3/18,21.59%,GIGYF2;TUT7;ZFP36
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.3537976002892402,0.5957937837567462,0.9354838709677419,1.0,1.0,4/9,30.81%,KIF16B;EMP2;PIK3C3;RAB7A
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.3734909514097349,0.5954162023138154,0.9571428571428572,1.0,1.0,1/7,9.27%,EMP1
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.3089056091627073,-0.5948726151089536,0.8823529411764706,1.0,1.0,3/10,12.83%,MRPS31;EEFSEC;PTCD3
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.3702127659574468,-0.5948397666855828,0.9024390243902439,1.0,1.0,5/5,63.05%,ROCK1;IKBKB;PPP1R12A;ROCK2;NUAK1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.33334692310269654,0.5946752742905395,0.9850746268656716,1.0,1.0,4/13,19.50%,FGFR1;FOXF1;FUT8;SULF2
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.3703278761879405,0.5913356686929327,0.9298245614035088,1.0,1.0,1/6,11.29%,MAGI2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.37360920434270956,-0.5905894258506613,0.9032258064516129,1.0,1.0,3/6,18.27%,HSPD1;NFAT5;CD47
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.38111702127659575,-0.5892823759843144,0.8888888888888888,1.0,1.0,5/5,61.97%,FCHSD2;WASF2;CYFIP1;ABI2;NCKAP1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.32032828950728154,-0.5892678729033959,0.9090909090909091,1.0,1.0,2/8,9.00%,ST3GAL6;UGCG
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.3038635252546479,0.587296971656493,1.0,1.0,1.0,11/23,33.84%,RAD21;TENT4A;NAA50;MCPH1;CHMP4B;CSNK2A1;ZNF207;KPNB1;CUL3;EML4;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.36068617565966826,0.5872614988549985,0.9491525423728814,1.0,1.0,2/7,17.85%,CD55;LGALS3
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3750805527313549,0.5871026518744074,0.9032258064516129,1.0,1.0,1/6,15.17%,SRSF7
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.3750805527313549,0.5871026518744074,0.9032258064516129,1.0,1.0,1/6,15.17%,SRSF7
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.3205639797818569,-0.5869565203484076,0.9,1.0,1.0,6/6,68.02%,ACBD6;OGDH;SUCLG2;ACACB;ACOT9;ACACA
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.28720861155100696,0.5867848311228361,0.9855072463768116,1.0,1.0,8/36,22.39%,MAP3K5;PINK1;PHLPP1;SDCBP;DUSP22;TAOK1;MAPK8IP3;PLCB1
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.32366222850180365,-0.586566311821144,0.9666666666666667,1.0,1.0,2/10,11.00%,ARHGAP12;GULP1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.32408170954092186,0.5860588821879237,0.9538461538461539,1.0,1.0,5/11,34.16%,ARFGEF1;CDH5;RACK1;CYRIB;RAP1B
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.36194891019578346,0.5857894184707939,0.8852459016393442,1.0,1.0,2/7,29.85%,UBE2B;PEX5L
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.31419754753744067,-0.5841364823489614,0.9629629629629629,1.0,1.0,2/15,14.82%,BICD1;CIRBP
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.3873175909148403,0.5837586008017741,0.9074074074074074,1.0,1.0,2/6,13.68%,NEDD4L;ITGB1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.3491040462076712,0.583357815360149,1.0,1.0,1.0,2/10,21.09%,TF;DNM2
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.2280868167243092,-0.5829983932150404,1.0,1.0,1.0,11/46,20.21%,SNX2;TBC1D5;ANKFY1;EEA1;EVI5;KLHL20;STX8;VPS50;TMEM87A;GBF1;VPS13A
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.31816741557079264,0.5823005816584702,0.9014084507042254,1.0,1.0,3/16,24.38%,KLF4;CDH5;PPARG
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.3774219219778067,0.5817013492423584,0.9649122807017544,1.0,1.0,2/6,37.16%,ZDHHC21;VCL
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.3636539497816167,0.5815952395426016,0.8955223880597015,1.0,1.0,3/8,20.56%,DLC1;ABL2;RASIP1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.3916459047780043,0.5813320992773303,0.9193548387096774,1.0,1.0,1/5,19.92%,MORF4L1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.3027887396695349,0.5797223704150195,1.0,1.0,1.0,7/30,28.95%,YTHDC1;SRSF7;TPR;ZFP36;THOC2;SRSF11;SMG1
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.38771660181203815,0.5764295503104617,0.9285714285714286,1.0,1.0,2/5,18.49%,HIF1A;TF
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.32172956975439604,-0.5753469759278476,0.9473684210526315,1.0,1.0,1/9,5.95%,TMEM106B
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.26720006823568937,0.574821289732229,0.9873417721518988,1.0,1.0,8/42,19.55%,ESR2;CCNH;WWTR1;NCOR2;NR2C1;HDAC7;NR1D2;NOTCH4
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.3877089481875001,0.5744949120555504,0.9661016949152542,1.0,1.0,1/6,7.38%,KDM1A
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.2805911508780843,-0.574139185024025,1.0,1.0,1.0,4/22,16.33%,OFD1;STARD9;INO80;CLASP1
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.31152902483493494,0.5738787577209612,1.0,1.0,1.0,5/22,24.38%,AGO2;TPR;STAT3;ZFP36;PPARG
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.3075831020638764,0.5734435753953244,1.0,1.0,1.0,2/19,9.99%,SMC6;RAD21
prerank,MSigDB_Hallmark_2020__Apical Surface,0.3234913699481198,0.5725516274115545,0.9682539682539683,1.0,1.0,3/13,21.70%,ATP8B1;SULF2;B4GALT1
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.32073911987817505,0.5705163098615906,0.9295774647887324,1.0,1.0,2/15,11.95%,OTUD7B;PPM1A
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.34358651243227517,0.5703911379876916,0.9861111111111112,1.0,1.0,4/10,21.59%,AGO2;TENT4A;BTG2;ZFP36
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.37606973161405965,0.566921175255737,0.9833333333333333,1.0,1.0,2/7,29.32%,CDH5;CDH18
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.2836549077941916,0.5661481237928371,0.9710144927536232,1.0,1.0,7/36,24.73%,CTNND2;CBFB;GRB10;SULF2;CCNY;CSNK2A1;RACK1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.37730713258465065,0.5648215053700282,0.9393939393939394,1.0,1.0,2/5,24.81%,AP1G1;SORT1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.3760037790376608,0.5631719172951047,0.9310344827586207,1.0,1.0,2/6,25.44%,PPARG;MTOR
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.33549182151779205,0.5613672195334602,0.971830985915493,1.0,1.0,5/9,37.18%,LIMK2;DNM2;RAB11A;CCDC186;SYNJ1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.28356325272619176,0.5612265960960323,0.974025974025974,1.0,1.0,2/32,7.36%,HSPH1;HSP90AA1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.32475334822825785,0.5610280501671915,0.953125,1.0,1.0,1/13,8.26%,RPL23
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.32300800318819667,0.5579273735968385,0.9264705882352942,1.0,1.0,3/11,20.66%,SMAD7;PODXL;AFDN
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.2642498115686377,0.5576140822079282,1.0,1.0,1.0,11/45,25.02%,TRIM5;RPS27A;TAB2;MTDH;MALT1;ARHGEF2;STAT3;NPM1;UBC;PRKCH;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3671222799344809,0.5563983931431313,1.0,1.0,1.0,4/5,33.84%,BRD4;NPM1;MECP2;RAB11A
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.2510118680014451,0.5550880315283052,1.0,1.0,1.0,10/77,18.33%,YTHDC1;U2SURP;SPEN;RBM17;STRAP;RALY;SRSF7;HNRNPH3;TRA2B;CSTF3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.3692188466531284,-0.5545485048356641,0.96875,1.0,1.0,1/5,9.06%,STXBP4
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.3906225299138979,0.5532140852208309,0.953125,1.0,1.0,2/5,17.98%,ERBIN;ARHGEF2
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.31327899593844144,0.5531401545090856,0.9558823529411765,1.0,1.0,4/12,26.35%,GOLPH3;MSN;CDC42;SIPA1L3
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.3481413451159474,0.5493238712822673,0.95,1.0,1.0,3/6,21.70%,FUT8;ST6GALNAC3;B4GALT1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.345207836537866,-0.5480497658282296,0.8857142857142857,1.0,1.0,1/5,9.67%,PIGU
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.36113955552523946,0.545723332204218,0.9142857142857143,1.0,1.0,3/6,29.24%,SETD3;WDR82;KMT2A
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.3008050543786572,-0.5455496716027354,0.9428571428571428,1.0,1.0,2/11,19.89%,PDGFB;NSMCE2
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.27260694886816966,0.5437402145942895,0.9859154929577465,1.0,1.0,8/28,24.78%,SCARB2;TBC1D15;CRK;PLXNA2;PAFAH1B1;RASIP1;RAB3GAP2;FGD4
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.3027439012884806,-0.5433776627738279,1.0,1.0,1.0,1/7,9.06%,STXBP4
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.3250864591646715,-0.5424948681629658,0.9142857142857143,1.0,1.0,6/6,67.57%,NSMCE2;CDC16;ANAPC5;CDC27;RB1;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.3250864591646715,-0.5424948681629658,0.9142857142857143,1.0,1.0,6/6,67.57%,NSMCE2;CDC16;ANAPC5;CDC27;RB1;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.3250864591646715,-0.5424948681629658,0.9142857142857143,1.0,1.0,6/6,67.57%,NSMCE2;CDC16;ANAPC5;CDC27;RB1;CUL3
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.3540353682267527,-0.5408674295183877,0.8918918918918919,1.0,1.0,1/5,8.58%,ST3GAL1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.32500034589588367,-0.5398990441528786,0.9210526315789473,1.0,1.0,1/6,13.57%,MTMR3
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.330316742081448,-0.5397873657734987,0.9666666666666667,1.0,1.0,8/8,67.07%,CCM2;RBPJ;STARD13;PRKD2;CTNNB1;RHOA;RHOB;ACVRL1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.3665912948842901,0.5397461251517356,0.9814814814814815,1.0,1.0,1/6,7.38%,KDM1A
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.32481158192241233,-0.537854106595161,0.9393939393939394,1.0,1.0,1/5,11.69%,MFF
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.33044558841862426,0.5359049836997377,1.0,1.0,1.0,1/11,5.26%,WDR48
prerank,GO_Biological_Process_2021__morphogenesis of an endothelium (GO:0003159),-0.3300531914893617,-0.5341727762927998,1.0,1.0,1.0,5/5,67.07%,CCM2;PRKD2;CTNNB1;RHOB;ACVRL1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.3551367112791354,0.5340038301310477,0.95,1.0,1.0,1/5,17.10%,DAG1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.3551367112791354,0.5340038301310477,0.95,1.0,1.0,1/5,17.10%,DAG1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.2562311887220189,0.5337771101720541,0.9705882352941176,1.0,1.0,13/29,38.62%,TNKS;OXSR1;CSNK2A1;WNK1;HIPK3;MAP2K1;CAMK2D;MAPK8;PRKDC;NLK;TBK1;MAPK1;TGFBR2
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.3614632979889184,0.5324821314753962,0.9402985074626866,1.0,1.0,3/5,25.23%,LPIN2;LPGAT1;SEL1L
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.2864462460611747,-0.5321518774149901,0.9428571428571428,1.0,1.0,3/10,20.88%,HSPD1;CD47;MAPK14
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.3397424524381198,0.5309658142069256,0.9838709677419355,1.0,1.0,1/9,7.04%,PINK1
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.32342597677135776,0.5306850629402864,0.9841269841269841,1.0,1.0,1/8,12.01%,FOXF1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.24075257495736643,0.5300985561569657,1.0,1.0,1.0,23/71,33.86%,YTHDC1;U2SURP;SPEN;RBM17;RALY;SRSF7;HNRNPH3;TRA2B;CSTF3;HSPA8;CWC22;SRSF11;PAPOLA;HNRNPU;MTREX;PRPF40A;CWF19L2;HNRNPH1;HNRNPF;HNRNPK;PRPF8;RNPC3;PTBP1
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.28565351583638104,-0.5296818808218563,0.9642857142857143,1.0,1.0,4/11,19.23%,PPP1R13B;NMT1;PMAIP1;YWHAG
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.28565351583638104,-0.5296818808218563,0.9642857142857143,1.0,1.0,4/11,19.23%,PPP1R13B;NMT1;PMAIP1;YWHAG
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.2898046049166431,0.5272107285764844,0.9552238805970149,1.0,1.0,4/17,20.45%,SIN3B;REST;MORF4L1;RCOR3
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.27596987616666346,-0.5270559822412697,1.0,1.0,1.0,2/21,5.58%,TENT2;THOC1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.31061153554434673,0.5266135081272798,0.9871794871794872,1.0,1.0,2/16,9.35%,PIK3R1;SLC38A2
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.3139043771000323,-0.5265486455530477,0.875,1.0,1.0,2/7,21.01%,CLASP1;PHLDB2
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.3554427606589946,0.5259042768171007,0.9821428571428571,1.0,1.0,1/6,12.88%,BCAR1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.29718192956035755,0.52585488572529,0.9710144927536232,1.0,1.0,2/21,10.20%,CCDC88A;TBC1D15
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.2949946751863685,-0.5253729654828662,0.9375,1.0,1.0,9/9,70.60%,POLR2A;BAZ2A;FUBP3;EPC1;PTMA;MMS19;MEF2A;POLR2B;THRB
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.343508326068072,0.5243040140454204,0.9696969696969697,1.0,1.0,2/5,21.12%,FOXC1;VEGFC
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.2840858943390029,0.5237524656498872,0.9861111111111112,1.0,1.0,6/26,22.34%,HIF1A;ATOH8;EGFL7;VEGFC;CAV2;SPARC
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.31360265956346306,0.5217116743823479,0.9714285714285714,1.0,1.0,3/12,19.55%,JAG2;NCOR2;NOTCH4
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.3289628366616769,0.5213699792012219,1.0,1.0,1.0,3/6,40.42%,KPNA1;KPNB1;DICER1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.3296659863704655,0.5189025595834846,0.9682539682539683,1.0,1.0,4/7,44.54%,ACACA;FAR1;HSD17B4;CBR4
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.2777417556225168,0.5185939337707093,0.9868421052631579,1.0,1.0,6/28,28.95%,YTHDC1;SRSF7;TPR;THOC2;SRSF11;SMG1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2777417556225168,0.5185939337707093,0.9868421052631579,1.0,1.0,6/28,28.95%,YTHDC1;SRSF7;TPR;THOC2;SRSF11;SMG1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.27690074367532364,0.5177729876243043,0.9868421052631579,1.0,1.0,6/29,28.95%,YTHDC1;SRSF7;TPR;THOC2;SRSF11;SMG1
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.3024439119065785,-0.5168916450806885,0.9230769230769231,1.0,1.0,2/5,18.03%,SPG11;RAB27A
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.2905043198336851,0.5167208040539981,0.9859154929577465,1.0,1.0,1/12,7.04%,PINK1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.3217811903492185,0.515551789109513,0.9375,1.0,1.0,3/7,36.87%,CSNK1D;NDEL1;RANBP9
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.2736388679484183,0.5128398348609347,0.9852941176470589,1.0,1.0,7/28,21.99%,PRNP;WWTR1;ENSA;DMD;ATP2B4;ARPP19;YWHAB
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.2634193452250962,0.5127289425779993,1.0,1.0,1.0,10/29,32.48%,PELI1;NEDD4L;UBE2B;AMFR;UBE2Q2;UBE2R2;UBE2H;UBR5;UBE3A;CUL3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.2819637424405899,-0.5105354064112679,0.9705882352941176,1.0,1.0,2/8,12.91%,HLA-F;HLA-A
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.31191148528354407,0.5093918023111752,0.9710144927536232,1.0,1.0,2/7,35.33%,TMEM65;DLL4
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.24411970706587857,0.5068170030387208,1.0,1.0,1.0,13/32,38.62%,TNKS;OXSR1;CSNK2A1;WNK1;HIPK3;MAP2K1;CAMK2D;MAPK8;PRKDC;NLK;TBK1;MAPK1;TGFBR2
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.22929394993535102,0.5063512046196318,1.0,1.0,1.0,26/85,33.86%,YTHDC1;U2SURP;SPEN;RBM17;CCNH;RALY;SRSF7;HNRNPH3;TRA2B;CSTF3;HSPA8;THOC2;CWC22;SRSF11;PAPOLA;HNRNPU;MTREX;PRPF40A;CWF19L2;HNRNPH1;HNRNPF;HNRNPK;PRPF8;RPRD1B;RNPC3;PTBP1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.3284928697275586,0.5060803049504309,1.0,1.0,1.0,1/6,12.01%,FOXF1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.28264148698285274,0.5059992349513373,0.9863013698630136,1.0,1.0,8/15,33.52%,PRKX;PODXL;RASIP1;MTSS1;MEF2C;RYR2;ACVRL1;RHOB
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.3295756372237534,0.5053544830347252,0.984375,1.0,1.0,3/5,34.77%,ADCY9;ZDHHC21;AKAP13
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.2944131550689568,-0.5044119906467776,0.8888888888888888,1.0,1.0,2/6,21.51%,MFF;OPA1
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.22551080587029587,-0.5043292642187848,1.0,1.0,1.0,2/29,7.36%,IVNS1ABP;WBP4
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.2657524891583351,-0.5015182555245289,0.9696969696969697,1.0,1.0,1/11,7.30%,PKD2
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.2945807233537521,-0.5009380519094726,0.972972972972973,1.0,1.0,1/5,12.27%,ARHGAP35
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.33014099494546423,-0.5000899946124655,0.9782608695652174,0.9992533817415237,1.0,6/6,67.07%,MBOAT2;PTPN11;TRPS1;ZBTB16;SOX5;ACVRL1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.2898041742558409,0.4970886485549117,0.9855072463768116,1.0,1.0,7/13,32.91%,HIP1R;YWHAB;YWHAE;PPP3CC;YWHAQ;YWHAZ;MAPK8
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.2728586115094479,-0.49685376493029265,0.9375,0.9987288633834983,1.0,5/11,28.47%,GIMAP4;RORA;GIMAP7;NFATC2;NR3C1
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.2603082247517972,0.49645185770045536,0.9838709677419355,1.0,1.0,3/15,17.58%,SULT1C4;ADSS2;TPST2
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.2965576504840809,0.495807345233669,0.9710144927536232,1.0,1.0,4/9,37.37%,UBE2B;UBE2H;PRKN;UBE2D3
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.3045137027620987,-0.494408411542068,0.9347826086956522,0.9979557542504809,1.0,1/7,5.79%,BMP2K
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.3057902661029184,0.4941789918783783,0.9846153846153847,1.0,1.0,3/7,31.82%,RELL1;SASH1;GADD45B
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.31353839371579206,0.4899202048738279,0.9393939393939394,1.0,1.0,3/6,26.93%,CHMP4B;SORT1;VCP
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.27719317263887683,0.4888800828828551,1.0,1.0,1.0,5/11,39.97%,GOLPH3;SLC38A9;SIK3;WDR59;LARS1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.29121202590932815,0.4888576223177907,0.9846153846153847,1.0,1.0,3/11,20.56%,DLC1;ABL2;RASIP1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.3119680172253084,0.4873636654045764,0.9726027397260274,1.0,1.0,4/7,34.45%,SLC1A2;SLC6A6;SLC7A5;SLC1A1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.25789295314868793,0.486577856073311,1.0,1.0,1.0,5/23,21.54%,PEBP1;MAP7;PIAS2;CHFR;PGS1
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.2631045467647211,-0.485126249855582,0.9615384615384616,0.9995648007304191,1.0,1/11,6.61%,NUP214
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.3038454478556859,0.48465870783331905,0.967741935483871,1.0,1.0,4/8,32.99%,TMEFF2;ADAM17;MRTFA;ACVRL1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.3115396075529654,0.4829976892089669,0.971830985915493,1.0,1.0,2/6,29.40%,FSCN1;RGCC
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.2719384710838788,0.482571368173453,1.0,1.0,1.0,3/12,25.44%,RAC1;MSN;MTOR
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.2480026909219187,0.4727019501666443,0.9857142857142858,1.0,1.0,7/19,33.33%,ATF2;NAA50;MORF4L1;CREBBP;PHF20L1;KAT6A;EP300
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.28854127617772785,-0.47254736665783403,1.0,1.0,1.0,2/6,18.03%,SPG11;RAB27A
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.31451199758768683,0.4709241423394981,1.0,1.0,1.0,3/5,29.93%,PIK3CB;CD63;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.2941529619257711,0.46904696989787487,0.96875,1.0,1.0,3/6,33.25%,SH3KBP1;CYRIB;PRKDC
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),-0.2597817407505989,-0.46528450269479193,1.0,1.0,1.0,8/8,74.10%,USP6NL;AKAP9;STX18;ARMH3;PDCD10;MAPK1;CAMSAP2;MAP2K1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.26848235253621877,0.46514000621437773,1.0,1.0,1.0,4/14,27.94%,BACE2;DAG1;ADAM9;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.25377577764685033,-0.4644795310779436,0.9714285714285714,1.0,1.0,1/10,6.43%,ELAPOR2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.2806977130591789,0.46205121248698006,0.9850746268656716,1.0,1.0,4/6,37.66%,DNAJC13;MAP2K1;USP7;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.27528831135426046,0.46025742991722146,0.9726027397260274,1.0,1.0,3/10,34.58%,MTOR;RGCC;MTPN
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.26437699680511184,-0.4594231684375874,1.0,1.0,1.0,9/9,73.65%,MDM4;PRKAA1;PDE3B;NCOR1;HDAC4;SNX3;IRAK3;CST3;EGFR
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.29563662706361743,0.4576311088940157,0.9705882352941176,1.0,1.0,3/7,31.45%,FLT1;FGR;PTK2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.2958784040494449,0.45622372572762737,1.0,1.0,1.0,3/6,40.35%,ELK4;HDAC9;SFPQ
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.24664490053450752,-0.4514978351469902,1.0,1.0,1.0,2/9,14.98%,BST2;MAP3K2
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.25673593604313383,0.44959269891293596,1.0,1.0,1.0,2/17,17.00%,AGO2;TPR
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.25673593604313383,0.44959269891293596,1.0,1.0,1.0,2/17,17.00%,AGO2;TPR
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.2551999537527757,0.44650563690194417,1.0,1.0,1.0,3/14,23.43%,ABL2;YWHAB;PHACTR4
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.2878150991146759,0.4437424883102697,1.0,1.0,1.0,2/7,29.40%,DAG1;RGCC
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.27573438663667205,0.4436988400978872,1.0,1.0,1.0,2/9,26.06%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.27836735367287935,0.43621229365137903,1.0,0.999258344230229,1.0,2/8,26.06%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.27836735367287935,0.43621229365137903,1.0,0.999258344230229,1.0,2/8,26.06%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.27836735367287935,0.43621229365137903,1.0,0.999258344230229,1.0,2/8,26.06%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.27836735367287935,0.43621229365137903,1.0,0.999258344230229,1.0,2/8,26.06%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.27993053302918347,-0.43426918021741123,1.0,1.0,1.0,2/5,20.88%,HSPD1;MAPK14
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.2798616653365257,-0.43294972399947956,1.0,0.998720404430327,1.0,6/6,72.08%,OPA1;GIMAP7;LRRK2;MFN1;AK3;GNAI3
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.2798616653365257,-0.43294972399947956,1.0,0.998720404430327,1.0,6/6,72.08%,OPA1;GIMAP7;LRRK2;MFN1;AK3;GNAI3
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),0.23669184771326898,0.42884371961531104,1.0,0.9995144341180415,1.0,4/12,32.99%,CDKN1A;TERF2IP;KMT2A;ACVRL1
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.25153047644397125,-0.4236519279218434,1.0,0.9983348267539959,1.0,8/8,74.93%,ATXN7;UIMC1;TRRAP;SUPT3H;USP3;USP15;USP7;USP22
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.2857972470900836,-0.4034266229533688,1.0,0.9984774843356562,1.0,2/5,15.54%,MDM2;UBB
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.2381484269881223,0.4006001813553472,1.0,1.0,1.0,2/13,21.09%,TF;DNM2
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.2630143404078286,0.39983920722394845,1.0,1.0,1.0,2/10,23.03%,DMD;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.24416573701479535,0.3862561167055631,1.0,1.0,1.0,3/8,32.48%,PPP1R10;USP22;CUL3
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.2376515838796144,0.380717800507237,1.0,1.0,1.0,2/11,26.06%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),0.25328385777221774,0.3791236188800775,1.0,0.9993714180070253,1.0,3/5,41.59%,TERF2IP;POLR2B;POT1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),0.25328385777221774,0.3791236188800775,1.0,0.9993714180070253,1.0,3/5,41.59%,TERF2IP;POLR2B;POT1
